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The efforts of most human-beings are consumed in the struggle for their daily 
bread, but most of those who are, either through fortune or some special gift, 
relieved of this struggle are largely absorbed in further improving their worldly lot.  
Beneath the effort directed toward the accumulation of worldly goods lies all too 
frequently the illusion that this is the  most substantial and desirable end to be 
achieved; but there is, fortunately, a minority composed of those who recognize 
early in their lives that the most beautiful and satisfying experiences open to 
humankind are not derived from the outside, but are bound up with the 
development of the individual's own feeling, thinking and acting.  
The genuine artists, investigators and thinkers have always been persons of this 
kind. However inconspicuously the life of these individuals runs its course, none the 
less the fruits of their endeavors are the most valuable contributions which one 
generation can make to its successors…. 
-Albert Einstein in Emmy Noether’s obituary (1935)1 
 
 
 
 
 
 
 
           To my family and mentors 
i 
 
Preface: 
This thesis has been submitted as a partial fulfillment of the requirements for obtaining 
a Ph.D. degree from the Technical University of Denmark (DTU). The research for the 
Ph.D. project was conducted at DTU-Nanotech, Department of Micro and 
Nanotechnology, from January 2007 to December 2010.  
This project was supervised by Associate Professor Winnie Svendsen, group leader of 
the Nano-Bio Integrated Systems (NaBIS) group in the Self-Organizing Materials for 
Nanotechnology (NanoSOM) section. The project was co-supervised by Associate 
Professor, Fridolin Okkels group leader of the Theoretical Microsystems Optimizations 
Group and Assistant Professor Maria Dimaki from NaBIS group. 
The project formed an integral part of the Chromosome Total Analysis project (c-tas) 
funded by research grants from FTP and Lundbeck along with 3 other Ph.D. projects. 
The overall aim of the C-TAS project was to create a total analysis system to identify 
translocations in patient samples. This research was conducted in close collaboration 
with Prof. Niels Tommerup and Asso. Prof. Asli Silahtaroglu from the Wilhelm 
Johanssen Centre of Functional Genomics at The Panum Institute and Prof. Zeynep 
Tumer from the Kennedy Institute.  
Mid-way through the project, I had an opportunity to spend 6 months in US as a 
Kauffman Global Scholar and observe some of the pioneers of ‘User-driven innovation’ 
- focusing on the imminent needs of the end-users. This immerse program allowed me 
to interact these thought leaders  at MIT (Sloan Business school, Media Labs, D-labs),  
Olin College of Engineering (Prof. Lynn Stein), Harvard (Whitesides group, Diagnostics 
for All), Stanford University (Biodesign Program), IDEO, among many others and 
followed by an internship at DEKA Research and Development, arguably one of the 
most innovative companies around. This experience changed my attitude towards 
research and to a greater extent even challenged the views I had adhered to in my 
earlier work. They pushed me to focus more on ‘what is needed’ than ‘what is possible’. 
The difference between ‘invention’ and ‘innovation’ were crystal clear in my head. In 
line with DEKA’s guiding motto “FAIL FAST AND SUCCEED SOONER”, I focused 
more on the result driven development track than lingering on dead ends or delaying 
issues.  
As a result, apart from the work included in this thesis, the project has also been 
instrumental in discovering a number of inventions which are currently under patent 
review and hence could not be included in this thesis due to confidentiality issues. A 
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chapter describing these inventions briefly has been appended to the thesis. Papers not 
included in the description of the thesis have been put in a separate appendix. 
In general, this thesis applies to readers with prior knowledge in micro and 
nanofabrication, simulations, microfluidic theory and some basic genetic and biological 
analysis experience. As this project was a multidisciplinary endeavor, there is a hope 
that biologists as well as geneticists will find it informative. Major emphasis of this 
work was on optimization of the current microfluidic toolkit to enable rapid integration 
and development of various existing and developed microfluidic platforms into 
commercially viable and readily deployable cytogenetic solutions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kgs. Lyngby 2800 
Pranjul Shah 
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Abstract: 
The field of microfluidics faces significant challenges in order to achieve wide-spread 
usage of microfluidic devices. Among the biggest challenges, there is an imminent need 
to develop microfluidic systems which are reliable, robust, user-friendly, 
reconfigurable, versatile, flexible, possibly automated, disposable, low cost and above 
all solving real problems.  
Taking microfluidics and miniaturized analytical systems a step further, this thesis is 
focused on achieving the vision of a chromosome total analysis system (C-TAS). The 
aim of this thesis was to develop a µtas system with functional integration to enable it to 
analyze chromosomes for possible chromosomal rearrangements called translocations. 
To realize such a C-TAS, the key challenge is to integrate various pre-processing steps 
(cell culture, cell lysis, chromosome extraction, chromosome isolation and waste 
manipulation) and finally the analysis (FISH) on a single chip. Hence, the biggest 
motivating factor for this research was the fact that we could power a chip to analyze 
rapidly and effectively human chromosomes and screen them for any possible 
translocations. This could prove to be a big leap forward in the field of cytogenetics and 
clinical diagnostics.  
In the beginning of the project, the focus was on developing a modular microfluidic 
platform for integrated sample handling and analysis, but later the focal point was 
shifted on realizing integrated solutions to lessen the complexities of existing protocols. 
In the course of the project, a first substrate independent versatile microfluidic 
motherboard was developed allowing easy interfacing of microfluidic modules via plug 
and play functionality. The integrated fluidic and electrical network in the motherboard 
provided users with substrate and design independence at the expense of size and 
position of fluidic and electrical interconnections. Our attempts to adapt the modular 
motherboard into C-TAS system provided significant insights into the existing work 
routines of the central labs. This lead to the transition of development efforts from the 
‘modular approach’ towards a more ‘integrated approach’. 
In an effort to tackle challenges with respect to identification of unknown chromosomal 
translocations, this thesis focused on developing a novel toolkit of miniaturized devices 
providing the features of cell culture, slide preparation and Fluorescence In-Situ 
Hybridization (FISH) analysis.  
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The key objectives included: 
• Development of a novel approach for culture of non-adherent cells such as 
peripheral T-lymphocytes.  
• Integration of a slide preparation protocol with the cell culture device, leading to 
a minimal handling device for sample pretreatment and slide preparation.  
• To complete the puzzle, the first miniaturized protocol for performing 
metaphase FISH analysis on chip was developed.  
• A novel FISH cartridge was developed to automate the FISH analysis and create 
a minimal handling integrated device for metaphase FISH analysis.  
• Finally, a strategy to integrate the new toolkit into a C-TAS was devised as a step 
towards development of a clinically viable system ready for deployment in 
genetic labs. 
Together with the development of the C-TAS, many efforts have been put into solving 
practical issues hampering progress of microfluidic technologies into commercial and 
clinical applications. Novel interconnection techniques were invented for rapidly 
interfacing microfluidic devices with the macro world. In brief: 
• The plug and play socket based approach was developed for the interfacing of 
various modules with the modular motherboard.  
• Spring actuated interconnections were developed to create the first self-actuated 
self-sealing microfluidic interconnect technology providing multiple, parallel, 
reusable, aligned and bonding-free interconnections demonstrated in both planar 
as well as vertical formats [Patent pending]. 
• Quickfix interconnects for adhocly attachable fluidic connections were devised in 
an attempt to create ultra low cost, reusable interconnects for easy interfacing 
with microfluidic devices [Patent – in process]. 
• Novel O-rings with functional scaffolds for microfluidic devices for neuronal and 
cell culture applications [Patent – in process]. 
Clinical validation and testing of applicability of the presented systems in relevant areas 
is currently underway through collaborators. The focus in the near future will be 
towards wide scale clinical implementation of this microfluidic toolbox. 
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Abstract in Danish: 
Microfluidics-feltet står overfor omfattende udfordringer for at opnå udbredt brug af 
mikrofluidiske devices. Blandt de største udfordringer er et presserende behov for 
udvikling af mikrofluidiske systemer som er pålidelige, robuste, brugervenlige, 
rekonfigurerbar, alsidige, fleksible, muligvis automatiserede, beregnede til engangs-brug, 
billige og frem for alt i stand til at afhjælpe faktiske problemer. 
Denne afhandling tager mikrofluidiske og miniaturiserede analytiske systemer ét skridt 
videre, idet fokus er opnåelsen af visionen om et kromosom total analyse system (C-TAS) 
[www.c-tas.dk]. Målet for projektet var udviklingen af et µtas system med funktionel 
integration der skulle gøre det i stand til at analysere kromosomer for mulige kromosom 
omlejringer som kaldes translokationer. For at opnå et sådan kromosom total analyse system, 
er den væsentligste udfordring integrationen af forskellige forbehandlingstrin 
(celledyrkning, celle lysis, kromosom udvinding, kromosom isolation og behandling af 
spildprodukter) og selve analysen (FISH) på en enkelt chip. Derfor har den væsentligste 
motivation for dette forskningsarbejde været ønsket om at gøre en chip i stand til 
hurtigt og effektivt at analysere menneskelige kromosomer, og screene dem for samtlige 
mulige translokationer. Dette ville kunne betyde et stort spring fremad indenfor feltete 
cytogenetik og kliniske diagnostik.   
I begyndelsen af projektet fokuseredes på udvikling af en modulopbygget mikrofludisk 
platform til integreret prøvehåndtering og –analyse, men senere rettedes fokus mod 
opnåelse af integrerede løsninger med henblik på reduktion af kompleksiteten i 
eksisterende protokoller. I løbet af projektet udvikledes et første substrat-uafhængigt, 
alsidigt mikrofluidisk motherboard som muliggør let tilkobling af mikrofluidiske moduler 
via plug-and-play funktionalitet. Det integrerede fluidisk og elektriske netværk i 
motherboard’et gav brugeren uafhængighed af substrat og design på bekostning af 
fastlåste størrelser og positioner for de fluidiske og elektriske forbindelser. Vores forsøg 
på at tilpasse dette modulære motherboard i C-TAS gav væsentlig indsigt i de 
arbejdsrutiner, som pt er etableret i centrallaboratorierne. Dette førte til at 
udviklingsindsatsen flyttedes fra en ”modulær tilgang” hen mod en mere ”integreret 
tilgang”. 
I et forsøg på at tackle udfordringerne vedrørende identifikation af ukendte kromosom 
translokationer, har projektet fokuseret på udvikling af et nyt sæt af redskaber bestående 
af miniaturiserede devices med funktioner der omfatter celledyrkning, objektglas klargøring 
og Fluorescence In-Situ Hybridization [FISH] analyse. 
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• Udvikling af en ny tilgang til kultur af ikke-klæbende celler såsom perifere T-
lymfocytter. 
• Integration af et objektglas klargøringsprotokol med cellekultursenheden, hvilket 
fører til en minimal håndteringsenhed for prøve forbehandling og 
objektglasklargøring. 
• Til at færdiggøre puslespillet, var den første miniaturiserede protokol for 
udførelse af metafase FISH analyse på chip udviklet. 
• En ny FISH patron blev udviklet for at automatisere FISH analyse og skabe en 
minimal håndterings integreret enhed for metafase FISH analyse. 
• Endelig en strategi for at integrere den nye værktæjskasse med C-TAS-systemet 
blev udtænkt, som vil resultere i en klinisk bæredygtigt system klar til 
indsættelse i genetiske laboratorier. 
Sammen med udviklingen af C-TAS, har vi også bestræbet os på at løse praktiske 
problemer, som hindrer fremskridt af teknologien mod kommercielle og kliniske 
anvendelser. Nye sammenkoblingsteknikker blev opfundet for hurtigt at kunne koble 
mikrofluidiske systemer med makro-verdenen. Kort sagt: 
• Plug and play stik blev udviklet til at koble forskellige moduler med 
motherboardet. 
• Sammenkoblinger baseret på fjeder-princippet blev udviklet til at skabe den 
første selvaktiverede og selvlukkende sammenkoblingsteknologi, der giver flere 
parallelle, genanvendelige, afrettede og limningsfrie sammenkoblinger. Dette er 
blevet demonstreret i både plane såvel som vertikale formater [Patentanmeldt]. 
• QuickFix sammenkoblinger til ad-hoc fluidiske forbindelser er blevet udviklet i 
et forsøg på at skabe billige, genanvendelige sammenkoblinger for nemme 
forbindelser med mikrofluidiske systemer [Patent - i processen]. 
• Nye O-ringe med funktionelle platformer for neuron- og cellekultur anvendelser 
[Patent - i processen]. 
 
Klinisk validering og afprøvning af anvendeligheden af de forelagte ordninger inden 
for de relevante områder er i øjeblikket i gang gennem samarbejdspartnere. I den 
nærmeste fremtid vil vi rette fokus mod den kliniske afprøvning af denne 
mikrofluidiske værktøjskasse. 
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CHAPTER  
INTRODUCTION 
 
While looking at the phenomenal progress that 
microfluidic technology has made in making 
inroads to various scientific disciplines, this 
chapter also introduces the background to the 
experimental work described further in this thesis 
which mainly concerns the development of a novel 
microfluidic toolkit for on-chip FISH analysis. 
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1.1 Microfluidics: The journey 
Microfluidics is an area of microfabrication that currently mainly focuses on the 
miniaturization of fluid-handling systems. For nearly two decades, microfluidics continued to 
be a part of the MEMS revolution and was initially considered a mere added functionality on 
integrated MEMS called ‘BioMEMS’. Incidentally, all throughout the 80’s, microfluidic 
development was mostly only focused on adding functionality to MEMS based Si devices. It 
was not until the early 90s, that microfluidics started to emerge as a major research direction. 
Only after Manz et al. coined the term ‘µTAS’, when they published their theoretical work on 
what they called “Miniaturised total chemical analysis system” in 1990, microfluidics and 
miniaturized analytical systems started to gain emphasis [1, 2]. In coming years, due to 
increasing funding support from DARPA, the term “Lab on Chip” was coined to include the 
efforts made towards miniaturizing lengthy laboratory protocols in miniaturized devices[3]. 
While the concept of a micro-total analysis systems (μTAS) and Lab on Chip (LOC), where 
sample transport and manipulation (including mixing, reaction, separation, and 
manipulation of chemicals and particles) take place on a miniaturized scale, has only recently 
caught interest, the underlying idea of shrinking chemical and biological analyses and 
reactions dates back to 1959. Richard Feynman professed the potential of miniaturization in 
the physical sciences in his now celebrated lecture “There is plenty of room at the bottom” [4]. 
Two decades later, Stephen Terry and co-workers fabricated and tested a gas chromatograph 
on a planar silicon wafer in what was the first ever publication of an integrated microfluidic 
gas chromatograph [5]. That was soon followed by IBM Inkjet Printer in 1979 [6-8], integrated 
miniaturized microconduits system for flow injection analysis in 1983 [9-11] and fluid 
dynamics study for miniaturized flow injection analysis in 1986 [12, 13].  
Much of this work went unnoticed and it was only after the publication of the conceptual μ-
TAS paper that there was an explosion of developments and discoveries in microfluidics[1]. 
Manz et al. suggested extending MEMS technologies to biology and chemistry [1, 2]. Another 
major event at the same time was the shifting focus of the microfluidics community from 
silicon to polymer based devices. Emergence of soft lithographic principles based on 
primarily PDMS material was instrumental in moving the fabrication process out of the 
cleanroom to lab benches [14-18]. This was a welcome change for chemists & biologists and 
this began to attract people from diverse fields to microfluidics and its possible applications, 
which continue even today. 
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Today, biological applications of microfluidic research seem to be the most promising 
commercially. The explosion of publications, patents and startups catering for in vitro and 
point of care diagnostics, drug discovery, high throughput screening, sequencing, among 
many others profess a promising journey ahead for biomicrofluidics [19-31]. The ability to 
devise systems at scales mimicking the natural habitat of cells is a fascinating pathway 
microfluidics has brought us to. 
Recently, microfluidics has been instrumental in first demonstrations of micro-scale systems 
capable of manipulating, organizing and handling single cells precisely [32-36]. The ability to 
probe cells and control their microenvironment in microfluidic systems has provided better 
tools for attempting to understand the complexities of nature. Since DNA was discovered, 
man has been accumulating vast amount of data through explorations in genomics, 
proteomics, biology, protein chemistry, etc in a quest to understand nature better. Until 
microfluidics, the toolkit for probing cells continued to be manual, semi-automated, low 
throughput and expensive for studying complex phenomena occurring at cellular 
dimensions.  
During the last decade, microfluidics has reaped the benefits of the miniaturization drive and 
has rolled out integrated analytical systems which are scaled down versions of the standard 
analytical systems found in central labs.  These systems are equipped with sampling, pre-
processing, analysis and detection units which function impeccably with the help of micro-
sized pumps, valves, mixers and reservoirs, and perform the same analytical operations with 
comparable and often better sensitivity and much higher throughputs than lab based 
equipments [37-40]. 
Where to next? 
Successful demonstrations of countless applications of microfluidic based technologies have 
flooded the literature [41] and patents space [42, 43]. But most of these attempts have ended 
up being mere toolkits for research and have failed to enter the commercial space. As a result, 
the public visibility of microfluidics based products is still very low [44, 45]. Hence, there is a 
constantly growing segment in the clinical user’s community and venture capital industry, 
who are starting to feel that microfluidics technology will only remain a toy for research and 
fail to cross the “Valley of Death” [46]. Of course there have been exceptions to this, but they 
have mostly been with respect to platforms developed for performing microfluidic unit 
operations mostly helpful in research space and not with actual end-user products [44, 45]. 
Today, most of the revenue in the field of microfluidic lab on chip systems continues to come 
from business-to-business trade and not from business-to-consumer space [19].  
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Microfluidics has shown promising potential for a wide range of applications in the field of 
genetics, genomics, proteomics, cell biology, biomedical analysis, chemical analysis, high 
throughput screening, drug discovery, polymer spinning, among countless others [38, 39]. 
But the significant lag in the commercialization of these applications has now become a cause 
for concern [47]. Microfluidics has been facing great hurdles in commercializing the 
university research demonstrators and turning them into end-user products partly due to 
high initial investments and high fabrication costs, but mostly due to the technology itself 
being immature and not ready to compete with the advance liquid handling platforms which  
continue to be the industry standard [48]. The hype generated around microfluidic 
technology and its potential applications is slowly starting to wither with the complexities of 
enabling and mainstreaming such systems becoming rapidly apparent. This is the classic 
pattern following the “Gartner Hype Cycle” and the first wave of microfluidic hype has 
seemed to pass over the research and microfluidic industry and in due time we will ride yet 
another wave, but hopefully this time with subtle moderation with the established 
benchmarks of commercial viability and applicability [47, 49].  
But the recent down path (failure of multiple startups to kick off and their subsequent 
folding) has clearly opened some eyes and in microfluidic circles, the need for redefining the 
development strategies is becoming increasingly evident [50]. Simultaneously there is a 
significant push for aligning future development efforts with the end-user expectations [51, 
52]. Nevertheless, microfluidics revolution is here to stay for a long time [19]. In years to come 
it will change the fundamental way of performing fluid-based analysis. But significant 
hurdles remain before microfluidic technologies and applications can be mainstreamed into 
commercial end-user products. Firstly, there is a need to standardize and thereby reduce the 
costs and time associated with development of microfluidic systems. But most importantly, 
the quest should be to solve the inherent issues [practicality, interoperability, compatibility 
with other analytical systems] with microfluidics deterring wide adoption and deployment of 
microfluidic technologies into the world outside research labs. 
This thesis forms a part of such translational efforts aiming to bridge the gaps between the 
microfluidic research and development at typical microfluidic labs like the one at DTU-
Nanotech and the targeted users. This work originated from a research project targeted at 
developing a lab-on-chip system for detection of chromosomal translocations. Using this 
research project as a starting point and a typical case, this thesis aims to highlight the 
underlying issues with the current microfluidic development efforts when aiming to solve 
other similar biological conundrums. In an effort to push research closer to expectations of 
the end-users, this thesis presents a novel microfluidic toolkit aiming to highlight and tackle 
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some critical challenges ahead for the microfluidic community which are currently delaying 
the wide scale adoption of microfluidics into clinical and industrial space.  
1.2 Incompatible domains: 
Microfluidics is in numerous ways unifying worlds. People from various backgrounds and 
disciplines are trying to work together in order to solve problems inherently spanning across 
multiple sciences. Microfluidics has now become the underlying enabling technology which 
has now sprawled into countless fields of applications. While microfluidics seems very 
compatible and readily amenable to accommodate complex problems in various fields, the 
practical issues concerning using microfluidics technologies widely and adopting 
microfluidics- based solutions in daily routines is in fact not that simple.   
Researchers (biologists, chemists, environmental researchers, toxicologists, etc) unanimously 
agree that they see potential in miniaturizing their current experimental setups and use 
microfluidics to provide them numerous benefits by reducing reagent costs, sample volumes, 
analysis time and providing them higher throughput. This simple realization has attracted 
scores of researchers to attempt blending their research domains with microfluidics. Without 
any doubt, it is indeed a fascinating technology with huge potential and it’s a great 
opportunity to do things very differently than they are done currently in many fields.  
But then why hasn’t the potential of this technology materialized? A critical look at the 
current microfluidic research activities can show why the potential of this technology has not 
been materialized. 
• The quest of a killer application 
While the quest for a killer application continues, researchers continue to push and 
extend the boundaries of microfluidics technologies every day [52]. Papers depicting 
numerous versions of similar or slightly varying devices providing applications in cell 
biology, PCR, cell trapping, chemical analysis, genomics, gradient analysis, etc among 
others have sprawled the microfluidic literature space [42]. But the inherent lack of 
these devices to transcend the boundaries laid by end-users on counts of applicability, 
usability and viability has indeed moved us away from the actually path of discovery 
of the killer application. 
 
 
Evoluting microfluidics: Moving toward clinical applications 
 
6   
 
 
• Lack of standardization 
The mammoth task of replacing the petri dishes and titer plates in clinical labs cannot 
be accomplished if the newer microfluidic formats do not interface with the rest of the 
clinical equipments. The need for standardizing size and material of microfluidic 
devices has been continually ignored and has significantly affected the onset of 
adoption of microfluidic based clinical devices [51]. There has been an increased 
demand for standardizing the development efforts synonymous to the standards 
adopted by the semiconductor industry earlier on leading to the phenomenal success 
of the semiconductor industry. 
• Lack of direction 
Identifying the real needs of the end-users which demand a microfluidic solution is a 
first step in mainstreaming microfluidics. In many cases, development efforts are 
directed at miniaturizing existing lab scale setups into micro-sized devices. The 
process of identification of actual user needs is often ignored in lieu of benefits 
microfluidics will provide them in cost, time, sensitivity, etc. Hence, most attempts at 
creating miniaturized microfluidic versions of existing protocols fail miserably to 
account for existing work routines, interfacing to rest of the clinical environment, end-
user ability and most importantly to provide any real incentive with can justify 
changing to microfluidic based devices. But the problem is in the assessment of needs 
and verifying applicability of targeted solutions[50]. It is equally important to match 
expectation of the end-user in terms of functionality, simplicity, ease of handling and 
adaptability to their existing daily routine[53].  
 
 
 
 
 
 
Microfluidics is not a miniaturization exercise.. don’t make it one! 
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1.3 Need for a new approach: The road ahead 
This PhD project was part of a larger research project titled “Chromosome Total Analysis 
System” which aimed to detect chromosomal translocations or alterations on a lab-on-chip 
setup. The vision was to create a modular microfluidic system capable of handling various 
sequential steps of the Fluorescence In-Situ Hybridization protocol [Fig. 1.1], which will be 
described in detail in chapter 2. 
 
Figure 1.1: The modular C-TAS system 
Researchers for many years have focused on developing microfluidic platforms to replace the 
classical fluid-handling platforms [pipetting robots].  The goal has generally been to benefit 
from miniaturization and provide to end-users the benefits that typically are proclaimed for 
microfluidics based systems [Fig 1.2].  
 
Figure 1.2: Typical goals for microfluidic platforms development 
But if these goals were accurate, all microfluidic device manufacturers would be selling 
platforms but as the case is currently most revenue for microfluidic companies comes from 
chip based sales. And as it also appears the emerging formats in microfluidics industry for 
high throughput devices are also geared towards making use of existing analysis and fluid 
handling setups i.e. devices in titer plate formats [45].  
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Hence, there is clearly a difference in the market expectation and the research direction. These 
widely proclaimed expectations have been benchmarked into every microfluidic researcher’s 
mind and this project started with the same goals to build a microfluidic platform to allow 
integration and seamless functionality of various modular units for performing a biological 
analysis.  
Coming back to the C-TAS project, our challenge was to build a motherboard to allow for 
sample preparation (cell isolation, cell capture, cell culture, fixation, chromosome extraction) 
and subsequent analysis of a patient sample for possible translocations. A group of PhD 
students with multi-disciplinary backgrounds were put together and assigned the following 
projects based on the vision of C-TAS system [Fig. 1.1]. 
Project 1: Isolation of chromosomes from whole blood 
Project 2: Sorting of chromosomes 
Project 3: Fluorescence In-Situ Hybridization 
Project 4: Integration into a C-TAS system 
As generally happens, a miniaturizing exercise was initiated and the projects went through a 
phase targeted at imitating the standard traditional lab protocols in their miniaturized 
microfluidic versions. After many design iterations and couple of years, the result was a 
modular microfluidic motherboard with integrated fluidic and electrical connections, which 
interfaced with a cell culture chip, a dielectrophoresis (DEP) based chromosome sorting 
device and a FISH on chip module [Fig. 1.3]. This research or rather re-search endeavor 
encompassing 8 man-years of work was met with skepticism and general criticism with 
respect to the complexity of the handling protocol and difficulties in terms of integrating the 
microfluidic motherboard in clinical settings. The consensus was that it would not only be 
difficult to integrate such a platform in existing work routines at central labs, but will also be 
almost impossible to train technicians to shift to the new protocol. Unless fully automated, we 
concluded that our platform was not feasible for implementation in clinical labs. 
These complexities stemmed from the fact that the project had clearly focused more on the 
descriptions of existing protocols and not on end-users needs. We had succeeded in our 
project requirements, but failed to breach the most common barrier hurting wide-scale 
microfluidic adoption – change. The biggest difficulty for microfluidics in breaching the 
barriers of medical devices and diagnostics markets is unwillingness and inflexibility of end-
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users to adopt newer technologies which don’t comply with existing work routines and 
protocols.  
At this stage, the end-users were put into the equation and attempts were made to bridge the 
gap in our knowledge of the existing work routines in the labs and identifying the real needs 
of the intended end-users. It was simply an eye opening experience. And it became apparent 
that too much focus on miniaturization had led us to a mere microfluidic version of the 
current solution. While the resultant solution did reduce volume of reagents, analytes, costs 
per test, among others, but the real challenge in central labs was not just the time of analysis 
and cost of the reagents. The fact that the manual protocol kept the technicians occupied for 4 
days was a greater issue than the expenses and time related to the tests. Hence, we had 
clearly missed the need to first optimize and possibly minimize the handling time of the 
protocol by some level of automation, even before attempting to miniaturize the protocol.  
 
Figure 1.3: Modular microfluidic motherboard with 3 sockets for C-TAS modules. The pictures show meandering channel 
for the integrated mixer and circular rotors for fluid valving. 
Identifying actual user needs is a process of interacting with the end-user, observing their 
work routines, probing details of every step of the existing protocols to figure out minor and 
often hidden details ignored on protocol descriptions. This exercise gives you a better 
understanding of finding the right balance between what is microfluidically possible and 
figuring out what is actually needed in terms of development to push applications and 
products based on microfluidic technologies into commercial space. Following such a needs 
definition exercise for the C-TAS project, it was discovered that while above goals are 
partially correct and applicable to few applications [Fig. 1.2], but there was an urgent need to 
tailor the future microfluidic development efforts towards: 
Evoluting microfluidics: Moving toward clinical applications 
 
10   
 
 
• Portability (as point-of-care assays are touted to be the biggest market segment for 
microfluidic applications [19]),  
• New techniques for efficient sample preparation, separation and analysis 
• Low cost high volume production 
• Automation (with reagents and sample handling providing sensitivity matching the 
industry standards or better) 
• User-friendliness (in comparison to the ability of targeted end-user, in our case a 
regular lab technician working in central lab).  
• The creation of a library of compatible materials and their properties and their 
compatibility with various cell types (and preferably force suppliers to adhere to the 
standards as materials routinely vary from batch to batch) 
• A fixed standard size for future devices (based on standardized toolkit of methods 
for fabrication of devices) analogous to standards that were created for the 
semiconductor industry [51, 54]  
This revelation also opened new venues and project ideas for individual C-TAS projects 
which lead to a new roadmap and project goals for designing the C-TAS system. In close 
collaboration with technicians at our collaborating clinical labs, we designed a new strategy 
and goals for the C-TAS system to make it: 
• Simple and easy to handle 
• Integrated 
• Possibly automated or needing minimal handling (self sufficient) 
• Compatible with existing equipment (slide-sized) 
• Needing minimal change in existing work routines. 
While developing the C-TAS system with above goals was the core focus of this project, the 
need for a flexible microfluidic toolkit which solves the practical issues and concerns of end-
users in widely adopting microfluidic technologies had became very apparent. As a result, lot 
of attention was allocated to practical issues like bubble traps, interconnections, bonding and 
assembling techniques, among others to add flexibility and versatility to the microfluidic 
toolkit. Multiple inventions providing novel solutions for critical microfluidic applications 
have been discovered during this project, which has resulted in numerous patents which are 
described in Chapter 6. 
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1.4 A step in the right direction: New objectives and 
end-goals 
Understanding the end-user’s current challenges not only helped us redefine our end-goals 
but also made more sense of our earlier blunders. Observing the technicians in action 
provided us greater insights into the existing standard protocols and related minutiae which 
play a big role in the technician’s final choice of technique. The modular schema of the C-TAS 
protocol complicated the existing work routines and also created additional technical 
challenges in form of needs for integrating new functionality. [For e.g. cell trapping, cell 
sorting, need for concentration of cells due to dilution, among others – see Chapter 2].  
Hence, the following new project objectives based on a step-by-step approach leading to a 
simple integrated solution for performing FISH on chip were adopted.  
• To design a sample preparation module to perform cell culture, arrest and fixation of 
blood sample, which can later be integrated with a FISH module [Paper 1].  
• To realize a separate approach for splashing based spreading of metaphase 
chromosomes [Paper 2].  
• To demonstrate a novel protocol for performing FISH on a chip [Paper 3]. 
• Finally, to merge the sample preparation, spreading device and the FISH chip into a 
monolithic integrated FISH device with minimal handling, providing the possibility 
to automate. 
All throughout this development work, the underlying goal and efforts were to provide the 
end-user with simplicity and ease of handling matching and in-line with their existing work 
routines. We hope that someday the results of these efforts will be welcomed through the 
doors of clinical labs. As the majority of experiments in this thesis are directed towards 
advancing of traditional cytogenetic techniques, the next section will describe the standard 
cytogenetic techniques with the present state of the art which is in the process of being 
redefined by the work presented further in this thesis. 
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1.5 Advanced microtechnologies for detection of 
chromosome abnormalities1 
Dorota Kwasny, Indumathi Vedarethinam, Pranjul Shah, Maria Dimaki, Asli Silahtaroglu, 
Zeynep Tumer, Winnie E. Svendsen 
The overall goal of cytogenetic analysis is to detect chromosome abnormalities in patient 
samples. This analysis is a standard procedure for prenatal as well as postnatal diagnosis and 
cancer detection. Cytogenetic techniques such as karyotyping by banding have been for the 
last years complemented by molecular cytogenetic techniques such as fluorescent in situ 
hybridization (FISH). FISH is recently evolving towards on chip detection of chromosome 
abnormalities with the development of microsystems for FISH analysis. The challenges 
addressed by the developed microsystems are mainly the automation of the assay 
performance, reduction in probe volume, as well as reduction of assay time. The recent focus 
on the development of automated systems for performing FISH on chip is summarized in this 
review. 
Keywords: Fluorescent in situ hybridization, FISH on chip, microsystems, cytogenetic analysis 
Introduction  
 
Conventional methods for disease diagnosis are based on analysis of cells, biochemical 
pathways, and infectious agents. Chromosome studies provide cytogenetists with valuable 
information as chromosome disorders are a major category of genetic disease [55]. The 
incidence of chromosome abnormalities in live births is around 0.7 % [56]. Specific 
chromosome abnormalities are responsible for more than 100 identifiable syndromes, thus an 
understanding of cytogenetics and chromosome disorders is important [55]. The rapidly 
growing field of biomedicine focuses on detecting the genetic causes of diseases by means of 
molecular diagnostics. This involves studying of DNA and RNA as diagnostic targets. 
Cytogenetics is a study that concentrates on cell analysis with special focus on chromosomes. 
The conventional cytogenetic analysis known as chromosome analysis or karyotyping is 
based on the analysis of metaphase chromosomes through banding techniques and 
microscopy. The typical resolution is in the range of 5 – 10 megabases and depends on the 
compaction of the chromosome and number of bands. Karyotyping is still a gold standard for 
                                                            
1 Excerpt of an Invited review: Submitted to BioEssays. This section will introduce the basic cytogenetic techniques setting 
the premises for the rest of the thesis.  
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cytogenetics; however, new technologies have been developed to improve the resolution 
power of chromosome abnormalities detection. One of the mostly used techniques in 
molecular cytogenetics is fluorescence in situ hybridization, which has been a bridge between 
cytogenetics and molecular genetics. Even though preparation of FISH analysis is laborious it 
has grown in popularity in cytogenetic laboratories all over the world. However, to make the 
analysis a more standard procedure in genetic diagnostics some efforts need to be done to 
automate the protocol. Nowadays researchers focus on the development of integrated, 
miniaturized systems for more sensitive and rapid analysis of biological samples at low cost. 
Recently some efforts have been made towards fabrication of systems for analysis of 
chromosome abnormalities with the goal being a reduction of costs, sample volume, and 
hybridization time related to FISH analysis, and automation of assay. In this paper, we 
review the current state of the art of the microsystems developed for abnormalities detection. 
 
Chromosome abnormalities 
 
Chromosomes are nuclear structures composed of DNA and proteins. Their structure and 
number are highly preserved in different organisms with a typical human cell containing 46 
chromosomes. Conventional and molecular cytogenetic techniques are used to study the 
structure and number of chromosomes and to detect chromosome abnormalities [57]. A 
chromosome abnormality may be numerical or structural. Numerical abnormalities such as 
Down syndrome (three copies of chromosome 21), Turner syndrome (X chromosome 
monosomy) occur when an atypical chromosome number is present in the cell. Structural 
abnormalities can be balanced rearrangements, such as inversions or translocations; or 
unbalanced, such as deletions and duplications. Depending on the nature and size of the 
chromosome abnormality, different cytogenetic and molecular cytogenetic techniques are 
employed. Chromosome abnormalities are often associated with congenital anomalies, 
dysmorphic features, growth retardation and learning disabilities [58]. 
Furthermore, numerical chromosome abnormalities, deletions and translocations are also 
associated with cancer [59, 60]. Over the years cytogenetic analysis has become an integral 
part of genetic disorders and myeloid malignancies diagnosis. Genetic material is available in 
cell nucleus in different forms depending on the cell cycle phase. During interphase cells do 
not divide, the DNA in the form of chromatin is enclosed in a nuclear membrane with the 
chromosomes visible but not detectable as single entities [Fig. 1.4 A]. The most condensed 
and highly coiled form of DNA – metaphase chromosomes - is visible during a metaphase, 
with the chromosomes still enclosed in a nuclear membrane [Fig. 1.4 B].  
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20 cells needs to be fully analyzed to obtain reliable results [61]. A mitogenic stimulation with 
colchicine is further performed to arrest the cells in metaphase and thus increase the number 
of metaphase spreads for the analysis. After treatment with hypotonic solution, the cells are 
splashed on the glass slide with ice-cold water [Fig.1.5 D] to obtain the metaphase spreads 
[Fig.1.5 E]. The karyotyping by banding relies on staining such chromosomes fixed on a 
surface and then further analyzing these under a microscope, while FISH requires a use of 
fluorescently labeled probes [Fig. 1.5F]. FISH is based on the hybridization between two DNA 
sequences, a fluorescently labeled probe and its complementary sequence on a chromosome. 
The fluorescent microscopy visualization of a hybrid between a probe and genetic material 
reveals the presence, number and distinct location of targeted sequences [62, 63]. 
Over many years cytogenetic techniques have been evolving enabling more accurate and 
faster detection of chromosome abnormalities. Nevertheless, the conventional karyotyping by 
banding technique is still a standard procedure in cytogenetic laboratories over the world 
despite the need for trained technical staff [64-66]. Such a simple, but time-consuming 
analysis, allows for inexpensive diagnosis of numerical and structural chromosome 
aberrations at a limited resolution [67-69]. The main advantage of karyotyping by banding is 
that it is a whole genome screening technique, where the entire genome can be visualized at 
once [57]. The requirement for high quality metaphase chromosome spreads for karyotyping 
is challenging as some cells, such as solid tumor cells, cannot produce good spreads [66]. To 
overcome issues with the limited resolution of karyotyping, the requirement for dividing cell 
population and good quality metaphase spreads; a FISH technique is often used. The 
conventional banding analysis can only be carried out on metaphase chromosomes, while 
FISH may be performed both on metaphase and interphase chromosomes. Introduced over 30 
years ago, the FISH technique commenced a new era in the cytogenetic studies providing 
greater resolution than was possible with the karyotyping by banding technique [58, 64, 70, 
71]. The typical resolution obtained with FISH is in the range of 10-100 kilo bases sequences 
while karyotyping by banding has a resolution of 5-10 mega bases [64, 67, 71, 72]. FISH 
provides a simple, fast and reliable means to assess genetic instability in cancer [59, 60, 73, 
74]. Despite many advantages of performing FISH, it is not an alternative to karyotyping but 
a complementary technique. 
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Conventional FISH analysis 
For the cases involving chromosome abnormalities that need a higher resolution or analysis 
on non-dividing cells FISH is often applied. After fixing metaphase chromosomes or 
interphase nuclei to the glass slide FISH analysis starts. Firstly, chromosomes are washed, 
dehydrated through a series of alcohol washes and air-dried. A probe solution is then 
prepared by mixing it with a hybridization buffer containing formamide, salt and dextran 
sulfate [75]. After that both, the chromosomes on a glass slide and the probe solution are heat 
denatured. The probe in solution is placed immediately on ice and then applied directly to 
the slides. They are incubated overnight at 37°C in a moist chamber. After several washing 
steps to remove the unbound or nonspecifically adsorbed probe the slides are incubated in a 
dye solution (e.g. DAPI) to label the chromosomes. Stained chromosomes are visualized 
under an epifluorescent microscope with an appropriate set of filters to observe the probe 
signal and the chromosomes [76]. 
FISH complements karyotyping by banding, thus is often prepared as a second step to 
enhance diagnostic efficiency [61, 63, 77, 78]. Moreover, FISH enables identification of 
numerous microdeletions and microduplications syndromes that are not generally detectable 
by classical cytogenetics. Thus, it is often applied for cases with a visibly affected phenotype 
and apparently normal karyotype to identify otherwise undetectable chromosome 
abnormalities. Although, one of major limitations of FISH is that it can only be used to detect 
known abnormalities. It depends on a probe targeting a specific DNA sequence, e.g., to detect 
known translocations, microdeletions or specific chromosomes and hence can only be used to 
address questions for which DNA probes are available. 
FISH techniques 
One of the attractive features of FISH is that it can be performed both on metaphase spreads 
but also on interphase nuclei fixed on a glass slide providing valuable information about 
chromosome abnormalities [67, 74]. Interphase FISH has a great potential for screening large 
number of cells, as well as for examining archival samples. Interphase FISH is applicable for 
testing solid tumors as it eliminates the need for dividing cell population. It can also be 
performed very rapidly within 24 hours, as no cell culturing is required. Tumor cells often 
show numerical or structural changes in chromosomes that may provide information about 
the changes that initiated tumor formation. The analysis of metaphase chromosomes in solid 
tumors is hampered, as extensive culturing is necessary to obtain sufficient number of mitotic 
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cells, which in few cases may induce additional chromosomal changes. Furthermore, the 
metaphase spreads obtained from solid tumors have poor quality that makes their proper 
analysis troublesome [71, 79, 80]. Interphase FISH is used to identify numerical abnormalities 
as well as specific structural abnormalities, by targeting them with a specific DNA probe.  
On the other hand, metaphase chromosomes are widely used in cytogenetic analysis for 
standard karyotyping and FISH analysis. FISH can be used in metaphase cells to detect 
specific microdeletions at high resolution. It is also applicable in cases where it is troublesome 
to determine whether a chromosome has a simple deletion or is involved in some more 
complex rearrangement. Using metaphase spreads for analysis is beneficial as one can 
visualize the entire genome at once. Applying whole chromosome FISH probes, a complex 
mixture of sequences from the entire length of specific chromosomes available for all human 
chromosomes, enables detecting abnormalities at the genome level [81]. Simultaneous 
visualization of spectrally distinct fluorophores enabled the representation of different 
chromosomes with a unique fluorescent signature with a potential application to reveal 
complex structural abnormalities [57, 65, 67, 69, 74, 82, 83]. By performing such analysis we 
can obtain information about the unknown translocations between chromosomes at higher 
resolution than achievable by karyotyping by banding [74, 84-86]. However, such method 
requires specialized computer software, expensive equipment, and complex analysis by 
skilled technicians that can interpret the obtained data [57]. Moreover, limited use of FISH is 
also attributed to the high cost of FISH probes necessary to detect the chromosome 
abnormalities. 
Generally speaking, FISH techniques are utterly useful for the confirmation of chromosome 
abnormalities suspected based on previous findings, with the use of specific DNA probes. Its 
main advantage lies in the analysis that can be performed on both interphase and metaphase 
chromosomes depending on the specific disorder to be detected. Interphase FISH can be 
performed very fast, but metaphase FISH offers observation of the entire genome that may 
enable identification of complex rearrangements at a genome level. These techniques present 
many opportunities; however, their major disadvantage is the cost of reagents (mainly 
probes) and the requirement for an expensive high-resolution microscope. Development of 
novel micro assays could significantly increase the usage of these assays broadening our 
knowledge on chromosome abnormalities. 
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FISH techniques worldwide application 
For the FISH techniques to be used routinely in the laboratories all over the world certain 
challenges need to be addressed. As stated above the FISH techniques are continuously 
evolving, however their use is still limited due to high cost and long experimental time. Their 
use is sometimes advantageous as they are capable of detecting chromosome abnormalities at 
a higher resolution than karyotyping by banding. 
The major drawback of FISH analysis is the cost of the reagents used for the assays, mainly 
the fluorescent probes. In standard lab protocols 10-15 µl of probe are used per slide 
containing metaphase spreads or interphase nuclei [73]. Such analysis is normally performed 
on a single patient’s sample, thus the cost of a single analysis is extremely high. The 
development of a high throughput device for metaphase or interphase FISH analysis would 
reduce the volume of the probe used per single sample, at the same time reducing the cost of 
an experiment. Also, addressing the need for reduction in probe volume for single analysis 
would greatly increase the application of FISH in routine analysis.  
Another bottleneck of the analysis is the long experiment time. To perform a complete FISH 
analysis, even well trained technicians spend several hours in sample preparation as well as 
the waiting time in between each pre- and post- hybridization washes. There are at least 12-15 
different washes in a standard routine test that in total takes about 45 minutes. Apart from 
the cell culture work, the hybridization time is a very long process. At minimum, performing 
a FISH analysis with centromeric probes (repetitive sequences), will take 2 to 4 hours. 
Furthermore, in some FISH experiments the hybridization of a probe requires overnight 
incubation. The automation of sample preparation, probe delivery, imaging and analysis 
would result in molecular cytogenetic analysis to be performed routinely at the doctor’s office 
as a point-of-care diagnosis. 
For metaphase FISH analysis it is necessary to culture cells for three days. The disadvantage 
of such a culture method is the large volume of medium used and the fact that handling of 
suspension cells is tedious. This issue was currently addressed by developing a membrane 
based microfluidic bioreactor for suspension cell cultures, which makes preparation of 
chromosome spreads much easier [87, 88]. The proposed diffusion based microreactor 
facilitates culturing of lymphocytes but also expansion, hypotonic treatment, and fixation of 
cells with the possibility to avoid several tedious centrifugation steps [87]. Svendsen et al. 
developed a bioreactor for a suspension cells culture on the membrane with a microfluidic 
Evoluting microfluidics: Moving toward clinical applications 
 
20   
 
 
channel for media perfusion. The continuous flow ensures all the necessary nutrients to be 
delivered from the medium to the cells by diffusion. It enables fast solution changes for 
expansion and cell fixation to obtain high quality metaphase spreads. Separation of culture 
chamber by a membrane from the channel is beneficial as it protects the cells from air bubbles 
formed in the flowing medium and allows the perfusion to be started even before the cells 
settle on the membrane. Shah et al. modified the media perfusion channel to ensure more 
thorough transport of nutrients across the membrane to the resting cells [87]. Moreover, by 
performing CellTraceTM CFSE cell staining protocol it was demonstrated that cell 
proliferation on chip is better than in control experiment in a well plate culture. 
One of the many advantages of microdevices for complete chromosome analysis is the 
possibility to perform high throughput analysis. In cytogenetic laboratories chromosome 
analysis is performed several times a day on different patient samples. High throughput 
automatic devices for cell culturing, preparation of chromosome spreads or interphase nuclei, 
followed by detail FISH analysis would drastically speed up the process and provide fast 
results. 
Microsystems developed for FISH analysis 
In recent years the integration and automation of cytogenetic techniques has gained more 
attention. Most reports in this field focus on the development of an integrated microfluidic 
chip for interphase FISH analysis. This article reviews the recent developments in the field of 
microcytogenetics that address the need for automation, time and cost reduction in 
chromosome analysis. 
In 2007, Lee et al., presented one of the first examples of miniaturized devices for performing 
FISH analysis [89]. The presented work allows for high throughput FISH analysis on a cell 
array. The typically performed analysis lacks the possibility of conducting high throughput 
analysis as there is limited amount of samples available. To address this problem, the authors 
showed the possibility to array cells by spotting the small amounts of cell specimens onto a 
supporting matrix, which enables high throughput analysis. For the preparation of the chip, a 
glass slide was used as a supporting matrix.  1 mm thick perforated PDMS was bonded to a 
glass slide to form 96 cavities of 1.5 mm in diameter for spotting cells [Fig.1.6]. To enable 
microscopic cell identification a matrix corresponding to the 96 PDMS wells was 
microfabricated by photolithograpy on a glass slide. They have showed that 1 µl samples 
were spotted onto each PDMS well followed by air drying, removal of PDMS cover and 
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1.6 Thesis Overview 
Primarily work described in this thesis is targeted towards development of translocation 
analysis technologies supported by microfluidics-based techniques which can be used in 
clinical settings for standard cytogenetic analysis.  
Chapter 1 discussed the phenomenal success of microfluidics as a research tool for multiple 
disciplines. Finally, using this research project as an example, this chapter highlights the 
common problems with microfluidic research approaches which are continually moving 
microfluidic applications away from the wide scale implementation and public adoption. 
Chapter 2 introduces the concept and vision of a modular C-TAS system with development 
of a modular microfluidic motherboard. 
Chapter 3 highlights our step by step efforts towards reaching the goal of an integrated C-
TAS system.  
Chapter 4 is dedicated to describing side projects attempted related to the C-TAS system and 
other projects for developing a microfluidic toolkit for biological analysis in general.  
In Chapter 5 methods of simulation, fabrication, analysis and characterization related to the 
development of the microfluidic devices are presented in more details then described in 
earlier chapters. The reader is asked to refer to this chapter for more details of methods used. 
Chapter 6 provides a brief summary of the patents filed or in process concerning the 
discoveries and inventions made as part of this PhD project. 
Finally, Chapter 7 concludes the thesis with discussion of overall results. 
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CHAPTER  
MODULAR C-TAS 
 
This chapter introduces the C-TAS protocol which 
has been the primary goal of this PhD project.     
We will also describe the development of a 
modular motherboard providing substrate 
independent plug and play functionality. Finally, 
the experiments done on motherboard with an 
Impedance cytometer are extensively described. 
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2.1 C-TAS: The vision  
The C-TAS project was focused on achieving the vision of a miniaturized platform for 
performing chromosomal analysis [91]. Specifically, the critical mission was to design a 
microfluidic system capable of handling a patient blood sample and performing in sequence - 
a controlled cell culture based expansion and arrest of cells in metaphase, followed by 
isolation of T-lymphocytes (TLs), extraction of chromosomes, sorting of chromosomes, 
fixation of chromosomes on substrate, ending with a Fluorescence In-Situ Hybridization 
based detection of any chromosomal translocations on the patient’s sample [Fig. 2.1, courtesy: 
Winnie Svendsen]. Such a device could provide many benefits to the cytogeneticists for 
diagnosis of various diseases caused by chromosomal translocation i.e. by truncation or 
deletion of critical function genes [92]. 
 
Chromosome translocations are part of a major category of genetic disorders. The incidence 
of chromosome abnormalities is rapidly emerging as a common occurrence in the population. 
Hence, their early prognosis, diagnosis and treatment of related diseases are now a routine 
part of major genetic clinics. Chromosome translocations related cases are now forming big 
part of the cases involving spontaneous abortuses; congenital malformations, mental 
retardation, infertility, gonadal dysgenesis and for couples with repeated spontaneous 
miscarriages. Additionally, the field of cytogenetics is becoming very important in the 
workup of patients with hematologic/oncologic disorders. In congenital disorders these 
rearrangements have led to identification of novel disease genes. Hence, cytogenetic testing is 
extremely important for diagnosis, classification of disease, help with decisions about 
treatment and to monitor disease status and recovery.  Thus, our motivation was to provide 
the cytogeneticists with tools and strategies as part of the C-TAS system to minimize their 
existing workload by automating the entire diagnostic protocol and providing them the 
benefits of low cost, sensitive, minimal handling and automated system to perform 
translocation analysis followed by isolation of the translocated chromosomes for further 
molecular characterization via breakpoint analysis. 
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2.2 C-TAS: The challenge  
 
The mammoth task of realizing a C-TAS system was an exercise encompassing multiple 
disciplines including biology, genetics, image analysis, added with the new tasks attached to 
devising a miniaturized version of the protocol demanding expertise in microfluidics, micro 
and nanofabrication, surface chemistry, among others.  The task was assigned to a group of 4 
PhDs with backgrounds in multiple fields. The common understanding was to design and 
develop a modular plug and play based system to perform the entire chromosomal analysis 
protocol.  
 
The goal of this project was to design a strategy and develop a functional motherboard 
allowing for rapid plug and play based assembly of the C-TAS system by means of plugging 
in various modules covering the entire protocol. A microfluidic integrated solution for 
analyzing chromosomes from whole blood will need to integrate various sub modules to 
achieve a total chromosome analysis protocol [C-TAS protocol]. In the other 3 PhD projects 
which were part of the C-TAS project, tasks for preparing modules for firstly, whole blood to 
chromosome preparation, secondly, chromosome sorting and isolation and finally subsequent 
FISH analysis were being undertaken [Fig 2.2]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 2.2: The C-TAS protocol and original modules 
 
Module  
    3 
Module  
    2 
Module  
    1 
OSMOTIC LYSING OF RED BLOOD CELLS 
CULTURE OF ISOLATED LYMPHOCYTES 
ARREST & FIXATION OF LYMPHOCYTES 
CHROMOSOMES SORTING & ISOLATION 
FISH ANALYSIS 
ISOLATION OF LEUKOCYTES 
CHROMOSOMES FIXATION 
BLOOD 
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Modular microfluidic platforms are becoming increasingly relevant for biological analysis. 
The focus of this work is to address the biggest vexing challenges ahead of microfluidics: 
fluidic packing and system level integration & compatibility and interoperability among 
various microfluidic components. The efforts to mainstream microfluidic based biological 
applications and cell handling devices can only succeed, if platforms which enable easy 
integration and interfacing of microfluidic devices into the existing clinical setups emerge 
rapidly. These modular platforms will have to be based on robust technologies which can 
provide accurate fluid handling operations (actuation, valving, mixing, concentration, 
separation, reagent storage, among others) backed by a robust, low cost and mass producible 
fabrication technology.  
 
As a design problem, the motherboard approach amalgamates components belonging to two 
fundamental categories: fluidic components (channels, reservoirs, mixers, valves) and 
electrical circuits for providing electrical connections to the modules. The process of design of 
the motherboard was influenced by the number of needs which were used as development 
guidelines throughout the designing phase of the project [Fig. 2.3]. The motherboard should 
provide biochemical compatibility (for cell culture), fluid actuation, waste removal, channel 
surface passivation (non-reactive to samples), surface functionalisation, optical transparency, 
ease of microfabrication (no cleanroom and scalable), easy plug and play assembly strategy 
(taking maximum 5 s per module assembly), reusability (up to 20 times), easy cleaning 
protocol (cleaning by single solvent flushing), and low cost of development (under $50).  
 
Hence, my objective was to design a motherboard to easily integrate on an active platform all 
the functionalities for fluid routing, valving, mixing (for lysing red blood cells and fixing of 
metaphase lymphocytes), providing electrical connections, and overall providing effortless 
plug and play based interconnection strategy for rapid assembly of the  C-TAS system from 
the 3 modules. While modular motherboards have been around, no demonstrations of 
handling complex biological protocols as this one have yet been proposed [93-96]. While most 
demonstrators of modular platforms are passive and do not provide fluidic routing, some are 
made with materials which cannot allow for the platform to be reused for biological analysis.  
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Figure 2.3: Modular motherboard and the development challenge 
2.3 Impending decisions 
At the start of the project, some technical design rules had to be set to allow for 
interoperability of various sub-modules and these rules were also important to achieve easy 
interfacing of the modules with the motherboard, at the end of the project. These design 
decisions had to be made keeping in mind the requirements of the biological protocols, 
fundamental limits of micro and nanofabrication and at the same time leaving enough room 
for each PhD project to function individually. The key was to design a mechanism by which 
while progressing individually all the projects will lead to the development of a module 
compatible with the common motherboard. Hence it was important to have laid down some 
common design rules (size, materials, fabrication protocol, etc) for the project. 
2.3.1 Standardization 
The most important decision taken over the design phase of C-TAS project was to standardize 
the size of the modules. The benefits of standardizing device sizes were apparent. For the C-
TAS system, the foremost benefit of standardizing modules was to allow simultaneous 
development of the motherboard in parallel with the modules. And finally, adopting a 
standardized device format allows easy application of a plug and play motherboard 
developed for C-TAS project to other areas. In future, we envisaged that by means of 
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standardizing the device sizes, the output of the C-TAS project could be leveraged for other 
biological protocols. 
Final Design Specifications: 
The module dimensions were fixed to be 20 x 20 mm and the positions and number of fluidic 
inlets/outlets and electrical connections were decided as standards for all the modules to 
comply with based on all module requirements [Fig. 2.4].  The red dots highlight the positions 
of the electrical connections and the white dots depict fluidic interconnections. Arrays of 3 
interconnections (fluidic as well as electrical) are placed equidistant from the centre at a 
distance of 7 mm. The distance between the 2 interconnections in the array is 4 mm. There are 
6 fluidic and 6 electrical connections in total based on the requirements made from the C-TAS 
participants. 
 
 
 
 
 
 
Figure 2.4: Design specifications & schematic drawing for motherboard socket and modules (Red dots depict electrical 
connections and the white dots depict positions of fluidic interconnects. Size is not to scale (2x). 
This design was considered an ideal and viable solution as some of the modules were to be 
fabricated in the cleanroom and having a 2 x 2 cm module size was a good trade-off between 
having enough space on chip for structures and microfluidic handling while at the same time 
having sufficient number of chips per wafer to justify the fabrication costs. A maximum of 12 
chips per wafer can be fabricated with a chip size of 2 x 2 cm. Also, this was a standardization 
attempt for the prototyping stages of the project and can be easily modified as per the 
requirement of the modules or end-user and when moving towards a commercial solution.  
 
 
7 mm 
4 mm 
4 mm 
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2.3.2 Choice of material 
Biology is extremely complex and we started to realize the intricacies of the complex problem 
we had on our hands while picking the right material for the modules and motherboard. The 
choice of material is often the first consideration while designing microfluidic devices and 
systems; it was crucial to select material offering biocompatibility and protocol compatibility 
(in terms of fabrication and operation). Polymers are rapidly becoming the popular choice for 
development of microfluidic devices [42, 97-99]. The basic requirements from the material for 
this project was low cost, ability to bond to different substrates (Glass, Silicon) irreversibly, 
suitable for microfluidics, ease of fabrication, gas permeability, good optical properties, good 
chemical stability. Such a material can either be Polydimethylsiloxane (PDMS), Polymethyl 
methacrylate (PMMA), Polycarbonate (PC) or Cyclic Olefin Copolymer (COC). 
PDMS was selected as initial material of choice for the fluidic channels of the modules owing 
to the group’s expertise and experience with PDMS. Other factors considered were its widely 
cited biocompatibility, ease of fabrication, low cost, optical transparence, gas permeability, 
good chemical stability and abundance of literature to refer to for biological and cell handling 
protocols on PDMS based devices [14-18, 100-102]. In case of modules needing electrodes, the 
electrodes were to be fabricated on Pyrex wafers, which can be bonded on PDMS channels 
using oxygen plasma bonding [103, 104]. But over the course of the project, the modules 
evolved and ended up in materials other than planned during the initial design phase of 
project [Table 2.1]. As the work on individual modules is part of other PhD projects, related 
issues and solutions will not be described in details here. 
PMMA was the chosen material for preparing the motherboard due to ease of fabrication and 
in-house expertise with micromilling and laser-ablation on PMMA [105-107]. Using PMMA 
for the development was advantageous owing to PMMA being inexpensive, transparent, 
biocompatible and finally easy to fabricate using the methods listed above [108-111]. PMMA 
was used for the overall design optimization and test phase of the motherboard, but it was 
later discovered that PMMA cracks with ethanol treatment. Hence, to enable reusing of the 
motherboard, the final motherboard for testing with cells was fabricated in polycarbonate 
(PC), to allow for simple cleaning with ethanol.  
Table 2.1 depicts the path of evolution of the C-TAS modules during the project tenure 
including various materials used and fabrication methods tested in order to realize the 
modules. The table also highlights the final material of choice for the modules at the 
completion of the C-TAS project.  
  
 
Table 2.1: E
 
 
 
 
 
 
 
 
 
 
 
 
 
The comp
module d
to integra
in the tab
complexit
modules 
interconn
 
 
 
 
volution of C-
lexities of
evelopmen
te these de
le above
ies, a plug
developed
ections. Th
Dr. Ja
          
TAS modules
 the biolo
t and to a
vices into
 did not 
 and play
 in any
is mother
cob Lange  
                      
 and their fin
gical min
 greater ex
 a function
function a
 motherbo
 substrat
board was
       D
                      
Evoluting m
al versions 
utiae of th
tent even
al protoc
s intende
ard was 
e and pr
 designed,
r. Casper Cla
                     
icrofluidic
e C-TAS 
 the choice
ol. While t
d or wer
designed i
ovide the
 fabricated
usen            
                      
s: Moving to
protocol g
 of materi
he individ
e discard
n order to
m with 
 and teste
                 Ms
                 Ve
ward clinic
overned t
al. My pro
ual modu
ed due to
 integrate
electrical 
d as descr
. Indumath
darethinam
al applicati
  33
he course
ject goal w
les describ
 operatio
 and oper
and flui
ibed furth
i        
 
ons 
 of 
as 
ed 
nal 
ate 
dic 
er. 
Evoluting microfluidics: Moving toward clinical applications 
 
34   
 
 
2.4 Versatile motherboard for substrate independent 
plug and play microfluidics3 
Pranjul Shah,*a Romen Rodriguez-Trujilloa , Simon Levinsena , Maria 
Dimakia and Winnie Edith Svendsena 
a Department of Micro and Nanotechnology, Technical University of Denmark, Kgs. Lyngby 2800, Denmark 
This article presents a versatile modular motherboard which provides users compatibility 
with all substrates and eases the efforts with respect to developing microfluidic and electrical 
interconnections. By developing a simple plug and play motherboard and related interfacing 
techniques enabled by means of a simple press fit socket type assembly, this work presents an 
effortless ‘one touch’ plug and play protocol for simultaneous formation of rapid, multiple, 
aligned, flexible, reliable and reusable electrical and fluidic interconnections. In an effort 
towards standardizing microfluidic development efforts, this motherboard restricts the size 
of the microfluidic devices and locks in the positions of the electrical and fluidic 
interconnections. In doing so, the user is granted freedom to design their devices in any 
material as long as they follow the size and interconnections positioning guidelines. These 
user-designed modules can then be interfaced with the motherboard by attaching them with 
a pluggable PDMS lid ‘Pluggy’ by adhesive tape based assembly. The motherboard has 
integrated fluidic networks and electrical connectors accessible via sockets which provide 
seamless connectivity between the modules and macro world. This versatile motherboard 
takes a step further in standardizing the device size and provides the first demonstration of a 
substrate independent plug and play motherboard. We have tested the fluidic and electrical 
connectivity of the motherboard with an impedance cytometer for counting of micro 
particles. 
 
Introduction 
Despite an exponential growth in the patents and publications featuring microfluidic 
applications, the commercial and wide scale adoption of microfluidic based technologies has 
simply not come about [46, 50]. Microfluidic research in the last decade has led to successful 
demonstrations of applications in vast areas including but not limited to biology, genetics, 
                                                            
3 Submitted to Biomicrofluidics journal 
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medicine, chemistry, polymers, etc [112-116]. But the exponential growth of microfluidic 
based devices has not been complemented with techniques to interface and integrate such 
devices into multi-functional platforms [42]. As a result, the public visibility of these devices 
continues to be negligible. One can easily imagine countless possibilities of various analysis 
protocols which could be designed, if there was an interfacing protocol which would allow 
for arranging any of these successfully demonstrated devices in sequential or parallel fashion. 
However, the lack of such a system providing reliability, ease of handling and versatile 
assembly of microfluidic devices is hindering the growth of commercial and clinical 
microfluidic devices. 
The impending need to solve these practical concerns has been recognized and as a result 
many demonstrations of plug and play modular systems have come about as possible 
solutions. These modular systems should ideally provide leak-free assembly of fluidic 
interconnections, rapid simultaneous assembly of electrical connections, substrate 
independent operation allowing users the freedom to design their devices in any material as 
per the need of the applications and, most importantly, easy handling and assembly protocol 
suitable for non-technical personnel. These features should be coupled with on-board fluidic 
routing and valving operations and incorporate the possibility to automate the fluidic 
handling in the future. 
Although promising, none of the published systems accommodate all of the desired features 
and versatility in terms of substrates. Typically, these systems have been designed in many 
materials including silicon and polymers [93-96, 117-120]. Most of these systems lack 
provisions for establishing electrical connections for sensing applications, which are rapidly 
emerging as one of the major applications of microfluidics [88]. It could also be of interest to 
integrate optical connections in to such platforms [121]. While very few systems offer the 
possibility of establishing electrical and fluidic connections simultaneously [122, 123], none 
have the ability to provide flexibility of interfacing with microfluidic devices fabricated in any 
substrate.  
Simultaneously, the need for standardizing future development efforts has been repeatedly 
highlighted [51, 52]. But there is still not a single standardized technique in terms of 
interconnections and hence every research group has their own application specific or 
preferred way of fabricating these interconnects which they continue to use and progress 
[124-131]. In order to standardize interconnection technology for microfluidics, there is a need 
for a technique which can allow rapid, robust, flexible, multiple, reliable and easy fluidic and 
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electrical interconnections on microfluidic devices [129]. This is the key to moving 
microfluidic applications to market and increase the development of novel applications. 
We propose a novel socket type plug and play approach enabled by means of a PDMS 
interfacing lid – Pluggy. By means of adding an interfacing layer (Pluggy) which can bond to 
any substrate as well as form rapid, multiple, aligned fluidic and electrical connections with a 
motherboard, we have demonstrated the first substrate independent modular plug and play 
motherboard. In order to test the fluidic and electrical functionality of this device, we have 
interfaced an impedance cytometer which required multiple electrical as well as fluidic 
connections. 
 
Materials and methods 
Materials: 
Polymethyl methacrylate (PMMA) sheets used for fabricating the motherboard were ordered 
from NordPlast (Denmark). Polydimethyl Siloxane (PDMS), Silicone tubing, Blue film, 
alignment pins, syringes and other consumables were ordered from VWR Denmark. The 
medical grade double-sided adhesive tape (AR100) was procured from Adhesives Research 
(Ireland). The O-rings were ordered from M-seals (Denmark). A milling machine from Folken 
Industries (USA) was used to fabricate the motherboard and rotors. A 50W CO2 Laser system 
from Synrad Inc. (USA) was used to ablate the double sided adhesive tape. The drawings of 
the tape and the milling parameters for the motherboard were drawn using the commercial 
softwares Winmark and AutoCAD respectively. The spring contacts for the electrical 
connections of the motherboard were ordered from RS components (Rodium-plated 
Beryllium Copper pins: 261-5121). Beads were ordered from MicroBeads AS. 
Fabrication: 
We have developed a novel modular motherboard providing versatile substrate-independent 
plug and play functionality based on a socket type press-fit multiple interconnection 
assembly. Such a scheme allows establishment of rapid, multiple interconnections for 
microfluidic devices. This interconnect technology consists of a two parts assembly: The 
micromilled socket fabricated on the motherboard and an interfacing PDMS lid ‘Pluggy’ 
which interfaces with this socket providing effortless multiple, aligned, reliable, robust, 
fluidic and electrical connections in a matter of seconds by means of a simple ‘One touch’ 
plugging protocol. In order to have a standardized socket assembly to streamline future 
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microfluidic device development, we laid some design rules for all modules to be interfaced 
with the motherboard. The microfluidic device dimensions were fixed at 20 x 20 mm and the 
position of fluidic and electrical connections have also been fixed as shown in figure 2.5. 
Figure 2.6 depicts the schematic of the versatile modular motherboard with integrated press 
fit sockets. Each socket contains 12 interconnections (6 fluidic and 6 electrical) for interfacing 
with the modules based on the standard guidelines. The motherboard is fabricated using 
micromilling in 5 mm thick PMMA sheets [109, 132, 133]. In principle, the motherboard can 
be designed with multiple sockets, but in this work we only present a motherboard with 3 
sockets [Fig. 2.6].  
 
 
 
 
 
 
 
 
Figure 2.5: Designs specifications for the motherboard modules (Red dots depict 6 electrical connections and white dots 
depict the 6 fluidic connections). Overall dimension 20 x 20 mm. 
Figure 2.7 highlights the schematic of the fabrication process of the motherboard. In step 1, 
the sockets with the interconnection needles are milled. The height of the interconnections 
needles in the sockets is 3.9 mm. For fluidic interconnections, the needles have an inner 
diameter of 0.5 mm and an outer diameter of 1.4 mm. In the case of the electrical connections, 
the inner diameter of the needles is set at 0.7 mm to match the diameter of the spring pins. 
The outer diameter is fixed at 1.4 mm to allow leak-free and tight coupling with the flexible 
PDMS lid ‘Pluggy’ and silicone tubing. The motherboard also contains a fluidic network for 
placing rotors for valving and routing of fluids by means of turning the rotors manually or 
with stepper motors. 
 
 
20 mm 
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Figure 2.6: Schematic of the motherboard 
On the other side of the sockets, a concealed fluidic network is milled to provide fluidic and 
electrical connectivity to all the plugged modules (step 2). The fluidic channels are designed 
to be 500 µm wide and 200 µm deep. Every socket is interconnected by a rotor valve which 
can route fluids by means of turning the rotor to the required position.  
In order to actuate fluids pumps are used and to connect the motherboard with pumps, 
Plugports for plugging external silicone tubings with similar dimensions as needles in the 
sockets are placed separately outside the sockets on the motherboard. These tubing Plugports 
have needles with outer diameter (OD) of 1.4 mm and inner diameter (ID) of 0.5 mm which 
form tight seals with the silicon tubing (OD- 3mm and ID- 1mm). 
Finally, a 500 µm PMMA sheet is bonded on to the channels side of the motherboard to seal 
the fluidic network (step 3). The bonding is achieved by thoroughly cleaning both surfaces 
with Isopropyl alcohol (IPA), followed by UV activated thermal bonding in P/O/Weber 
bonding press at 90° C (15 kN bonding pressure, 60 s exposure in DYMAX EC5000 UV light 
source).  
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Figure 2.7: Steps of motherboard fabrication and assembly 
 
PDMS interfacing lid – Pluggy 
Pluggy consists of two parts: On one side, the interconnection connectors are placed and, the 
other side is the lid base, which bonds and provides support to the microfluidic chip. The 
PDMS lid mould is fabricated by micromilling in 4 mm and 3 mm PMMA sheets [109, 132, 
133] [Fig. 2.8]. The mould consists of 3 layers (from bottom to top): The alignment layer 
allows for fastening the alignment pins for forming through the holes (3 mm sheet), the 
connector layer for making connectors which form the tight seal with the motherboard socket 
(3 mm sheet) and finally the base layer, which forms the flat layer of the Pluggy lid, which 
bonds to the device and supports it during the plugging in procedure (4 mm sheet). The 
through hole is formed by passing a 1 mm alignment pin through the alignment hole and 
leaving it in the mould while fabricating the PDMS lids - Pluggy. Pluggy is moulded using 
the Sylgard 184 - PDMS kit by mixing in a 10:2 (weight: weight) ratio elastomer and curing 
agent using a replica moulding process [17, 18, 134]. The PDMS is cured at 60° C for 3-4 hours 
and then peeled from the mould using tweezers. The moulds are thoroughly cleaned after 
each use with detergent and air dried. This allows reusing the moulds for multiple times. 
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Figure 2.8: (Top) Schematic of the PDMS Lid mould (3 layers put together by screws in the blue slots towards the end) 
(Bottom) Schematic of a moulded Pluggy interfacing lid  
Adhesive Tape for assembly of modules 
The double-sided adhesive tapes (AR100) for bonding the Pluggy to any module are prepared 
by a laser ablation process (see Section: Assembly of a plug and play device) [105, 106, 135]. 
The CO2 laser (Synrad Inc, USA) is connected to a computer with a Winmark software based 
controller. The tapes are cut into 20 x 20 mm pieces as the motherboard standard and the 
interconnection holes are cut with a radius of 2 mm as per the positions specified by the 
design rules. The parameters used for ablating the tape are 25 W power, 300 mm/s velocity, 2 
mark passes and resolution of 800. 
Impedance Based Counting Device 
The Impedance Chip is made with electrodes fabricated on a Pyrex wafer bonded on to 
channels moulded in PDMS. The Pyrex wafer contains the electrodes (10 nm Ti followed by 
150 nm Au) patterned using positive photolithography and then followed by metal 
deposition. The mould for casting the PDMS channel is fabricated by KOH wet etching in 
silicon. The fluidic channels were moulded in PDMS using the replica moulding technique 
and holes were punched into the PDMS lid using a blunted needle to form the 
interconnections. The positions of the fluidic and electrical interconnections of the impedance 
chip are based on the design specifications of the motherboard. The PDMS lid with channels 
and the Pyrex chip with electrodes are cleaned thoroughly with Isopropyl alcohol (IPA), 
followed by thorough wash with DI water. Following the washing steps, the devices are air 
dried and exposed to Oxygen Plasma (Power: 100 mW, O2 air flow: 75 ml/min, Exposure 
time: 30 s). Following the exposure with oxygen plasma, the devices are aligned and brought 
in contact to bond them irreversibly [103, 136]. Typically, the devices are left overnight for the 
bonding to settle before use (or minimum 4 hrs). 
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Assembly of the plug and play module 
In order to bond the impedance chip on to the Pluggy, to create a module which can be 
plugged into the motherboard socket, we need to use the laser ablated double-sided adhesive 
tape [Fig.2.9]. Firstly, the surface of the Pluggy and the impedance cytometer chip to be 
bonded are wiped with a tissue soaked in ethanol to remove any dust particles. Secondly, the 
double-sided tape is attached to the impedance cytometer chip aligning the holes of the chip 
and the tape. Finally, Pluggy is bonded onto the other side of the double-sided tape making 
sure of the alignment of the interconnections [Fig 2.9]. This alignment process is simple as the 
chip and Pluggy are of the same dimensions. The substrate and the lid can be made bigger 
than 20 x 20 mm because as long as the interconnections are placed as per design guidelines, 
the module will still interface and function with the motherboard. But for the purpose of this 
work, we have used devices with outer dimension of 20 x 20 mm. The bonded module is left 
under pressure for 10 min before use [Fig. 2.9]. 
Impedance cytometer chip testing 
In order to test the motherboard, the Impedance cytometer module was prepared by bonding 
of Pluggy with the impedance cytometer chip. The module was plugged into the 
motherboard socket to create fluidic and electrical connections. Silicone tubing was used at 
the connecting plugport to form the world-to-chip connections. A mixture of 5 µm and 3 µm 
beads solution was prepared in PBS solution with 5% Tween to avoid clumping of the beads. 
The solution was injected in a syringe and it was elevated to a particular height to create a 
pressure difference when connected to the motherboard which actuates the fluids. With this 
solution, we can easily work with flow rates ranging from 1-10 nl/min. The motherboard 
setup was put under a microscope to simultaneously visualize and count beads when they 
pass through the detection zone. Figure 2.10 depicts the schematic of the measurement setup 
and the principle of impedimetric counting of particles. It is based on differential impedance 
measurements through a Wheatstone Bridge using three consecutive electrodes [137]. The 
bridge is excited at 1 V amplitude and 100 kHz frequency using a function generator (Thurlby 
Thandar Instruments TG2000) and the output signal is further processed to extract its low-
frequency modulation which provides information about the particle transitions. A stable 
flow reduces the noise in the signal and hence we waited for the flow to stabilize before 
recording the signals. The data acquisition is handled using a Labview DAQ card connected 
to a computer for recording the signals at 10k samples/sec. To decrease the noise, the entire 
setup with the microscope is placed inside a Faraday cage.        
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Figure 2.11: Rotor assembly on motherboard with integrated O-rings for leak proof interconnections 
Results and discussion 
Figure 2.12 shows the fully assembled motherboard with the rotor included and 3 sockets for 
plugging in modules. 
 
Figure 2.12: Fully assembled motherboard 
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Pluggy  
Figure 2.13 (left) shows the moulds with alignment pins inserted for moulding the PDMS 
interfacing lid – Pluggy. The alignment pins are removed post curing leading to through 
holes in the Pluggy for forming fluidic or electrical connections with the motherboard socket. 
The 3 layers of the Pluggy mould are then opened by unscrewing the alignment screws 
holding them together. Then the Pluggy is gently released by cutting the edges with a scalpel 
to have a cleanly cut sharp edge [Fig. 2.13 (right)]. 
 
Figure 2.13: (Left) Mold for curing PDMS based Pluggy with alignment pins for through holes.  (Right) PDMS Moulded 
Lid – Pluggy 
Fabrication of the Impedance chip  
Figure 2.14 shows the results of the fabrication of the electrodes as well as the PDMS lid with 
channels used for the impedance measurements.  
 
Figure 2.14: (Left) Electrodes on Pyrex wafer (Middle) Moulded Lid showing the PDMS channel structure and through 
holes for interconnections. (Right) Impedance chip after oxygen plasma bonding. 
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After oxygen plasma treatment, the moulded PDMS lid and Pyrex electrodes are aligned 
together under a microscope and bonded. The moulded impedance chip containing the Pyrex 
electrodes covered with a PDMS channel is depicted in fig. 2.14 (Bottom). 
‘One touch’ Plug and play assembly 
In order to plug-in the module assembly on the socket, the Pluggy connectors are aligned on 
the needles on the socket and gently plugged-in by applying pressure in the centre of the 
module with a single finger [Fig. 2.15]. This ‘one touch’ assembly protocol takes less than 5 s 
and provides any module on the motherboard with instant electrical and fluidic connections. 
The tubing for entering fluids is connected to Plugports on the motherboard and to the 
syringe pumps or pressure system on the other end. If the electrical connections are to be 
used the electrical measurement setup is put in place. The assembly is then ready for testing 
[Fig. 2.15]. 
 
Figure 2.15: (Left) One touch plug and play assembly  (Right) Impedance chip plugged on the motherboard showing 3 
electrical spring pins connecting to the impedance chip. (The fluidic connections are difficult to visualize due to channel 
width being 10 µm). 
Impedance cytometer 
The goal of this work was to demonstrate the functionality of the motherboard by using an 
impedance cytometer for counting of micro-particles. The performance of this chip was 
previously confirmed with a specially designed holder. Therefore, proper operation of the 
chip on the motherboard would confirm the fluidics as well as the electrical operation of the 
motherboard. In order to interface the impedance chip on to the motherboard, the chip was 
bonded with Pluggy using an adhesive tape based bonding as mentioned in the previous 
section and then plugged into the motherboard [Fig. 2.15]. The plugged impedance cytometer 
module on to the motherboard has been depicted in Figure 11 and it clearly indicates the 
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spring pins forming electrical contacts with the electrodes on the Pyrex wafer through the 
Pluggy. 
The setup for testing the impedance cytometer on the motherboard is depicted in Fig. 2.16. 
The motherboard is connected to a custom designed electronic board which modulates and 
filters the signal. The microscope provides visual confirmation of the beads in the channel, 
while a Labview based data acquisition program records the electronic signal. The 
microscope with the motherboard on it as well as the fluidic setup and the electronic board 
are placed in a Faraday cage [not shown in figure]. 
 
Figure 2.16:  (Left) Motherboard with integrated electrical connections on test setup with modulation board. 
Fluidic and electrical operation: 
The fluidic actuation was provided based on a pressure driven system. Figure 2.17 shows the 
beads transiting across the detection zone. The fluidic system works immaculately even with 
channels size of 10 μm x 10 µm. The beads used in the tests were of the sizes 3 and 5 μm. No 
clogging was observed with the beads and the device was used continuously for 3 days 
without any leakage problems. 
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Figure 2.17:  Beads transiting through the 10 µm channel across the detection zone 
Figure 2.18 shows the obtained signal highlighting transition of many beads passing through 
the system. A 100 points running average is applied to the original data once acquired in 
order to remove the noise. By counting the peaks recorded in the data, we can determine the 
number of beads that transited across the detection region. This is because the bead transition 
across the detection region changes the established electrical field in the channel, which can 
be visualised as a peak in the detected voltage signal. Looking closer into the region marked 
with the dotted lines in figure 2.18, one can clearly visualize the transition of one bead [Fig 
2.19]. For this experiment, the transition times of the beads were found to be around 50 ms, 
which was also verified from the videos recorded of the beads transiting across the 
electrodes. These results confirm the good electrical connectivity and robust fluidic 
interfacing of the impedance chip with the motherboard via the Pluggy based interfacing and 
assembly method.  
 
Figure 2.18: Graph of beads transiting across the detection zone. 
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Figure 2.19: Enlarged image of one transition from the fig. 2.18. 
Conclusion 
In conclusion, the motherboard provides a very versatile and universal interfacing solution 
for electrical and fluidic connections to virtually any microfluidic device, fabricated in any 
material. A rapid, inexpensive, flexible and reliable interconnection strategy has been 
presented with a standardization approach, to enable faster development of microfluidic 
devices. In order to test the electrical connectivity and fluidic stability of the motherboard a 
microchip for impedance based sizing of particles was used. The results of these tests 
highlight the applicability of the motherboard for numerous microfluidic applications 
needing a simple and efficient strategy for forming fluidic and electrical connections. With 
this approach, we have designed a truly versatile solution for assembling microfluidic devices 
compatible with any substrate and providing rapid world-to-chip interconnections in a 
matter of seconds. This tool provides the fundamental scientists an opportunity to 
concentrate on development of applications without needing to focus on developing the 
interconnections and other building blocks of their devices. It also provides a very good 
application in bio, chemical and other analysis, where modular approach is required. We 
envisage that the easy assembly protocol and ability to combine any microfluidic devices will 
lead to efforts in testing complex microfluidic device combinations not possible earlier due to 
substrate incompatibility. Future work will be focused on integrating simpler biological 
protocols on the motherboard. 
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2.5 Outlook 
A simple, plug and play, substrate-independent, modular motherboard was developed. Non-
technical professionals were trained on how to use this motherboard and were able to operate 
it successfully (over 95% success rate). Finally, the motherboard was showcased to our 
collaborators (end-users) with the proposed modules for performing the FISH protocol 
during our usual strategic meetings. During this demonstration, flow through the planned C-
TAS protocol [Section 2.2] was demonstrated using the modules of grooved culture chamber, 
dielectrophoresis based device for simultaneous lysing and extraction of chromosomes and 
subsequent FISH analysis using glass slide and PDMS complex device. Evaluating the 
modules and the motherboard, our collaborators commented on the complexities associated 
with the C-TAS protocol. Contrary to our expectations, the general feedback was that it 
would be very difficult if not impossible to implement it in genetic labs, unless it was 
automated. 
During the development phase of the project, we had anticipated that there was a huge need 
for the modular C-TAS motherboard, and our logical reasoning was that, this demand was 
sustained due to the length and complexities of the traditional protocol. But on the other 
hand, collaborators found our protocol to be extremely complex and not user-friendly. This 
lead us to questioning our reasoning and we began a quest to figure out as to - “What were 
the real issues with the traditional techniques which needed microfluidic solutions?”.      
There was a clear consensus that it was time for us to visit the labs in person and get some 
better understanding of the needed solutions. 
• What was the real issue with the traditional protocol?  
• What modifications were needed in the C-TAS protocol to make it clinically relevant? 
• But primarily - What were our collaborators expectation and vision of the C-TAS 
system? 
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Comparison to the clinical setup: 
After succeeding in prototyping a C-TAS motherboard and demonstrating its operation to the 
intended end-users, it occurred that the proposed solution did not provide the ease of 
handling and simplicity our end-users i.e. lab technicians were seeking. It was important to 
understand why the C-TAS protocol, based on a simple plug and play modular motherboard 
operated by pressing a switch on the syringe pumps, was too complex for implementation in 
a clinical setup. 
On extensive observation and discussions with technicians at partnering cytogenetic labs 
revealed the real problems and the issues with respect to the complexity of C-TAS protocol. 
The simplicity of performing traditional protocol with culture plates and pipetting by skilled 
technician cannot be compared via a simple comparison of the motherboard [Fig. 2.20]. 
 
Figure 2.20: Comparison of traditional culture plate with pipette and the complex motherboard based protocol needing 
syringe pumps (not shown in image) for actuation. Apart from complexities related to extra modules, the handling on the 
motherboard is also much complicated compared to the pipette based traditional protocol. 
Our observations and conclusions based on the interaction with our end-users is highlighted 
below. 
• The motherboard based platform was simply too complex to handle with respect to the 
existing work routines and technicians skillset. Hence, a degree of automation needs 
to be developed before presenting it to the end-users. 
 
• The technicians were well trained with using culture flasks and most operations of 
mixing with reagents to culturing cells took only seconds. This allowed technicians to 
handle multiple samples during a working day. Hence, the time and ease of handling 
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were important factor to consider when the unit operations conducted as part of the   
C-TAS protocol are concerned. 
 
• We had been giving considerable attention to the pursuit of sorting, separation or 
trapping of lymphocytes to culture only TLs in the culture chamber [See - Chapter 4]. 
This concept had to be altered to culturing whole blood as this was the routine 
practice in clinics. Secondly, the red blood cells did not interfere with the FISH signals 
as was anticipated and also most of them were lysed during the fixation of the TLs. 
This made our sample preprocessing step a lot simpler and turned it into merely a 
basic culture and fixation protocol. 
 
• In terms of the protocol, as the technicians need to focus on multiple samples during 
their daily routine, a step by step process is much better suited for their work process 
flow. This allows them to run multiple experiments simultaneously and stopping in 
between to work on other samples intermittently. 
 
• Handling of the devices needs to be more robust as technicians are pretty much used 
to working quickly with one sample in flasks or plates and putting it back into the 
incubators or fridges and moving on to the next sample. Delicacy of the microfluidic 
device handling and the waiting time associated is a daunting prospect for current 
technicians.  
 
• And finally, the bottom line is: Like every other product on the market, C-TAS needs 
to provide the end-user with an incentive to change. The incentive that technicians 
could care about are not low cost of device, less probe usage, better sensitivity, simpler 
protocol or automation providing them free time to handle more samples during a day 
rapidly, but ease of existing workload, simpler work flow, automated data capture 
and analysis. The cost and other factors are only marginally important. 
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CHAPTER  
INTEGRATED C-TAS 
 
This chapter presents the experimental work 
related to the development of a set of microfluidic 
devices for cell culture, sample pretreatment, 
metaphase spread preparation and leading to the 
development of first metaphase FISH analysis on 
chip. Finally, we describe the efforts towards 
automating the entire FISH analysis protocol. 
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3.1 Integrated C-TAS system: Needs and Approach 
Our focus of development had to be shifted from modular microfluidic platforms towards 
developing an integrated C-TAS system for providing the end-users with a simple solution 
that continues to provide the traditional ‘ease of handling’ but also benefits from the 
advantages of a microfluidics based cell handling. Such a system should ideally also get rid of 
the complexities and practical challenges of interfacing with microfluidics. Additionally it 
should provide users with a ‘blackbox’ that looks and functions from the outside like the 
traditional systems but inherently packs in the advances that go hand in hand with 
microfluidics based miniaturized systems i.e. low cost, small sample volume, easy sample 
preparation and analysis, simple assembly and operation, etc. 
While it seemed at first like going back to scratch again, we realized that we had actually 
learned a lot via the efforts targeted at developing the modular C-TAS system. While 
modular microfluidic platforms offer benefits of fluid and cell handling [Chapter 2] they 
generally do not provide the ease of handling unless automated, which is one advantage of 
integrated systems.  
Integrated monolithic systems can be designed to have simpler interfacing and easy handling 
protocols due to the possibility of combining modules and sharing features among several 
modules. We had already devised a toolkit for performing C-TAS protocol [Section 2.2] on 
motherboard in the form of modules. Now we wanted to integrate these modules and design 
an integrated monolithic version of the C-TAS protocol. As a result, we could quickly zoom 
through the design phase of the integrated C-TAS approach and come up with a new setup of 
objectives which were matched with a realistic step by step approach for achieving the vision 
of a user friendly, simple integrated C-TAS system.  
New objectives and the step by step approach: 
• To design a sample preparation module to perform cell culture, arrest and fixation 
which can later be integrated with a FISH module [Paper 1: Microfluidic Bioreactors 
for non-adherent cell cultures].  
 
• To realize a new reliable and integrated approach for sample preparation including 
splashing based spreading of metaphase chromosomes [Paper 2: FISHprep: A novel 
integrated device for metaphase FISH sample preparation].  
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• To demonstrate a novel protocol for performing FISH on a chip. [Paper 3: Metaphase 
FISH on Chip: Miniaturized microfluidic device for Fluorescence In-Situ 
Hybridization]. 
 
• Finally, the sample preparation, spreading device and the FISH chip were to be 
merged into a monolithic integrated FISH device providing minimal handling and 
possibility to automate [Fig. 3.1].  
 
The following sections 3.2, 3.3 and 3.4 are papers published in peer-reviewed journals. As 
these papers are directed towards a specific scientific audience not all details of the 
procedures are described. For more information, on any methods described in this chapter, 
the readers of this thesis are referred to Chapter 5 Methods. 
All the descriptions of cost, time, simplicity, ease of handling, reagent volumes are mentioned 
with respect to the standard protocols as existing currently at the Wilhelm Johannsen Centre 
for Functional Genome Research (WJC), The Panum Institute. All these following sections 
discuss the improvements in relation to the development of microtechnologies for these 
standard protocols. E.g. there might exist versions of standard techniques which involve less 
FISH probe volume usage but these minimize the scan area as well, and the process followed 
is not the usual standard. In the context of this thesis, the standard protocol is always 
considered to be the most routine FISH sample preparation and analysis protocol used for 
typical every day analysis at WJC [Section 1.5]. 
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Figure 3.1: Schematic of the integrated C-TAS system. The schematic highlights proposed step by step approach for 
developing an integrated C-TAS system. The results are depicted in (a) Section 3.2: Cell culture, arrest and fixation device 
(b) Section 3.3:  Metaphase spread preparation device and (c) Section 3.4: FISH analysis device are presented. (d) 
Automation of the reagents injection (AutoFISH protocol) by means of FISH reagent cartridge.  
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3.2 Microfluidic Bioreactors for culture of non-
adherent cells4 
Pranjul Shah1, Indumathi Vedarethinam1, Dorota Kwasny1, Lars Andresen2, Maria 
Dimaki1, Søren Skov2 and Winnie Edith Svendsen1 
1. Technical University of Denmark, DTU-Nanotech, Orsteds Plads, Building 345 East,Denmark 
2.  University of Copenhagen, Department of Veterinary Disease Biology, Stigbøjlen 7, Denmark 
Abstract 
Microfluidic bioreactors (µBR) are becoming increasingly popular for cell culture, sample 
preparation and analysis in case of routine genetic and clinical diagnostics. We present a 
novel µBR for non-adherent cells designed to mimic in vivo perfusion of cells based on 
diffusion of media through a sandwiched membrane. The culture chamber and perfusion 
chamber are separated by a sandwiched membrane and each chamber has separate 
inlet/outlets for easy loading/unloading of cells and perfusion of the media. The perfusion of 
media and exchange of nutrients occur through the sandwiched membrane, which was also 
verified with simulations.  Finally, we present the application of this device for cytogenetic 
sample preparation, whereby we culture and arrest peripheral T-lymphocytes in metaphase 
and later fix them in the µBR. The expansion of T-lymphocytes from an unknown patient 
sample was quantified by means of CFSE staining and subsequent counting in a flow 
cytometer. To conclude on the applicability of µBR for genetic diagnostics, we prepare 
chromosome spreads on glass slides from the cultured samples, which is the primary step for 
metaphase FISH analysis. 
Key Words 
Microfluidic Bioreactors (µBR), non-adherent cells, cytogenetics, membrane-based bioreactor, 
T-lymphocytes 
 
 
 
                                                            
4 As published in journal ‐ Sensors and Actuators B: Chemical 2011 
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3.2.1 Introduction 
Despite successful demonstrations and obvious benefits of µBRs, traditional cultures continue 
to be very widely used in diagnostic labs in flasks, multi-well plates, bioreactors, etc.[138]. 
There are a number of outstanding issues hampering the widespread clinical adoption of the 
µBRs [139], mainly owing to lack of user friendliness, routinely occurring bubble issues [140-
142], problems with interfacing with the macro-world (interconnections), cumbersome 
processes for depositing/seeding cells, biocompatibility [143] and finally adaptability to 
culturing various cell types (adherent or non-adherent cells) [144, 145]. These issues have 
delayed the mainstreaming of µBR despite the inability of traditional methods to provide to 
the cells controlled microenvironments resembling their in vivo state (short distances between 
cells, continuous perfusion of nutrients, waste removal, cellular structures providing 
adhesion) [146]. Meanwhile, traditional culture techniques (such as transwell membranes and 
gel based 3D cultures) continue to be laborious and expensive. Recently, it has also been 
noted that cells routinely alter their morphology, metabolism and growth rate in culture 
flasks [147]. Hence, there is clearly a need to replace the existing traditional techniques with 
more controlled, in vivo like novel cell culture techniques to enable better understanding of 
cell biology [148]. Microfluidic based µBR’s can offer this by helping us benefit from 
specialized and microenvironment controlled cell culture systems offering possibilities of 
more relevant and in-vivo like in vitro studies currently not possible with traditional 
techniques (e.g. gradient analysis  [149, 150], drugs screening [151, 152],   chemotaxis [153-
155], stem cell differentiation  [156, 157], etc. 
In recent years, a steady input of publications demonstrates successful culture of various cell 
and tissue types [158-160] and even co-cultures models [161-163], highlighting a promising 
future for µBRs in cell biology, neurobiology, genetics, proteomics, pharmacology and tissue 
engineering among others. While a vast amount of research has been put into solving 
problems like biocompatibility [142, 143], bubbles [141, 142], interconnections [129, 164]; there 
is still considerable lack of efforts in developing µBRs capable of handling non-adherent cells 
and providing them with a “homeostasis” microenvironment [146, 165]. This has also been 
influenced by the fact that the majority of analysis in cell biology and tissue engineering 
needs culture of adherent cells [113, 114, 125, 144, 166-168] which allows for perfusion over 
the cells attached to a surface unlike in the case of non-adherent cells that require a trapping 
mechanism.  
Contrary to the popular interests, our development efforts with respect to µBRs have mostly 
focused on non-adherent cell cultures mainly due to interests in developing a lab-on-chip 
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device to perform fluorescence in situ hybridization (FISH) on a chip.   In order to enable a 
micro total analysis system (µTAS) capable of performing FISH, we needed to recreate a 
sample pre-treatment device capable of replacing traditional culture flasks and titer plates, 
which can culture whole blood, arrest T-lymphocytes in metaphase, followed by subsequent 
inducement of a hypotonic state and ending with the fixation of the cells [84, 91]. Earlier work 
with non-adherent cell cultures has failed to provide a successful alternative to culture flasks 
due to the complexity of the devices and cell seeding procedures [169] and also due to the 
complexities with respect to retrieving the cells after culture for ensuing analysis [170-173]. 
Cytogenetists routinely perform the above mentioned sample preparation of whole blood 
into fixed metaphase cells for routine genetic analysis [68, 74, 174-177]. Slight variations of 
this sample pre-treatment methods form the initial steps of the majority of the cytogenetic 
diagnostic tests [178-185]. Hence, a device which can perform an automated sample 
preparation including expansion of T-lymphocytes (by mitogenetic stimulation with PHA), 
arrest of stimulated interphase cells in metaphase (by colcemid) and finally fixation of 
metaphase cells (using fixative – acetic acid:methanol (1:3)) can constitute a big leap in 
pushing µBRs into genetic labs for diagnostic sample preparations among many possible 
applications. 
We have developed an innovative µBR enabling diffusion based perfusion to cells suspended 
on a sandwiched membrane separating the culture and perfusion chamber [Fig. 3.2]. 
Successful tests confirm that the presented µBR continues to provide the benefits generally 
associated with miniaturized microfluidic devices: low cost, portability, reduced sample and 
reagent volume, suitability for visual inspection, bubble free operation, chemical resistance 
against harsh solutions like fixative and biocompatibility. Moreover the device provides easy 
and effortless handling of non-adherent cell cultures on a microfluidic device. Our µBR there 
constitutes a simple and easy solution for cytogenetic sample preparation for culturing whole 
blood for expansion and arrest of T-lymphocytes, providing hypotonic treatment and finally 
fixing the cells for subsequent analysis. Moreover, by means of separation of 
loading/unloading of cells and perfusion channels using a two chamber approach, we have 
now enabled easy retrieval of cells followed by culture and/or fixation based pre-treatment. 
We present the results of the quantification process for the expansion of T-lymphocytes by 
means of CFSE staining. Finally, we validate the applicability of our µBR for diagnostic 
protocols by preparing chromosome spreads as a starting point for metaphase FISH analysis. 
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Figure 3.2: Schematic of the µBR. (Top) culture chamber (bottom) perfusion chamber (middle) sandwiched PC membrane 
3.2.2. Materials and Methods 
3.2.2.1 Reagents and Materials 
Polycarbonate (PC) sheets were ordered from Nordplast. 5 µm pore sized PC membrane 
(Whatman 7060-4713) was ordered from VWR Denmark. The other reagents and materials 
used for the experiments like Silicone tubing, Teflon tubing, RPMI (Invitrogen: SKU 72400-
021), phytohemagglutinin (PHA), Fetal bovine serum (FBS) (Sigma-Aldrich:F9665), colcemid, 
acetic acid, methanol, DI water, ethanol, 3 way port valves, microscope slides, 4' 6-Diamidino-
2-phenylindole (DAPI) and Ficoll-Paque plus were ordered from VWR Denmark and other 
traditional suppliers as listed. CFSE stain for cell viability assays was ordered from 
Invitrogen, Germany. The solvent for bonding the PC sheets was freshly prepared by mixing 
isopropanol: acetylacetone (1:1). The devices were milled with a micromilling machine 
(Folken Industries, Glendale, USA) using tools ordered from Kyocera Inc. And finally, the 
devices were bonded in a bonding press (P/O/Weber, Remshalden, Germany) after exposure 
with a UV light source (Dymax EC5000, Connecticut). A flow cytometer from Accuri C6 was 
used for cell proliferation assays. A Zeiss Axio Observer Z1 microscope was used for analysis 
of spreads. 
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3.2.2.2 µBR Design 
The µBR consists of two chambers: a culture chamber and a perfusion chamber separated by a 
sandwiched PC membrane [Fig. 3.2]. The culture chamber is designed in the form of a single 
monolithic chamber, while the perfusion chamber consists of a meandering channel allowing 
for even diffusion of media in the entire culture chamber and rapid removal of any bubbles 
arising in media. Both chambers have separate access inlets and outlets for easy seeding and 
retrieval of cells, and perfusion of media, see Fig. 1. All inlets are connected to a 3 way 
stopcock allowing us to avoid bubbles during changing of media and other reagents. The 3 
stopcocks also allow for easy loading/unloading of cells in the culture chamber and later, for 
changing perfusion of various reagents in the perfusion chamber.  The cells are loaded in the 
culture chamber through the cell inlet and retrieved for further analysis via the cell outlet. 
Once the cells are loaded, the cells inlet is closed and the perfusion inlet is used to perfuse the 
cells via diffusion through the PC membrane. The steps of the µBR protocol and 
corresponding valve states are shown in Table 1. 
Table 3.1: Cell culture protocol for µBR with state of valves at each stage and inlet/outlet operation type. *The time of 
culture is dependent on the cell type  and length of experiment (generally ranges between 48 h and 3 weeks). 
 
 
3.2.2.3 µBR Simulation 
We conducted an extensive simulated study of the flow through our µBR to validate our 
hypothesis of providing even diffusion based perfusion in the entire cell culture chamber. The 
simulations were done using Comsol Multiphysics 3.5 and combining the Convection and 
Diffusion and the Generalised Laminar Flow modules. There are three subdomains used: the 
culture chamber, the membrane and the perfusion channel. The subdomain representing the 
membrane has been simulated using the Darcy law for convection in porous media. Thus a 
term of a volume force on the liquid given by uF
rr ⋅−= α  has been added in the flow mode, 
where u
r
 is the velocity of the fluid and α is a constant that can be roughly calculated using 
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the Darcy number. This is given by Da=η/α · L2, where η  is the viscosity of the fluid and L  is 
the characteristic length scale of the system. By assuming a value for the Darcy number equal 
to 410−  and the typical length scale of our system to be 10 µm, we can calculate that
sm
kg
3
11101⋅=α 5. For diffusion through the membrane the diffusion coefficient of the 
diffusing species has been altered by multiplying with the porosity of the membrane, which is 
a good approximation. 
Two main types of simulative studies were undertaken to optimize the experimental protocol 
for µBR. In the first case we would like to see how long it takes for the media to be exchanged 
with another, e.g. when adding KCl through the perfusion inlet for the hypotonic treatment. 
The flow problem was solved in steady state and the result used for the Convection and 
Diffusion problem, where the concentration in the perfusion inlet was set to 1. The diffusion 
coefficient for KCl was set to sm /102
29−⋅ . 
In the second case we would like to see how the diffusion of media through the membrane 
occurs during the culturing phase. In this case the concentration of the various relevant 
species, e.g. oxygen and glucose is already established in the entire domain, as the chamber 
and perfusion channels are primed. By assuming that half the chamber volume is occupied by 
glucose consuming leukocytes, we simulated the concentration of glucose into the culture 
chamber when a certain amount is being consumed by the cells (set to sm
mol
3
41066.2 −⋅
) 
[186]. The diffusion coefficient of glucose was set to sm /107.6
210−⋅ [187]. 
 
3.2.2.4 µBR Fabrication 
The µBR is fabricated in two parts by micromilling in 1 mm thick PC sheets. The top [Fig. 3.2] 
part consists of the 250 µm deep culture chamber with cell inlet and cell outlet. The bottom 
part consists of the 300 µm deep and 500 µm wide perfusion meander with connected 
perfusion inlet and outlet. The overall chip dimensions are 26 mm x 30 mm. The 
interconnections for the inlets and outlets are formed by embedding silicon tubing while 
bonding the two parts [188]. A PC membrane with 5 µm pore size is sandwiched between the 
                                                            
5  The characteristic length has been changed to 10 µm (thickness of the membrane), resulting in α = 1011 kg/ 
m3s. This has modified the filling pattern in the bioreactor slightly [Fig. 3.4]. An erratum has been sent to the 
Sensors and Actuators B. 
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two parts during bonding providing the scaffold for the cell culture and diffusion of media 
and nutrients.  
3.2.2.5 µBR Bonding 
In order to bond the two parts, UV activated solvent bonding was used. The two parts were 
exposed to a UV light source for 30 s followed by 5 s exposure with solvent 
(isopropanol:acetylacetone(1:1)).  In order to have a uniform exposure of the two parts to the 
solvent, the solvent is applied to a tissue and the two parts are lightly rubbed on to the wet 
tissue for 5 s. The two parts are allowed to rest for 15 s to allow for evaporation of the solvent. 
Finally, PC membrane and silicon tubings for interconnections are placed between the two 
parts and put in a P/O Weber bonding press at 125 °C with 10 kN pressure for 45 minutes.  
It is critical to place the membrane without leaving any crease for leak-free bonding. Hence, 
the membrane was stretched at the edges after placing it between the two parts. The bonding 
protocol had to be optimized for providing leak-free bonding and to guarantee successful 
evaporation of the bonding solvent from the µBR. In order to allow for successful evaporation 
of the bonding solvent through the PC parts, we increased the time of the bonding from the 
recommended 30-45 min. Although leak proof bonding was achieved after only 20 min of 
bonding, we wanted to ensure with the extra bonding time that no solvent was trapped in PC 
which could prove toxic for the cells. The bonded device is allowed to cool under pressure 
down to 50°C before releasing the pressure and removing it from the bonding press to 
compensate for the stress induced during cooling of PC. 
 
3.2.2.6 Sample Isolation 
A blood sample from a healthy donor was acquired from the blood bank. In order to purify 
and isolate the peripheral lymphocytes, Ficoll-Paque PLUS (GE Healthcare: 17-1440-02) was 
used to fractionate the several blood components by centrifuging at 2500 rpm for 15 min (as 
described by the manufacturer). The sample was adjusted to 2 × 106 cells/mL using RPMI 
1640 + 10% fetal bovine serum (FBS). 
 
3.2.2.7 CellTraceTM   CFSE   Staining 
The cells were stained with CellTraceTM CFSE fluorescence stain at a concentration of 0.7 µM 
in phosphate buffer saline (PBS) and incubated at 37°C for 15 min. The cells were re-pelleted 
and resuspended in pre-warmed cell culture medium and incubated for 30 min. The cells 
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were then centrifuged and resuspended in pre-warmed fresh medium and subjected to 
culturing. 
3.2.2.8 µBR culture tests 
In order to sterilize the µBR, the device was entirely filled with 10% ethanol solution for 5 min 
and later washed with PBS for 10 min. This was done also to prime the chip and remove any 
trapped air in the culture and perfusion chamber. Before seeding of cells, the device was 
perfused with RPMI 1640 + 10% FBS for 1 h using 37.5 µL/h flow rate (equivalent to 0.1 
chamber volume/min) at 37 ⁰C to stabilize the temperature of the device under the culture 
conditions. A 500 µL buffy coat containing 2 ×106 cells/mL was seeded into the culture 
chamber through the cell inlet by opening only the perfusion outlet connected to the waste 
collector. This ensured that all the cells were trapped on the membrane while the media 
solution containing the cells was filtered through the membrane to the perfusion outlet. The 
cells inlet was then closed and followed by perfusion of media through the perfusion inlet at 
75 µL/h (0.2 chamber volume / min) with RPMI 1640 + 10% FBS containing 10 µL/mL PHA. 
After 72 hours of mitogenic stimulation, we stopped the perfusion and collected the cells 
through the cell outlet by flushing media from the cell inlet. As the cells are loaded through 
the membrane, a slower flow rate is used for loading to avoid excessive pressure on the cells 
which could diffuse through the 5 µm pores. The unloading flow rate is faster compared to 
the loading flow rates as the unloading does not occur through the membrane. The collected 
cells were observed using a fluorescence cytometer to confirm the expansion of the cells. For 
control experiments, in parallel to the µBR cultures, CFSE stained cells were cultured in 
culture flasks and similarly observed using a fluorescence cytometer. 
 
3.2.2.9 µBR sample pre-treatment tests 
In experiments, where we wished to perform the FISH sample pretreatment using a patient 
sample, we followed the µBR culture protocol and then we replaced the media with 75mM 
KCl solution at 0.4 chamber volume/min (150µL/h) for 25 min. This hypotonic treatment 
induced swelling of the cells. The µBR cell culture chamber is then perfused with freshly 
prepared cold fixative (acetic acid:methanol(3:1)) at 0.4 chamber volume/min (150 µL/h) for 
30 min. Between each change of perfusion, we removed the bubbles in the syringes using a 3 
port valve. For control cultures, the traditional FISH slide preparation protocol was 
performed as described in section 3.2.2.10. 
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3.2.2.10 Control FISH slide preparation protocol 
To prepare the control slides with chromosome spreads, we added 500 µL of buffy coat 
containing 4×106 cells/mL to 10 mL of RPMI 1640 + 10% FBS containing 10 µL/mL PHA 
(Invitrogen: SKU 10576-015) and incubated them at 37°C and 5% CO2 for 68 hours. Later, the 
cells were arrested in their metaphase by adding 6 µg/mL colcemid for 2 hours. The cells 
were centrifuged at 190 × g for 10 minutes and the supernatant was discarded. The isolated 
pellet was then resuspended in 10 mL 75 mM KCl (Sigma-Aldrich P9327) for 20 min before 
the cells were collected by centrifuging at 190×g for 10 minutes. The supernatant was 
discarded leaving the pellet in about 0.5 mL of KCl solution. Slowly 10 mL of fixative 
(methanol:acetic acid(3:1)) was added a drop at a time all the while continuously mixing on a 
vortex. Finally, the fixed cells were collected at 190 ×g for 10 min, and the same fixation 
process was repeated twice more to confirm fixation of the entire pellet.  
 
3.2.2.11 Spreading of chromosomes 
In order to test the viability of the proposed µBR, the retrieved fixed cells from the control 
and the µBR sample preparation tests were tested by preparing chromosome spreads on a 
glass slide. Acquiring good chromosome spreads forms the first and major step of successful 
metaphase FISH analysis [189, 190]. It also provides a confirmation of successful expansion of 
the lymphocytes, followed by arrest and fixation. To prepare the chromosome spreads, 
standard microscope glass slides were treated with a corona system for 1 min, resulting in a 
wetting behavior of the glass surface as described by Haubert et al.[191] The slides were 
stored in cold water at 4ºC in a coplin jar. The slides were removed from the jar carefully 
leaving a thin water film on the surface of the slide. Two drops of fixed cells were applied to 
the wetted glass surface using a pipette in order to cover the entire glass slide. Later the glass 
slide was left to dry at room temperature overnight. The chromosome spreads achieved were 
stained with DAPI and observed with a fluorescent microscope.  
 
3.2.3. Results and Discussion 
3.2.3.1 µBR Fabrication  
The final device after bonding is shown in figure 3.3. During the bonding process, the PC 
membrane becomes an integral part of the PC sheets. The suspended membrane creates an 
optical effect of a transparent overall µBR and blurry cell culture and perfusion chamber.  
Evoluting microfluidics: Moving toward clinical applications 
 
66   
 
 
 
Figure 3.3: µBR with the interconnections 
3.2.3.2 µBR Simulation  
Figure 3.4 shows the diffusion of KCl into the culturing chamber when entering through the 
perfusion inlet 200, 1000 and 2000 s after switching the fluid from media to KCl. The 
simulation shows that after 2000 sec, corresponding to about 33 min, the solution in the 
culture chamber is almost completely replaced by KCl. In the experiments we have used 25 
min of perfusion time for KCl, as it is not necessary to fully exchange the fluid to achieve cell 
swelling. Simulations dealing with the concentration of glucose when assuming that cells are 
consuming a certain amount per second per volume showed that for at least 72 hours the 
glucose concentration remains roughly the same as in the buffer solution. This means that the 
culture chamber provides the cells with adequate nutrients throughout the culture period.  
3.2.3.3 µBR protocol 
The overall culture protocol is illustrated in Table 3.1. The process starts with sterilization and 
priming of the chip followed by seeding of cells via cell inlet.  Figure 3.5 shows the seeded 
lymphocytes on top of the membrane in the culture chamber. The pores in the PC membrane 
can be seen in the background. After 72 hours of mitogenic stimulation, there was an evident 
increase in the size of the cell cytoplasm [Figure 3.6]. After completion of µBR protocol the 
cells were collected and studied in a cytometer for validating the expansion of the cells by 
means of CFSE stain. In order to test the reusability of the µBR, which might be applicable for 
industrial batch  processes, we re-cleaned the µBR with 10% ethanol and tested again with the 
µBR culture protocol [see- supplementary information].  
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Figure 3.4: The diffusion of KCl through the membrane for complete media exchange in the culture chamber. Diffusion 
occurs both through the perfusion channel/membrane interface and through the culture chamber. 
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Figure 3.5: Cells on day 1 on the membrane 
 
Figure 3.6: Proliferated cells on the membrane on day 4. It was difficult to focus on the membrane on day 4 due to multiple 
layers of cells. 
 
3.2.3.4 CFSE Proliferation assay: 
The collected cells were tested for proliferation in a flow cytometer by using CFSE staining of 
the cells. CFSE is a fluorescent stain that is retained within the cells throughout development 
and mitosis. The label is inherited by daughter cells after cell division but will have a lower 
florescence intensity which can be monitored on a flow cytometer. The CFSE stained cells 
were either left untreated or stimulated with PHA and cultured in the µBR device for three 
days and then analyzed for fluorescence intensity on a flow cytometer. In parallel, as a 
control, we also cultured cells with or without PHA stimulation in a normal plastic culture 
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dish. As seen in figure 3.7, a large fraction of PHA stimulated cells cultured in the µBR device 
started to proliferate as seen by the decrease in fluorescence intensity when compared to 
unstimulated cells.  
On comparing the µBR results of the expansion of lymphocytes with the expansion on the 
petri dish, it is clearly evident that the µBR shows much better proliferation, depicted by the 
well defined second and emerging third peak in the CFSE fluorescence intensity from the 
chip sample data. 
 
Figure 3.7:  Control and PHA stimulated growth count for 3 days culture in culture flask and on chip 
3.2.3.5 Spreading of the chromosomes: 
The cells retrieved from the µBR and control cultures after the FISH sample preparation 
protocol i.e. expansion, hypotonic treatment and fixation of the cells were spread on glass 
slides. The spreads obtained were stained using DAPI and observed in an AxioVision Z1 
Observer microscope. The results of the spreads received from the control and the µBR are 
presented in figure. Ample metaphase chromosome spreads were achieved on the glass slides 
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for µBR confirming successful sample pre-treatment and expansion of the peripheral 
lymphocytes [Fig. 3.8].  On further evaluation, we found no differences in the number and 
quality of the spreads from control and µBR samples, suggesting that the diffusion-based 
feeding provides a viable alternative for the expansion of peripheral T-lymphocytes and 
clinical cytogenetic sample preparation. 
 
Figure 3.8: (Left) metaphase spreads from control samples (Right) metaphase spreads from µBR samples 
3.2.4. Conclusion 
A novel microfluidic bioreactor (µBR) was presented to enable controlled culture of non-
adherent cells. The proposed device was tested with peripheral T-lymphocytes for sequential 
expansion as well as for cytogenetic slide preparation. The proposed µBR provides an easy 
and user-friendly solution for non-adherent cell cultures. The µBR tackles some of the most 
common challenges with respect to non-adherent cell cultures like providing diffusion based 
perfusion, shear stress, easy loading/unloading, removal of waste, trapping of cells, etc. The 
simple design with separate inlet/outlet for cells and perfusion chamber provides ease of 
handling and possibility of automating the protocol in the future. There are numerous other 
venues where the proposed device could prove beneficial and highly applicable such as co-
cultures and adherent cell cultures. This device will soon be deployed in collaborating clinics 
to test its validity in clinical setups. We are also in the process of testing the presented µBR 
device for long term amniocytes culture for prenatal diagnostics. 
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Supplementary data 
Reusing the µBR: 
The µBR was reused to check the possibility of using the same device for more than one 
occasion. In order to clean the chip, the chip was flushed with 10% ethanol solution for 30 
min. After this, the µBR culture protocol was performed using cells stained with CFSE. We 
tested the cell expansion using a flow cytometer with CFSE staining. The decrease in the 
intensity of the fluorescence shows successful proliferation of the T-lymphocytes on the 
reused chip. While not suitable for medical diagnostic applications, reusability of µBR can 
prove beneficial in industrial batch fermentation applications or in low resource settings. 
 
Figure 3.9: PHA stimulated growth count for 3 days T-lymphocytes culture on a reused chip.  
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Abstract: We present a novel integrated device for preparing metaphase chromosomes 
spread slides (FISHprep). The quality of cytogenetic analysis from patient samples greatly 
relies on the efficiency of sample pre-treatment and/or slide preparation. In cytogenetic slide 
preparation, cell cultures are routinely used to process samples (for culture, arrest and 
fixation of cells) and/or to expand limited amount of samples (in case of prenatal 
diagnostics). Arguably, this expansion and other sample pretreatments form the longest part 
of the entire diagnostic protocols spanning over 3–4 days. We present here a novel device 
with an integrated expansion chamber to culture, arrest and fix metaphase cells followed by a 
subsequent splashing protocol leading to ample metaphase chromosome spreads on a glass 
slide for metaphase FISH analysis. The device provides an easy, disposable, low cost, 
integrated solution with minimal handling for metaphase FISH slide preparation. 
 
Keywords: Fluorescence In Situ Hybridization (FISH); lab on chip; genetic analysis; 
cytogenetics; chromosome spreading; metaphase FISH; chromosomal translocations 
3.3.1. Introduction  
Fluorescence In-Situ Hybridization (FISH) is an indispensable molecular cytogenetic 
technique for diagnosis of both inherited and acquired chromosomal abnormalities at a much 
higher resolution than conventional karyotyping[73, 74, 85, 192-199]. Novel FISH based 
techniques are commonly used in diagnosis of various diseases. Recently, interphase FISH 
has gained much popularity, and as a result metaphase FISH has received lesser attention, 
which has significantly derailed the progress made in progressing metaphase FISH analysis 
technologies [78, 80, 90]. Interphase FISH offers numerous advantages compared to 
                                                            
6 As published in journal – Micromachines 2011 
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metaphase FISH, such as better resolution (down to 1–15 kB) [200-203], wide range of 
commercial probes [204-208], shorter analysis time (for prenatal studies, dysmorphology, 
tumor-specific markers) [181, 195, 200, 209-213] and finally advantages of commercial 
imaging systems reducing data analysis time[214]. However, interphase FISH has limitations 
with respect to identification of unknown chromosome abnormalities and rearrangements 
like translocations. This is because interphase FISH relies on the availability of probes, which 
limits its applications only for the identification of known translocations[84, 215, 216]. As a 
result, metaphase FISH, still continues to be widely used for diagnosis of chromosomal 
aberrations in case of unknown translocations[217]. 
 
Most of these FISH-based techniques have very similar sample preparation protocols and 
despite such widespread use of FISH analysis, the sample preparation continues to be a 
manual, cumbersome and lengthy process leading to significant delays in the diagnosis as 
well as subsequent treatment of patients. Slide quality is one of the most important factors 
affecting the efficiency of FISH probe hybridization, and also the intensity and clarity of the 
FISH signals. Also, it is widely known that in all conventional metaphase preparations there 
are a large number of nuclei present suitable for interphase FISH studies[196]. Hence an 
automated system for FISH sample preparation can prove beneficial in multiple venues[73]. 
Considering the need for culturing various other cell types for FISH sample preparation 
(lymphocytes, amniocytes, chorionic villi and solid tumors), it would be highly beneficial to 
integrate the culturing protocol in such a system. This is particularly true in case of prenatal 
diagnosis, where the starting sample volume is not large enough to run all the necessary 
diagnosis tests. 
 
Carefully evaluating the sample preparation protocol, it becomes evident that the most time 
consuming step is the expansion or culture of the lymphocytes (or other cell types like 
amniocytes, solid tumors, etc.) often taking from 72 h up to two weeks. Due to our interest, 
we only focus on metaphase FISH analysis and will not detail the steps of immobilization and 
preparation of interphase cells. However, every metaphase preparation includes cells in the 
interphase phase as well. For more information kindly refer to novel techniques for 
interphase FISH and related protocol for cells immobilization[80, 90, 218]. 
 
Molecular Cytogeneticists are extremely aware of the importance of preparing good 
metaphase chromosome spreads for getting a reliable FISH analysis[189, 190, 219]. The 
conventional short term protocol for preparing metaphase chromosome spreads from 
lymphocytes includes a 72 h cell expansion (with mitogenic stimulation) step, followed by 
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arrest of cells in metaphase and later fixation in Carnoy’s fixative (1:3 vol:vol—acetic acid and 
methanol). Once fixed, the cells are splashed on a glass slide with a thin film of water on it, in 
order to form the chromosome spreads. While it sounds trivial and continues to be a very 
common protocol in cytogenetic labs, there are numerous variants of slightly modified 
protocols prevailing among the community with differences in time of culture, fixation, 
volume of stimulant, mitotic arrest and a vast number of different methods to prepare the 
chromosome spreads on the slides[189, 190, 219].  
 
While many devices for controlled spreading of chromosomes exist, none of these devices 
have included integrated cell expansion and fixation chamber into the spreading device[190, 
220, 221]. As a result, these steps (expansion, arrest and fixation) still need to be performed in 
traditional culture flasks. Also, the size of these existing spreading devices tend to be much 
larger compared to the proposed FISHprep device. This has led to reduced applicability or 
usage of these chromosome spreader or dropper tools, as they can be readily replaced by a 
pipette in the hands of a skilled technician. We have recently presented an integrated device 
to perform Metaphase FISH on a chip and included a splashing protocol for preparation of 
these metaphase spreads[84]. But we feel that lack of a complete sample pre-processing 
device (i.e., Culture, Arrest and Fixation of cells) coupled with a mechanism to prepare 
chromosome slides has been the missing link for designing a fully automated sample-to-FISH 
analysis device. Hence, we have developed FISHprep—a novel splashing device integrated 
with a microfluidic cell culture chamber capable of cell expansion, arrest, fixation and finally 
splashing of fixed cells on a glass slide to provide metaphase chromosomes spreads for 
further FISH analysis. This device provides an easy to handle, low cost, disposable, integrated 
solution for the entire metaphase FISH slide preparation protocol. 
3.3.2. Experimental Section 
3.3.2.1. Materials and Chemicals 
Polycarbonate (PC) sheets procured from Nordplast (Denmark) were used to fabricate the 
FISHprep device. Glass slides (SuperFrost), syringes, 3 port valves, paper clips, silicone 
tubings, Teflon tubings and a 5 µm pore sized PC membrane (Whatman 7060-4713) were 
ordered from VWR Denmark. Chemical reagents such as Phosphate Buffered Saline (PBS), 
phytohemagglutinin (PHA), Roswell Park Memorial Institute (RPMI) medium, Fetal bovine 
serum (FBS) were ordered from Sigma-Aldrich. Carboxyfluorescein succinimidyl ester (CFSE) 
stain used for viability studies was ordered from Invitrogen Germany. DAPI (4’,6-diamidino-
2-phenylindole) (Invitrogen) was used as a counter stain for coloring the chromosomes. 
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Experiments were conducted using blood samples from unknown donors received from the 
Blood Bank of the Rigshospitalet in Denmark. 
3.3.2.2. Apparatus 
A micromilling machine (Folken Industries, Glendale, AZ, USA) was used for milling the 
FISHprep devices parts and a UV light source (DYMAX EC5000) was used for treating the 
surfaces before bonding them under pressure in a bonding press (P/O/Weber, Remshalden, 
Germany). Finally, a Zeiss Axio Observer Z1 Fluorescent microscope was used for analysis of 
the spreads and a flow cytometer (Accuri c6) was used for analysis of cell proliferation. 
3.3.2.3. Fabrication 
A schematic of the FISHprep device is shown in Figure 3.10.  
 
Figure 3.10: Exploded view of the FISHprep device top and bottom part. A polycarbonate membrane is sandwiched between 
the two parts to form the barrier between the culture chamber and perfusion meander. 
The device is fabricated by micromilling in Polycarbonate Sheets. The bottom part contains a 
meander channel (1 mm wide, 300 µm deep) for perfusion and a slot for sliding in glass slides 
(56 × 26.2 mm). The top part contains a cell culture chamber (250 µm deep) with a cell inlet 
channel and a cell outlet channel connected to the splashing chamber’s fixed cells inlet. It also 
includes another channel to act as an inlet for splashing water on the glass slide. A 
polycarbonate membrane (5 µm pore size) is sandwiched between the perfusion channel and 
the cell culture chamber during the bonding process of the two parts. The two parts are 
bonded together using UV activated bonding[188]. First the two parts are wiped clean with 
IPA followed by rigorous wash with a detergent soap and water. Subsequently the two parts 
are thoroughly air dried and exposed to UV for 45 s. Before putting the two parts together a 
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PC membrane and interconnection plugs (Silicon tubing: Outer Diameter (OD) 3 mm, Inner 
Diameter (ID) 1 mm) are placed on the lower part. A Silicon tubing U-plug is placed at the 
cell outlet of the culture chamber and connected to the fixed cells inlet of the splashing 
chamber. Finally, the top part is placed on the lower part and put in a P/O/Weber bonding 
press at 130 °C for 30 min.  
3.3.2.4. Paper Clip Valve: Leakage Test 
In order to connect the culture chamber and splashing device, we have devised a simple and 
easy paper clip based valving strategy. This strategy was adopted in order to utilize tools 
commonly available in the cell labs and also to keep the protocol simple. A 3 mm OD silicone 
tubing is bonded from the cells outlet to the cells inlet of the splashing device [Fig. 3.11]. The 
tubing forms an external U-section out of the device providing enough room for putting on a 
paper clip to stop the flow. The paper clip valve was tested at increasing flow rates to identify 
the maximum permissible flow rate before leakage occurs and to validate the applicability of 
these valves for the cell culture protocol. The flow rate was increased gradually using a syringe 
pump and the flow rate at which the device leaked was recorded. 
  
Figure 3.11: (a) Bonded FISHprep device (b) FISHprep device depicting paper clip based valving procedure. 
3.3.2.5. Culturing Protocol  
The device is cleaned and primed by flushing 10% ethanol solution for 5 min and later 
washed with PBS for 10 min to remove any traces of ethanol from the culture chamber. This 
priming and sterilization helps to remove any trapped air in the culture and perfusion 
chamber. Before cells are seeded in the culture chamber, the device is perfused with RPMI 
1640 + 10% FBS for 1 h at the flow rate of 37.5 µL/h (the device is kept at 37 °C in a CO2 
incubator). A 500 µL buffy coat with a cell count of 2 × 106 cells/mL was seeded into the 
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culture chamber through the cell inlet by opening only the perfusion outlet connected to the 
waste collector. This protocol for seeding ensures that all the cells get trapped onto the 
membrane while the suspension media is filtered out from the perfusion outlet. Finally, the 
cells inlet is closed and a perfusion of fresh media is started through the perfusion inlet at 75 
µL/h with RPMI 1640 + 10% FBS containing 10 µL/mL PHA. After 72 h of mitogenic 
stimulation, the perfusion is stopped and after wait time of 5 min, (which ensures that the 
flow has completely stopped) the paper clip valve is opened and the spreading protocol is 
initiated. Cells seeded in a well plate served as a control for the expansion experiments. 
3.3.2.6. CFSE Staining Protocol 
In order to confirm the expansion of lymphocytes on the culture chamber, the cells were 
stained with CellTraceTM CFSE fluorescence stain (Invitrogen, Germany), at a concentration of 
0.7 µM in phosphate buffer saline (PBS) and incubated at 37 °C for 15 min. The cells were later 
re-pelleted and resuspended in pre-warmed cell culture medium and incubated for 30 min. 
The cells were then centrifuged and resuspended in pre-warmed fresh medium and subjected 
to culturing in the FISHprep culture chamber. The CFSE stained cells were stimulated with 
PHA and cultured for 72 h. Finally, the cells were collected through the cell outlet. In order to 
collect the cells after culture to analyze their expansion, the U-plug was sliced via a scalpel 
and disconnected from the splashing chamber. Later, the cells were extracted from the cell 
outlet by flushing culture media from the cell inlet. To conclude on the expansion, the 
collected cells were analyzed for fluorescence intensity using a flow cytometer. 
3.3.2.7. Spreading Protocol 
In these experiments, the aim was to perform the FISH sample pretreatment. Therefore, after 
the culture protocol we replaced the media with 75 mM KCL solution at 0.4 chamber 
volume/min (150 µL/h) for 25 min. This hypotonic treatment induced swelling of the cells. 
Finally, in order to fix the cells, the chamber is perfused with freshly prepared fixative (acetic 
acid:methanol-3:1) at 0.4 chamber volume/min (150 µL/h) for 30 min. Between each change 
of perfusion, by use of 3 port stopcock, it was ensured that the bubbles were removed before 
starting the perfusion. For control, simultaneous cultures were conducted in culture flasks 
followed by the traditional FISH slide preparation protocol[196]. 
On completion of the sample preparation protocol, the paper clip valve was opened, which 
connected the spreading chamber to the cells culture chamber outlet. This allows the flushing 
of fixed cells from the culture chamber on the glass slide. A glass slide treated with corona for 1 
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min is inserted into the splashing chamber slide slot. The corona treatment helps to activate the 
surface and improves the wetting behavior of the slide leading to better spreads[191]. Finally, 
in order to create metaphase spreads on the slide, a drop of cold water is dropped on to the 
glass slide via the separate inlet for water. This is quickly followed by a drop of fixed cells 
suspension from the cell chamber by opening the paper-clip valve. The slide is allowed to dry 
for 2 min before removing it from the FISHprep device. This is currently done manually by use 
of syringe pumps, which opens the possibility of automation in future. The process is repeated 
onto three to four slides in order to have ample slides to have quantified FISH analysis (it is a 
routine process in standard FISH analysis to prepare at least three slides). For the control 
cultures, the traditional metaphase FISH sample preparation protocol is followed and later, the 
chromosome spreads are prepared using the dropping technique by an experienced 
technician[196]. 
3.3.2.7. Analysis 
The slides with chromosome spreads are stained with DAPI and sealed with a coverslip. Later 
they are analyzed using an AxioVision Z1 Observer microscope to analyze the metaphase 
spreads and thereby validate the applicability of the FISHprep device for metaphase FISH 
sample preparation. As a final step, the slides prepared with FISHprep device were analyzed 
using the traditional metaphase FISH protocol[196]. A centromeric probe targeting X-
chromosome (Kreatech, NL) was used for the FISH analysis. 
3.3.3. Results and Discussion 
3.3.3.1. Fabrication 
The fabricated FISHprep device is shown in Figure 3.11. The interconnections to the syringe 
pumps are made by inserting a Teflon tubing (OD 1.2 mm) in the silicon plugs (ID 1 mm) 
bonded between the PC sheets. At every interconnection before the syringe, a 3 way valve is 
attached to the Teflon tubing to allow for easy changing of reagents (sterilizing compounds, 
media, fixative, etc.) and removal of bubbles for bubble-free operation device operation.  
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3.3.3.2. Paper Clip Valve: Leakage Test 
The paper clip based valving technique was tested for isolation between the culture chamber 
and the splashing chamber until the cells had been fixed in the culture chamber for 72 h. The 
FISHprep devices were tested for increasing flow rates starting from 150 µL/h up to 750 
µL/h. The flow rate of 150 µL/h represents the maximum perfusion rate for the fixation 
protocol used for sample preparation in the culture and fixation chamber [Fig. 3.12(a)]. The 
first signs of leakage in the device were visible only after 500 µL/min flow rate due to lateral 
flow in the PC membrane at the bonding interface [Fig. 3.12 (b)]. Even at such high flow rates, 
there was no flow through the paper clip valve; the leakage only occurred through the short 
bonding edge in the FISHprep device. Also, it was noticed that the device was still 
functioning well without any leakage, when the flow rate was again reduced to 150 µL/h 
[Fig. 3.12 (b)]. 
   
Figure 3.12: (a) Paper clip valve of the external U-section: Isolation of flow from culture chamber to splashing chamber (b) 
Flow through culture chamber on to the splashing chamber on opening of the paper clip valve (Leakage in the device at 500 
µL/min flow rate).  
3.3.3.3. Expansion and Spreading Protocol 
Figure 3.13(a) shows the seeded lymphocytes on top of the membrane in the culture chamber. 
The pores in the PC membrane can be seen in the background. After 72 h of mitogenic 
stimulation with PHA, we could see a significant increase in the size of the cell cytoplasm 
(Figure 3.13(b)).  
 
Leakage 
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3.3.3.4. CFSE Proliferation Assay 
The cells collected from the FISHprep culture chamber were analyzed in a flow cytometer by 
using CFSE staining of the cells. CFSE stain is retained within the cells throughout 
development and mitosis. On proliferation, the label is inherited by daughter cells but with a 
lower florescence intensity which can be monitored on a flow cytometer. Figure 3.14 shows 
results of fluorescence analysis of 20 µL of FISHprep culture samples. The cells show 
signature peaks of proliferation as depicted by the decrease in fluorescence intensity. In 
contrast, the negative cultures of lymphocytes (without PHA) on the FISHprep device, hardly 
show any growth which confirms that the FISHprep device does not induce any activation or 
expansion of the lymphocytes due to microfluidic handling. As our interests were related to 
procuring ample FISH spreads to conduct a FISH analysis, we didn’t culture the cells for 
longer time or quantify the culture dynamics in the FISHprep culture chamber. It might be of 
interest at a later point to culture cells for longer durations for characterization and 
comparison of the growth pattern of cells on the FISHprep device with traditional cultures. 
There is a possibility that cells in FISHprep culture device might follow a different expansion 
cycle compared to the culture flask[147]. 
         
Figure 3.13: FISHprep culture (a) Cells on Day 0 (b): Cells on Day 3 (background shows pores in the PC membrane). 
(Inset—Enlarged cytoplasm on Day 3). 
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Figure 3.14: CFSE proliferation assay results. Count of cells vs. the fluorescence intensity of CFSE stained cells 
analyzed by fluorescence cytometer. (Control experiments relate to negative control of cultures on FISHprep device 
without PHA stimulation). 
3.3.3.5. Analysis of the Spreads 
The spreads obtained from the integrated device and the control flask cultures were stained 
with DAPI and analyzed using an Axio Observer Z1 microscope. Figure 3.15 (a,b) presents 
the spreads achieved from the FISHprep device and control flask samples respectively. The 
mitotic index in both the slides was found to be above 75%. The spreads on the FISHprep 
device were comparable to the spreads received with control samples.  
 
Finally, Figure 3.16 shows the results of the traditional metaphase FISH protocol applied to 
the samples prepared using the FISHprep device. The FISH signals acquired for the X-
chromosomes in the spreads validate the compatibility of this proposed sample preparation 
technique for cytogenetic analysis. Hence, we concluded the promising applicability of 
FISHprep device for metaphase FISH sample preparation. 
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Figure 3.15: (a) (Top) Chromosome spreads prepared using the FISHprep device (b) (Bottom) Chromosome spreads 
achieved using the manual dropping technique. Offset pictures present high magnification images. 
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Figure 3.16: FISH analysis on the FISHprep samples (The FISH signals indicate the presence of two X-chromosomes in the 
chromosome spreads and cells). 
3.3.4. Conclusions  
A novel, simple, minimal handling, integrated device (FISHprep) was presented for 
processing samples and preparing slides for FISH analysis. The presented device provides a 
simple, low cost, disposable alternative to traditional sample preparation technique including 
culture, arrest, fixation and subsequent preparation of glass slides with metaphase 
chromosome spreads. The inclusion of a membrane based culture chamber into the FISHprep 
device opens possibilities for expanding the applicability of the device to other cell types like 
amniocytes or chorionic villus, where controlled long term expansion of cells is of great 
interest due to small amounts of available sample volume. In the near future, we aim to 
integrate the Metaphase FISH on chip protocol into the FISHprep protocol to create a 
chromosome total analysis system. 
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3.4 Metaphase FISH on chip: Miniaturized Microfluidic Device for 
Fluorescent in situ Hybridization7 
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Abstract: Fluorescence in situ Hybridization (FISH) is a major cytogenetic technique for 
clinical genetic diagnosis of both inherited and acquired chromosomal abnormalities. 
Although FISH techniques have evolved and are often used together with other cytogenetic 
methods like CGH, PRINS and PNA-FISH, the process continues to be a manual, labour 
intensive, expensive and time consuming technique, often taking over 3–5 days, even in 
dedicated labs. We have developed a novel microFISH device to perform metaphase FISH on 
a chip which overcomes many shortcomings of the current laboratory protocols. This work 
also introduces a novel splashing device for preparing metaphase spreads on a microscope 
glass slide, followed by a rapid adhesive tape-based bonding protocol leading to rapid 
fabrication of the microFISH device. The microFISH device allows for an optimized 
metaphase FISH protocol on a chip with over a 20-fold reduction in the reagent volume. This 
is the first demonstration of metaphase FISH on a microfluidic device and offers a possibility 
of automation and significant cost reduction of many routine diagnostic tests of genetic 
anomalies.  
Keywords: Fluorescence in situ Hybridization (FISH); lab on chip; genetic analysis; 
cytogenetics; chromosome spreading; metaphase FISH; chromosomal translocations 
 
3.4.1. Introduction 
During the last decade microfluidic techniques have evolved into a new genre of research 
areas targeting integration of laboratory protocols into miniaturized devices called lab on 
chip (LOC) or micro total analysis systems (µtas) [38-40, 222, 223]. The ability to control small 
                                                            
7 As published in journal – Sensors 2010 
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sample volumes on micro-sized devices is immensely appealing for techniques involving 
handling of ultra small volumes of cells or other analytical samples [224]. This has spurred an 
exponential growth in the number of research articles published in the field of LOC systems 
targeting complex biological protocols to benefit from the low volume, high throughput and 
low cost features provided by the microfluidic devices [91, 224, 225]. We have created a novel 
metaphase FISH chip to benefit from the low dead volumes associated with microfluidic 
devices as FISH protocol reagents and commercial probes are more expensive than gold (over 
$400 for 100 µL of probe used in this work)  [80, 90].  
 
FISH is a sensitive diagnostic cytogenetic tool routinely used to visualize numerical and 
structural chromosomal aberrations [73, 193, 195, 197, 215, 226-229]. The traditional FISH 
protocol includes steps like immobilization of interphase nuclei or metaphase chromosomes, 
probe labeling, RNAse treatment, denaturation of chromosomal and probe DNA, 
hybridization, post hybridization wash and image processing. FISH is routinely used by 
cytogeneticists in applications ranging from chromosome labeling and mapping, 
identification of gene expression sites, tissue analysis, mRNA synthesis tracking, tumour 
genetic alterations monitoring, identifying infections from viruses and other diagnostic 
pathological applications including cancer e.g., leukemia [71, 198].  
Interphase and Metaphase FISH are two types of commonly used chromosomal FISH 
techniques. Each has their specific applications and advantages. Interphase FISH is used to 
identify numerical abnormalities as well as specific structural abnormalities. Thus, Interphase 
FISH depends on a specific probe, e.g., to detect known translocations, microdeletions or 
specific chromosomes and hence can only be used to address questions for which DNA 
probes are available. Lack of conformity of interphase FISH is a major disadvantage when 
using this technique for prenatal diagnostics [86]. On the other hand, metaphase FISH can be 
used to visualize the insertion, deletion or other rearrangement involving a specific region of 
the genome, with a resolution determined by the probe used [228]. Metaphase FISH can be 
performed on samples with unknown translocations by targeting all the chromosomes using 
multi-color FISH probes [85], derived from plasmids, cosmids, bacterial artificial 
chromosomes (BAC) and yeast artificial chromosomes (YAC) [229]. Recently Interphase FISH 
was demonstrated on a microfluidic device which highlights the obvious benefits of 
miniaturizing and automating the FISH protocol in a microfluidic system [78, 80, 90]. But 
metaphase FISH protocol has been elusive owing to the difficulty of handling chromosomes 
on a chip and fixing the chromosomes on a closed microfluidic device [78]. As a result, in 
spite of FISH being a very powerful cytogenetic tool, it continues to be an expensive and 
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reasonably time consuming method. There is clearly a need for replacing the traditional 
method with a fast and low-cost method making this technique widely available and easy to 
handle.  
Our efforts have been directed at designing a miniaturized protocol for performing 
metaphase FISH in a controlled manner on a microfluidic device. It is widely known that the 
results of classical banding techniques, FISH analysis or Comparative Genomic Hybridization 
(CGH) are dependent on the quality of the metaphase spreads [190]. Hence the result of any 
FISH analysis depends on consistency of spreading of chromosomes [230]. During the 90s 
metaphase spreading techniques were widely investigated and many labs developed their 
own version of optimized standard methods [194, 231-235]. This led to a number of theories 
on what determines the quality of metaphase spreads on the glass slide, including the 
distance and the angle of dropping of the fixed cells onto the slide, the diameter of the 
pipette, the evaporation of the fixative, the temperature of the slide, the hypotonic treatment 
of the chromosomes, and the whole air drying process [189, 230, 236]. Renewed interest has 
seen a number of attempts towards making devices for preparation of chromosome spreads, 
which rely on controlled angle and conveyors [221], temperature gradient and humidity [190] 
and most recently the chromosome dropper tool which relies on dropping angle and height for 
fixing metaphase spreads on glass slides [220]. But none of these three devices are remotely 
close to the miniaturized size we are targeting or give any new insights into the mechanism of 
spreading compared to what was already published in the 90s. Through literature review and 
our own preliminary experiments we found that the basis of chromosome spreading is rooted 
in the optimum rate of evaporation of the fixative from the glass slide. Hliscs et al. suggests 
that the mechanism of chromosome spreading is a slow process, which leads to stretching of 
chromosomes via flattening [219]. Spurbeck et al. mentioned that in the process of spreading 
the fixative evaporates, leading to build up of surface tension causing the metaphase cell to 
flatten, which eventually leads to bursting of the cell membrane and spreading of the 
chromosomes [230]. Henegariu et al. also concluded that dropping of chromosomes from a 
height doesn’t improve the spreading [190]. Hence, we concluded that in order to realize a 
micro-splashing device which produces reliable metaphase spreads on a glass slide sufficient 
for conducting routine FISH analysis; we need to incorporate a mechanism to allow for 
optimum evaporation of the fixative leading to stretching of the chromosomes and flattening 
of the cells. This could be aided by environmental factors like temperature of the slide and 
humidity but the focus has to be on maintaining an optimum rate of fixative evaporation. 
In order to account for that, we devised a novel splashing device with open chamber, which 
allows for easy evaporation of the fixative. The device provides 11 mm dropping height with 
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two inlets—one for cold water and one for the fixed mitotic cells suspension. Apart from the 
splashing device, a novel metaphase FISH protocol was developed using a microFISH device. 
This microFISH device provides the possibility of replacing the traditional Coupling Jar and 
turning it into a miniaturized microfluidic device. We have looked into possible replacements 
of glass slides with various common polymers but found them unfavorable for FISH protocol 
on mainly three counts. Firstly, the spreading of the metaphase chromosomes on the glass 
slides is highly aided by the surface properties of the glass like contact angle and free surface 
energy. Secondly, polymers exhibit auto-fluorescent behaviour which hinders the analysis 
due to interference with the FISH probe signals. Finally, some polymers like PMMA couldn’t 
withstand the fixative used for fixing the metaphase chromosomes and cracked on contact. 
Hence, we found it ideal to continue using the traditional microscope glass slides as substrate 
which also offers the benefits of easy integration into existing workplace protocols in 
cytogenetic labs. In order to minimize the time of fabrication of the microFISH device, an easy 
protocol for rapid bonding based assembly has been developed. With this the glass slide can 
be turned into a microFISH device in a matter of seconds by using an adhesive tape-based 
stencil and bonding technique (described later in Fabrication section). The ease of operation 
and handling in this protocol has been targeted to allow non-technical personnel to easily 
conduct these tests. The rapid fabrication protocol leaves room for conducting multiple tests 
simultaneously. In addition, the novel protocol allows for an over 20-fold reduction in 
reagent volume, which is significant considering the costs of commercially available probes. 
We hope that this first demonstration of metaphase FISH on a chip, will spur renewed efforts 
in automating metaphase FISH on a chip leading to wider access to low cost, reliable and fast 
genetic diagnostics in clinical environments. Although the presented device has been 
developed for metaphase FISH, we feel that the protocol could also be applied for Interphase 
FISH. 
3.4.2. Experimental Section  
3.4.2.1. Materials and Chemicals 
Polymethylmethacrylate (PMMA) sheets procured from Nordplast (Denmark) were used to 
fabricate the Splashing device; Polydimethylsiloxane (commonly known as PDMS, Sylgard 184, 
Dow Corning, USA) was used to fabricate the microFISH device. Glass slides (SuperFrost), 
syringes and silicone tubing were obtained from traditional suppliers (Sigma-Aldrich, VWR). 
SU8-2075 resist was ordered from Microchem (Germany). Double-sided adhesive tape AR100 
(50 µm thickness) was procured from Adhesive Research Inc. (Ireland). All the reagents used 
in the FISH experiment were purchased from Invitrogen (Paisley, UK). 1 µL of RNAse (10 
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µg/µL) stock solution was mixed with 99 µL of 2 × SSC for removal of RNA. The probe was 
purchased from Kreatech Diagnostics (Amsterdam, The Netherlands) and it was used as 
recommended by the manufacturer. 20 × SSC (sodium citrate, sodium chloride) was 
purchased from G-Biosciences (USA) and further dilutions were made using Milli-Q water. 
The stock of absolute ethanol was used to make dilutions (50%, 60%, 90%, 99%  
ethanol). 4’,6-diamidino-2-phenylindole (DAPI, Invitrogen) was used as a counterstain used for 
colouring the chromosomes. Blood sample of a female patient was received from the Wilhelm 
Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular 
Medicine. Cold water used for spreading chromosomes was kept at 4 °C. 
3.4.2.2. Apparatus 
A micromilling machine (Folken Industries, Glendale, USA) was used for milling the 
splashing device, 50 W CO2 Laser Machine (Synrad Inc., USA) was used for ablating the 
adhesive tapes, a photolithographic spinner and aligner from Carl-Zeiss were used for 
fabricating the master mould for PDMS microFISH device and a Zeiss Axio Observer Z1 
Fluorescent microscope was used for analysis of the spreads and FISH signals. 
3.4.2.3. Fabrication 
The fabrication protocol has been summarized in Figure 3.17. The figure details the protocol 
for splashing metaphase spreads on the glass slide using the splashing device followed by the 
rapid fabrication of the microFISH device to perform the metaphase FISH analysis protocol. 
The details of the fabrication protocol will be explained in the following subsections. 
3.4.2.3.1. Glass Slide with Stencil  
The stencil for localization of metaphase spreads is created using a double-sided medical 
grade tape. The double-sided adhesive tape is fabricated using a laser ablation process with a 
CO2 laser [105, 106, 135]. The laser is operated at 20 W power at 250 mm/s laser velocity using 
resolution of 800. The operating parameters are set using the Winmark software (Synrad Inc, 
USA). The design of the tape corresponds to the design of the microFISH device (Figure 2). 
When the tape is ablated using the CO2 laser, one side of the tape cover is peeled and the tape 
is bonded to the centre of the glass slide as shown in Figure 3.18. This tape-glass slide 
complex acts as a stencil when the glass slide is used in the splashing chip to create 
metaphase spreads. The localization of the metaphase spreads is achieved by removing the 
top cover of the tape which allows selective patterning on the glass slide in the centre where 
the tape is fully ablated using the CO2 laser for creating the microFISH chamber. 
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Figure 3.17: Schematic Protocol for splashing the metaphase spreads followed by rapid assembly of the microFISH device. 
(a) Bonding of the double-sided adhesive tape stencil on the glass slide; (b) Spreading of the metaphase spreads in the 
splashing device; (c) Peeling off the top cover of the double-sided tape stencil to leave only the spreads in the centre of the 
glass slide and to expose the adhesive layer to bond the PDMS microFISH lid; (d) Aligning the PDMS lid on to the 
adhesive tape; (e) Assembly of the microFISH by bonding the PDMS lid on to the tape using gentle pressure; (f) Making the 
interconnection holes and connecting the syringes for world-to-microFISH device fluidic connections. 
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3.4.2.3.3. Master for PDMS Chip and Moulding of the PDMS MicroFISH Chip 
The master for the microFISH device lid was prepared in a cleanroom using a traditional 
photolithography process. The structures were created on a Silicon wafer in SU-8 photoresist 
using negative patterning. The recipe for creating the master is shown in Table 3.2. This 
master can be used several times for moulding the microFISH device lid [Fig. 3.20]. The 
microFISH device lid is moulded in PDMS using traditional soft lithography techniques 
described in [18] and peeled away from the Silicon/SU-8 master. The final PDMS microFISH 
device lid is shown in Figure 3.20. The lid is then bonded on the glass slide with metaphase 
spreads for assembling the microFISH device. 
Table 3.2: Recipe for fabrication of SU-8 mould using negative photolithography process. 
Step Type  Parameters 
1 Spin-coating of SU-8 Acceleration: 200 rpm/s, Speed: 1,000 rpm, Time 40 seconds 
2 Soft Bake Temperature: 50 °C, Time: 5 hrs, Ramp up Time: 15 mins 
3 Exposure Time: 30 seconds Type: Soft 
4 Post Exposure Bake Temperature: 50 °C, Time: 5 hrs, Ramp up Time: 15 mins 
5 Development First: 4 minute, Final: 1 minute 
 
 
(a)      (b) 
Figure 3.20: (a) Master for moulding PDMS microFISH device lid fabricated in SU-8 photoresist over silicon wafer; (b) 
PDMS microFISH device lid moulded using PDMS elastomer. 
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3.4.2.3.4. Assembly of the MicroFISH Device 
The double-sided adhesive tape stencil used for spreading chromosomes is now used as a 
bonding layer for assembling the microFISH device. Peeling the top cover off the tape 
provides a silicone bonding layer for the microFISH device lid (Figure 5). The PDMS lid is 
irreversibly attached to the glass slide using the silicone adhesive layer by gently applying 
pressure across the PDMS lid [Fig. 3.21]. Once the device is assembled the holes are made in 
the PDMS lid for access ports to create interconnections.  
 
(a)      (b) 
Figure 3.21: (a) Peeling off top cover of the double-sided tape stencil to expose the silicone adhesive layer                (b) 
Assembled microFISH device by bonding the microFISH device lid on to the silicone adhesive layer. 
3.4.2.3.5. Interconnects 
The access holes in the microFISH device lid are made on the top side in the PDMS lid. The 
holes are made using a 22 gauge syringe needle (0.7 mm outer diameter). The interconnects 
are formed by inserting an 18 gauge syringe (1.2 mm outer diameter) with a bigger outer 
diameter than the interconnection holes, which forms a tight seal into the microFISH device. 
The syringes are connected to silicone tubing with inner diameter 1 mm and outer diameter 3 
mm to provide the world-to-microFISH device contacts [Fig. 3.22]. In order to test the device, 
silicone tubings are connected with syringe pumps (not shown in the figure) which provides 
the pressure needed to actuate the reagents and probes through the microFISH device. 
 
Figure 3.22: Fully assembled microFISH device with interconnects and tubings to connect it to the syringe pump. 
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3.4.2.4. Procedures 
3.4.2.4.1. Splashing Protocol 
The chromosome suspensions used for creating the metaphase spreads were prepared by 
standard methods [22]. Peribpheral blood lymphocyte cultures were prepared and treated 
with 75 mM KCl hypotonic solution for 5 minutes during the harvesting stage. Claussen et al. 
signified the importance of proper hypotonic treatment for achieving good quality metaphase 
spreads [31]. The hypotonic treatment causes the mitotic cells to swell leading to the 
chromosomes moving to more peripheral locations, which allows for evenly spreading of the 
chromosomes during fixative evaporation. After the mitotic cells are treated with the 
hypotonic solution they are fixed using the fixative (methanol/acetic acid, 3:1). The fixative is 
added drop by drop to the cells all the while mixing thoroughly on a vortex. To compare the 
spreads achieved using the traditional dropping method and the splashing device, control 
slides were prepared using the manual dropping method and test slides were prepared using 
the splashing device. Before dropping the cell suspension on the control slides, the slides are 
kept in distilled water at 4 °C. On the other hand, the test slides were prepared using the 
splashing device, where one drop of glacial water was dropped on to the slide followed by a 
drop of the fixed mitotic cell suspension through the two dedicated inlets [Fig. 3.22]. The 
slides were allowed to air dry in the open chamber of the splashing device. As a final step, 
both test and control slides were heated at 75 °C degrees for 3 min, which improves the 
fixation of the chromosomes to the slide. 
 
 
(a)     (b) 
Figure 3.23: (a) Sliding of the glass slide with stencil into the splashing device; (b) Splashing device with glass slide. The 
stencil is positioned under the syringes for splashing glacial water followed by fixed mitotic cells for spreading. 
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3.4.2.4.2. FISH Protocol 
The FISH protocol was conducted on both the control and test slides using the microFISH 
device. After assembling the microFISH device using the glass slides with chromosome 
spreads, the optimized FISH protocol was conducted on all the slides. The inlet of the 
microFISH device was connected with a syringe pump for treating the metaphase spreads 
with the FISH reagents and probes. The specific temperatures associated with the FISH 
protocol were provided by a hot plate setup. Firstly,  
RNAse (10 µg/µL) was delivered through the inlet. Following the RNAse treatment, the 
microFISH device was kept in the humidity chamber at 37 °C for one hour. Later 2 × SSC was 
loaded at room temperature for washing the metaphase spreads. The microFISH device was 
then dehydrated with increasing percentages of ethanol (70%, 80% and 99%), and the device 
was heated at 75 °C to denature the chromosomal DNA for 5 minutes. Simultaneously, probe 
DNA was denatured at 75 °C for 5 minutes in the water bath. Then the probe was entered into 
the device and the inlet and outlet were closed to avoid evaporation of the probe. The 
microFISH device was incubated in the humidity chamber at 37 °C overnight for hybridization. 
Subsequently, 50% formamide was delivered as post hybridization wash at 42 ºC. Final 
washing was performed with 0.1 × SSC at 60 °C, 4 × SSC and 1 × PBS at room temperature. 
The details of the conventional FISH protocol and optimized FISH protocol can be found in 
Table 3.3. 
3.4.2.4.3. Analysis 
DAPI was applied to the hybridized targets on the test slides in microFISH chamber and in 
case of control samples, slides were mounted with cover slips. The Zeiss AxioObserver Z1 
fluorescent microscope was used to view and analyze the samples for counting the 
metaphase spreads and the FISH hybridization signals. The chromosomes spreads on the 
control and test slides were counted manually using the traditional method. 
 
3.4.3. Results and Discussion  
3.4.3.1. Splashing Device and Metaphase Spreads 
The motivation behind the splashing device was to create a microfluidic device which can 
provide reliable and sufficient number of metaphase spreads on a glass slide. After spreading 
the chromosomes on the slide using the traditional method and the splashing device, the 
slides were stained with DAPI. The metaphase spreads were counted manually in the 
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fluorescence microscope at 20× magnification. Figures 3.24 (a,b) show the images of the 
metaphase spreads obtained using the conventional method and splashing device 
respectively. In order to validate the splashing device protocol, we conducted tests using two 
different cell suspension samples. Table 3.4 shows the comparison of average spreads 
obtained using the two techniques.  
 
Table 3.3: Comparison of conventional FISH method and microFISH protocol showing over 23 fold reduction in total 
reagents used and a 2 fold reduction in the probe volume (highlighted in yellow) which is the most expensive reagent for 
conducting FISH analysis. All steps of the FISH protocol are presented and in case of the microFISH protocol the flow rates 
used for the FISH reagents are also presented. 
      
Conventional  
protocol 
microFISH 
protocol 
Step No.: Name of the step Vol Vol Flow rate 
1 RNAse 100 µL 25 µL 5 µL/min 
2 Wait 60 mins   No flow 
3 Wash 2 × SSC 75 mL 3 mL 200 µL/min 
4 70% Alcohol 25 mL 1 mL 200 µL/min 
5 90% Alcohol 1 mL 1 mL 200 µL/min 
6 100% Alcohol 1 mL 1 mL 200 µL/min 
7 Drying-Air   NA 
8 70% formamide 25 mL  NA 
9 90% Alcohol 25 mL  NA 
10 100% Alcohol 25 mL  NA 
11 Probe 10 µL 5 µL 2 µL/min 
12 Hybridisation time Overnight Overnight No flow 
13 50% Formamide 75 mL 3 mL 200 µL/min 
14 0.1 × SSC 25 mL 3 mL 200 µL/min 
15 4 × SSC 25 mL 1 mL 200 µL/min 
16 1 × PBS 25 mL 1 mL 100 µL/min 
17 DAPI  15 µL 5 µL 2 µL/min 
Total Reagent volume 327.2 mL 14.1 mL   
 
Table 3.4: Average number of metaphase spreads found in the microFISH chamber (3 × 3 mm2) using manual dripping 
method and our splashing device protocol. 
 
  Sample 1  Sample 2 
Control Slide 41 52 
Splashing device 29 34 
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(a)                                                                                  (b) 
Figure 3.24: (a) Metaphase spreads stained with DAPI on the control slides prepared using the traditional dropping method 
(Inset—40× resolution); (b) Metaphase spreads stained with DAPI on the test slides prepared using splashing protocol 
(Inset—40× resolution). 
Even though the average numbers of spreads obtained by using the splashing device are 
comparatively lower, we could obtain sufficiently good chromosome spreads in order to 
perform the FISH analysis. The lower chromosome spread counts may be due to the 
splashing conditions such as height, temperature and humidity as described in the 
introduction. While in average the number of chromosome spreads was significantly lower in 
the splashing device, it must be noted that in certain samples, we found the number of 
chromosome spreads to be higher compared to the control slides. Considering that the 
splashing experiments were not studied in detail, we believe that the splashing protocol can 
be optimized by altering and controlling the various other factors like temperature, humidity, 
etc.  
  
(a) (b) 
Figure 3.25: (a) FISH analysis on the control slide. The two green dots highlight the two X chromosomes in the female 
sample; (b) FISH analysis on the test slide. The two green dots highlight the two X chromosomes in the female sample. 
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Moreover, the simple fabrication protocol of the splashing device using micro milling of 
PMMA sheets allows us to control the height of splashing if needed by addition of more 
PMMA layers to increase the height of the splashing syringe. The integrated stencil and 
bonding layer of the adhesive tape allows for localization of the metaphase spreads on the 
glass slide in the splashing device. Thus, the splashing device not only provides an ability to 
reliably create metaphase spreads on glass slide but also provides a possibility of automating 
the image analysis procedure in the future due to ease of finding the metaphase spread using 
software and an automated stage. A number of companies (Zeiss, BioView and Vysis) and 
research groups are working on optimizing the data acquisition protocols as this continues to 
be a major issue after the FISH protocol [237, 238]. Automation of the analysis procedure is 
currently an on-going work where we are aiming to divide the microFISH device chamber 
into smaller segments to create smaller FISH microchambers corresponding to the microscope 
objective. 
3.4.3.2. FISH Protocol Results 
After the preparation of the chromosome spreads, FISH analysis was performed on the 
peripheral blood lymphocyte chromosomes using an X chromosome centromeric probe. A 
female patient sample was used in order to show the validation of the microFISH device 
protocol and the results obtained with XX chromosomes [Fig. 3.25(b)] confirm the successful 
FISH analysis result. The conventional FISH protocol was also performed on the slides to 
compare and evaluate the microFISH device efficiency [Fig. 3.25(a)].     As can be seen in 
Table 3.3, the reagent volume needed in traditional FISH analysis is 327 mL, but now has 
been reduced to only 14 mL, which is a major step in reducing the costs associated with FISH 
analysis. As mentioned earlier, the most expensive reagent in traditional FISH analysis is the 
probe (costing approx. $90 per test). In the microFISH protocol the volume of this has been 
reduced to half (highlighted in yellow in Table 3.3). This alone cuts the cost associated with 
conducting the routine FISH analysis in half. Considering the cost of fabricating these 
microFISH devices is less than $2, these successful FISH results will give a major push 
towards making genetic analysis a routine screening test.  
3.4.4. Conclusions  
We have successfully demonstrated the first metaphase FISH on a microfluidic device. This 
work also presents an alternative method for slide preparation and hybridization of FISH 
probes. The achievements gained in the present study will be used in further improvement of 
the methodology and aim to develop a completely automated system for performing 
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miniaturized FISH on chip. The micro splashing device designed for spreading metaphase 
chromosomes on a glass slide provides more reliable and easy alternative for creation of 
metaphase spreads. The rapid and easy assembly protocol for the microFISH device allows 
for quick transformation of a simple glass slide into a microFISH device, which makes it an 
ideal solution for integration into existing work routines at cytogenetic labs. Our current 
efforts are focused on further miniaturization of this device, which will offer significant 
benefits with respect to sample preparation and reduction in reagent costs. We are also 
working towards improving the chromosome spreading protocol by further miniaturization 
of the splashing chamber and localized micro-spotting of fixed cells, optimizing the 
hybridization efficiency using temperature and electro-kinetic effects, automating the 
protocol by incorporation of reagent reservoirs and improving the analysis by developing 
automated software for data acquisition and metaphase spread recognition. In the longer run, 
we envisage to create a chromosome total analysis system providing a more efficient and 
cheaper solution to the traditional protocol and enable faster diagnosis. 
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3.5 AutoFISH: FISH Reagent cartridge for minimal handling FISH  
On successful demonstration of the first miniaturized device for performing FISH 
(microFISH), our concentration was shifted towards developing a simple FISH protocol, 
which requires minimal handling from the technicians and offers a possibility to automate in 
the future. The major workload and stress factor in order to perform the FISH analysis 
(interphase and metaphase) is related to treating the slides with interphase cells or 
chromosome spreads with multiple reagents in a very tight time controlled sequence (Table 
3.5).   
Table 3.5: Comparison of time and reagent volume used for performing traditional FISH protocol compared to the 
microFISH protocol (Only the time of the protocol is indicated but the time with respect to handling can differ from person 
to person) 
 
 
We carefully evaluated both the interphase and metaphase FISH protocol and both of them 
have a very similar sequence of reagent treatments starting with RNAse exposure, followed 
by ethanol based drying of slides, denaturing of the DNA with temperature treatment, 
followed by probe hybridization and finally post hybridization washes with 50% formamide, 
saline-sodium citrate buffer (SSC) and phosphate buffered saline (PBS) to remove unbounded 
probes and unspecific bindings. In between these reagent washes, there is also a need for air 
drying the slides and often visualizing under the microscope to check if the earlier treatment 
  Traditional FISH microFISH protocol 
Step No.: Process Vol Time Vol Flow rate Time 
1 RNAse 100 µL 1 min 25 µL 5 µL/min 5 min 
2 Wait    60 min   No flow 45 min 
3 Wash 2 × SSC 75 mL 5 min( 3x) 3 mL 200 µL/min 15 min 
4 70% Alcohol 25 mL 2 min 1 mL 200 µL/min 5 min 
5 90% Alcohol 1 mL 2 min 1 mL 200 µL/min 5 min 
6 100% Alcohol 1 mL 2 min 1 mL 200 µL/min 5 min 
7 Drying-Air   5-10 min   NA  
8 70% formamide 25 mL 5 min   NA  
9 90% Alcohol 25 mL 2 min   NA  
10 100% Alcohol 25 mL 2 min   NA  
11 Probe 10 µL 20 min 5 µL 2 µL/min  
12 Hybridisation time   Overnight   No flow 12 hrs 
13 50% Formamide 75 mL 5 min( 3x) 3 mL 200 µL/min 15 min 
14 0.1 × SSC 25 mL 5 min( 3x) 3 mL 200 µL/min 15 min 
15 4 × SSC 25 mL 5 min 1 mL 200 µL/min 5 min 
16 1 × PBS 25 mL 5 min 1 mL 100 µL/min 5 min 
17 DAPI  15 µL 1 min 5 µL 2 µL/min 2.5 min 
327.2 mL  14 - 16 hrs 14.1 mL 13 hrs  
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was successful.  Hence, to perform these washes on a chip, there was a need to devise a 
reagent storage technique to allow for sequential injection of the reagents to the interphase 
cells or chromosomes immobilized on the surface. 
After a thorough literature search on different techniques to store and inject multiple reagents 
in a microfluidic device, we were left with practically two options. One for on-chip storage in 
reservoirs and subsequent injection by multiple actuators placed on each of these reservoirs 
as previously proposed by Xie et. al[239]. And the second option was to store all the reagents 
on single tubing in the form of reagent cartridge by means of air spacers to separate the 
reagents and avoid mixing presented earlier by Whitesides group [240].  
We evaluated both the techniques for their advantages and mainly for their respective 
complexities when implementing the FISH protocol. In the end, we decided on using the 
technique of storing the reagents on tubing for a number of reasons. The major disadvantages 
with respect to using Xie’s cartridge were the material of the cartridge (PDMS); and the 
complexity of loading and unloading the reagents which would be difficult to implement and 
automate in the clinical setup. Also, PDMS is known for being permeable to gases and as a 
result it would not be advisable to store FISH reagents on a PDMS based cartridge as they 
would quickly evaporate and not permit longer storage. Also, the need for multiple actuators 
(one per reservoir or reagent) will end up complicating the fabrication and setup. On the 
other hand, the cartridge system of storing reagents on a tube has number of benefits: need of 
only one actuator for all reagents, easy storage, simple loading procedure and comparatively 
easy sealing procedure. But the major advantage of using tubing cartridge compared to Xie’s 
cartridge was the ability to use the air spacers in the cartridge for air drying the samples 
between different reagents, which is difficult to implement with the other options. 
But the task of storing the FISH reagents on a cartridge and applying them in a sequence was 
not simple. Considering the current volume of reagents used for microFISH protocol [84], we 
would need tubing longer than 10 meter (1 mm internal diameter) in order to store all the 
reagents required (14.1 ml). This was not a practically feasible solution. As a result, we 
focused our efforts initially on optimizing the microFISH protocol and minimizing the 
reagent volume further to perform the FISH analysis using a cartridge.  
The novel protocol (AutoFISH) developed as part of the currently on-going work for 
optimization of the microFISH is highlighted in Table 3.6. For optimizing the protocol, we 
evaluated every parameter of the microFISH protocol and tuned all the reagent volumes by 
performing step by step FISH and checking operation at each step. After several initial 
iterations, we can now perform interphase FISH using only 2 µL probe volume with over 60% 
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success rate. We are confident further optimizations will provide better success rates and also 
lead to reduction in the volumes of reagents for performing FISH analysis, but further 
experiments could not be conducted due to closing down of labs at DTU-Nanotech.  
During the FISH reagent cartridge tests, we used only 2 µL of probe volume as part of the 
optimization process, which is a huge cost reduction for the cost per FISH tests. This is 
because, the probes are expensive (over $400 for 100 µL) and they continue to be the limiting 
factor for mainstreaming FISH based diagnostic tests for prenatal and hematological 
disorders.  
Table 3.6: Comparison of microFISH and the current version of AutoFISH protocol. 
      
microFISH  protocol AutoFISH protocol 
 
Step No: Name of the step Volume Flow rate 
 
Volume 
 
Flow rate 
 
Temperature 
1 RNAse 25 µL 5 µL/min 25 µL 5 µL/min 37 °C 
2 Wait 60 mins  No flow  No flow  
3 Wash 2 × SSC 3 ml 200 µL/min 150 µL 15 µL/min Room temp. 
4 70% Alcohol 1 ml 200 µL/min 50 µL 15 µL/min Room temp. 
5 90% Alcohol 1 ml 200 µL/min 50 µL 15 µL/min Room temp. 
6 100% Alcohol 1 ml 200 µL/min 50 µL 15 µL/min Room temp. 
7 Probe 5 µL 2 µL/min 2 µL 1 µL/min 75 °C 
8 Hybridisation time Overnight  12 hrs Room temp. 
9 50% Formamide 3 ml 200 µL/min 150 µL 15 µL/min 42 °C 
10 0.1 × SSC 3 ml 200 µL/min 150 µL 15 µL/min 60 °C 
11 4 × SSC 1 ml 200 µL/min 50 µL 15 µL/min Room temp. 
12 1 × PBS 1 ml 100 µL/min 50 µL 15 µL/min Room temp. 
13 DAPI  5 µL 2 µL/min 5 µL 15 µL/min Room temp. 
Total Reagent volume 14.1 ml  732 µL   
 
During this optimization process, we also realized the issues with using PDMS based 
microFISH device. Due to permeability of PDMS, there was significant evaporation of the 
reagents and trapping of probes in PDMS. Hence, for the tests with the FISH reagent 
cartridge, we changed the material of the FISH device from PDMS to cyclic olefin copolymer 
(COC) in order to avoid evaporation of the reagents allowing us to use much lower volumes 
for FISH analysis [Fig. 3.26]. The devices were micromilled and the adhesive tapes used to 
assemble the AutoFISH device were laser-ablated.  
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Figure 3.26: (Left) AutoFISH device designed in COC with 3 inlets (extra inlet for probe) (Right) Glass slide with tape 
stencil to spread metaphase chromosomes and bond the COC lid to create an AutoFISH device. 
 
3.5.1 Fish Reagent Cartridge 
Loading of reagents 
After optimization of the FISH protocol, we were interested in testing the minimal handling 
protocol by sequential injection of reagents from a FISH reagent cartridge [Fig. 3.27]. In order 
to minimize the evaporation of the reagents, we used polyethylene (PE) tubing for the FISH 
cartridge. A syringe pump was used to load the reagents in the cartridge (1 m of PE tubing). 
A 10 ml syringe was filled with 5 ml PBS solution. As a first step, a 200 µL of 100% ethanol 
plug was withdrawn to rinse the tubing completely. Later, 200 µL of PBS was injected into the 
cartridge to prime the cartridge and the syringe pump. After this the pump was switched to 
withdraw mode and all the reagents other than the FISH probe were loaded onto the 
cartridge with air spacers of 50 µL. These air spacers provide timing gate and also facilitate 
drying of the slide by flushing the previous reagent out of the FISH chamber. Due to the 
viscous nature of the probe and to avoid unnecessary exposure of the probe to the residue of 
the other reagent’s in the cartridge, we modified the microFISH device design and added a 
separate inlet for probe [Fig. 3.26]. This was done to avoid contamination of the probe and to 
make it possible to design a device offering possibility to automate easily.  
Probe   Inlet 
 
Reagent Inlet                              Waste outlet    
                                FISH 
                           CHAMBER 
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Figure 3.27: Loading of reagents on the FISH cartridge with air spacers to separate the reagents. 
AutoFISH Testing 
The fixed cells were splashed onto the glass slides using the splashing protocol and after 
visual confirmation of spreads on the glass slide, the adhesive tape based bonding protocol 
was used for assembling the AutoFISH device by means of bonding the COC lid to the glass 
slide [section 5.5.8]. The AutoFISH protocol was followed as described in Table 3.6. The 
interconnections were glued to the AutoFISH device as shown in Fig. 3.28.  
 
Figure 3.28: Testing of AutoFISH device with reagent cartridge (showing interconnections for rapid connection of the 
FISH cartridge) 
Air spacers 
FISH Reagents 
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Reagent cartridge protocol 
A hot plate was used for applying temperature treatment as part of the AutoFISH protocol 
[Table 3.6].  The syringe pump was programmed to sequentially inject all the reagents and the 
air spacers until alcohol washes. This results in alternate application of the reagent washes to 
the spreads followed by an air drying step similar to the conventional protocol. Until the 
probe was to be applied, the probe inlet was kept sealed with a paper clip. The probe was 
loaded on another cartridge called the FISH probe cartridge (shorter PE tubing – 12-15 cm) 
which was later connected to the probe inlet after removing the paper clip. The probe was 
applied at a very low flow rate (1 µL/min) as the probe mix is very viscous which often leads 
to the probe-mix plug breaking into smaller plugs.  On application of the probe to the entire 
FISH chamber, all the inlets were sealed with parafilm and further closed with paper clips to 
avoid any evaporation during the hybridization process. Typically, the devices were left in 
the incubator overnight (shortest period tested was 12 hours) to ensure hybridization of the 
probe to the chromosomes.  
On the next day, the FISH process is started again after overnight hybridization, whereby the 
FISH reagent cartridge is connected again to the reagent inlet. The probe inlet remains closed 
and the waste outlet is opened during application of the FISH reagents. The heating cycles for 
formamide and SSC application are achieved using the hot plate. On completion of the 
AutoFISH protocol, DAPI is applied to the FISH chamber through the probe inlet and all the 
inlets are sealed again with parafilm and paper clips.  
3.5.3. Results 
The slides were analyzed using a Zeiss Axio Observer Z1 fluorescent microscope after 20 min 
of application of DAPI. While there were plenty of interphase signals, we didn’t find any 
signals in the metaphase spreads, which could be due to a number of reasons. Firstly, as these 
tests were done in a makeshift lab in Copenhagen University created due to closing down of 
our regular labs at DTU-Nanotech, we did not have any calibration on the equipments in this 
new lab.  Secondly, during the process of relocation we could have contaminated our 
reagents and finally, the probe was over a year old and therefore possibly inactive. As these 
experiments were the last batch of experiments done as part of the project, we did not have 
time to conduct proper controls to evaluate the other factors which could have gone wrong 
with the experiments. New tests and controls to check on the other possible factors to 
progress this work further will be undertaken when our labs reopen.  
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Nevertheless, the most promising signs of optimism came from the fact that most of these 
tests clearly showed FISH signals in interphase nuclei, which indicated that the reagent 
cartridge based AutoFISH protocol works for interphase FISH [Fig. 3.29]. The single green 
circles highlighting the green dots in the nuclei of interphase cells, show the presence of a 
single X chromosome in this donor’s sample.  None of the metaphase spreads showed any 
clear indication of hybridization. The successful results with interphase nuclei suggest 
possible problems with the protocol, equipment, reagents or the probe which needs to be 
optimized for metaphase FISH to work.   
 
Figure 3.29: FISH signals on interphase cells (Green circles highlight the interphase signals) 
With these promising results, we concluded that this was the way ahead in order to realize a 
minimal handling FISH protocol which minimizes the workload of the technicians and offers 
possibility to automate. In conclusion, we have shown a promise for possible automation of 
FISH protocol using FISH reagent cartridges. Further optimization is needed for improving 
the FISH signals and leading to validation of AutoFISH protocol for metaphase FISH analysis. 
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We clearly see application of this protocol for automating interphase FISH as well as 
metaphase FISH in near future. 
In hindsight, the AutoFISH protocol provides a reduction in the volume of the reagents and 
handling time. While the AutoFISH protocol in itself is comparable to the traditional protocol, 
the reduction offered in the handling time improves the workflow in the clinics. In principle, 
the technicians could follow the same protocol and get results in couple of days, but as the 
technicians cannot work round the clock to complete the analysis the only effective way to 
improve the time to results is by automating the protocol. 
 
3.5.4 Outlook 
With the development of miniaturized tools for sample processing (µBR), slide preparation 
(FISHprep) and miniaturized FISH analysis (microFISH), we have provided the 
cytogeneticists with a new toolkit for performing routine FISH analysis. Ease of handling, 
simplicity and compatibility to the existing work routines and protocols in cytogenetic labs 
has been the key consideration in the design and development of this integrated FISH 
analysis platform.  
Focusing on ease of use, we have moved away from the practical concerns (interconnects, 
complex protocols, biocompatibility), which hamper the adoption of the microfluidic devices 
in biological analysis. Finally, we target our efforts to automate the FISH protocol, by means 
of integrating the reagent handling (storage and sequential injection) on a cartridge. With 
successful initial results on performing FISH analysis on interphase cells, we are optimistic 
about further adapting the protocol for metaphase FISH analysis. 
As a final step, we have developed software for controlling reagent cartridge including 
controlled sequential injection of reagents. In the near future, by means of adding software 
based hot plate control to the current software, we aim to develop fully automated 
miniaturized FISH analysis protocol controlling simultaneously the reagent application and 
thermal cycling. 
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CHAPTER  
SIDE PROJECTS 
 
Until now, we have described the work done 
towards development of the modular and 
integrated versions of the C-TAS protocol. In this 
chapter we will describe the various devices 
attempted to isolate lymphocytes from whole 
blood and to trap single cells and chromosomes.  
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4.1 The Quest of the Lymphocytes 
Lab on a chip technologies are set to revolutionize diagnostics by bringing the hospitals to 
the patient’s bedside. However, the major bottleneck towards success of these lab-on-chip 
systems is to integrate the pre-processing steps like cell sorting and cell isolation on the 
chip.  This is a continuing hurdle and simultaneously there is a need for low cost, simple 
and efficient solutions which can handle sample pre-processing at the patient’s bedside 
without the need for bulky centrifuges and other equipment commonly found in central 
labs. 
For conducting genetic analysis on blood, the first step is always to isolate the white blood 
cells (Leukocytes - WBCs) from the plasma and red blood cells (erythrocytes - RBCs).  In 
human blood, the WBCs comprise only about 6-10% of blood and their proportion to RBC 
and platelets is roughly 1:700 and 1:30 respectively. Hence, it makes it extremely crucial that 
the blood cells are sorted and the WBCs are isolated before any further genetic analysis can 
be carried out.   
In pursuit of the modular C-TAS system, we focussed initially on a number of techniques to 
isolate WBCs from whole blood. The main focus was to develop techniques which can be 
easily integrated on the C-TAS module and function seamlessly with the other C-TAS 
modules to complete the C-TAS protocol. The aim was to develop a sorting or separation 
module which can isolate the WBCs by processing the whole blood or diluted blood and 
deliver the isolated WBCs for further analysis to the culture and lysis modules. In relation to 
dilution which often occurs due to efforts related to sorting or separation of the cells, we 
also focussed considerably efforts concentrating the cells again for subsequent analysis.  
4.2 Integrating Continuous Flow Separation Systems 
Sorting of biochemical materials on chip is quickly becoming the biggest bottleneck for 
realizing µTAS chips. In case of clinical diagnostics systems dealing with blood, it remains 
the last hurdle to overcome in terms of miniaturizing the pathological diagnostic systems. 
While a variety of continuous flow microfluidic sorters have been proposed in the last 
decade, none of them provide efficient and reliable high throughput fractionation of 
undiluted blood cells[241].  
Ideally, continuous flow separation systems are visualized as shown in the block diagram 
below. 
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Figure 4.1: A typical continuous flow separation procedure: sample is injected continuously together with a carrier liquid 
into a wide separation chamber, a force acts at an angle to the direction of flow and sample components are deflected from 
their flow path and thus spatially separated.  
The applied force field varies according to the size and intrinsic properties of the particles to 
be separated and the properties of the carrier fluids. These devices are tuned to precisely 
handle small volumes of samples, such as proteins, DNA solutions, cell suspensions and 
occasionally blood.  
The ease of integration provided by these systems makes continuous flow separation systems 
very applicable for the C-TAS system.  These systems can be easily used as modules on µTAS 
systems and can function seamlessly to provide the isolated blood cells for further 
downstream processing and FISH analysis. We have worked towards developing modules 
based on 3 different techniques and used those to separate blood cells (or isolate WBCs) for 
further analysis with the C-TAS system. 
• Pinch flow fractionation system (PFF) 
• Dual pinch flow fractionation system (DPFF) 
• Microfluidic FACSlyser 
 
Due to dilution of blood cells on the C-TAS modules it was important to develop strategies to 
either trap cells or concentrate them before they were fixed so that we have ample metaphase 
spreads for final FISH analysis. Two major strategies were tested in this relation, one based 
on trapping of cells using cell traps and the other focusing more on concentration of 
lymphocytes for subsequent FISH analysis. Finally, trapping of chromosomes on antibodies 
was targeted, which was an attempt to manipulate and localize chromosomes on a device to 
enable easy FISH analysis later on.  
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4.3 Pinch flow fractionation (PFF) 
Pinch flow fractionation is a method used for continuous separation of particles. PFF relies on 
pinching of a fluid stream containing particles (such as beads or cells) by another stream 
flowing at typically 10-25 times faster flow rates in a narrow channel segment called the pinch 
segment[242] [Fig 4.2]. This method relies solely on the hydrodynamic properties of the 
carrier fluids to efficiently separate the particles based on their sizes. In the pinch segment 
[suitable width 100 µm], by virtue of flow ratios of the fluids at the inlet stream, the particles 
in the particle stream get aligned to the wall of the pinch segment. This leads to smaller 
particles centring on to streamlines closer to the wall and the larger particles centring to 
streamlines away from those on which the smaller particles centre onto [Fig 4.2]. This leads to 
larger particles following a different streamline compared to the smaller particles [Fig. 4.2]. 
Hence, on leaving the pinch segment, when the particles enter the separation chamber, they 
follow the flow streamlines in which their centres lie. This leads to a spatial separation of the 
smaller and larger particles in two different streams flowing parallel to each other in the 
separation chamber. As shown, the smallest particles will flow close to the channel wall and 
the largest closer to the centre of the separation chamber [Fig 4.2]. Ideally if you place the 
outlets with respect to the separate streams the different particles will be collected in different 
outlets. 
 
Figure 4.2: The model of the pinch flow fractionation system (reproduced from [242]) 
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While the separation of the particles occurs due to the laminar flow profile and alignment of 
the particles to different flow streams based on their sizes, but the sorting of these particles in 
the outlet streams can further be tuned by carefully designing the hydraulic resistances of the 
outlet streams[243, 244].  Yamada et al. highlights that the four parameters which needs to be 
tuned to achieve effective separation of the particles are flow ratios, flow rates, width of the 
pinch segment and microchannel geometries[242].  
In the interest of time and in order to focus more on the project requirements, the project was 
divided into the theoretical project and an associated experimental project. The theoretical 
project was undertaken by two at the time bachelor students, Karsten Brandt Andersen and 
Simon Levinson under supervision of Asso. Prof. Fridolin Okkels. The results of this work, 
lead to novel insights which functioned as the guidelines for the design and the experimental 
work related to pinch flow fractionation experiments [245, 246].  
Theoretical model 
An extensive theoretical study was undertaken to understand the variables involved in the 
designing of a pinch flow fractionation system for sorting of blood cells. We were interested 
in understanding, how the variations in pinch segment width, flow ratios of particles and 
aligning fluids, geometries of the channels, effects of the edge curvature at the end of the 
pinch segment, angle of inlets meeting the pinch segment and overall the tuning of the 
hydrodynamic resistances of the sorting channels affected the sorting of the particles[245].   
Consider the schematic of the model as described in fig. 4.2. The radius of the smallest 
particle is r and that of the largest is R.  Similarly, width of the pinch segment is w and flow 
rate of the particle inlet is Qinlet and the flow rate of the aligning flow is depicted as Qmain. In 
brief, the flow ratios to be used depend on the width of the pinch segment and radius of the 
smallest particles [245]. In order to calculate the relation between the above parameters a new 
variable (intersection width ratio) is designed which is calculated as 2r/w. Figure 4.3 shows 
the flow ratios to be used based on the intersection width ratio, which allows to identify the 
flow ratios to be used based on a particular pinch segment width and the radius of particles 
to be sorted. 
For detailed description, please refer to the guide for designing “Pinch flow fractionation 
devices”[245]. This theoretical model enabled us to improve the sorting efficiency of the 
system by designing the hydraulic resistances of the outlet channels and by controlling the 
fractionation boundary in the separation chamber [245].  
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Figure 4.3: Ratio of Flow rates compared to the intersection width ratio assuring aligning of the particles to the channel 
walls in the pinch segment [245]. 
Fabrication, testing and discussion 
Based on the theoretical calculations from the theory project, Pinch Flow fractionation devices 
were designed and fabricated in SU-8 using traditional photolithography process [Section 
5.2.1]. The SU-8 mould was used to cast the channels into PDMS [Section 5.3.3]. The inlets and 
outlets were created by punching holes using a blunt needle and press-fit with a larger needle 
into the holes leading to leak proof interconnections. The devices were tested with latex beads 
of 5 µm and 9 µm, resembling the size of the erythrocytes and lymphocytes. Other techniques 
like laser ablation [Section 5.3.2] and transparency based photolithography were also tested 
for fabricating the PFF devices[247]. 
While this model of PFF functions well with particles [as also simulated] which have well 
defined sizes and rigid boundaries (such as beads), it fails to consider and provision for the 
elastic nature of the cell membrane. Firstly, the theoretical models fail to take into 
consideration the elasticity of the cell membrane[248] and cell drifting layer (or cell free 
layer)[249] . Secondly, the problems with cell sizes variation from person to person make it 
difficult to design a universal system for sorting of white blood cells. Due to realization of 
these issues which highlight the non-applicability of a PFF system for sorting of blood cells, 
we concluded that the Pinch Flow fractionation system cannot be used for sorting of blood 
cells.  
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4.4 Dual pinch flow fractionation (DPFF) 
In principle, for the C-TAS system to perform further downstream analysis, even few WBCs 
could be sufficient. A novel symmetric version of Pinch flow fractionation was 
conceptualized and tested with nano particles for size exclusion based filtration of particles. 
The idea was to create symmetry in the pinch segment whereby the smallest particles (RBCs) 
will continue to flow into outer collection channels, but the larger particles (WBCs) will 
follow streamlines closer towards the centre of the pinch segment. Now by carefully tuning 
the flow rates in the PBS buffer stream (aligning stream), a state could be reached where most 
of the RBCs and WBCs will enter the outer collection channels, but only the largest of the 
WBCs (about 5%) will enter the central stream and get isolated [Fig. 4.4]. This concept was 
devised as in principle for C-TAS system to function, we only need few WBCs which could 
later be cultured and used for further analysis. 
 
Figure 4.4: Concept of blood sorting via DPFF 
 
Considering the shortfalls of pinch flow fractionation system to isolate WBCs from whole 
blood, we have designed the novel symmetric model of Dual Pinch Flow Fractionation 
(DPFF). This symmetric model [Fig 4.4] utilizes enhanced hydrodynamic effects at dual 
interface system to selectively isolate only the largest of the WBCs from the whole blood. 
Also, the DPFF model incorporates the two shortcomings of the PFFF model and inherently 
takes into account the cell elastic behaviour and cell drifting effect [Fig. 4.5] as the system 
does not depend on sorting of the particles, rather than just the fact that the largest of the 
WBCs will follow into central streamlines. 
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The concept was designed to remove the uncertainties of the Pinch flow fractionation system 
by replacing the traditional pinch flow system where particles were aligned on only one wall 
of the pinch segment. Instead of the earlier version, we have realized a more symmetric 
system with simultaneous pinching of particles on both the walls of the pinch segment. The 
resultant symmetric system can function as high size based filter for particles based on tuning 
of the flow rates and hydrodynamic resistances of the collection channels [Fig. 4.4].  
 
Figure 4.5: Concept of blood filtration on Dual Pinch flow fractionation device. 
 
Principle of the DPFF 
Figure 4.6 illustrates the simulation of the principle of DPFF model. The DPFF is made of 3 
inlets, 1 central aligning fluid inlet and 2 sample inlets with particles. Like the earlier PFF 
system, the idea is to align the particles in the sample inlet to the walls of the pinch segment, 
but instead of aligning them to one of the pinch segment channel walls, in the case of DPFF 
the particles are aligned to both the channel walls.  
 
Figure 4.6: Illustration of DPFF model. The central channel collects only the WBCs, while the outer channels will collect 
most of the WBCs and RBCs.  
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As shown in figure 4.6, this system was designed to operate in a manner that it separates 
separates the larger WBCs in the central outlet while most of the RBCs and the WBCs exit 
from the side channels. The requirements for optimisation of the experimental protocol are 
less strict with this system as we in principle only need to ensure that the central outlet does 
not get contaminated with smaller cell types. 
 
The effect at the broadening or the separation section is analogous to the one in PFFF; due to 
the expanding laminar flow profile, the smaller particles flow through the outer outlets as 
their centre lies in the fluid streams closer to the pinch segment walls, which continue to flow 
into the outer outlets. Similarly, the largest of the particles tend to flow towards the central 
streams as their centre lies into central flow lines away from the streamlines closer to the 
pinch segment walls. In case, the outlet resistances are equal, by carefully tuning the flow 
rates, the separation position can be tuned in such a manner that only the largest of the 
particles align into the flow lines entering the central isolation outlet. Hence, in the case of 
blood, the largest particles being the WBCs they are collected in the central outlet stream and 
isolated.  
 
Field programmable DPFF devices 
 
In another approach, apart from simulating the outlet resistances and calculating the required 
resistances, it is also possible to design DPFF systems with variable resistances to tune the 
flow entering the central outlet stream [Fig 4.7]. This concept provides the capability of 
programming the DPFF systems while testing as required. This capability of programming 
DPFF systems is essential because of the complex variations of blood cells. Blood cells sizes 
differ from person to person and vary accordingly to their health state and cycle of cell 
division[250-253]. Hence, this functionality could prove to be very important if the C-TAS 
system is to be commercialized. 
 
This system could be designed with possibility to tune the hydrodynamic resistances by 
designing multiple outlets in the isolation channel to alter the exclusion size below which the 
cells or particles flow out to the outer channels. Figure 4.7 below shows the central outlet with 
multiple side channels providing an option to pick any one of them as required to tune the 
hydrodynamic resistance of the central collection outlet. The further away the outlet is moved 
from the separation chamber, the higher the resistance of the channel leading to the smallest 
fraction of the flow from the separation chamber entering the central inlet.   
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Figure 4.7: Tunable DPFF to tune the sorting of particles based on selection of different outlets at the time of application. 
 
Due to interest of time and emergence of other simpler strategies, the DPFF system was never 
tested with cells, but we present the proof of principle of the DPFF and its application for 
sized based tunable filtration of particles tested with nanoparticles. 
 
Fabrication, testing and discussion 
The DPFF system has not been tested with blood cells due to focus on other methods, but in 
order to validate the principle we tested the this system for isolation of micro and 
nanospheres formed by self-assembly of peptides. These particles are formed in a 
microfluidic channel by means of droplet emulsification process and their sizes ranged from 
200 nm to 5 µm. We were interested in separating the particles below 3 µm in the outer 
channels and the larger ones in the central outlet.  
The fabrication protocol similar to devices made for testing PFF systems was followed. In 
order to achieve the goal of isolating particles below 3 µm into the outer channels and the 
higher to be isolated via the central channel, the flow rates were tuned to separate all particles 
smaller than 3 µm to exit in to the outer channels [Fig. 4.8].  
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Figure 4.8: Flow profile of the separation experiment. The flow rates were 0.8 μl/min for the particles solution and 20 
μl/min for the aligning flow. Channel height is 31 μm. Pictures are edited by adding dots to outline the flow not clearly 
visible in the picture. 
Based on the tests above, we could observe isolation of peptide microspheres larger than 3 
µm in the central outlet [Fig. 4.9]. Unfortunately, due to the high shear forces and dilution of 
the peptide stock solution by the aligning fluids these spheres disintegrated on isolation at 
the outlet and resulted into flakes [Fig. 4.9].  
 
Figure 4.9: Microparticles extracted out of the DPFF system central outlet containing particles larger than 3 µm. 
 
10 µm  3‐5 µm spheres 
Spheres disintegrating 
into  flakes  
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Due to our focus on achieving the a simple C-TAS system, we decided to go away from the 
PFF systems and move to RBC lysing based isolation of white blood cells. In the near future, 
we aim to repeat the tests with beads and publish this work as a novel technique for size 
exclusion filtering of the largest particles of a mixed solution. We foresee numerous 
applications of this technique in polymer, pharmaceutical and cosmetic industry working 
with colloids and nanoparticles. 
4.5 Microfluidic FACSlyser: Lysing based isolation of lymphocytes  
This work was directed towards creating an efficient, and simple microfluidic mixer capable 
of lysing erythrocytes selectively on chip by mixing them with water, thus enhancing 
separation of WBCs. In clinical diagnostics, blood cells are separated using FACSlyse 
protocol, whereby RBCs are lysed using lysants. Most of these lysants function on the 
principle of providing the RBCs with a hypotonic shock. WBCs are generally more resistant 
to these lysants and hypotonic treatments compared to RBCs and hence they lyse later than 
the RBCs. Using this window of time, the RBCs are lysed and the unlysed WBCs are 
collected soon after and put under isotonic conditions in phosphate buffered saline (PBS) 
Solution.  
Recently attempts have been made to miniaturize and integrate this protocol on a 
miniaturized device by Sethu et al. by means of utilizing microfluidic mixers to mix the 
lysant and the whole blood[254-256].  
 
 
 
 
 
 
 
 
Figure 4.10: (a) Stroock’s design (b,c) Yang’s designs 1 and 2 (Bottom) Our proposed design 
(a) 
 
(b) 
 
(c) 
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On simulating the mixers used by Sethu et al., we found that there was significant room for 
improving the system by optimizing the mixer which would allow us faster lysing and 
subsequently rapid isotonic inducement for WBCs [256]. The earlier experiments have used 
the herringbone structures presented by Stroock’s et al[257]. We were interested in 
optimizing these mixers to enable rapid microscale mixing of RBCs and WBCs. As a result, 
we conducted an extensive study of the mixing dynamics of the Stroock’s herringbone 
mixer and focused on the parameters which can be optimized for improving the mixing. 
As it happens in research, Yang et al. presented their results on optimization of the Stroock’s 
design while we were still working on our optimizations, which highlighted that Stroock’s 
mixer can indeed be optimized and that the efficiency of herringbone mixers can be 
improved by up to 40%[258]. This work suggested two new designs for improving mixing 
based on the simple harmonic mixing principle [Fig 4.10]. The new designs were compared 
extensively with Stroock’s design to understand the influence of the change in the design 
and the resultant mixing dynamics leading to better mixing. The conclusion was that Yang’s 
design 1 did not have much improvement compared to Stroock’s design and the periodic 
sweeping of the flow splitting boundary across the channel width did not have any 
justifiable optimization in the mixing rate. But in the case of design 2 there was significant 
improvement in the average vorticity across the length of the groove which was improving 
the mixing efficiency. Vorticity is the amount of fluid spin or circulation created due to the 
hydrodynamic mixing of the flow lines. Hence, a design providing better vorticity will 
induce a faster mixing of the fluids. We also found that the optimal number of herringbones 
per cycle is 6, after which having more herringbones per half cycle of mixer does not have 
any further increase in the vorticity. Hence, it was suggested to limit the number of 
herringbones per cycle to 6[259].  
Hence, in the end we proposed a new design based on our findings, which contained 
periodic flow switching after every half cycle as in case of the Stroock’s design but 
improving the vorticity of the mixer by using herringbones from Yang’s design 2 [Fig. 4.11]. 
This was simulated by using two different concentration fluids as input parameters 
assigning them to one of the input channels. Figure 4.11 (b) shows more vorticities forming 
in our proposed device compared to the original Stroock’s herringbone mixer (a). The blue 
and red vortices display the intensity of the mixing behavior induced by the mixers, where 
it can be seen clearly that Fig. 4.11 (b) has much more helical spins in the fluidic channel. 
This was done because we found that the asymmetry index or flow splitting boundary is 
optimized at 1/3 and 2/3 of the channel width as in the case of Stroock’s design[260]. 
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Figure 4.11: Improved vorticity in our design (b) compared to the Stroock’s Design (a) 
We were also interested in understanding the difference in mixing profile in case of having 
herringbones as ridges or as grooves. As a result, we also simulated our design with ridges 
and grooves to better our understanding of the mixing profile in both the cases. 
 
Figure 4.12: (Left) Mixing in one cycle of our design with herringbone ridges (Right) Mixing in our one cycle of our 
design with herringbone grooves. (Red indicates concentration of 0 and blue indicates concentration of 1) 
Evoluting microfluidics: Moving toward clinical applications 
 
  121
 
 
(a)         (b)                     (c)
(d)          (e)
The results showed that the mixing profile with grooves and ridges was very different and 
in all the designs grooves were better in mixing the fluids compared to the ridges [Fig 4.12].  
Finally, we compared our design with all the previous presented designs. Figure 4.13 shows 
the cross section at the end of one mixing cycle from all the mixers. In order to simulate 
mixing in one cycle of each design, we added concentrations to the fluids as depicted by red 
(concentration 0) and blue (concentration 1). This allowed us to use the convection-diffusion 
model of COMSOL, to study the effective mixing at the end of one cycle of mixing. 
 
     
 
 
 
 
 
 
Figure 4.13: Figures show the simulations of concentration-diffusion profiles of the cross section after one mixing cycle. (a) 
Stroock’s design (b) Yang’s design1 (c) Yang’s design 2 (d) Our design with ridges (e) Our design with grooves. (Note: (a-
c,e) show the contour of the groove and (d) doesn’t have a black outline of the groove as it has been simulated with a ridge to 
compare the difference in mixing (also shown in Fig 4.12(Left))) 
 
Figure 4.13 (e) clearly shows a more homogeneous mixing compared to all the other 
herringbone mixers. There is clearly not much difference in Stroock’s design and Yang’s 
design 1. Our design with grooves clearly shows higher mixing compared to the design with 
ridges as is evident by blending of the red and blue colours. In conclusion, the simulations 
showed better mixing efficiency with the novel design and it was then time to test the lysing 
efficiency. 
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Fabrication and Testing 
 
Figure 4.14: Schematic of the microfluidic FACSlysing principle and Laser ablated FACSLyser. 
Figure 4.14 shows a schematic of the principle of the microfluidic FACSlyser for isolation of 
leukocytes and the laser ablated FACSlyser device. The control mixers based on Stroock’s 
design and test mixers based on our design were fabricated using CO2 laser ablation process 
in PMMA [Section 5.3.2] and bonded using UV activated thermal bonding [Section 5.4.2].  We 
used autoclaved DI water and pure blood to test the lysing of RBCs [Fig.4.15].  
 
Figure. 4.15:  (Left) Blood at inlet focused by DI water streams (Right) Blood at outlet focused by PBS solution. 
The results showed the lysing of RBCs indicated by the decrease in red colour of the mixture 
at the outlet [Fig. 4.15 (right)]. But when we tried to culture the lymphocytes, after lysing with 
DI water there was no growth observed, despite the cells appearing viable with Trypan blue 
staining [Fig. 4.16]. Trypan blue is a live-dead stain providing quick assessment of the 
viability of cells. As cells with intact membrane exclude this dye, they appear brighter and 
highlight a well defined membrane compared to dead cells whose membrane is easily 
breached by the dye and appear dark bluish in colour. 
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Figure 4.16: Trypan blue based viability testing for cells collected from FACSlyser. The background shows debris of the 
lysed erythrocytes. 
As a result, we concluded that the DI water treatment was harsh on the lymphocytes and 
switched to other commercially available lysants like VitaLyse (BioE), RBC Lyser (Sigma 
Aldrich) and freshly prepared 0.75 mM KCL solution. But unfortunately, none of these 
lysants (even those which claimed 99% selectivity to erythrocytes) could isolate lymphocytes 
which could be cultured and used for spreading metaphase chromosomes.  
Figure 4.17 shows the results of cell proliferation assay conducted with the WST-1 assay 
[Roche Diagnostics]. This colorimetric assay is used for studying the growth of the cells over 5 
days, by means of measuring absorbance of the cell suspension treated with WST-1 assay in 
order to measure their proliferation, based on their metabolic consumption of assay dye. As 
can be seen in the figure, the cell cultures for RBC Lyser and KCL show some growth, but the 
growth curve didn’t show the typical steep curve as expected in lymphocyte cultures. 
Unfortunately, none of the cells (including controls where the cells were lysed using the 4 
lysants on eppendorf tubes) showed any significant proliferation, which also confirmed our 
hypothesis that the lysants affect the proliferation of the lymphocytes but not the viability. 
Nevertheless, we wanted to quantify the lysing based on the microfluidic FACSlyser and 
compare it with the lysing on the traditional eppendorf tube based vortexing using the 
previously mentioned RBC lysants. Hence, we adopted the photometric detection technique 
to compare the lysing of RBCs on chip and on tube with vortex exposed to the lysant buffer 
for same amount of time [261-263]. 
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Figure 4.17: Colorimetric Cell Proliferation WST-1 assay for validating the viability and expansion of Leukocytes after 3 
days culture [Section 5.6.11]. 
The photometric detection assay works on the principle of measuring absorbance of UV light 
by haemoglobin and other RBC components dissolved in the lysate. On comparing the results 
of absorbance of different lysed solutions from microfluidic FACSlyser and the traditional 
technique it was observed that the lysing was marginally better on the FACSlyser. The best 
lysing was achieved using the DI water, while the least amount of lysing was observed using 
0.75mM KCL solution and Sigma Aldrich RBC lysing solution. Sodium dodecyl sulfate (SDS) 
buffer was used as control which lyses 100% of the cells. SDS solubilizes the cell membrane as 
a result releasing the entire cytoplasmic material in the lysate. On comparison, the VitaLyse 
solution from BioE was a better lysant for lysing RBC’s from a whole blood solution. 
At later stages of the project, during our visit to our collaborators we figured out that they 
typically prefer to culture whole blood, and arrest and fix lymphocytes instead of isolating 
lymphocytes prior to culturing. They also mentioned that they believe that the FACSlyse 
process does affect the lymphocytes. Hence despite showing viability during Trypan blue 
live-dead staining they might not proliferate. This reconfirmed our hypothesis that the 
lysants affect the proliferation capability of the cells. 
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Figure 4.18: Quantification of lysing on chip and comparison with traditional FACSlysing technique for different lysing 
solutions. 
We were also suggested to culture the whole blood first, followed by arrest and then apply 
subsequent lysing of the erythrocytes in FACSlyser with KCL. This will lead to isolation of 
arrested lymphocytes which don’t need further culturing and could be directly splashed as 
they have already been treated with hypotonic solution. This was not tested as we had 
already started to develop the integrated FISH version, but the herringbone mixer was 
meanwhile tested for fixation of the cells by PhD student Indumathi Vedarethinam with good 
success. Hence this project was dropped and the results with improved mixing efficiency of 
the microfluidic herringbone based mixer were presented at the COMSOL User conference in 
2008 and published in the proceedings of the conference [259]. 
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4.6 Hydrodynamic cell traps 
This work was conducted in collaboration with PhD student Jacob Lange and Master student 
Peter Paluszewski. In order to culture lymphocytes, it was important to trap them or isolate 
them from the rest of the blood components. In this work, cell traps were designed to trap 
lymphocytes in a microfluidic system. Hydrodynamic traps for sequential trapping of beads 
have been published before by Tan et al[264]. We wanted to apply the same trapping 
principle for sequential trapping of lymphocytes, after lysing of the red blood cells with the 
herringbone system. This was important for physical localization of cells and to allow for the 
debris to be removed from the lymphocytes, which could possibly provide background signal 
at a later stage. 
The design of the cell trap and working principle are highlighted in Figure 4.19. The trapping 
mechanism is illustrated in the inset figure. 
 
Figure 4.19: The schematic of the trapping system with inset pictures focussing on the positioning of cell traps before 
meanders and depicting the trapping mechanism of a cell in the cell trap. 
The cell traps and the meanders are placed alternately in the inlet channel and finally the 
outlet channel is formed by connecting the last meander to the outlets of all the cell traps. The 
cell traps are designed to be 5 µm wide in order to allow flow through but trap particles 
larger than 5 µm. The placement of meanders after each trap ensures the cells or particles 
flow through the traps because at each cell trap, the cell finds the resistance of the cell trap to 
be lower compared to that of the meander ensuring the cell gets trapped.  
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The hypothesis further was that once a cell is trapped in any cell trap, it’s resistance will 
increase compared to the meander and hence the next cell will flow through the meander into 
the next cell trap until all the cell traps are filled after which the cells flow straight to the 
outlet. 
Considering the height of the channel is 30 µm, the low Reynolds number ensures the flow 
follows Hagen-Poiseuille principles. This allows for easy interpretation of the hydrodynamic 
resistance in terms of an electrical circuit, as shown in fig. 4.20. 
 
Figure 4.20: (Left) one trap system (Right) Equivalent electrical circuit diagram based on hydrodynamic resistances of the 
one trap system 
Here, Rmeander, Rchannel, Rsquaretrap, Rback channel resemble the hydrodynamic resistances of the 
meander, channel between the trap and meander, the square part of the cell trap and the 
channel connecting the square trap to the outlet channel respectively. 
Hence, applying Ohm’s law and calculating the hydrodynamic resistances of meander and 
the cell trap by using the dimensions of the trap and the meander, we get, 
Ralternate = 3.27 x 1013 Pa s m-3 
Rtrap = 1.91 x 1013 Pa s m-3 
Thus, the trap will receive majority of the flow leading to trapping of the cells. Based on 
theoretical evaluation, we concluded that this design will work for any number of traps as far 
as there are 3 or more traps connected in series. For more details on the theoretical model and 
the calculations please refer to Appendix A. 
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Fabrication and testing 
The devices to test the cell trapping principle were fabricated in PDMS and bonded on to 
another flat PDMS using oxygen plasma based bonding [Fig. 4.21] [Section 5.4.1]. The master 
for moulding the device was fabricated in SU-8 on a silicon wafer and later replica moulded 
into PDMS [Section 5.2.1, 5.3.3].  
 
Figure 4.21: 10 µm polystyrene beads trapped in the cell traps (Image courtesy: Jacob Lange) 
The device was tested with beads and Jurkat cells to test the applicability of the cell traps to 
capture individual cells [Fig. 4.22]. The device functioned very well with polystyrene beads 
and several beads were trapped into each trap due to bead-bead stiction which was later 
minimalized using 20% Tween solution.  
 
Figure 4.22: Jurkat cells (15 µm) squeezing through a 5 µm cell trap 
When the solution was changed to cell suspension, the problems with trapping cells started to 
emerge. Cells are simply too elastic to be trapped. Jurkat cells as large as 15 µm in radius 
could squeeze through the 5 µm cell traps [Fig. 4.22] and later a publication highlighted how 
Jurkat cells can pass through 2 µm constrictions[169]. Hence this was the end of our efforts to 
take this cell trapping system further. Looking back, this system can find many applications 
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with beads based assays needing individual trapping and functionalisation of the beads. 
Later, Tan and Takeuchi presented another variation of the previous cell traps with chambers 
for culturing and trapping cells which look more promising[265]. 
4.7 Gravitational conditioning of cells 
This work highlights development of another microfluidic technique for concentration of cells 
using gravity assisted sedimentation.. The concept of this device is presented in Figure. 4.23. 
The device consists of a loading channel and a concentration channel separated by channels 
which allow sedimentation of the cells without getting washed away due to the flow in the 
loading channel. The flow in this device works based on stop and flow principle, whereby the 
flow is stopped on filling of the channel with cells and the stop is initiated when the cells 
have sedimented into the convection free zone of the sedimentation channel. Finally, all the 
cells are collected into the concentration channel and extracted via the outlet of the 
concentration channel. 
Design 1: Validation test 
 
Figure 4.23: Schematic of design 1. 
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The figure 4.23 depicts the schematics of design 1. There is one inlet connected to two 
channels, the top loading channel and the bottom concentration channel [in later designs the 
common inlet was dropped and separate inlets/outlets were chosen for both channels]. The 
outlets are switched by using 3 way port valves. Initially, all outlets are kept in open state and 
the entire device is filled with PBS buffer. In order, to start the concentration protocol, the 
concentration outlet is closed and the cells are loaded via the inlet into the loading channel. 
Hence during loading and sedimentation of the cells the outlet for loading channel was 
opened and closed synchronous to the stopping of flow. The concentration channel outlet was 
kept closed all the time until the cells were to be extracted. 
Fabrication and testing 
These devices were micro-milled into PMMA sheets and bonded using UV activated thermal 
bonding [Section 5.4.2]. Interconnects were formed as described earlier by embedding silicon 
plugs into ball end milled channels[188] . The device was tested with diluted Jurkat cells with 
a concentration of 105 cells /ml [Fig. 4.24].  
 
Figure 4.24: Sedimentation of cells from loading channel into concentration channel via the sedimentation channel 
The cells were concentrated upto 7 cycles and then extracted via the concentration channel 
outlet and counted using a cell counting slide chamber [Fig. 4.24]. In all experiments, we 
found a typical 5-7 times up concentration of the cells which is also presented in the Fig. 4.25.  
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               First cycle after 1 min (stop time)                   Third cycle after 3 min (stop time) 
Figure 4.25: Cells concentrated in the concentration channel after 1 and 3 min of the concentration protocol relating to the 
first and third cycle of the protocols respectively. 
 
Design 2: Grooved chamber  
Due to sequential manipulation and handling of cells during lysing and fixation of cells on 
the C-TAS motherboard, there was a significant dilution of cells. This created a need for 
concentration of the cells before flushing them to the next module, which is traditionally done 
by centrifugation process in bulky centrifuges. In order to achieve concentration of cells on 
the motherboard, a strategy of trapping cells by gravity based sedimentation was utilized, 
whereby cells were concentrated in a stagnant flow in the grooves of a grooved chamber [Fig. 
4.26].  
The grooved chamber was designed as a culture chamber to provide diffusion based 
perfusion to the cells loaded at the bottom of the grooves [266]. Due to the high aspect ratio of 
the grooves, the perfusion in perpendicular direction above the grooves will not enter the 
groove which creates a convection free diffusion dominant zone in the grooves [Fig. 4.26]. 
While this device never functioned as a culture device as intended, it was tested on the 
motherboard for gravitational trapping based concentration of cells.   
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Figure 4.26: Grooved chamber for gravitational concentration of cells. The cells are perfused from  A to B i.e. perpendicular 
to grooves leading to sedimentation of the cells in the grooves on stopping of the flow and subsequent trapping in the 
convection free zone on restarting of the flow.  
 
The concept was to trap the cells in the convection free zone by sedimentation of the grooves 
by means of stopping the flow intermittently [Fig. 4.27]. Once the cells pass into the diffusion 
dominant zone in the grooves the flow is started again to refill the chamber above the grooves 
with new cells. During the refill process, the cells in the grooves continue to sediment as they 
see no convection. Lange et al. have demonstrated that the flow in any microgrooves with 
twice the height than the width of the groove, will only be diffusive and the cells in the 
grooves will not see any convection [266].  
 
Figure 4.27: (Left) Simulation of flow across the grooves showing convection above the groove and diffusion in the grooves 
(Right) Stop and Flow based gravitational trapping of cells  
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Assembly and testing 
The devices used to test the motherboard were kindly provided by Jacob Lange, who was 
developing the C-TAS culture module. A pluggable module was assembled by adhesive 
bonding based assembly of the Pluggy and grooved chamber. The dilute T-Lymphocyte cell 
suspension was prepared with concentration of 105 cells/ml and loaded in a 1 ml syringe. A 
syringe pump was used to actuate the cells through the motherboard. The syringe pump was 
programmed to pump for 1.5 min and then stop the flow for 3.5 min. When the diluted cells 
were flushed into the grooved chamber filled with Phosphate Buffered Saline (PBS) buffer, 
the flow was stopped when the chamber was filled with cells. Once the cells had sedimented 
in to the grooves and left the convection zone, the flow could be restarted to enter more cells 
into the grooved chamber without disturbing the sedimentation of the cells which were no 
longer in the transverse flow lines reach. This process can be used repeatedly to up 
concentrate the dilute cells, which can later be collected via the unloading outlet or perfused 
to culture on the culture chip. 
Results of concentration 
   
Figure 4.28: Time lapse of concentration of cells using gravitational sedimentation into convection free zone of the grooved 
chamber. 
Figure 4.28 highlights the results of the gravitational concentration of cells in the grooved 
chamber. The cells took roughly 3 min to leave the convection zone and enter into the 
diffusion zone and hence the syringe pump was programmed to flush cells for 1.5 min and 
then stop flow for 3.5 min at 2 µl/min. After every cycle an image was taken and the results 
of the cells concentrated in the grooves after 2, 8 and 15 cycles have been depicted in the 
Figure 4.28. The increasing concentration of cells was clearly evident after every cycle of 
sedimentation.  
This chip was originally designed for cell culture work, but due to a fault in the design the 
flow was uneven in the chamber [266]. As a result, there were more cells getting collected in 
  After 2 rounds of sedimentation   After 8 rounds of sedimentation  After 15 rounds sedimentation 
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the edge of the chip compared to the central grooves [Fig. 4.29]. With 15 rounds of 
gravitational sedimentation, we processed 50 ± 3 µl of cell suspension each time and 
concentrated cells with an average efficiency of 69%. The experiment was conducted 10 times 
for 3 different samples. The cells were counted before the sedimentation protocol and after as 
an end point result to calculate the average concentration efficiency of the device. The aim of 
this experiment was not to characterize the system, but to ascertain if it would be possible to 
load cells on the culture chip and concentrated that way. It was also important to figure out 
how many cycles would be needed to capture sufficient amount of cells to conduct the FISH 
protocol. The entire protocol took 75 min in total for the 15 rounds of sedimentation. 
 
Figure 4.29: (Left) Magnified image of concentration showing multiple layer buildup of cells and (Right) Higher 
concentration of cells in the edge of the grooved chamber due to unbalanced hydrodynamic resistances due to clogging in the 
middle of groove. 
We successfully demonstrated the concept of gravitational sedimentation of cells in the 
grooved chamber on a motherboard. However, due to changes in the culture device, we 
didn’t use the grooved chamber for C-TAS protocol. Nevertheless, these results highlight the 
applicability of the motherboard for manipulating cells and the possibility of using the 
sedimentation principle for loading and concentrating cells in the culture chamber. If this 
device is to be used as sedimentation based device for concentrating cells then optimizing the 
sedimentation protocol will be the first task. But as we realized it would take over 1 h to 
capture sufficient amount of cells to start the cell culture protocol, we discarded this solution 
from the C-TAS protocol and hence no experiments were conducted to characterize the 
system further or optimize the stoppage and flushing times to improve the concentration 
efficiency. 
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4.8 Continuous gravitational fractionation of lymphocytes 
In the above experiments, the sedimentation of the cells was purely based on the gravity. As a 
result, this was a time consuming process which would need fair amounts of time if we 
intended to concentrate a large volume of cell suspensions (300 nL/cycle). In order to increase 
the speed of the process and to improve applicability for C-TAS project, we redesigned the 
gravitational concentrators into various designs providing high throughput concentration of 
cells as well as novel approaches for utilizing the same designs for Ficoll-paque based sorting 
of the cells i.e. without the need for stopping the flow. 
Ficoll-Paque is widely used in biological labs to extract WBCs from whole blood. The 
principle of operation is density driven fractionation of whole blood as the density of Ficol-
Paque medium is between the density of the red blood cells and the white blood cells leading 
to their separation into separate layers above and below the Ficoll medium [Fig 4.30]. 
 
Figure 4.30: Operation of Ficoll-Paque based isolation of blood sub-types. (www.ge.com) 
The principle of continuous flow sorting of lymphocytes using a gravitational fractionation 
device is based on simultaneous sedimentation of erythrocytes in the Ficoll-paque and 
floatation or anti-sedimentation of lymphocytes. Hence if you imagine a mixture of blood 
cells in Ficoll-paque solution passing through a microfluidic channel, the erythrocytes are 
continually sedimenting in  this channel, while the lymphocytes are continually rising due to 
the anti-sedimentation or floatation caused due to rapidly sedimenting erythrocytes [267]. 
Hence, in principle if you have the channel long enough you could just extract the 
lymphocytes from the top of the channel after a certain time.  
But we were interested in utilizing the high throughput system which benefited from 
hydrodynamic flow manipulation, leading to faster sedimentation of the cells due to their 
slipping into a no flow zone at each gravitational trap. We simulated this high throughput 
Evoluting microfluidics: Moving toward clinical applications 
 
136   
 
 
system to calculate the number of gravitational traps required in an array for trapping 100% 
of the lymphocytes in the system.  
Simulations of high throughput gravitational trapping of erythrocytes: 
It was well known from literature that erythrocytes sediment roughly about 0.8 µm/s and at a 
faster rate in Ficoll-paque due to creation of a density gradient [268]. In order to simulate the 
sedimentation of erythrocytes in the high throughput gravitational sedimentation system, we 
simulated sedimentation of particles by adding a gravitational drop of 3 mm/hr on the 
particles. In traditional microfluidic systems, effect of gravity is neglected as a result. The 
flow through such a trapping system appears as shown in Fig. 4.31 
 
Figure 4.31: Depicting normal flow of cells without including gravitational sedimentation 
But from earlier results, we were aware of the rapid sedimentation of cells in microfluidic 
systems. Hence, we were interested in optimizing the earlier design into a continuous flow 
separation gravitational sedimenter. We started with optimizing the 3 designs depicted in 
Fig. 4.32. Soon we realized the need for reducing vertical lifts in the design which disrupts the 
sedimentation of the erythrocytes. Hence, we avoided the top two designs in the Fig. 4.32. But 
on simulation of the bottom design, we observed the lack of convection-diffusion boundaries 
leading to rapid sedimentation of the erythrocytes. Hence, we created a new design with a 
novel stepped approach [Fig. 4.33], whereby the gravitational traps were arranged in a 
stairway-like fashion, and each trap was placed in the place of a step. In this way the output 
of the first trap (one at the top) will lead to the inlet of the next trap placed a step below 
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leading to no vertical lifts in the fluids. This also ensures that multiple convection-diffusion 
boundaries exist for the cells to sediment into at every trap. These systems benefit from the 
similar principle but have an advantage due to multiple arrays of traps being positioned in a 
sequence leading to faster trapping of particles without the need for stopping of flow. 
 
 
 
 
Figure 4.32: High throughput gravitational hydrodynamic sedimentation designs 
After iterative simulations, we discovered that placing 9 gravitational traps connected in 
sequence, we can capture all the erythrocytes from the cell suspension [Fig. 4.33]. Also, 
considering that the lymphocytes feel an anti-sedimentation rate (simulated as equal to the 
sedimentation rate of erythrocytes i.e. 0.8 µm/s), they will continue to flow and rise in the 
convective stream towards the top of the channel and as a result can be sorted and isolated in 
the outlet [Fig. 4.34]. In these simulations, the erythrocytes and lymphocytes are simulated by 
tracing the trajectory of particles of diameter 6 and 9 µm under the effect of gravity.  
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Figure 4.33: High throughout gravitational sedimentation of erythrocytes 
 
Figure 4.34: Depicting isolation of lymphocytes due to floatation in Ficoll-Paque medium. 
Unfortunately, due to time constraints and other interesting discoveries, these results only 
ended up only as a theoretical study. It has been spun off now into a Master’s project and 
hopefully we will soon have results to corroborate this fascinating theoretical observation. 
4.9 Antibody based trapping of chromosomes 
During the course of the C-TAS project, a number of surface modification techniques were 
tested. The major goal of these experiments was to develop a toolkit to immobilize or rather 
capture chromosomes on a surface functionalized with an antibody via a linker (surface 
binding molecule).  All the surface modifications work was conducted with Jacob Lange 
(another PhD student also part of C-TAS project) and under the guidance of Asso. Prof. 
Mogens Havsteen Jakobsen. With the intention to use known chemistries for modifying the 
Flow
Flow
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surface, we started with triazine, 2,4,6-trichloro-1,3,5-triazine (TsT) based selective activation 
and Polyethylene Glycol (PEG) based passivation chemistry developed by the Surface 
Chemistry group.  
 
Anti CENP-A Immobilization 
 
In order to test our hypothesis that we could capture chromosomes by using surface-bound 
antibodies having affinity to specific regions of the chromosomes, we needed to activate 
selective regions on the surface to bind the antibody while passivate the rest of the regions so 
that the chromosomes don’t bind unselectively. To begin the TsT- PEG surface chemistry was 
tested with Biotin-Streptavidin assay to mimick the binding of antibody and histones[266].  
On successful results of this test assay, we switched to immobilizing CENP-A (Centromeric 
Protein) which binds to histones on the centromere of chromosomes. 
 
The surface was prepared with TsT-PEG chemistry and the antibody was patterned 
selectively on to the surface by means of selective patterning using a stenciled PDMS 
membrane. The membrane was fabricated as described below and applied to the surface 
covered with PEG [Fig. 4.35].  After selectively patterning of the activation and immersion of 
the wafer in antibody solution, we had localized spots containing antibodies. The 
chromosomes suspension was prepared in a polyamine buffer using the technique described 
by Wray et al[269]. Later, a drop of suspension was applied to the surface and left overnight 
to hybridize. Overnight hybridization times were preferred as chromosomes have slower 
diffusion.  
 
 
Figure 4.35: Fabrication of PDMS membranes to act as stencil for selective surface activation for antibody binding. 
 
Unfortunately, the results were not as successful as with the test assay. While the antibodies 
could be localized using the technique shown in Figure 4.36, which was promising, the 
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chromosomes were nevertheless bound to the entire surface and not selectively to anti CENP-
A [Fig. 4.37].  
 
Figure 4.36: Process of surface passivation, selective activation and subsequent trapping of the antibodies 
 
We tested the results with numerous other substrates like COC, PMMA and even TiO2 coated 
silicon wafers. But the results were the same, leading us to conclusion that the surface 
chemistry was not that specific. 
 
Figure 4.37: (Left) Anti-CENP A patterning showing clear defined edge of coating (Right) Showing unspecific binding of 
chromosomes on both the sides of the dotted line demarking the edge of the CENP-A coating. 
In the end, we concluded that this surface chemistry toolbox will not work for chromosomes 
and we had to revert back to traditional chromosome immobilization techniques as described 
in Paper 1.  Looking back, we could have done few things differently especially to improve 
the hybridization. Firstly we could have treated the chromosome suspension with elevated 
temperature (75°C) to denature the DNA before applying them to the surface. Finally, a flow 
based system would be better suited to avoid unspecific binding of the chromosomes based 
on sedimentation.  
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CHAPTER  
METHODS 
 
This chapter serves as a compendium of the 
methods used as part of the experimental work 
described earlier in this thesis. All the 
methodologies related to the design, simulations, 
fabrication and further, the biological analysis 
protocols are explained in detail.   
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5.1 Simulations 
When necessary, extensive theoretical studies have been conducted as part of optimization 
exercises in order to assist in the designing process, leading to fundamentally sound designs 
as well as to characterize the flow through microfluidic devices presented in earlier chapters. 
The simulations were always conducted using COMSOL Multiphysics software (versions 3, 
3.4 and 3.5). 
Table 5.1: Parameters used for theoretical analysis of various microfluidic systems 
Device Constant Description Value Unit Source 
Microfluidic 
Bioreactor 
(µBR) 
U Inlet Velocity of perfusion  2.083e-11 m3/s  
W Width of perfusion meander 5 x 10-4 M  
hculture Height of culture chamber 2.5 x 10-4  M  
Hperfusion Height of perfusion meander 3 x 10-4  m  
ρ Density of water 1 x 103 kg/m3  
η Viscosity of water 1 x 10-3 Pa s  
φmembrane Membrane Porosity 0.14  Manufacturer 
Dglucose Diffusion coefficient of Glucose  6.7 x 10-10 m2/s [187] 
DKCl Diffusion coefficient of KCl 2 x 10-9 m2/s [270] 
 Glucose consumption 2.66 x 10-4 mol/ m3s [186] 
 Concentration of glucose in media 11.11 mM Manufacturer  
 Porosity of the membrane 0.14  Manufacturer 
Continuous 
Gravitational 
Sedimenter 
Rrbc Radius of red blood cells 5 x 10-6 m  
Rwbc Radius of white blood cells 9 x 10-6 m  
U Inlet Flow velocity 6.6 x 10-4 m/s  
Srbc Erythrocyte Sedimentation Rate 0.8 x 10-6 m/s [268] 
Swbc Leukocyte Anti-Sedimentation Rate 0.8 x 10-6 m/s [267] 
Ρ Density of water 1 x 103 kg/m3  
Η Viscosity of water 1 x 10-3 Pa s  
T Thickness of channel 1 x 10-4 m  
FACSlyser 
Dblood Diffusion coefficient of RBC 6.8 x 10-14 m2/s www.nanomedicine.com 
Dlysant Diffusion coefficient of KCL 2 x 10-9 m2/s [270] 
Ulysant Inlet velocity of lysant 1 x 10-4 m/s  
Ublood Inlet velocity of blood 1 x 10-4 m/s  
Ρ Density of water 1 x 103 kg/m3  
Η Viscosity of water 1 x 10-3 Pa s  
c0 Concentration of blood stream 1 mol/ m3  
c1 Concentration of lysant stream 0 mol/ m3  
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Integrated relevant modules of “Convection-Diffusion” and “General Laminar Flow”, part of 
the MEMS - Microfluidics application mode were used to match the scale and aspects of the 
problems being simulated. The simulations were conducted in transient or stationary modes 
depending on the design problem. The various constants used as part of the simulation work 
are listed in Table 5.1. 
Microfluidic Bioreactor 
The entire system was simulated. Version 3.6 of COMSOL Multiphysics was used by 
coupling the General Laminar Flow and the Convection-Diffusion application modes. The 
two physics modes could however be solved independently so first the fluid flow was solved 
for in a steady state analysis. The solution was saved and used for solving the concentration 
using a transient analysis from 0 to 2000 s with the solution stored in 50 s time intervals. In 
the first case we looked at how KCl fills the channel and chamber in this period. The actual 
concentration of KCl is not important and therefore a concentration of 1 M was used at the 
inlet as a “normalized” concentration for the KCl. In the case of glucose consumption by the 
cells the transient analysis was conducted from 0 to 72 hours with a time step of 5000 s. The 
initial concentration in the all subdomains was set to 10 mM, as was the inlet concentration at 
the solution inlet. In this case the concentration values are therefore absolute. All boundaries 
apart from the inlet and outlet were set to “wall” for the laminar flow application mode and 
to “insulation/symmetry” for the convection-diffusion application mode. 
Gravitational Sedimenter 
The entire problem was simulated with version 3.6 of COMSOL Multiphysics using the 
General Laminar Flow module. In this case we simulated the flow through the system and 
then processed the solution by adding streamlines. By modifying the solution parameters, we 
added tracking of 200 particles released simultaneously at the inlet. For simulation of the 
erythrocytes, we added a velocity component in Z direction equivalent to the free fall velocity 
or sedimentation velocity of cells (3 µm/s). Similarly for simulation of the leukocytes, we 
added an anti-sedimentation rate or floatation rate equivalent to the sedimentation rate of 
erythrocytes [267]. The particle sizes were tuned accordingly to 5 and 9 µm during the 
particle tracking to match the sizes of the erythrocytes and leukocytes respectively. All 
boundaries apart from the inlet and outlet were set to “wall” for the laminar flow application 
mode. 
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Microfluidics FACSlyser 
The entire mixer was simulated with version 3.6 of COMSOL Multiphysics by coupling the 
General Laminar Flow and the Convection-Diffusion application modes using 3D geometry 
mode. As both the modules can be solved independently, at first we solved the fluid flow in a 
steady state. Later, by using this flow solution, we added concentration of 1 and 0 to the two 
mixing streams. In this case we looked at how quickly the fluids mixed in the mixer. The 
cross sectional plots of the mixers were taken after one cycle of mixing to compare the 
different mixer geometries. The mixers were also tested for their efficiency in mixing with 
respect to having the herringbone structures in the channels placed as ridges or as grooves. 
All boundaries apart from the inlet and outlet were set to “wall” for the laminar flow 
application mode and to “insulation/symmetry” for the convection-diffusion application 
mode. 
5.2 Cleanroom fabrication protocols 
5.2.1 Fabrication of SU-8 master 
This section describes the process of making a SU-8 master which can be reused several times 
to replica mould PDMS structures. The SU-8 master is made by spinning SU-8 2075 (obtained 
from microchem.com) on a Si (1 0 0) wafer using a Karl Suss (KS) spinner.  The spinning 
parameters are selected based on the required height of the channel structures. SU-8 2075 is a 
negative photoresist with a high viscosity. The SU-8 resist is exposed (with a Karl Suss 
aligner) using a dark field mask and subsequently developed with Propylene Glycol Methyl 
Ether Acetate (PGMEA) to create raised channels structures on the Si wafer. The overall 
process flow for SU-8 master fabrication is described in Table 5.2. 
 
A syringe filled with SU-8 2075 resist is allowed to rest for 18 hr prior to use to allow for 
degassing of the air which could be trapped during loading of the syringe due to high 
viscosity of the resist. Failing to remove trapped air will result in uneven spinning of the 
resist over the wafer. Degassing could also be improved by heating the resist to 60 ⁰C. 
Simultaneous to the degassing of SU-8, we leave Si wafers in the 250 ⁰C oven to dehydrate 
them to improve adhesion of the SU-8 resist to the wafer. For spin coating SU-8 roughly 4-5 
ml of SU-8 is used per wafer and the process recipe for spinning the SU-8 is run based on the 
desired height of the channel structures (100 µm for microFISH and 40 µm for Pinch Flow 
Fractionation devices). 
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Table 5.2: SU-8 master fabrication recipe 
 Process Step Equipment Protocol Comments 
1 Degassing SU-8 Syringe and SU-8 
Load Syringe and Wait 
18 hrs 
Leads to air 
bubbles getting 
accumulated at the 
top of the syringe 
2 Dehydration of Si 
Si (1 0 0) wafer and 
an oven 
Temp. 250 ⁰C for 18 
hrs 
Dehydrates the 
wafers 
3 Spinning of SU-8 KS Spinner 
Typically  
Time: 30-80 s, 
Acceleration: 200 
rpm/s  and Speed: 
1000-5000 rpm 
Parameters differ 
from design to 
design and 
described further 
in individual 
devices 
4 Prebaking SU-8 Hotplate 
95 ⁰C for  5 hrs with 
ramp time of 30 min 
Cooling period  of 
3 hr 
5 Exposure KS Aligner 
Design dependent – 
typically time: 30 – 120 
s with intermittent 
wait times of 15-30 s, 
Intensity of 9 mW/cm2 
Parameters differ 
with each design 
based on the 
devices. 
6 Postbaking SU-8 Hotplate 
95 ⁰C for  5 hrs with 
ramp time of 30 min 
Cooling period  of 
3 hr 
7 Development 
PGMEA developer 
baths 
First 4 min and later 
final 1 min 
First is for rough 
development 
8 Washing Isopropanol (IPA) 
Rigorous flushing of Si 
Wafer 
 
9 Drying Air drying chamber 
Air drying to remove 
any IPA 
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A polished Al hotplate setup is used for pre and post exposure baking at 95 ⁰C for 5 hrs to 
remove any stress from the SU-8 resist. The exposure time is set accordingly to the thickness 
of the SU-8 resist layer. This baking step leads to evaporation of the solvent from SU-8 and 
improves the resist film adhesion to the wafer. Post baking leads to better cross-linking of the 
exposed SU-8 regions and reduces appearance of cracks and bowing of certain regions due to 
internal stresses. For developing the structures, PGMEA baths are used. The first 
development is a rough development which dissolves the unexposed and uncrossed linked 
SU-8 followed by a final development. Finally, the wafers are thoroughly washed in IPA and 
air dried in the automatic dryer.  
 
5.2.2 Fabrication of Silicon Master 
The master mould for curing PDMS channels can also be made in Si (1 0 0) wafer by KOH 
based anisotropic wet etching process defining pyramidal structures for channels. The 
process used for fabricating the Si master using KOH wet etch is highlighted in Table 5.3.  
The wet oxidation process is used to grow oxide to act as a mask for KOH etch. The HMDS 
treatment improves the adhesion of the resist to the wafers. Before spinning the resist on to 
the Si wafer, the nozzle of the Track 1 spinner is cleaned and spin coating is tested on 3 test 
wafers. After this step, 1.5 µm AZ5214E resist is spun on the Si wafer followed by a soft 
baking recipe. The KS Aligner is used for hard contact exposure of the resist for 7 s with 
intensity of 9 mW/cm2.   
Following oxide removal with BHF, liftoff is performed by acetone rinse and finally the Si 
wafer is etched with KOH to define the raised channel structures. Dektak profiler is used to 
characterize the height of the channel structures. 
 
5.2.3 Fabrication of Pyrex electrodes chip 
After treating the Pyrex wafers with HMDS, 1.5 µm layer of AZ5214E resist was spun on to 
the wafers. Following the first exposure with an inverted mask, a reversal bake is applied 
which is followed by a flood exposure to define the electrodes. After development, the 
electrodes are created in Wordentec by deposition of 10 nm Ti and 150 nm Au. Finally, the 
process ends with a lift off. The detailed sequence of the process is listed in Table 5.4. 
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Table 5.3: Process flow for fabricating Silicon Master with KOH wet etch process 
 Process Step Equipment Protocol Comments 
1 
Thermal wet 
oxidation 
Boron drive-in 
Recipe: Wet 1050 
H20: 30 min 
N2: 20 min 
Thickness: 300 nm 
KOH mask 
2 Film inspection Flimtek Measure film thickness  
3 HMDS HMDS oven 
Program 4, 
Recipe time: 30 min 
T = 150°C 
Improve resist 
adhesion 
4 Spinning resist SSI spinner 
Prebake: 90°C 
Time = 60 s 
Resist: AZ5214E 
Recipe: 1.5 µm 
BHF mask 
5 Exposure KS Aligner 
Hard Contact 
Time: 7 s 
Intensity: 9 mW/cm2 
 
6 Development Developer 2 Time: 70 s  
7 Oxide etch BHF tank 
Time: 4 min 
Rate: 80 nm/min 
Protect backside 
with blue film 
8 Rinse Acetone Bath Time: 15 min 
Strips remaining 
resist 
9 
7up (98% 
sulphuric acid and 
ammonium 
sulphate) 
7 up bath 
Time: 10 min 
Temp: 80ºC 
Remove any 
residues and get a 
smoother etch 
10 Silicon Etch 
KOH 28%, 
Wet etch bath 
Time: 7.5 min 
Rate: 1.28 µm/min 
Temp: 80 ⁰C 
Channel height of 
10 µm for 
impedance 
cytometer chip. 
11 Oxide Etch HF tank 
Time: 10 min 
Rate: 80 nm/min 
Strip remaining 
oxide 
12 
Cleaning with 
7 up 
7 up bath 
Time: 10 min 
Temp: 80 ⁰C 
 
13 Characterization Dektak 
Measurement of 
channel height 
Remove any 
residues and get a 
smoother etch 
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Table 5.4: Process flow for creating electrodes on a Pyrex wafer. 
 Process Step Equipment Protocol Comments 
1 HMDS HMDS oven 
Program 4, 
Recipe time: 30 min 
T = 150°C 
Improve resist 
adhesion 
2 Spinning resist SSI spinner 
Prebake: 90°C 
Time = 60 s 
Resist: AZ5214E 
Recipe: 1.5 µm 
 
3 Exposure KS Aligner 
Hard Contact 
Time: 4 s 
Intensity: 9 mW/cm2 
 
4 Inversion bake Hot plate 
REV120 
Temp: 120 ⁰C 
Time: 2 min 
 
5 Flood Exposure KS Aligner 
Time: 30 s 
Intensity: 9 mW/cm2 
 
6 Development Developer 1 or 2 
Time: 70 s 
Wash: 3 min in water 
 
7 Drying Air Dryer Recipe  
8 
Electrode 
Deposition 
Wordentec 
10 nm Ti 
150 nm Au 
E-beam 
evaporation 
9 Lift-Off Lift-Off bench 
Acetone + Ultrasound 
Time: 30-60s 
Continue until all 
metal is fallen off 
10 Drying Spin Dryer Time: 2 min  
 
5.3 Polymer fabrication protocols 
5.3.1 Micromilling:  
Micromilling relies on the mechanical removal of material from substrates by use of specially 
designed tools [Fig. 5.1]. These tools are readily available in a variety of sizes [25 µm to 6 mm] 
and shapes based on the application [end mills, ball end mills, drills, etc]. Milling machines 
consist of stationary tool holders where tools can be controlled in the Z axis and a moving X-
Y stage to move the substrate with respect to the tool leading to patterning of the substrate. 
The tools are rotated during operation leading to either cutting or drilling in the substrate 
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based on the tool selected i.e. either end mills for cutting channels and drill for drilling holes 
for interconnections.  
Structures of feature sizes down to tens of micrometers can be milled dependent on the 
overall accuracy of the machine and the flatness of the substrate. The desktop Mini-Mill 
machines used for the experimental work contain stepper motors controlling the XYZ stage 
micro-positioning down to a resolution of 1 µm. The repeatability of the system with 
inclusion of the spindle-runout is typically found to be less than 5 µm. As Nordplast, our 
substrate supplier specifies a variation of 20 µm in a 10 x 10 cm PMMA sheet, we expect on 
average to have a 2 µm difference in our channel dimensions for the typical 2 x 2 cm devices.  
Another source of error is the quality of the tool, and also with wear the tool dimensions 
change and the flute loses its features. Yet, the difficulty associated with detecting 
dimensional changes of tools remains a limitation.  
  
Figure 5.1: (Left) Micromiling process (Right) Tools used for micro milling (Courtesy: Janpo) 
The parameters used for the milling are dependent on the tool and substrate to be milled. 
Typically, you vary the feed rate, Z step size and the tool rotation speed depending on the 
features of the device.  Commercial CAD software’s AutoCAD and Solidworks were used to 
draw the 2D and 3D versions of the devices respectively and finally converted to the machine 
readable G-code using Lazycam and EZcam softwares. The milling machines were controlled 
using Mach3 software. Due to the relatively high reproducibility (with precision of 5 µm) of 
devices fabricated with micromilling technique, this project made use of micromilling 
extensively for fabrication of the motherboard, microfluidic devices and moulds for PDMS 
lids [271]. In order to account for the melting of the polymers at high rotational speeds, 
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generally low rotational speeds (2000 – 14000 rpm) and cooling with Milli-Q water was 
preferred. All devices were cleaned using Isopropanol and later sonicated in an ultrasonic 
bath to remove any burrs remaining on the milled features.   
5.3.2 Laser ablation 
Laser ablation is another technique used as part of the PhD project to pattern substrates. The 
laser used for ablation of the polymers and adhesive tapes is a CO2 laser from Synrad Inc., 
USA, with an output power of 50 W and a wavelength of 10.6 µm.  
 
Figure 5.2: (Top) Typical Gaussian profile of structures (under 400 µm) ablated in PMMA with fewer than 60% laser 
power (Bottom) Typical profile of a large channel structure (wider than 1 mm) made in PMMA with 50% laser power. 
Another typical effect observed in channel structures made with laser ablation is the edges near the channel sides on both 
sides (marked with dotted circles). This is believed to be mostly the result of re-solidification of ablated polymer or cold 
fracture at the interface [272]. 
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A controller unit is attached to the laser which allows the user to control the path of the beam 
through a commercial drawing and control software: WinMarkPro (v 5.1.1.5942). In the setup, 
the focusing mirrors deflect the beam onto a work area of 110 mm by 110 mm positioned 
under the lens at a focal length of 189 mm. The parameters used for laser ablation of a 
substrate depend on the design and required features. The typical parameters controlled to 
tune the ablation of the devices are laser power (percentage of the total power), velocity 
(mm/s), resolution (dots per inch) and mark passes (no. of laser passes). Generally, the device 
designs were drawn in CorelDraw or AutoCAD and later exported to Winmark software to 
ablate using the laser.  
Laser ablation is a relatively rapid technique for creating microfluidic structures and can be 
recommended for rapid prototyping and quick testing of microfluidic devices. To compare 
with micromilling, a 200 µm wide and 200 µm deep channel with length of 5 cm will only 
take few seconds to ablate using this technique, while with micromilling it can easily take 
over 30 min. Only drawbacks of laser ablation technique are the highest resolution achieved 
[~100 µm], the Gaussian profile of laser ablated structures [Fig. 5.2] and compatibility to only 
few materials. For detailed description of the technique refer to Christiansen and Hansen et al. 
[106, 247]. 
5.3.3 Replica Moulding 
Replica moulding is a rapid prototyping technique which belongs to the family of polymer 
fabrication techniques grouped as “Soft Lithography”[14-16]. Replication methods are 
generally suited for applications where multiple copy of a master or mould needs to be 
generated rapidly. This technique is often used in multiple forms like injection moulding, hot 
embossing and casting. These methods depend on solidification or hardening of a liquid 
polymer or softened polymer by means of a thermal, optical or chemical treatment, when in 
contact with a rigid or elastomeric master with a particular pattern which needs to be 
replicated. During, this PhD project, we used the PDMS casting technique to generate 
multiple copies of devices from Si, SU-8 or PMMA masters. The PDMS Kit (Sylgard 184) was 
ordered from Dow Corning. The typical ratios of PDMS and curing agent used were as per 
the manufacturer specifications i.e. 10:1. Only in case of the Pluggy, we used 10:2 ratio for 
PDMS and the curing agent to gain more mechanical strength due to substantive cross-
linking leading to the harder and more rigid Pluggy. 
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5.4 Bonding 
5.4.1 PDMS bonding protocol 
Oxygen plasma based bonding of PDMS to various substrates is a well documented 
procedure [191, 273]. We used this technique for bonding PDMS to Pyrex wafers for sealing 
the channels and assembling the devices [Chapter-2]. This technique offers numerous 
advantages being simple, quick and providing a good irreversible bond. The protocol used 
for bonding PDMS lids (with channels) to Pyrex devices (with electrodes) is listed in Table 
5.6. 
 
Table 5.5: PDMS Replica Moulding 
 Process Step Equipment Protocol Comments 
1 Mix Precursors Plastic containeer 
Mix 10:1 (wt/wt) 
PDMS and curing 
agent 
For Pluggy: Use 10:5 
Mix thoroughly for 
2 mins.  
2 Degassing  PDMS Vacuum Chamber 
Time: 45 min 
Pressure: 0.2 mbar 
 
3 Casting  Oven 
Pour PDMS mixture 
over the master and 
heat cure. 
 
Temperature:  
60 ⁰C (3 hrs) 
85 ⁰C (2 hrs) or 
Overnight at room 
temperature. 
 
4 
Remove casted 
PDMS  
Tweezers 
Gently remove the 
casted PDMS replica 
from the master 
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Table 5.6: Process flow for bonding PDMS to other substrates using Plasma oxidation 
 
 Process Step Equipment Protocol 
1 Cleaning surfaces 
Isopropanol 
DI water 
Clean the surfaces to 
be bonded thoroughly 
with IPA followed by 
DI Water 
2 Drying 
Compressed 
Nitrogen 
Dry the surfaces 
thoroughly with N2 
3 Surface activation 
Oxygen 
Plasma 
Asher 
O2 gas flow: 100 
mL/min 
Power = 100 W 
Time = 30 s 
4 Bonding Microscope 
Align the devices 
under the microscope 
and put the surfaces 
together as fast as 
possible. Leave for at 
least 15 mins before 
use. Typically 
overnight  for the 
bonding to settle. 
5 PostBake Oven 80 ⁰C for 15 mins 
 
The oxidation of PDMS changes the surface properties and turns it hydrophilic, due to 
creation of hydroxyl groups on the surface as part of the dehydration process. As the 
hydrophilic surface forms chemical bonds rapidly with other surfaces, it helps in bonding 
PDMS lids to Pyrex device. The hydroxyl groups will regroup and the hydrophobic 
properties of PDMS start to re-emerge in about 10 min. In order to slow down this reversal 
process, it is suggested to put the exposed PDMS in DI water until used[103, 104, 136, 274]. 
The post bake leads to rapid and stronger bonding of devices. 
 
5.4.2 Thermal bonding 
For bonding devices made in PMMA and PC, we preferred thermal bonding protocol over 
adhesive bonding for biocompatibility and reproducibility issues. Two different bonding 
techniques were used for bonding micromilled substrates: UV activated bonding[275, 276] for 
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PMMA, PC and solvent activated bonding for PC[266]. In order to bond the devices, they 
were first rigorously cleaned with detergent to remove any burrs in the channels or milled 
structures. This was followed by a 3 s dip in 70% ethanol which was immediately followed by 
a Milli-Q water washing step for 1 min. After drying the devices with compressed air, they 
were ready to be activated with UV exposure. Exposing PMMA and PC to UV light source 
(DYMAX EC5000) results in a thin layer of activated surface on the substrates, which has 
reduced glass transition temperature compared to the bulk substrate. This allows for rapid 
thermal bonding of the substrates at lower temperatures than the bulk glass transition 
temperature. In case of solvent bonding, the solvent was freshly prepared by mixing 
isopropanol: acetylacetone (1:1). In order to have a uniform exposure of the solvent to the 
substrates, the solvent is applied to a tissue and the two parts are lightly rubbed on to the wet 
tissue for 5 s. The two parts are allowed to rest for 15 s to allow for evaporation of the solvent. 
The substrates were always bonded in P/O/Weber bonding press at pressures typically 
about 0.5 kN/cm2 of bonding surface area. 
 
5.5 Device Recipes 
5.5.1 Fabrication of modular motherboard 
Owing to the design features of the motherboard, especially the depth of the sockets, we had 
only two choices for fabrication of motherboard i.e. micromilling or laser ablation. But due to 
the Gaussian profile of the tall features fabricated with laser ablation process, micromilling 
was chosen for motherboard fabrication. The motherboard sockets were milled in PMMA or 
PC using a 2 mm end mill while the through holes for the needles were made using a 500 µm 
drill.  The plug-in ports for external fluidic connections were milled using 1 mm end mill and 
500 µm drills. The electrical through holes were milled with a 700 µm drill. The fluidic 
channels on the back of the sockets were milled using 500 µm end mills and finally the 
motherboard channels were sealed by bonding a flat PMMA sheet to conceal the fluidic 
channels [Section 5.4.2].  
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Figure 5.3: Rotors assembly on motherboard for flow routing 
The rotors were fabricated separately and attached to the motherboard via screws. To 
assemble the rotors, O-rings were placed in between rotor and motherboard connections to 
form leak proof interconnections [Fig. 5.3]. The rotors were operated manually. 
 
5.5.2 Fabrication of Pluggy mould 
The mould for casting Pluggy lids is micromilled in PMMA. It consists of 3 layers as shown in 
the figure 5.4. From bottom to top: Alignment layer for putting through pins for forming through 
holes (3 mm PMMA sheet), connecter layer for forming connectors which form the tight seal with 
the motherboard socket (3 mm PMMA sheet) and finally base layer which is a flat layer which 
bonds to the device and supports it during the plugging in procedure (4mm PMMA sheet). The 
through hole is formed by passing a 1 mm alignment pin through the alignment hole and leaving 
it in the mould while moulding of the PDMS lids – Pluggy. 
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Figure 5.4: (Top) Schematic of the PDMS Lid mould layers (put together by screws in the blue slots towards the edges)  
(Bottom) schematic of moulded Pluggy 
 
5.5.3 Fabrication of Microfluidic Cell Culture Device (µBR) 
The µBR devices are micromilled in PC material and bonded together using UV activated 
solvent bonding. The devices are exposed to UV light for 30 s followed by a 5 s exposure to 
the bonding solvent. Before putting the devices into bonding press, the membrane and 
silicone tubings are assembled in between the two parts. The irreversible leakproof bonding is 
achieved at 125 °C with 10 kN pressure for 45 min. Typically, the recommended bonding time 
for PC is 30 min but we use the extra time to ensure evaporation of the solvent from the PC. It 
is important that no solvent is left inside the device, which could possibly prove toxic to the 
cells. The interconnections to the syringe pumps are created by press fitting Teflon tubing’s 
through the silicone interconnection tubings. 
 
5.5.4 Fabrication of FISH prep device 
The FISHprep devices are micromilled in PC material and bonded together using UV 
activated thermal bonding. The devices are exposed to UV light for 30 s and bonded in the 
bonding press at 130 °C with 10 kN pressure for 30 min.  Before the two parts are put in the 
bonding press, the membrane and silicone tubings for interconnections and the U-plug are 
assembled in between the two parts. The solvent bonding was not used for FISHprep devices 
because leak proof bonding was achieved by increasing the temperature to 130 °C instead of 
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125 °C. In this way, we could reduce the bonding time as well as minimize any chances of 
solvent related toxicity to the cells. 
 
5.5.5 Fabrication of splashing device 
The splashing device was micromilled in three 5 mm thick PMMA sheets. The top two layers 
have the splashing window for creating the open splashing chamber to splash the cells 
suspension onto the slides. The top layer has typically one set (in some cases two sets) of 
aligned needles (one for water and one for cell suspension) slightly bent towards the end and 
focused towards the splashing point. The bottom layer has a slot for inserting glass slides. 
The 3 layers are either screwed together or bonded using thermal bonding. 
 
Figure 5.5: Splashing device with two sets of inlets (typically splashing device has only one set of needles) 
 
5.5.6 Fabrication of Gravitional Sedimenter 
The gravitational sedimentation device was micromilled in a 2 mm thick PMMA sheet. The 
loading channel was milled with a 500 µm end mill and the concentration channel was milled 
using a 200 µm end mill. The lid for sealing the channels was also made in PMMA by 
micromilling and contained slots for assembling silicone tubing interconnections. The devices 
were sealed using UV activated thermal bonding as described earlier. 
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5.5.7 Fabrication of FACSlyser 
The FACSlyser was fabricated by laser ablation process in 2 mm thick PMMA sheets. Firstly, 
the channels with interconnections were ablated followed by the ablation of the herringbone 
structures in the channels. The parameters used for ablation are depicted in the table 5.7. The 
lids were formed by ablating through holes in the position of inlets and outlets with radius of 
2.7 mm. The devices were bonded using UV activated thermal bonding described earlier. The 
interconnections were formed by press fitting 3 mm outer diameter silicone tubing in the 2.7 
mm holes in the lid [Fig. 5.6]. A leak proof seal was obtained by pressing through a 1.2 mm 
outer diameter needle in the silicone tubing with inner diameter of 1 mm. 
 
Table 5.7: Laser ablation parameters of FACSlyser in PMMA. Passes means number of runs per design feature. Power 
means % power from the total power, Resolution means dots per inch of the marking. 
 Structures Parameters 
1 Channels [~400 um deep] 
Passes: 2 
Power: 35% 
Resolution: 600 
Velocity: 400 mm/s 
 
2 Herringbones [~200 um] 
Passes: 2 
Power: 20% 
Resolution: 800 
Velocity: 600 mm/s 
 
3 Lid – Interconnects 
Passes: 2 
Power: 80% 
Resolution: 400 
Velocity: 300 mm/s 
 
4 Cut-Out 
Passes: 10 
Power: 80% 
Resolution: 200 
Velocity: 200 mm/s 
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Figure 5.6: Interconnections of FACSlyser with press fitted silicone tubing inserts and needles 
 
5.5.8 Fabrication of adhesive tape stencil and assembly of devices 
The laser ablation process was used to pattern the stencils used in the splashing device for 
localizing chromosomes spreads on glass slides. The AR100 double-sided tape used was 
procured from Adhesives Research, Ireland. The tape consists of silicone glue supported by 
an acrylic support layer [25 µm]. The tape was ablated using 2 passes of 35% power at 
resolution of 800. The cover from one side of the tape is peeled and applied on to corona 
treated glass slides. This tape acts as a stencil to localize the chromosome spreads, when a 
drop of cold water is splashed on to the glass slide followed by a suspension of fixed cells. 
Finally, the cover from the second side of the tape is removed and the FISH devices are 
bonded onto the glass slide to create the microfluidic FISH chamber. 
 
5.5.9 Fabrication of adhesive tape for Pluggy 
The laser ablation process was used to pattern the adhesive tapes for bonding Pluggy with 
any modules. The AR100 double-sided tape used was procured from Adhesives Research, 
Ireland. The tape contains 12 x 2 mm holes placed in the positions of the interconnections as 
per the design specifications. The tape was ablated using 2 passes of 35% power at resolution 
of 800. The tape is cut out into squares of 2 x 2 cm2 to match the dimensions of the modules. 
 
5.5.10 Fabrication of the impedance cytometer chip 
The impedance Cytometer chip is formed by bonding a PDMS lid with channels onto a pyrex 
wafer with electrodes. The master is created in Si wafer and replica molded in PDMS as 
described earlier. The electrodes are fabricated on Pyrex wafer and finally, the impedance 
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chip is put together by oxygen plasma bonding. Before bonding the PDMS lid onto the Pyrex 
chip, through holes are made in PDMS for fluidic connections. Finally, the impedance chip is 
bonded onto a Pluggy by double-sided tape and plugged onto the motherboard for forming 
electrical and fluidic connections. 
 
5.5.11 Fabrication of microFISH device: 
The microFISH device was moulded from a SU-8 master mould fabricated on a Si wafer. The 
channel height was around 100±4 µm. The parameters used for spin coating were acceleration 
of 200 rpm/s, Speed of 1,000 rpm and Time 40 seconds. The PDMS microFISH lid was casted 
by curing PDMS at 60 °C for 4 hrs. The microFISH devices were bonded onto glass slides with 
chromosome spreads by means of adhesive tape based bonding. The holes for 
interconnections were formed by a 0.9 mm blunt needle and the fluidic connections were 
created by press fitting a 1.2 mm needle in the 0.9 mm hole forming a leak proof sealing.  
 
5.5.12 Fabrication of PFF & DPFF devices: 
The PFF devices were molded from a SU-8 master mould fabricated on a Si wafer. The height 
of the channels was around 40 ± 2 µm. The parameters used for spin coating were 
acceleration of 100 rpm/s, Speed of 5,000 rpm and Time 60 seconds. The PDMS PFF devices 
were casted by curing PDMS at 60 °C for 4 hrs. The devices were bonded onto Pyrex or 
Silicon wafers by oxygen plasma bonding to form irreversible bonding of the PFF devices. 
The holes for interconnections were formed by a 0.9 mm blunt needle and the fluidic 
connections were created by press fitting a 1.2 mm needle in the 0.9 mm hole forming a leak 
proof sealing.  The same protocol was followed for DPFF devices for testing of sorting with 
peptide nanospheres. 
  
Figure 5.7: PFF devices bonded onto Si wafer.  
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5.6 Biological Protocols 
5.6.1 Conventional Jurkat culture 
Jurkat cells were used to test all culture devices primarily after which the devices were tested 
with healthy donor samples. As a result, all through the project, Jurkat cells were maintained 
at 37 ⁰C in 5% CO2 with approximately 0.5 x 106 cells/ml confluence in RMPI-1640 media 
containing 10% FBS, 100 units/ml penicillin and streptomycin and 2 mM Glutamax. Jurkat 
cells were also used for the gravitational sedimentation and concentration experiments. 
 
5.6.2 Processing of the buffy coat 
All blood samples used as part of the PhD project were acquired from the Blood bank of 
Rigshospitalet. These buffy coat samples were stored at room temperature until used 
(maximum of 24 hours). For longer storage, the leukocytes were purified using Ficoll-Paque 
medium by centrifugation at 1000 rpm for 15 min. Later, they were diluted in media and 
stored at 5 ⁰C until further use. Stored leukocytes were used only for testing of flow through, 
counting cells and also for sedimentation of cells in microfluidic devices presented earlier. 
 
5.6.3 Conventional expansion 
For control experiments, in order to compare the results obtained from the microfluidic 
devices, conventional expansion of buffy coat was performed simultaneous to the tests on the 
devices. The protocol included culture of 5 µl/ml of buffy coat in RPMI 1640 media 
containing 10% FBS, 100 units/ml penicillin and streptomycin, 2 mM Glutamax and 10 µl/ml 
of phytohemagglutinin (PHA) stock solution as suggested by supplier. The cells were 
incubated at 37 ⁰C in 5% CO2. For purpose of FISH sample pretreatment these cultures lasted 
72 hours before the expanded cells were collected. 
 
5.6.4 Priming and cleaning of the device 
Before the bonding of the devices, the parts were dipped in 70% ethanol to remove any dust 
or other toxic particles from the surface. Immediately after bonding the device, they were 
stored in Ziploc bags to avoid contamination. Before seeding the cells, in order to clean and 
prime the culture devices, 10% ethanol solution was flushed through the system for 5 min 
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and later the systems were washed with PBS for 10 min. Between changing reagents, bubbles 
were removed using the stopcocks to ensure proper priming of the devices before seeding the 
cells. 
 
5.6.5 µBR and FISHprep culture protocol 
Before seeding of cells, the device was perfused with RPMI 1640 + 10% FBS for 1 hr at 37.5 
μl/hr (equivalent to 0.1 chamber volume/min). A 500 μL buffy coat containing 2 × 106 
cells/mL was seeded into the culture chamber through the cell inlet by opening only the 
perfusion outlet connected to the waste collector. This ensured that all the cells were trapped 
on the membrane while the media solution containing the cells was filtered through the 
membrane to the perfusion outlet. The cells inlet was then closed and followed by perfusion 
of media through the perfusion inlet at 75 μl/hr (0.2 chamber volumes/min) with RPMI 1640 
+ 10% FBS containing 10 μl/ml PHA. After 72 hours of mitogenic stimulation, we stopped the 
perfusion and collected the cells through the cell outlet by flushing media from the cell inlet.  
 
5.6.7 FISH sample pre-treatment tests:  
For FISH sample pretreatment experiments in µBR and FISHprep devices, we followed the 
culture protocol (5.6.6) for 72 hrs and then replaced the media with 75mM KCL solution at 0.4 
chamber volume/min (150 μl/hr) for 25 minutes. This hypotonic treatment induced swelling 
of the cells. The cell culture chamber is then perfused with freshly prepared cold fixative 
(acetic acid:methanol-3:1) at 0.4 chamber volume/min (150 μl/hr) for 30 min. Later, the cells 
were arrested in their metaphase by perfusion of media containing 6 μg/mL colcemid for 25 
mins. Between each change of perfusion, we removed the bubbles in the syringes using a 3 
way stopcock. In order to perform the conventional spreading protocol, the fixed cells were 
extracted from the cell outlet. In case of FISHprep device, slide fixation protocol, the 
FISHprep splashing protocol was used to prepare metaphase chromosome spreads on the 
glass slides. 
 
5.6.8 Conventional chromosome spread preparation 
For the spreading of chromosomes to prepare metaphase spreads, standard microscope glass 
slides were treated with a corona for one minute to clean the slides and improve their wetting 
behavior. The slides were stored in a coplin jar immersed in water at 4 ⁰C until used. At the 
time of use, these slides are gently removed from the coplin jar, leaving a thin film of water 
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on the glass surface. The majority of the water was removed by tapping the slide into the 
bench a few times, leaving only a very thin film of water on the surface. Two drops of fixed 
cells were applied to the surface straightaway approximately 20 mm apart from each other. 
The preferred dropping height was roughly 10-11 mm. The slides were left aside for 15 min to 
dry completely and in order to observe the spreads a phase contrast microscope was used. 
Often to quicken the spread formation process on humid days, the slides were put on a hot 
plate at 40 ⁰C. 
 
5.6.9 Splashing protocol 
In order to form the spreads using the splashing device, a drop of cold water is splashed on to 
the glass slides pre-cleaned with corona.  After the water drop is splashed on the glass side, 
the fixed cells are flushed through the second outlet on to the splashing chamber.  In case of 
the FISHprep device, this includes opening the paper clip valve. Finally, a drop of fixed cells 
suspension is dropped on the water droplet on the glass slide. The glass slide is left in the 
splashing chamber until the slide is dry and then observed under the microscope for 
evaluating the spreads. In case of the microFISH splashing protocol, the slide is removed and 
following the bonding of the microFISH PDMS lid, the FISH protocol is performed on the 
splashing chamber. The FISHprep splashing protocol was optimized (from microFISH 
protocol) by studying the effect of temperature of slide storage (at 4ºC in coplin jar filled with 
DI water), temperature of water for wetting the slides (preferably glacial water), age of 
fixative solution (now preferred with freshly prepared fixative) and the drying time (10 min). 
As a result of these optimizations, the spreads achieved with FISHprep protocol are better 
than earlier published microFISH splashing protocol and comparable to spreads achieved 
using manual splashing technique. In 85% of cases, we achieve over 50 spreads with the new 
protocol which is comparable to the traditional protocol and sufficient for the FISH analysis. 
 
5.6.10 CFSE viability assay 
The size of lymphocytes varies from person to person and can range from 9-14 µm in the same 
sample. As a result in lymphocyte cultures, unless you track the same cell for 3 days measuring 
cell sizes to ascertain growth doesn’t provide any reliable data. As a result, dyeing based 
techniques are used frequently to analyze cell proliferation and growth qualitatively as well as 
quantitatively. These dyes typically target cellular components which can be quantified using 
different analytical techniques. The CFSE fluorescence stain (Invitrogen, Germany) provides a 
much homogenous cellular labeling and as a result is widely used for inter-generational tracking 
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of cell growth and proliferation. Using this cytoplasmic dye, researchers can successively track 
upto 10 generations of lymphocytes [277-279] [Fig. 5.8 (Left)]. 
CFSE is a fluorescent stain that is retained within the cells throughout the cell division cycle i.e. 
development and mitosis. The label is inherited by daughter cells after cell division but due to the 
division in a lower florescence intensity which can be monitored on a flow cytometer [Fig. 5.8 
(Right & Top)]. For our experiments the cells were stained with CellTraceTM CFSE fluorescence 
stain (Invitrogen, Germany) at a concentration of 0.7 μM in phosphate buffer saline (PBS) and 
incubated at 37°C for 15 min. The cells were re-pelleted and resuspended in pre-warmed cell 
culture medium and incubated for 30 min. The cells were then centrifuged and resuspended in 
pre-warmed fresh medium and subjected to culturing. The collected cells were tested for 
proliferation in a flow cytometer by using CSFE staining of the cells. The CFSE stained cells were 
either left untreated (for control) or stimulated with PHA and cultured in the culture devices for 
72 hrs. After this, they were analyzed for fluorescence intensity on a flow cytometer. In parallel, 
as a control, we also cultured cells with or without PHA stimulation in a normal plastic culture 
dish [Fig. 5.8 (Right & Bottom)].   
  
Figure 5.8: (Left) Tracking 10 generations of cells using CFSE stain [279] (Right & Top) Schematic of the CFSE staining 
and related signals for 3 generations of a cell (Right & Bottom) µBR testing via CFSE staining [Paper-2]. 
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5.6.11 WST-1 assay 
WST-1 is a cell proliferation assay (Roche Applied Science) used extensively for its capability 
to perform the entire assay from culture to analysis in the same microtitre plate. The 
underlying principle of this assay is the cleaving of the stable tetrazolium salt WST-1 to a 
soluble formazan by a complex cellular mechanism that occurs primarily at the cell surface. 
This bioreduction depends on the glycolytic production of NAD(P)H in viable cells. 
Therefore, the amount of formazan dye generated in the well directly correlates to the 
number of metabolically active cells in the culture. Typically in our experiments, we used this 
assay for measuring viability of the cells extracted from the FACSlyser. As a result, we would 
take a 90 µl of the cells suspension from the test cultures and add 10 µl of the cell proliferation 
reagent WST-1 to the well. Typically, the measurements of the formazan production are taken 
using a ELISA plate reader at intervals of 0.5, 1, 2 and 4 hrs. After optimization of the assay 
and incubation periods, we only took measurements of future test assays at 40 min and 3 hr 
intervals. Before the assay was applied to the test cultures, a control assay was run with 
Jurkat cells to confirm the functionality of the assay. Figure 5.9 shows the proliferation curve 
of Jurkat cells and the measured absorbance with respect to the growth of Jurkat cells which 
depicts the characteristic growth curve of proliferation as expected. 
 
Figure 5.9: Validation of WST-1 assay with Jurkat cells test assay 
 
 
 
 
0
0,5
1
1,5
2
2,5
10E‐5 10E‐4 10E‐3 10E‐2 10E‐1
Absorbance
A 450
No. Of Cells
Evoluting microfluidics: Moving toward clinical applications 
 
166   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evoluting microfluidics: Moving toward clinical applications 
 
  167
 
 
 
CHAPTER  
PATENTS 
 
This chapter serves as a compendium of the 
methods used as part of the experimental work 
described earlier in this thesis. All the 
methodologies related to the design, simulations, 
fabrication and further, the biological analysis 
protocols are explained in detail.   
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6.1 Multiplexed Analyte Concentration Measurement  
[ PCT Phase, 2009, Patent Application # 09169729.2-2404] 
This patent describes a technique for multiplexed protein concentrations from a patient 
sample. Proteins are used as indicators of different diseases. Therefore, accurate measurement 
of the concentration of specific proteins is a valuable tool to diagnose a wide range of 
potential diseases, e.g. viral-, bacterial-, parasite infections and autoimmune diseases and to 
determine whether the disease is in an active state. The critical point is to be able to measure 
the protein concentration for specific proteins (antibodies and hormones) in the bloodstream. 
Currently, these tests are conducted either manually using Enzyme-Linked Immunosorbent 
Assays (ELISA) or high throughput automated versions based on chemiluminescence 
techniques. While ELISA continues to be a labor-intensive, costly and time consuming 
process, chemiluminescence techniques have been associated with high upfront costs (above 
$200000) and false positive reports. Today’s dominating technologies can only measure a 
single concentration at a time, taking between 4 – 6 hours before the result is available and 
requiring considerable manual labor and extensive use of expensive equipment. Fast and 
multiple protein concentration measurements is a serious issue for hospitals and laboratories 
which conduct thousands of these measurements on a yearly basis and they often need to 
measure several different protein concentrations just in order to diagnose a single disease. 
Our diagnostic technology fills this gap, with a microfluidic bead-based immunoassay 
technique which provides cheaper, faster, automated, point-of-care, multiplexed protein 
concentration measurements. Removing the need for a spectral signal acquisition as in the 
case of ELISA and chemiluminescence techniques, this technique reduces the cost related to 
the initial setup as well as opens up possibilities of extending the applications to point-of-care 
settings. 
The technology 
Immunoassays represent a predominant form of analysis in the modern-day clinical analysis 
repertoire. Immunoassays are quantitative analyses based on utilizing the binding properties 
of an antibody to a specific antigen in a sample. This interaction between antibody and 
antigen is converted into a measureable signal that can be related to the concentration of a 
specific protein. 
Current State of the art within Immunoassays is Enzyme Linked Immuno Sorbent Assay 
(ELISA). ELISA converts the concentration of a specific protein into a measurable signal by an 
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antibody-bound enzyme converting a non-colored substance into a colored substance. The 
color intensity of this substance is measured with a spectrometer and corresponds to a certain 
concentration of a specific protein. As shown in figure 6.1, the traditional ELISA method 
involves multiple reaction steps and equal number of washing steps with different reagents 
resulting in an overall measurement time between 4 - 6 hours. In case of ELISA, antibodies of 
interest are bound to the surface of a multiwall plate and target protein in the form of a 
patient sample is applied to this plate. This results in the antibody-antigen coupling which is 
of interest to detect. In order to detect, this binding in the subsequent 3 steps another 
antibody is bound to this protein, which is in turn bound to a fluorophore, which fluoresces 
when illuminated in an ELISA plate reader [Fig 6.1]. This fluorescent signal is hence directly 
related to the amount of protein bound to the antibodies on the surface. Unspecific binding 
signals are removed by multiple washing steps in between each of the steps.  
As a result of such a lengthy protocol, ELISA is considered to be both a slow and labor 
intensive method needing multiple reagents and a bulky spectrometer. Often ELISA testing is 
highly automated using expensive automated equipments which can offer possibility of 
lowering operational costs at the expense of huge investment costs. However the 
measurement time cannot be reduced because of the binding events required between each 
step in the process, and even though it is highly automated, it still requires a significant 
amount of manual work from the lab-technician both in post and pre-analysis. 
 
Figure 6.1: Steps of ELISA based techniques 
In contrast, while our technology is also based on detecting the antibody-antigen interaction 
like ELISA, we do not need multiple reactions steps to convert this binding into a measurable 
signal. Our technology exploits the fact that the antibody-antigen interaction can be converted 
into a detectable electrical signal, revealing the concentration of a specific protein in a sample 
[Fig. 6.2]. Furthermore, with our unique multiplexing feature, this technology makes it 
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possible to simultaneously measure the concentration of multiple proteins in a sample, which 
is not possible with ELISA. We anticipate that we will be capable of measuring 10 different 
protein concentrations simultaneously and deliver the result within minutes. 
 
Figure 6.2: Steps of our technology 
Going into the specifics, our technology depends on impedance based electrical detection of 
antigen-antibody binding on the surface of a bead. Using antibody bound beads instead of 
surface bound beads, we open up the possibility of multiplexing this assay by means of 
microfluidic manipulation of beads across a detection zone. We foresee numerous advantages 
of our technology compared to the industry standard ELISA, in terms of cost, time, sensitivity 
and the biggest of all the ability to multiplex the assay [Fig. 6.3]. 
 
Figure 6.3: Comparison of our technology with ELISA. 
In order to be able to multiplex this technology, we have moved away from binding the 
antibodies on to the electrode or device surface. Currently, we are working on two strategies 
for multiplexed protein concentration measurement. 
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As shown in the figure 6.7, two beads with different antibodies each targeting a different 
region on the target protein are shown. Once two these beads and the protein conjugate, it 
results in the creation of a dimer. In this detection technique, we rely on the time difference in 
the transition of dimers (bead-bead complex) and monomers (unbound beads) in the 
detection region to calculate the amount of protein in the sample. 
In order to multiplex this technique, we rely on the time difference of transition of dimers of 
different sized beads and unbound beads [Fig. 6.8]. To ascertain that the transition times vary, 
we have devised microfluidic flow focusing strategies to align the dimers with the flow, to 
allow the detection system to differentiate between the dimers and single beads by increasing 
the transition time difference. 
 
Figure 6.8: Multiplexing of bead-bead conjugates by means of differentiating the transition times. 
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6.2 Radial peristaltic pump  
[2010, Patent Application # 10159495.0-2315]  
This patent relates to the invention of a novel radial peristaltic pump enabling simultaneous 
pumping and addressing of multiple channels. Pumps are useful in a multitude of 
applications ranging from large-scale industrial process pumps to bed-side infusion pumps in 
hospitals.  
Generally pumps have singular outlet capacity, but peristaltic pumps have shown capability 
to pump multiple channels simultaneously. This has found many applications in the infusion 
pumps market and recently in microfluidic high throughput applications. However, existing 
peristaltic pump systems have limitations in the number of channels they are able to pump 
simultaneously. The current miniaturized versions only pump about 8-12 channels, due to the 
assembly being based on rollers.   
Developing on this model, a novel radial pump assembly has been designed capable of 
pumping at least 4 times the number of channels using the traditional single motor. This 
system operates on the same principle for pumping the fluids but utilizes cd-like radial 
structures with ridges which compress the elastomeric channels and in process actuates the 
fluids. 
Furthermore, while various pump brands and designs are available on the market, they don’t 
have the capability to address individual channels which is an important application when 
there is a need for sequential injection of fluids. Our radial peristaltic pump provides the 
ability to pump multiple channels (20 plus) simultaneously and to control them in multiple 
combinations to pump multiple fluids precisely and addressably. 
Applications: 
This technology will reduce costs and prove highly beneficial for applications needing 
pumping of multiple fluids (eg. high throughput analysis, drug screening applications, 
infusion pumps for emergency care). The potential market for the technology was just below 
$500m in 2007 and is expected to reach more than $1 billion in 2012. 
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6.3 Multichannel infusion pump  
[2010, Patent Application # 10159494.3-2320] 
Infusion pumps form a key part of patient care especially in diseases like diabetes, analgesia, 
chemotherapy and several others. While the market is full of expensive pumps for hospital 
care ($1000 plus) and personal care ($2500-$5000), the high costs are prohibitive of being 
widely applied to healthcare globally. Also in many cases, these high end pumps don’t have 
the ability to pump multiple fluids simultaneously (hence the need for multiple pumps), 
which is often the need for maintaining and providing life support in Intensive Care units. 
Hence, a solution which is cheap to allow wider access and has ability to pump multiple 
channels simultaneously can prove to be a benefit for hospitals and patients worldwide. 
We are simultaneously targeting two different segments of the market, with the current 
development focus. Our novel low cost (< $1000) pump is designed to pump multiple 
channels simultaneously and can be made in multiple form factors (personal-disc player size 
to a personal patch pump size) to suit the requirements based on setting either at a hospital 
bed-side or a personal infusion pump for diabetes management or home-care.  The ability to 
pump multiple fluids simultaneously could simplify the work routine for nurses and reduce 
accidents which are often caused due to wrong dosages as a consequence of the complex 
setups in the emergency units. Also, an ultra low power, low cost (< $100-$200) and self-
actuated version of this pump is currently under development to suit the needs of the 
patients in remote locations and 3rd world countries. 
The market for personal wearable pumps for diabetes management is over $1 billion and 
growing. The market for hospital pumps is equally large and expanding. But the biggest 
opportunity with this technology is to open up new markets in the 3rd world countries with 
the low cost version of this pump, where patients today continue to use needles for diabetes 
and pain management. 
 
 
 
 
Evoluting microfluidics: Moving toward clinical applications 
 
178   
 
 
6.4 Spring-actuated microfluidic interconnects   
[PCT Phase, 2010, Patent Application # 10164907.7-1270]  
This patent depicts a novel self-actuating self-sealing interconnection technology based on 
integrated compression springs used to seal and actuate interconnects. Interconnections are 
the top practical concern regarding wide scale application of microfluidic technologies. The 
issues with interfacing microfluidic devices with other existing setups continue to derail the 
progress made by successful demonstrations of microfluidic applications. 
With this technology, we provide a simple method for creating rapid, aligned, multiple, 
parallel, reusable, self-actuating, self-sealing fluidic and electrical interconnections [Fig. 6.12]. 
The need of flexible microfluidic platforms is widely recognized and with this technology we 
are targeting to build a simple microfluidic platform solving practical issues outstanding with 
microfluidic device interfaces. Taking a step further, this interconnect technology comes with 
integrated bubble traps minimizing the need for developing bubble trapping strategies on 
board microfluidic devices. 
 
 
 
Figure 6.12: (Left) View of fluidic connection holder with a microfluidic chip. (Right) View of the electrical connections on 
a silicon nanowire chip with alignment accuracy down to 25 µm. 
Moving towards standardization of microfluidic device development, these interconnects 
have been developed in microscope slide sized formats in planar as well as upright settings 
allowing easy operation with all microscope types. The focus of current development is 
towards building slide-sized microfluidic devices compatible with this interconnect 
technology i.e. cell culture devices, high throughput migration analysis devices, mixers, 
gradient generators, etc to widen the applications of this platform. 
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6.5 Sandwiched membranes  
[In process] 
This technique highlights the development of novel injection molded sandwiched 
membranes, with integrated features allowing rapid assembly of microfluidic devices with 
scaffolds for cell and neuronal culture applications.  
Membranes are always difficult to integrate in microfluidic devices and especially so, in cases 
where the devices need to be assembled and sealed after seeding or placement of biological 
analytes on top of integrated membranes functioning as scaffolds. This process necessitates 
sealing of microfluidic devices without application of temperature or adhesive based 
bonding, which makes it imperative to rely on good mechanical sealing for leak-proof 
operation.  
Routinely, this is attempted with O-rings, which has provided partial success at low pressure 
and flow rates. But this continues to be a difficult solution which doesn’t provide good 
success rate and gets considerably challenging when you put cells or brain slices in the 
equation. Some of these challenges were faced by other members of the research group, 
which lead to a need for an easy solution for integrating membranes in microfluidic devices 
after loading of biological material. 
These sandwiches membranes provide the much needed ease of handling, reliable seals, 
rapid assembly and most importantly, a biocompatible bonding-free solution for neuronal 
and cell culture applications. In the preliminary tests, the flow rates in our brain slice culture 
devices could be increased from the routine 0.5 µl/min up to 50 µl/min without any leakage 
(100 fold improvement) which are sufficient for cell culture and neuronal applications.  
We aim to further integrate novel functionality via multi-component injection molding for 
developing biochemical sensors based on this active scaffolds. 
 
 
 
[Related publication pending – Novel scaffolds for microfluidic cell and neuronal cultures] 
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6.6 Adhocly attachable microfluidic interconnections 
[In review – publication pending] 
Microfluidic Interconnections have never been so easy to handle. Offering the simplest of all 
the interconnection solutions presented in this thesis, QuickFix interconnects allow for rapid 
one second assembly of microfluidic interconnects based on two interconnection strategies 
(magnetic and adhesive tape based). This technique offers reliable, reusable, flexible (single or 
multiple), bonding free, adhocly attachable, ultra low cost interconnection scheme for rapid 
assembly and testing of microfluidic devices. 
The newer version of these interconnects is designed with integrated bubble traps allowing 
bubble free long term operations for cell culture and other biological applications. With the 
inclusion of an integrated circular recess for O-rings, this interconnects offer leak-free fluidic 
operation at relatively high flow rates (tested up to 200 µl/min).  
Due to the optimized current design, these interconnects can easily be mass produced using 
injection molding technique. This interconnects have been fabricated and tested in various 
formats in multiples of 3 and 5 interconnections for testing the possibility to establish 
multiple fluidic interconnections simultaneously.  
With on-going development, we aim to integrate these interconnects with the microfluidic 
systems presented in the earlier chapters. 
 
 
 
 
 
 
 
 
[Related publication pending – Plug2Flow: Adhocly attachable microfluidic applications] 
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CHAPTER  
CONCLUSIONS 
 
In this chapter, we summarize the results described 
in the previous sections and present our new laws 
of microfluidic research which have led to 
numerous exciting discoveries and resulted in the 
evolution of the microfluidic toolkit available for 
cytogenetic analysis.  
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Conclusion and Outlook 
Microfluidics is an ideal tool for tackling problems in biology and medicine. The ability to 
provide control over the immediate microenvironment of individual cells is a fascinating 
science in itself. I envision that it is only a matter of time before the large amount of research 
based demonstrations lead to breakthroughs which pave their way into the clinical labs. 
While the significant contributions and achievements in the fields of diagnostics, sensors, 
chemical assays, genetics, etc. have been duly noted, there is still a long way ahead before 
they can address real problems leading to clinical solutions.  
This thesis presented such efforts towards bridging streams of microfluidics and clinical 
cytogenetics. In an effort to tackle the practical concerns inherently rooted in current 
microfluidic toolkits, this thesis presented novel interconnection techniques to form rapid, 
reliable, robust, flexible, multiple, aligned, reusable fluidic as well as electrical interconnects. 
The overall aim of this PhD. project was to develop a miniaturized microfluidic system for 
total chromosome translocation analysis on a microfluidic device. The initial goal was to 
develop a modular system for enabling plug and play functionality, which will effectively 
function with various modules related to the FISH analysis protocol and be used for analysis 
of translocations in traditional cytogenetic laboratories. In pursuit of this goal, we developed 
a novel versatile microfluidic modular motherboard providing substrate independent plug 
and play functionality. This motherboard was tested for fluidic and electrical connectivity 
with various modules and discussed as a possible solution for standardizing microfluidic 
development efforts. 
Based on critical feedback from the end-user and collaborators, the goals for the PhD project 
were changed to focus more on development of an integrated system, providing ease of 
handling, minimal complexity, compatibility with existing setups and work routines and 
most importantly lead towards an automated FISH protocol. This led to a focused user-
driven research effort, leading to the development of multiple devices which cumulate to 
entire Fluorescence In-Situ Hybridization protocol currently used for clinical genetic analysis.  
A microfluidic bioreactor (μBR) which was a more suitable and better solution for culturing 
non-adherent cells compared to traditional culture flasks was designed and it provided cells 
with a controlled micro-niche mimicking their in vivo extra-curricular matrix.  
This μBR device was modified to integrate a chromosome slide preparation protocol, which 
will lead to the development of a FISHprep device providing complete FISH sample 
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preprocessing to the slide preparation protocol for preparing metaphase FISH chromosome 
slides.  
On completion of the slide preparation device, the focused was aimed towards realizing a 
miniaturized device for performing low cost and low reagent volume FISH analysis. These 
efforts lead to microFISH, which was the first demonstration of performing metaphase FISH 
analysis on a microfluidic chip.  
In order to realize a minimal handling FISH protocol and provide a possibility to automate 
FISH analysis, the AutoFISH protocol was developed by means of a FISH reagent cartridge. 
After the positive initial results achieved with interphase FISH using a FISH reagent 
cartridge, the next step is to use FISH cartridge for metaphase FISH analysis and thereby 
automating the FISH protocol using an automated sequential reagent injection protocol. 
Finally, not just adhering to the C-TAS project, this PhD has led to multiple patent pending 
inventions related to the development of novel micro pumps, interconnects, functional 
membranes and a new diagnostic technology for multiplexing immunoassays on a chip.        
In doing so, three new laws of microfluidic research have evolved which we suggest are used 
by any future microfluidic researcher attempting to develop clinically relevant medical 
devices. 
1) Be the lead user  
Before you even start designing a microfluidic device, it’s a must that you spent time 
familiarizing and using the traditional protocol or methods you aim to change. Only 
by becoming the end-user yourself, you will realize the other complexities and minor 
details not often listed in the printer versions of the protocols. 
2) Research and don’t re-search. 
Microfluidics has a lot more to offer than just miniaturized versions of current devices. 
Be creative and explore the possibilities. 
3) Usability is in fact user-ability 
The often commonly used word for microfluidic devices ‘Usability’ fails to recognize 
and put into equation the end-user’s ability. Hence, most common and claimed user-
friendly solutions in microfluidic research labs are nightmarish for the end-users. 
 
With the new laws and the evolved microfluidic toolkit, we aim to develop novel clinical 
devices, catered for the clinical end-users. 
Evoluting microfluidics: Moving toward clinical applications 
 
184   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evoluting microfluidics: Moving toward clinical applications 
 
  185
 
 
 
 
 
 
BIBLIOGRAPHY 
 
 
 
 
Evoluting microfluidics: Moving toward clinical applications 
 
186   
 
 
1.  Manz A, Graber N, Widmer HM: Miniaturized total chemical‐analysis systems  ‐ A novel concept  for 
chemical sensing. Sensors and Actuators B‐Chemical 1990, 1(1‐6):244‐248. 
2.  Blom N, Fettinger JC, Koch J, Ludi H, Manz A, Widmer HM: Implementing chemical sensors in industry ‐ 
Novel approaches. Sensors and Actuators B‐Chemical 1991, 5(1‐4):75‐78. 
3.  Harrison DJ, Manz  A,  Fan  ZH,  Ludi H, Widmer HM:  Capillary  electrophoresis  and  sample  injection 
systems integrated on a planar glass chip. Analytical Chemistry 1992, 64(17):1926‐1932. 
4.  Feynman R: There’s plenty of room at the bottom. Engineering and Science 1960, 23(5):22‐36. 
5.  Terry SC, Jerman JH, Angell JB: Gas‐Chromatographic air analyzer fabricated on a silicon‐wafer.  IEEE 
Transactions on Electron Devices 1979, 26(12):1880‐1886. 
6.  Bassous  E,  Baran  E:  Fabrication  of  silicon  nozzle  arrays  for  ink  jet  printing.  Journal  of  the 
Electrochemical Society 1977, 124(8):C310‐C310. 
7.  Bassous E, Taub HH, Kuhn  L:  Ink  jet printing nozzle arrays etched  in  silicon. Applied Physics  Letters 
1977, 31(2):135‐137. 
8.  Petersen KE: Fabrication of an integrated, planar silicon ink‐jet structure IEEE Transactions on Electron 
Devices 1979, 26(12):1918‐1920. 
9.  Hansen EH, Ruzicka  J, Krug FJ, Zagatto EAG: Selectivity  in Flow‐Injection Analysis. Analytica Chimica 
Acta 1983, 148(APR):111‐125. 
10.  Ruzicka J: Flow‐Injection analysis  ‐ From test tube to  integrated microconduits. Analytical Chemistry 
1983, 55(11):1040‐&. 
11.  Thogersen N, Janata J, Ruzicka J: Flow‐Injection Analysis and Cyclic Voltammetry. Analytical Chemistry 
1983, 55(12):1986‐1988. 
12.  Denboef G, Schothorst RC, Appelqvist R, Beecher GR, Bergamin H, Emneus J, Fang Z, Gorton L, Hansen 
EH, Hare PE et al: Flow‐Injection Analysis (FIA) ‐ A personal view. Analytica Chimica Acta 1986, 180:1‐
67. 
13.  Vanderlinden  WE:  Flow‐Injection  analysis  in  online  process‐control.  Analytica  Chimica  Acta  1986, 
179:91‐101. 
14.  Xia YN, Whitesides GM: Soft lithography. Annual Review of Materials Science 1998, 28:153‐184. 
15.  Xia YN, Whitesides GM: Soft  lithography. Angewandte Chemie‐International Edition 1998, 37(5):551‐
575. 
16.  Xia YN, Rogers  JA, Paul KE, Whitesides GM: Unconventional methods  for  fabricating and patterning 
nanostructures. Chemical Reviews 1999, 99(7):1823‐1848. 
17.  Duffy DC, McDonald JC, Schueller OJA, Whitesides GM: Rapid prototyping of microfluidic systems  in 
poly(dimethylsiloxane). Analytical Chemistry 1998, 70(23):4974‐4984. 
18.  McDonald  JC, Duffy DC, Anderson  JR, Chiu DT, Wu HK, Schueller OJA, Whitesides GM: Fabrication of 
microfluidic systems in poly(dimethylsiloxane). Electrophoresis 2000, 21(1):27‐40. 
19.  Emerging Markets for Microfluidic Applications: Market Report. In.: Yole Developpement; 2009. 
20.  Wlodkowic D, Cooper JM: Tumors on chips: oncology meets microfluidics. Current Opinion in Chemical 
Biology 2010, 14(5):556‐567. 
21.  Brandenburg A, Curdt F, Nestler  J, Otto T, Wunderlich K, Michel D:  Integrated point of  care  testing 
system based on low cost polymer biochips. In: Advanced Biomedical and Clinical Diagnostic Systems 
Vii. Edited by MahadevanJansen A, VoDinh T, Grundfest WS, vol. 7169; 2009. 
22.  Sun S, Yang MH, Kostov Y, Rasooly A: ELISA‐LOC:  lab‐on‐a‐chip for enzyme‐linked  immunodetection. 
Lab on a Chip 2010, 10(16):2093‐2100. 
23.  Rosen  Y,  Gurman  P:  MEMS  and  Microfluidics  for  Diagnostics  Devices.  Current  Pharmaceutical 
Biotechnology 2010, 11(4):366‐375. 
Evoluting microfluidics: Moving toward clinical applications 
 
  187
 
 
24.  Lee  WG,  Kim  YG,  Chung  BG,  Demirci  U,  Khademhosseini  A:  Nano/Microfluidics  for  diagnosis  of 
infectious diseases in developing countries. Advanced Drug Delivery Reviews 2010, 62(4‐5):449‐457. 
25.  Wurm M, Schopke B, Lutz D, Muller  J, Zeng AP: Microtechnology meets systems biology: The small 
molecules of metabolome as next big targets. Journal of Biotechnology 2010, 149(1‐2):33‐51. 
26.  McCaughan F, Dear PH: Single‐molecule genomics. Journal of Pathology 2010, 220(2):297‐306. 
27.  Coupland P: Microfluidics for the upstream pipeline of DNA sequencing  ‐ a worthy application? Lab 
on a Chip 2010, 10(5):544‐547. 
28.  Lombardi  D,  Dittrich  PS:  Advances  in  microfluidics  for  drug  discovery.  Expert  Opinion  on  Drug 
Discovery 2010, 5(11):1081‐1094. 
29.  Kool J, Lingeman H, Niessen W, Irth H: High Throughput Screening Methodologies Classified for Major 
Drug  Target  Classes  According  to  Target  Signaling  Pathways.  Combinatorial  Chemistry  &  High 
Throughput Screening 2010, 13(6):548‐561. 
30.  Gupta K, Kim DH, Ellison D, Smith C, Kundu A, Tuan J, Suh KY, Levchenko A: Lab‐on‐a‐chip devices as an 
emerging platform for stem cell biology. Lab on a Chip 2010, 10(16):2019‐2031. 
31.  Cheong R, Paliwal S, Levchenko A: High‐content screening  in microfluidic devices. Expert Opinion on 
Drug Discovery 2010, 5(8):715‐720. 
32.  Kim JK, Bang HW, Chung S, Chin‐Yu AD, Chung C, Jo HS, Yoo JY, Chang JK: Single‐cell manipulation and 
fluorescence detection in benchtop flow cytometry system with disposable plastic microfluidic chip. 
In: Microfluidics, Biomems, and Medical Microsystems. Edited by Becker H, Woias P, vol. 4982; 2003: 8‐
20. 
33.  Pilarski LM, Lauzon  J, Strachan E, Adamia S, Atrazhev A, Belch AR, Backhouse CJ: Sensitive detection 
using microfluidics  technology  of  single  cell  PCR  products  from  high  and  low  abundance  IgH VDJ 
templates in multiple myeloma. Journal of Immunological Methods 2005, 305(1):94‐105. 
34.  Wang HY, Lu C: High‐throughput and real‐time study of single cell electroporation using microfluidics: 
Effects of medium osmolarity. Biotechnology and Bioengineering 2006, 95(6):1116‐1125. 
35.  Ryley  J,  Pereira‐Smith  OM:  Microfluidics  device  for  single  cell  gene  expression  analysis  in 
Saccharomyces cerevisiae. Yeast 2006, 23(14‐15):1065‐1073. 
36.  Zare  RN,  Kim  S:  Microfluidic  Platforms  for  Single‐Cell  Analysis.  In:  Annual  Review  of  Biomedical 
Engineering, Vol 12. vol. 12; 2010: 187‐201. 
37.  Zhang CS, Xing D,  Li YY: Micropumps, microvalves, and micromixers within PCR microfluidic  chips: 
Advances and trends. Biotechnology Advances 2007, 25(5):483‐514. 
38.  Vilkner T, Janasek D, Manz A: Micro total analysis systems. Recent developments. Analytical Chemistry 
2004, 76(12):3373‐3385. 
39.  West J, Becker M, Tombrink S, Manz A: Micro total analysis systems: Latest achievements. Analytical 
Chemistry 2008, 80(12):4403‐4419. 
40.  Dittrich  PS,  Tachikawa  K, Manz  A: Micro  total  analysis  systems.  Latest  advancements  and  trends. 
Analytical Chemistry 2006, 78(12):3887‐3907. 
41.  Kamholz AE: Proliferation of microfluidics in literature and intellectual property. Lab on a Chip 2004, 
4(2):16N‐20N. 
42.  Mark  D,  Haeberle  S,  Roth  G,  von  Stetten  F,  Zengerle  R:  Microfluidic  lab‐on‐a‐chip  platforms: 
requirements, characteristics and applications. Chemical Society Reviews 2010, 39(3):1153‐1182. 
43.  Becker H: IP or no IP: that is the question. Lab on a Chip 2009, 9(23):3327‐3329. 
44.  Haeberle  S,  Zengerle  R: Microfluidic  platforms  for  lab‐on‐a‐chip  applications.  Lab  on  a  Chip  2007, 
7(9):1094‐1110. 
Evoluting microfluidics: Moving toward clinical applications 
 
188   
 
 
45.  Gartner  C,  Becker  H,  Anton  B,  Rotting  O:  The  microfluidic  toolbox  ‐  Tools  and  standardization 
solutions  for  microfluidic  devices  for  life  sciences  applications.  In:  Microfluidics,  Biomems,  and 
Medical Microsystems Ii. Edited by Woias P, Papautsky I, vol. 5345; 2004: 159‐162. 
46.  Becker H: Mind the gap! Lab on a Chip 2010, 10(3):271‐273. 
47.  Becker H: Hype, hope and hubris: the quest for the killer application  in microfluidics. Lab on a Chip 
2009, 9(15):2119‐2122. 
48.  Becker H: It's the economy. Lab on a Chip 2009, 9(19):2759‐2762. 
49.  Ouelette J: A new wave of microfluidic devices. In: The Industrial Physicist. 2003. 
50.  Whitesides G: Solving problems. Lab on a Chip 2010, 10(18):2317‐2318. 
51.  Klapperich CM: Microfluidic diagnostics: time for industry standards. Expert Review of Medical Devices 
2009, 6(3):211‐213. 
52.  Blow N: Microfluidics: in search of a killer application. Nature Methods 2007, 4(8):665‐668. 
53.  Becker H: Microfluidics: a technology coming of age. Medical device technology 2008, 19(3):21‐24. 
54.  Standardization  IOf: Microscopes  ‐  Slides.  Part  I:  Dimensions,  Optical  properties  and  marking.  In: 
Optics and Optical Instruments. Switzerland; 1986. 
55.  Jackson  L:  Cytogenetics  and  molecular  cytogenetics.  Clinical  Obstetrics  and  Gynecology  2002, 
45(3):622‐639. 
56.  Hsu L: Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Genetic Disorders 
and the Fetus, 4th ed. Edited by Milunsky A. Baltimore: The Johns Hopkins University Press; 1998. 
57.  Kluin  P,  Schuuring  E:  Molecular  cytogenetics  of  lymphoma:  where  do  we  stand  in  2010? 
Histopathology 2011, 58(1):128‐144. 
58.  Cheung SW, Shaw CA, Yu W, Li JZ, Ou ZS, Patel A, Yatsenko SA, Cooper ML, Furman P, Stankiewicz P et 
al: Development and validation of a CGH microarray for clinical cytogenetic diagnosis (vol 6, pg 422, 
2005). Genetics in Medicine 2005, 7(7):478‐478. 
59.  Fox  JL,  Hsu  PH,  Legator  MS,  Morrison  LE,  Seelig  SA:  Fluorescence  In‐Situ  Hybridization  ‐  poerful 
molecular tool for cancer prognosis. Clinical Chemistry 1995, 41(11):1554‐1559. 
60.  Sandberg  AA,  Meloni‐Ehrig  AM:  Cytogenetics  and  genetics  of  human  cancer:  methods  and 
accomplishments. Cancer Genetics and Cytogenetics 2010, 203(2):102‐126. 
61.  Dave BJ, Sanger WG: Role of Cytogenetics and Molecular Cytogenetics  in  the Diagnosis of Genetic 
Imbalances. Seminars in Pediatric Neurology 2007, 14:2‐6. 
62.  Volpi EV, Bridger JM: FISH glossary: an overview of the fluorescence  in situ hybridization technique. 
Biotechniques 2008, 45(4):385‐+. 
63.  Campbell  LJ:  Cytogenetic  and  FISH  techniques  in myeloid  malignancies.  In: Methods  in  Molecular 
Medicine. Edited by Iland H, Hertzberg M, Marlton P: Humana Press Inc; 2006: 13‐26. 
64.  de Klein A, Tibboel D: Genetics. Seminars in Pediatric Surgery 2010, 19(3):234‐239. 
65.  Park  JH,  Woo  JH,  Shim  SH,  Yang  SJ,  Choi  YM,  Yang  KS,  Cha  DH:  Application  of  a  target  array 
Comparative Genomic Hybridization to prenatal diagnosis. Bmc Medical Genetics 2010, 11. 
66.  Beatty B, Mai S, Squire J: FISH. A Practical Approach. Oxford: Oxford University Press; 2002. 
67.  Trask  BJ: Human  cytogenetics:  46  chromosomes,  46  years  and  counting. Nature  Reviews Genetics 
2002, 3(10):769‐778. 
68.  Smeets  D:  Historical  prospective  of  human  cytogenetics:  from  microscope  to  microarray.  Clinical 
Biochemistry 2004, 37(6):439‐446. 
69.  Fauth  C,  Speicher  MR:  Classifying  by  colors:  FISH‐based  genome  analysis.  Cytogenetics  and  Cell 
Genetics 2001, 93(1‐2):1‐10. 
70.  Andrieux  J,  Sheth  F: Comparative  genomic  hybridization  array  study  and  its utility  in detection of 
constitutional and acquired anomalies. Indian Journal of Experimental Biology 2009, 47(10):779‐791. 
Evoluting microfluidics: Moving toward clinical applications 
 
  189
 
 
71.  Jain KK: Current Status of Fluorescent In‐Situ Hybridisation. In: Medical Device Technology. vol. 15(4); 
2004: 14‐17. 
72.  Gambardella S, Ciabattoni E, Motta F, Stoico G, Gullotta F, Biancolella M, Nardone A, Novelli A, Brunetti 
E, Bernardini L et al: Design, Construction and Validation of Targeted BAC Array‐Based CGH Test for 
Detecting the Most Commons Chromosomal Abnormalities. In., vol. 3. Genetics Insights; 2010: 9‐21. 
73.  Jiang F, Katz RL: Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in 
cytology. Diagnostic Molecular Pathology 2002, 11(1):47‐57. 
74.  Nath  J,  Johnson KL: A review of  fluorescence  in situ hybridization  (FISH): Current status and  future 
prospects. Biotechnic and Histochemistry 2000, 75(2):54‐78. 
75.  Trask BJ: Fluorescence in‐situ hybridization ‐ Applications in cytogenetic and gene‐mapping. Trends in 
Genetics 1991, 7(5):149‐154. 
76.  Garimberti  E,  Tosi  S:  Fluorescence  in  situ  Hybridization  (FISH),  Basic  Principles  and Methodology. 
Fluorescence in situ Hybridization (FISH): Protocols and Applications 2010:3‐20. 
77.  Tonnies  H:  Modern  molecular  cytogenetic  techniques  in  genetic  diagnostics.  Trends  in  Molecular 
Medicine 2002, 8(6):246‐250. 
78.  Zanardi A, Bandiera D, Bertolini F, Corsini C, Gregato G, Milani P, Barborini E, Carbone R: Miniaturized 
FISH for screening of onco‐hematological malignancies. 2010, BioTechniques, 49, 1:497‐504. 
79.  van der Ploeg M: Cytochemical nucleic acid research during the twentieth century. European Journal 
of Histochemistry 2000, 44(1):7‐42. 
80.  Sieben  VJ,  Marun  CSD,  Pilarski  PM,  Kaigala  GV,  Pilarski  LM,  Backhouse  CJ:  FISH  and  chips: 
chromosomal analysis on microfluidic platforms. IET Nanobiotechnology 2007, 1(3):27‐35. 
81.  Kearney L, Horsley SW: Molecular cytogenetics in haematological malignancy: current technology and 
future prospects. Chromosoma 2005, 114(4):286‐294. 
82.  Speicher  MR,  Carter  NP:  The  new  cytogenetics:  Blurring  the  boundaries  with  molecular  biology. 
Nature Reviews Genetics 2005, 6(10):782‐792. 
83.  Levsky  JM,  Singer  RH:  Fluorescence  in  situ  hybridization:  past,  present  and  future.  Journal  of  Cell 
Science 2003, 116(14):2833‐2838. 
84.  Vedarethinam I, Shah P, Dimaki M, Tumer Z, Tommerup N, Svendsen WE: Metaphase FISH on a Chip: 
Miniaturized Microfluidic Device  for Fluorescence  in  situ Hybridization.  Sensors 2010, 10(11):9831‐
9846. 
85.  Liehr  T,  Starke  H,  Heller  A,  Kosyakova  N,  Mrasek  K,  Gross  M,  Karst  C,  Steinhaeuser  U,  Hunstig  F, 
Fickelscher  I  et  al:  Multicolor  fluorescence  in  situ  hybridization  (FISH)  applied  to  FISH‐banding. 
Cytogenetic and Genome Research 2006, 114(3‐4):240‐244. 
86.  Lee  C,  Lemyre  E,  Miron  PM,  Morton  CC:  Multicolor  fluorescence  in  situ  hybridization  in  clinical 
cytogenetic diagnostics. Current Opinion in Pediatrics 2001, 13(6):550‐555. 
87.  Shah  P,  Vedarethinam  I,  Kwasny  D,  Andresen  L,  Dimaki  M,  Skov  S,  Svendsen  WE:  Microfluidic 
bioreactors for culture of non‐adherent cell. Sensors and Actuators B:Chemical 2011. 
88.  Svendsen WE, Castillo‐Leon J, Lange JM, Sasso L, Olsen MH, Abaddi M, Andresen L, Levinsen S, Shah P, 
Vedarethinam  I  et  al: Micro  and  nano‐platforms  for  biological  cell  analysis.  Sensors  and Actuators 
A:Physical 2011. 
89.  Lee DS, Lee JH, Min HC, Kim TY, Oh BR, Kim HY, Lee JY, Lee CK, Chun HG, Kim HC: Application of high 
throughput  cell  array  technology  to  FISH:  Investigation  of  the  role  of  deletion  of  p16  gene  in 
leukemias. Journal of Biotechnology 2007, 127(3):355‐360. 
90.  Sieben  VJ,  Debes‐Marun  CS,  Pilarski  LM,  Backhouse  CJ:  An  integrated  microfluidic  chip  for 
chromosome enumeration using  fluorescence  in situ hybridization. Lab on a Chip 2008, 8(12):2151‐
2156. 
Evoluting microfluidics: Moving toward clinical applications 
 
190   
 
 
91.  Dimaki  M,  Clausen  CH,  Lange  J,  Shah  P,  Jensen  LB,  Svendsen  W:  A  microfabricated  platform  for 
chromosome separation and analysis. In: Proceedings of the 17th International Vacuum Congress/13th 
International Conference on Surface Science/International Conference on Nanoscience and Technology. 
Edited by  Johansson  LSO, Andersen  JN, Gothelid M, Helmersson U, Montelius  L, Rubel M,  Setina  J, 
Wernersson LE, vol. 100; 2008. 
92.  G.T. L: Genetic translocations and other chromosome aberrations: Nova Science Publishers; 2008. 
93.  Gonzalez  C,  Collins  SD,  Smith  RL:  Fluidic  interconnects  for  modular  assembly  of  chemical 
microsystems. Sensors and Actuators B‐Chemical 1998, 49(1‐2):40‐45. 
94.  Shaikh KA, Ryu KS, Goluch ED, Nam JM, Liu JW, Thaxton S, Chiesl TN, Barron AE, Lu Y, Mirkin CA et al: A 
modular microfluidic  architecture  for  integrated  biochemical  analysis.  Proceedings  of  the National 
Academy of Sciences of the United States of America 2005, 102(28):9745‐9750. 
95.  Wu A, Wang  L,  Jensen  E, Mathies  R,  Boser  B: Modular  integration  of  electronics  and microfluidic 
systems using flexible printed circuit boards. Lab on a Chip 2010, 10(4):519‐521. 
96.  Sun  K,  Wang  ZX,  Jiang  XY:  Modular  microfluidics  for  gradient  generation.  Lab  on  a  Chip  2008, 
8(9):1536‐1543. 
97.  Ni M, Tong WH, Choudhury D, Rahim NAA, Iliescu C, Yu H: Cell Culture on MEMS Platforms: A Review. 
International Journal of Molecular Sciences 2009, 10(12):5411‐5441. 
98.  Attia  UM,  Marson  S,  Alcock  JR:  Micro‐injection  moulding  of  polymer  microfluidic  devices. 
Microfluidics and Nanofluidics 2009, 7(1):1‐28. 
99.  Becker H, Locascio LE: Polymer microfluidic devices. Talanta 2002, 56(2):267‐287. 
100.  Mata  A,  Fleischman  AJ,  Roy  S:  Characterization  of  polydimethylsiloxane  (PDMS)  properties  for 
biomedical micro/nanosystems. Biomedical Microdevices 2005, 7(4):281‐293. 
101.  Qin D, Xia YN, Whitesides GM: Soft lithography for micro‐ and nanoscale patterning. Nature Protocols 
2010, 5(3):491‐502. 
102.  McDonald  JC,  Whitesides  GM:  Poly(dimethylsiloxane)  as  a  material  for  fabricating  microfluidic 
devices. Accounts of Chemical Research 2002, 35(7):491‐499. 
103.  Zou  J,  Wong  PY:  Thermal  effects  in  plasma  treatment  of  patterned  PDMS  for  bonding  stacked 
channels. In: Micro‐ and Nanosystems. Edited by LaVan DA, Ayon AA, Madou MJ, McNie ME, Prasad SV, 
vol. 782; 2004: 125‐130. 
104.  Jo BH, Van Lerberghe LM, Motsegood KM, Beebe DJ: Three‐dimensional micro‐channel fabrication in 
polydimethylsiloxane (PDMS) elastomer. Journal of Microelectromechanical Systems 2000, 9(1):76‐81. 
105.  Jensen MF, Noerholm M,  Christensen  LH, Geschke O: Microstructure  fabrication with  a  CO2  laser 
system: characterization and fabrication of cavities produced by raster scanning of the  laser beam. 
Lab on a Chip 2003, 3(4):302‐307. 
106.  Klank  H,  Kutter  JP,  Geschke  O:  CO2‐laser  micromachining  and  back‐end  processing  for  rapid 
production of PMMA‐based microfluidic systems. Lab on a Chip 2002, 2(4):242‐246. 
107.  Geschke O, Klank H, Telleman P: Microsystem Engineering of Lab‐on‐a‐chip Devices: Wiley‐VCH; 2004. 
108.  Chen  Y,  Zhang  LY,  Chen G:  Fabrication, modification,  and  application  of  department  of  analytical 
poly(methyl methacrylate) microfluidic chips. Electrophoresis 2008, 29(9):1801‐1814. 
109.  Ogilvie IRG, Sieben VJ, Floquet CFA, Zmijan R, Mowlem MC, Morgan H: Reduction of surface roughness 
for  optical  quality  microfluidic  devices  in  PMMA  and  COC.  Journal  of  Micromechanics  and 
Microengineering 2010, 20(6):8. 
110.  Stangegaard M,  Petronis  S,  Jorgensen  AM,  Christensen  CBV,  Dufva M:  A  biocompatible  micro  cell 
culture chamber (mu CCC) for the culturing and on‐line monitoring of eukaryote cells. Lab on a Chip 
2006, 6(8):1045‐1051. 
Evoluting microfluidics: Moving toward clinical applications 
 
  191
 
 
111.  Stangegaard M, Wang Z, Kutter JP, Dufva M, Wolff A: Whole genome expression profiling using DNA 
microarray  for  determining  biocompatibility  of  polymeric  surfaces.  Molecular  Biosystems  2006, 
2(9):421‐428. 
112.  Szantai E, Guttman A: Genotyping with microfluidic devices. Electrophoresis 2006, 27(24):4896‐4903. 
113.  Andersson H, van den Berg A: Microfluidic devices for cellomics: a review. Sensors and Actuators B: 
Chemical 2003, 92(3):315‐325. 
114.  El‐Ali J, Sorger PK, Jensen KF: Cells on chips. Nature 2006, 442(7101):403‐411. 
115.  Srivastava Y, Marquez M, Thorsen T: Microfluidic electrospinning of biphasic nanofibers with  Janus 
morphology. Biomicrofluidics 2009, 3(1):6. 
116.  Vanapalli  SA,  Duits  MHG,  Mugele  F:  Microfluidics  as  a  functional  tool  for  cell  mechanics. 
Biomicrofluidics 2009, 3(1). 
117.  Frische N, Datta  P, Goettert  J: Development of  a biological detection platform utilizing  a modular 
microfluidic  stack.  Microsystem  Technologies‐Micro‐and  Nanosystems‐Information  Storage  and 
Processing Systems 2010, 16(8‐9):1553‐1561. 
118.  You BH, Chen PC, Park DS, Park S, Nikitopoulos DE, Soper SA, Murphy MC: Passive micro‐assembly of 
modular,  hot  embossed,  polymer  microfluidic  devices  using  exact  constraint  design.  Journal  of 
Micromechanics and Microengineering 2009, 19(12):11. 
119.  Yuen PK: SmartBuild ‐ A truly plug‐n‐play modular microfluidic system. Lab on a Chip 2008, 8(8):1374‐
1378. 
120.  Yuen PK, Bliss JT, Thompson CC, Peterson RC: Multidimensional modular microfluidic system. Lab on a 
Chip 2009, 9(22):3303‐3305. 
121.  Perozziello G, Simone G, Candeloro P, Gentile F, Malara N, Larocca R, Coluccio M, Pullano S, Tirinato L, 
Geschke  O  et  al:  A  Fluidic  Motherboard  for  Multiplexed  Simultaneous  and  Modular Detection  in 
Microfluidic Systems for Biological Application Micro and Nanosystems 2010, 2:227‐238. 
122.  Yang  Z, Maeda  R:  A world‐to‐chip  socket  for microfluidic  prototype  development.  Electrophoresis 
2002, 23(20):3474‐3478. 
123.  Benavides GL, Okandan M, Jenkins MW, Hetherington D, Galambos P: Precision alignment packaging 
for  microsystems  with  multiple  fluid  connections.  ASME  International  Mechanical  Engineering 
Congress and Exposition, Proceedings 2001, 2:3295‐3302. 
124.  Unger MA, Chou HP, Thorsen T, Scherer A, Quake SR: Monolithic microfabricated valves and pumps 
by multilayer soft lithography. Science 2000, 288(5463):113‐116. 
125.  Gomez‐Sjoberg R, Leyrat AA, Pirone DM, Chen CS, Quake SR: Versatile, fully automated, microfluidic 
cell culture system. Analytical Chemistry 2007, 79(22):8557‐8563. 
126.  Gomez‐Sjoberg  R,  Leyrat  AA,  Quake  SR:  ANYL  350‐Highly  automated  microfluidic  system  for  cell 
biology. Abstracts of Papers of the American Chemical Society 2008, 236:350‐ANYL. 
127.  Liu J, Hansen C, Quake SR: Solving the "world‐to‐chip" interface problem with a microfluidic matrix. 
Analytical Chemistry 2003, 75(18):4718‐4723. 
128.  Thorsen T, Maerkl SJ, Quake SR: Microfluidic large‐scale integration. Science 2002, 298(5593):580‐584. 
129.  Fredrickson  CK,  Fan  ZH:  Macro‐to‐micro  interfaces  for  microfluidic  devices.  Lab  on  a  Chip  2004, 
4(6):526‐533. 
130.  Christensen AM, Chang‐Yen DA, Gale BK: Characterization of interconnects used in PDMS microfluidic 
systems. Journal of Micromechanics and Microengineering 2005, 15(5):928‐934. 
131.  Chen  H,  Acharya  D,  Gajraj  A,  Meiners  JC:  Robust  interconnects  and  packaging  for  microfluidic 
elastomeric chips. Analytical Chemistry 2003, 75(19):5287‐5291. 
132.  Rodrigues E, Lapa RAS: Development of Flow Systems by Direct‐milling on Poly(methyl methacrylate) 
Substrates Using UV‐Photopolymerization as Sealing Process. Analytical Sciences 2009, 25(3):443‐448. 
Evoluting microfluidics: Moving toward clinical applications 
 
192   
 
 
133.  Rodrigues  E,  Lapa  RAS:  Development  of  micro‐flow  devices  by  direct‐milling  on  poly(methyl 
methacrylate)  substrates with  integrated  optical  detection. Microchimica Acta  2009,  166(3‐4):189‐
195. 
134.  Anderson JR, Chiu DT, Jackman RJ, Cherniavskaya O, McDonald JC, Wu HK, Whitesides SH, Whitesides 
GM: Fabrication of topologically complex three‐dimensional microfluidic systems  in PDMS by rapid 
prototyping. Analytical Chemistry 2000, 72(14):3158‐3164. 
135.  Bowden M, Geschke O, Kutter  JP, Diamond D: CO2  laser microfabrication of an  integrated polymer 
microfluidic manifold for the determination of phosphorus. Lab on a Chip 2003, 3(4):221‐223. 
136.  McMahon  JJ, Kwon Y,  Lu  JQ, Cale TS, Gutmann RJ: Bonding characterization of oxidized PDMS  thin 
films.  In: Thin Films‐Stresses and Mechanical Properties X. Edited by Corcoran SG, Joo YC, Moody NR, 
Suo Z, vol. 795; 2004: 99‐104. 
137.  Rodriguez‐Trujillo R, Castillo‐Fernandez O, Garrido M, Arundell M, Valencia A, Gomila G: High‐speed 
particle detection in a micro‐Coulter counter with two‐dimensional adjustable aperture. Biosensors & 
Bioelectronics 2008, 24(2):290‐296. 
138.  Freshney I: Culture of Animal Cells: A Manual of Basic Technique, 5th edn. NJ,USA: Wiley‐Liss; 2005. 
139.  Young EWK, Simmons CA: Macro‐ and microscale fluid flow systems for endothelial cell biology. Lab 
on a Chip 2010, 10(2):143‐160. 
140.  Kang E, Lee DH, Kim CB, Yoo SJ,  Lee SH: A hemispherical microfluidic channel  for  the  trapping and 
passive dissipation of microbubbles. Journal of Micromechanics and Microengineering 2010, 20(4):9. 
141.  Zheng  WF,  Wang  Z,  Zhang  W,  Jiang  XY:  A  simple  PDMS‐based  microfluidic  channel  design  that 
removes bubbles for long‐term on‐chip culture of mammalian cells. Lab on a Chip 2010, 10(21):2906‐
2910. 
142.  Sung JH, Shuler ML: Prevention of air bubble formation in a microfluidic perfusion cell culture system 
using a microscale bubble trap. Biomedical Microdevices 2009, 11(4):731‐738. 
143.  Regehr KJ, Domenech M, Koepsel  JT, Carver KC, Ellison‐Zelski  SJ, Murphy WL,  Schuler  LA, Alarid ET, 
Beebe DJ: Biological  implications of polydimethylsiloxane‐based microfluidic  cell  culture.  Lab on a 
Chip 2009, 9(15):2132‐2139. 
144.  Kim  L,  Toh  YC,  Voldman  J,  Yu  H:  A  practical  guide  to  microfluidic  perfusion  culture  of  adherent 
mammalian cells. Lab on a Chip 2007, 7(6):681‐694. 
145.  Young  EWK, Beebe DJ:  Fundamentals of microfluidic  cell  culture  in  controlled microenvironments. 
Chemical Society Reviews 2010, 39(3):1036‐1048. 
146.  Walker  GM,  Zeringue  HC,  Beebe  DJ:  Microenvironment  design  considerations  for  cellular  scale 
studies. Lab on a Chip 2004, 4(2):91‐97. 
147.  Yeon JH, Park JK: Microfluidic cell culture systems for cellular analysis. Biochip Journal 2007, 1(1):17‐
27. 
148.  Meyvantsson  I, Beebe DJ: Cell Culture Models  in Microfluidic Systems. Annual Review of Analytical 
Chemistry 2008, 1:423‐449. 
149.  Takayama S, Ostuni E, LeDuc P, Naruse K, Ingber DE, Whitesides GM: Selective chemical treatment of 
cellular microdomains using multiple laminar streams. Chemistry and Biology 2003, 10(2):123‐130. 
150.  Walker GM, Sai JQ, Richmond A, Stremler M, Chung CY, Wikswo  JP: Effects of  flow and diffusion on 
chemotaxis studies in a microfabricated gradient generator. Lab on a Chip 2005, 5(6):611‐618. 
151.  Fujii S, Uematsu M, Yabuki S, Abo M, Yoshimura E, Sato K: Microbioassay system  for an anti‐cancer 
agent test using animal cells on a microfluidic gradient mixer. Analytical Sciences 2006, 22(1):87‐90. 
152.  Shaughnessy L, Chamblin B, McMahon L, Nair A, Thomas MB, Wakefield J, Koentgen F, Ramabhadran R: 
Novel approaches to models of Alzheimer's disease pathology for drug screening and development. 
Journal of Molecular Neuroscience 2004, 24(1):23‐32. 
Evoluting microfluidics: Moving toward clinical applications 
 
  193
 
 
153.  Diao  JP, Young  L, Kim S, Fogarty EA, Heilman SM, Zhou P, Shuler ML, Wu MM, DeLisa MP: A  three‐
channel  microfluidic  device  for  generating  static  linear  gradients  and  its  application  to  the 
quantitative analysis of bacterial chemotaxis. Lab on a Chip 2006, 6(3):381‐388. 
154.  Saadi W, Wang SJ, Lin F, Jeon NL: A parallel‐gradient microfluidic chamber for quantitative analysis of 
breast cancer cell chemotaxis. Biomedical Microdevices 2006, 8(2):109‐118. 
155.  Koyama  S, Amarie D,  Soini HA, Novotny MV,  Jacobson  SC:  Chemotaxis  assays  of mouse  sperm  on 
microfluidic devices. Analytical Chemistry 2006, 78(10):3354‐3359. 
156.  Chung BG, Flanagan LA, Rhee SW, Schwartz PH, Lee AP, Monuki ES, Jeon NL: Human neural stem cell 
growth and differentiation in a gradient‐generating microfluidic device. Lab on a Chip 2005, 5(4):401‐
406. 
157.  Tourovskaia A, Figueroa‐Masot X, Folch A: Differentiation‐on‐a‐chip: A microfluidic platform for long‐
term cell culture studies. Lab on a Chip 2005, 5(1):14‐19. 
158.  Lam RHW, Kim MC, Thorsen T: Culturing Aerobic and Anaerobic Bacteria and Mammalian Cells with a 
Microfluidic Differential Oxygenator. Analytical Chemistry 2009, 81(14):5918‐5924. 
159.  Gobbels K, Thiebes AL, van Ooyen A, Schnakenberg U, Braunig P:  Low density  cell  culture of  locust 
neurons in closed‐channel microfluidic devices. Journal of Insect Physiology 2010, 56(8):1003‐1009. 
160.  Giridharan  GA,  Nguyen  MD,  Estrada  R,  Parichehreh  V,  Hamid  T,  Ismahil  MA,  Prabhu  SD,  Sethu  P: 
Microfluidic Cardiac Cell Culture Model (mu CCCM). Analytical Chemistry 2010, 82(18):7581‐7587. 
161.  Barbulovic‐Nad  I, Au SH, Wheeler AR: A microfluidic platform for complete mammalian cell culture. 
Lab on a Chip 2010, 10(12):1536‐1542. 
162.  Hui  EE,  Bhatia  SN:  Micromechanical  control  of  cell‐cell  interactions.  Proceedings  of  the  National 
Academy of Sciences of the United States of America 2007, 104(14):5722‐5726. 
163.  Kane BJ, Zinner MJ, Yarmush ML, Toner M: Liver‐specific functional studies in a microfluidic array of 
primary mammalian hepatocytes. Analytical Chemistry 2006, 78(13):4291‐4298. 
164.  Weibel  DB,  DiLuzio  WR,  Whitesides  GM:  Microfabrication  meets  microbiology.  Nature  Reviews 
Microbiology 2007, 5(3):209‐218. 
165.  Yu HM, Meyvantsson I, Shkel IA, Beebe DJ: Diffusion dependent cell behavior in microenvironments. 
Lab on a Chip 2005, 5(10):1089‐1095. 
166.  Zhang BY, Kim MC, Thorsen T, Wang ZH: A self‐contained microfluidic cell culture system. Biomedical 
Microdevices 2009, 11(6):1233‐1237. 
167.  Kimura H, Sakai H, Yamamoto T, Sakai Y, Fujii T: Development of Micro Perfusion Cell Culture Device 
to Create In Vivo‐Like Environments for Long‐Period and Real‐Time Monitoring of Cells Activities. In: 
Micro‐NanoMechatronics and Human Science, 2006 International Symposium on: 5‐8 Nov. 2006 2006; 
2006: 1‐6. 
168.  Kimura  H,  Yamamoto  T,  Sakai H,  Sakai  Y,  Fujii  T:  An  integrated microfluidic  system  for  long‐term 
perfusion culture and on‐line monitoring of  intestinal  tissue models. Lab on a Chip 2008, 8(5):741‐
746. 
169.  Nevill JT, Cooper R, Dueck M, Breslauer DN, Lee LP: Integrated microfluidic cell culture and lysis on a 
chip. Lab on a Chip 2007, 7(12):1689‐1695. 
170.  Liu K, Pitchimani R, Dang D, Bayer K, Harrington T, Pappas D: Cell culture chip using  low‐shear mass 
transport. Langmuir 2008, 24(11):5955‐5960. 
171.  Korin  N,  Bransky  A,  Khoury  M,  Dinnar  U,  Levenberg  S:  Design  of  Well  and  Groove  Microchannel 
Bioreactors for Cell Culture. Biotechnology and Bioengineering 2009, 102(4):1222‐1230. 
172.  McAdams TA, Sandstrom CE, Miller WM, Bender  JG, Papoutsakis ET: Ex vivo expansion of primitive 
hematopoietic cells for cellular therapies: An overview. Cytotechnology 1995, 18(1‐2):133‐146. 
Evoluting microfluidics: Moving toward clinical applications 
 
194   
 
 
173.  Sandstrom CE, Bender  JG, Miller WM, Papoutsakis ET: Development of novel perfusion chamber  to 
retain  nonadherent  cells  and  its  use  for  comparison  of  human  ''mobilized''  peripheral  blood 
mononuclear  cell  cultures  with  and  without  irradiated  bone  marrow  stroma.  Biotechnology  and 
Bioengineering 1996, 50(5):493‐504. 
174.  Jacobs PA, Baikie AG, Brown WMC, Strong JA: The somatic chromosomes in mongolism. Lancet 1959, 
1(APR4):710‐710. 
175.  Ford CE,  Jones KW, Miller OJ, Mittwoch U, Penrose  LS, Ridler M, Shapiro A: The  chromosomes  in a 
patient showing both Mongolism and the Klinefelter syndrome. Lancet 1959, 1(APR4):709‐710. 
176.  Ford  CE,  Jones  KW,  Polani  PE,  Dealmeida  JC,  Briggs  JH:  A  sex‐chromosome  anomaly  in  a  case  of 
gonadal dysgeneis (Turners syndrome). Lancet 1959, 1(APR4):711‐713. 
177.  Rowley JD: New consistent chromosomal abnormality in chronic myelogenous leukemia identified by 
quinacrine fluorescence and giemsa staining. Nature 1973, 243(5405):290‐293. 
178.  Manning  M,  Hudgins  L:  Professional  Practice  Guidelines  C. Array‐based  technology  and 
recommendations  for  utilization  in  medical  genetics  practice  for  detection  of  chromosomal 
abnormalities. Genetics in Medicine 2010, 12(11):742‐745. 
179.  Bystricka  D,  Zemanova  Z,  Brezinova  J,  Gancarcikova M,  Grosova  L,  Sarova  I,  Izakova  S,  Berkova  A, 
Michalova  K:  The Assessment of Array  Comparative Genomic Hybridization  in Complex Karyotype 
Analyses. Folia Biologica 2010, 56(5):223‐230. 
180.  Krabchi K,  Lavoie  J, Coullin P, Bronsard M, Pellestor F, Yan  J, Drouin R: From  the  conception of  the 
PRINS to its coronation. MS: Medecine Sciences 2004, 20(4):465‐473. 
181.  Xu J, Chen Z: Advances in molecular cytogenetics for the evaluation of mental retardation. American 
Journal of Medical Genetics Part C: Seminars in Medical Genetics 2003, 117C(1):15‐24. 
182.  Mennicke K, Yang J, Hinrichs F, Muller A, Diercks P, Schwinger E: Validation of primed in situ labeling 
for  interphase analysis of chromosomes 18, X, and Y  in uncultured amniocytes. Fetal Diagnosis and 
Therapy 2003, 18(2):114‐121. 
183.  Velagelati GVN, Shulman LP, Phillips OP, Tharapel SA, Tharapel AT: Primed  in situ  labeling  for  rapid 
prenatal diagnosis. American Journal of Obstetrics and Gynecology 1998, 178(6):1313‐1317. 
184.  Phillips OP, Velagelati GVN,  Shulman  LP,  Tharapel  SA, Martens  PR, Wachtel  SS,  Tharapel AT:  Rapid 
prenatal  diagnosis  by  primed  in  situ  labeling  (PRINS).  American  Journal  of Human  Genetics  1997, 
61(4):918. 
185.  Li F, Fang WG, Wu BQ, Wang JJ, Zhong HH, Heng WJ: Molecular cytogenetic detection of trisomy 21 in 
interphase nuclei and metaphase chromosomes. Chinese Medical Journal 1999, 112(9):840‐844. 
186.  Baierlei.Jl, Foster JM: Studies on Energy Metabolism of Human Leukocytes. 2. Mechanism of Pasteur 
effect in Human Leukocytes. Blood 1968, 32(3):412‐&. 
187.  Marucci M, Pettersson  SG, Ragnarsson G, Axelsson A: Determination of  a diffusion  coefficient  in a 
membrane  by  electronic  speckle  pattern  interferometry:  a  new  method  and  a  temperature 
sensitivity study. Journal of Physics D: Applied Physics 2007, 40(9):2870‐2880. 
188.  Sabourin D, Dufva M, Jensen T, Kutter J, Snakenborg D: One‐step fabrication of microfluidic chips with 
in‐plane,  adhesive‐free  interconnections.  Journal  of  Micromechanics  and  Microengineering  2010, 
20(3). 
189.  Claussen  U,  Michel  S,  Muhlig  P,  Westermann  M,  Grummt  UW,  Kromeyer‐Hauschild  K,  Liehr  T: 
Demystifying  chromosome  preparation  and  the  implications  for  the  concept  of  chromosome 
condensation during mitosis. Cytogenetic and Genome Research 2002, 98(2‐3):136‐146. 
190.  Henegariu O, Heerema NA, Wright LL, Bray‐Ward P, Ward DC, Vance GH: Improvements in cytogenetic 
slide  preparation:  Controlled  chromosome  spreading,  chemical  aging  and  gradual  denaturing. 
Cytometry 2001, 43(2):101‐109. 
Evoluting microfluidics: Moving toward clinical applications 
 
  195
 
 
191.  Haubert K, Drier T, Beebe D: PDMS bonding by means of a portable, low‐cost corona system. Lab on a 
Chip 2006, 6(12):1548‐1549. 
192.  Liehr  T:  Fluorescence  In‐Situ  Hybridization  (FISH)  :  Application  guide,  1st  edn.  Berlin  Heidelberg: 
Springer‐Verlag; 2009. 
193.  Ward  BE,  Gersen  SL,  Carelli MP, McGuire NM,  Dackowski WR, Weinstein M,  Sandlin  C, Warren  R, 
Klinger  KW:  Rapid  prenatal  diagnosis  of  chromosomal  aneuploidies  by  fluorescence  in  situ 
hybridization: clinical experience with 4,500  specimens. American  Journal of Human Genetics 1993, 
52(5):854‐865. 
194.  Sasai  K,  Tanaka  R,  Kawamura  M,  Honjo  K,  Matsunaga  N,  Nakada  T,  Homma  K,  Fujimura  H: 
Chromosome spreading techniques for primary gastrointestinal tumors. Journal of Gastroenterology 
1996, 31(4):505‐511. 
195.  Tepperberg J, Pettenati MJ, Rao PN, Lese CM, Rita D, Wyandt H, Gersen S, White B, Schoonmaker MM: 
Prenatal  diagnosis  using  interphase  fluorescence  in  situ  hybridization  (FISH):  2‐year  multi‐center 
retrospective study and review of the literature. Prenatal Diagnosis 2001, 21(4):293‐301. 
196.  Squire  J, Marrano P, Kolomeitz  E:  FISH  in  clinical  cytogenetics,  First  edition  edn. Oxford New  York: 
Oxford Publishers, USA; 2002. 
197.  Weise  A,  Liehr  T:  Fluorescence  in  situ  hybridization  for  prenatal  screening  of  chromosomal 
aneuploidies. Expert Review of Molecular Diagnostics 2008, 8(4):355‐357. 
198.  Tanas MR, Goldblum JR: Fluorescence In Situ Hybridization in the Diagnosis of Soft Tissue Neoplasms: 
A Review. Advances in Anatomic Pathology 2009, 16(6):383‐391. 
199.  Braselmann H, Kulka U, Baumgartner A, Eder C, Muller I, Figel M, Zitzelsberger H: SKY and FISH analysis 
of radiation‐induced chromosome aberrations: A comparison of whole and partial genome analysis. 
Mutation Research‐Fundamental and Molecular Mechanisms of Mutagenesis 2005, 578(1‐2):124‐133. 
200.  Jobanputra V, Sobrino A, Kinney A, Kline  J, Warburton D: Multiplex  interphase FISH as a  screen  for 
common aneuploidies in spontaneous abortions. Human Reproduction 2002, 17(5):1166‐1170. 
201.  Pergament  E,  Chen  PX,  Thangavelu  M,  Fiddler  M:  The  clinical  application  of  interphase  FISH  in 
prenatal diagnosis. Prenatal Diagnosis 2000, 20(3):215‐220. 
202.  Garson  JA,  Vandenberghe  JA,  Kemshead  JT:  High‐resolution  in  situ  hybridization  technique  using 
biotinylated NMYC  oncogene  probe  reveals  periodic  structure  of  HSRs  in  human  neuroblastoma. 
Cytogenetics and Cell Genetics 1987, 45(1):10‐15. 
203.  Garson JA, Vandenberghe JA, Kemshead JT: Novel non‐isotopic in situ hybridization technique detects 
small (1 Kb) unique sequences  in routinely G‐banded human chromosomes: fine mapping of N‐myc 
and beta‐NGF genes. Nucleic Acids Research 1987, 15(12):4761‐4770. 
204.  Cremer  T,  Lichter  P,  Borden  J,  Ward  DC,  Manuelidis  L:  Detection  of  chromosome  aberrations  in 
metaphase  and  interphase  tumor  cells  by  in  situ  hybridization  using  chromosome‐specific  library 
probes. Human Genetics 1988, 80(3):235‐246. 
205.  Julien C, Bazin A, Guyot B, Forestier F, Daffos F: Rapid prenatal diagnosis of Down's syndrome with in‐
situ hybridisation of fluorescent DNA probes. Lancet 1986, 2(8511):863‐864. 
206.  Guyot  B,  Bazin  A,  Sole  Y,  Julien  C,  Daffos  F,  Forestier  F:  Prenatal  diagnosis  with  biotinylated 
chromosome specific probes. Prenatal Diagnosis 1988, 8(7):485‐493. 
207.  Stumm M, Wegner RD, Bloechle M, Eckel H: Interphase M‐FISH applications using commercial probes 
in prenatal and PGD diagnostics. Cytogenetic and Genome Research 2006, 114(3‐4):296‐301. 
208.  Dziubinski  JM,  Sarosdy MF, Kahn PR, Ziffer MD,  Love WR,  Zadra  JA,  Schellhammer PF, Bokinsky GB, 
Stenzel TT: Multiple fluorescence in situ hybridization (FISH) probes increase sensitivity for detection 
of bladder cancer. Journal of Urology 2006, 175(4):890. 
Evoluting microfluidics: Moving toward clinical applications 
 
196   
 
 
209.  Brown J, Saracoglu K, Uhrig S, Knight SJL, Lucas SJA, Speicher MR, Eils R, Kearney L: Development of a 
multicolour FISH assay for subtelomeric chromosome rearrangements in leukaemia. Cytogenetics and 
Cell Genetics 1999, 85(1‐2):O018. 
210.  Kearney  L:  The  impact  of  the  new  fish  technologies  on  the  cytogenetics  of  haematological 
malignancies. British Journal of Haematology 1999, 104(4):648‐658. 
211.  Kearney  L:  Multiplex‐FISH  (M‐FISH):  technique,  developments  and  applications.  Cytogenetic  and 
Genome Research 2006, 114(3‐4):189‐198. 
212.  Insabato L, Bernasconi B, Glatz K, Dirnhofer S, Krugman  J, Fend F, Capella C, Tibiletti MG, Di Vizio D, 
Pettinato G et al: High‐throughput tissue microarray FISH analysis in 226 surgically resected gastric B‐
cell lymphomas. Frequencies of trisomy 1, 3,12 and gains of X chromosome. Laboratory Investigation 
2002, 82(1):541. 
213.  Tibiletti MG:  Interphase FISH as a new  tool  in  tumor pathology. Cytogenetic and Genome Research 
2007, 118(2‐4):229‐236. 
214.  Denice  S,  Matt  R,  Kim  O,  S  BJ:  Integrating  a  FISH  imaging  system  into  the  cytology  laboratory. 
CytoJournal 2010, 7(3). 
215.  Genetics  ACoM:  Prenatal  interphase  fluorescence  in  situ  hybridization  (FISH)  policy  statement. 
American Journal of Human Genetics 1993, 53(2):526‐527. 
216.  Schwartz  S:  Efficacy  and  applicability  of  interphase  fluorescence  in  situ  hybridization  for  prenatal 
diagnosis. American Journal of Human Genetics 1993, 52(5):851‐853. 
217.  Christel E‐S, Stefan G, Inga N, Andrea H, Susanne B, Simone H, Monika K, Christian T, Reiner S, Almuth 
C:  Conflicting  results  of  prenatal  FISH with  different  probes  for Down's  Syndrome  critical  regions 
associated with mosaicism for a de novo del(21)(q22) characterised by molecular karyotyping: Case 
report. Molecular Cytogenetics 2010, 3(16). 
218.  Zanardi A, Bandiera D, Bertolini F, Corsini CA, Gregato G, Milani P, Barborini E, R. C: Miniaturized FISH 
for screening of onco‐hematological malignancies. Biotechniques 2010, 49(1):497‐504. 
219.  Hliscs  R, Muhlig  P,  Claussen  U:  The  spreading  of  metaphases  is  a  slow  process  which  leads  to  a 
stretching of chromosomes. Cytogenetics and Cell Genetics 1997, 76(3‐4):167‐171. 
220.  Qu  YY,  Xing  LY,  Hughes  ED,  Saunders  TL:  Chromosome  Dropper  Tool:  Effect  of  slide  angles  on 
chromosome  spread  quality  for  murine  embryonic  stem  cells.  Journal  of  Histotechnology  2008, 
31(2):75‐79. 
221.  Yamada K, Kakinuma K, Tateya H, Miyasaka C: Development of an  instrument for chromosome slide 
preparation. Journal of Radiation Research 1992, 33:242‐249. 
222.  Reyes DR, Iossifidis D, Auroux PA, Manz A: Micro total analysis systems. 1. Introduction, theory, and 
technology. Analytical Chemistry 2002, 74(12):2623‐2636. 
223.  Auroux  PA,  Iossifidis  D,  Reyes  DR,  Manz  A:  Micro  total  analysis  systems.  2.  Analytical  standard 
operations and applications. Analytical Chemistry 2002, 74(12):2637‐2652. 
224.  Castillo J, Tanzi S, Dimaki M, Svendsen W: Manipulation of self‐assembly amyloid peptide nanotubes 
by dielectrophoresis. Electrophoresis 2008, 29(24):5026‐5032. 
225.  Crane MM, Chung K, Stirman  J, Lu H: Microfluidics‐enabled phenotyping,  imaging, and screening of 
multicellular organisms. Lab on a Chip 2010, 10(12):1509‐1517. 
226.  Leung WC, Waters JJ, Chitty L: Prenatal diagnosis by rapid aneuploidy detection and karyotyping: a 
prospective  study  of  the  role  of  ultrasound  in  1589  second‐trimester  amniocenteses.  Prenatal 
Diagnosis 2004, 24(10):790‐795. 
227.  Evans MI, Henry GP, Miller WA,  Bui  TH,  Snidjers RJ, Wapner  RJ, Miny  P,  Johnson MP,  Peakman D, 
Johnson A et al:  International,  collaborative assessment of 146 000 prenatal karyotypes: expected 
Evoluting microfluidics: Moving toward clinical applications 
 
  197
 
 
limitations if only chromosome‐specific probes and fluorescent in‐situ hybridization are used. Human 
Reproduction 1999, 14(5):1213‐1216. 
228.  Laan  M,  Kallioniemi  OP,  Hellsten  E,  Alitalo  K,  Peltonen  L,  Palotie  A:  Mechanically  stretched 
chromosomes as targets for high‐resolution fish mapping. Genome Research 1995, 5(1):13‐20. 
229.  Korenberg  JR,  Yangfeng  T,  Schreck  R,  Chen  XN:  Using  fluorescence  in  situ  hybridization  (FISH)  in 
genome mapping. Trends in Biotechnology 1992, 10(1‐2):27‐32. 
230.  Spurbeck  JL,  Zinsmeister  AR,  Meyer  KJ,  Jalal  SM:  Dynamics  of  chromosome  spreading.  American 
Journal of Medical Genetics 1996, 61(4):387‐393. 
231.  Barch MJ, Lawce HJ, Arsham MS: Peripheral Blood Culture, 2nd edn. New York, NY, USA: Raven Press; 
1991. 
232.  Chattopadhyay  S, Marinduque B, Gilbert  F: Ovarian  cancer protocol  for  the preparation of banded 
metaphases from tumor‐tissue. Cancer Genetics and Cytogenetics 1992, 59(2):210‐212. 
233.  Gibas LM, Grujic S, Barr MA, Jackson LG: A simple technique for obtaining high‐quality chromosome 
preparations  from  chorionic  villus  samples  using  FDU  synchronization.  Prenatal  Diagnosis  1987, 
7(5):323‐327. 
234.  Miron PM: Preparation, Culture and Analysis of Amniotic  Fluid  Samples. New York, NY, USA:  John 
Wiley & Sons; 1995. 
235.  Warburton D: Preparation and Culture of Products of Conception and Other Tissue for Chromosome 
Analysis. New York, NY, USA: John Wiley & Sons; 1995. 
236.  Deng  W,  Tsao  SW,  Lucas  JN,  Leung  CS,  Cheung  ALM:  A  new  method  for  improving  metaphase 
chromosome spreading. Cytometry Part A 2003, 51A(1):46‐51. 
237.  Netten  H,  Young  IT,  vanVliet  LJ,  Tanke  HJ,  Vroljik  H,  Sloos  WCR:  FISH  and  chips:  Automation  of 
fluorescent dot counting in interphase cell nuclei. Cytometry 1997, 28(1):1‐10. 
238.  Theodosiou Z, Kasampalidis LN, Livanos G, Zervakis M, Pitas L, Lyroudia K: Automated analysis of FISH 
and immunohistochemistry images: A review. Cytometry Part A 2007, 71A(7):439‐450. 
239.  Ling  X,  Premachandran  CS,  Chew M,  Ser  Choong  C: Development  of  a Disposable  Bio‐Microfluidic 
Package With Reagents Self‐Contained Reservoirs and Micro‐Valves  for a DNA Lab‐on‐a‐Chip  (LOC) 
Application. IEEE Transactions on Advanced Packaging 2009, 32(2):528‐535. 
240.  Linder V, Sia SK, Whitesides GM: Reagent‐loaded cartridges for valveless and automated fluid delivery 
in microfluidic devices. Analytical Chemistry 2005, 77(1):64‐71. 
241.  Pamme N: Continuous flow separations in microfluidic devices. Lab on a Chip 2007, 7(12):1644‐1659. 
242.  Yamada M, Nakashima M, Seki M: Pinched flow fractionation: Continuous size separation of particles 
utilizing a  laminar  flow profile  in a pinched microchannel. Analytical Chemistry 2004, 76(18):5465‐
5471. 
243.  Takagi  J,  Yamada M,  Yasuda M,  Seki M:  Continuous  particle  separation  in  a microchannel  having 
asymmetrically arranged multiple branches. Lab on a Chip 2005, 5(7):778‐784. 
244.  Sai Y, Yamada M, Yasuda M, Seki M: Continuous separation of particles using a microfluidic device 
equipped with flow rate control valves. Journal of Chromatography A 2006, 1127(1‐2):214‐220. 
245.  Andersen K, Levinsen S: Design and simulation of pinchflow  fractionation  for blood cell separation. 
Bachelor Thesis. Technical University of Denmark; 2007. 
246.  Andersen KB,  Levinsen  S,  Svendsen WE, Okkels  F: A  generalized  theoretical model  for  "continuous 
particle separation  in a microchannel having asymmetrically arranged multiple branches". Lab on a 
Chip 2009, 9(11):1638‐1639. 
247.  Christiansen  N,  Hansen  M:  Pinch  Flow  Fractionation  for   Blood  Cell  Separation.  Bachelor  Thesis. 
Technical University of Denmark; 2007. 
Evoluting microfluidics: Moving toward clinical applications 
 
198   
 
 
248.  Seki M: Continuous Particle classification in microfluidic system. In: µTAS 2007 ‐ Eleventh International 
Conference on Miniaturized Systems for Life Sciences and Chemistry: 2007; Paris; 2007. 
249.  Faivre M, Abkarian M, Bickraj K, Stone HA: Geometrical focusing of cells  in a microfluidic device: An 
approach to separate blood plasma. Biorheology 2006, 43(2):147‐159. 
250.  Adler SM, Denton RL: Erythrocyte sedimentation‐rate  in newborn period. Journal of Pediatrics 1975, 
86(6):942‐948. 
251.  Cantini F, Salvarani C, Olivieri I: Erythrocyte sedimentation rate and C‐reactive protein in the diagnosis 
of polymyalgia rheumatica. Annals of Internal Medicine 1998, 128(10):873‐874. 
252.  Erkhov  VS,  Ageenko  AI:  Detecting  blood  group  antigen  on  human  cells|is  based  on  erythrocyte 
sedimentation rates. In.; 1997. 
253.  Wetteland P, Roger M, Solberg HE, Iversen OH: Population‐based erythrocyte sedimentation rates in 
3910 subjectively healthy Norwegian adults. A statistical study based on men and women from the 
Oslo area. Journal of Internal Medicine 1996, 240(3):125‐131. 
254.  Russom A, Sethu P, Irimia D, Mindrinos MN, Calvan SE, Iris GA, Finnerty C, Tannahill C, Abouhamze A, 
Wilhelmy  J  et  al:  Inflammation  and  Host  Response  to  Injury  Large  Scale  Collaborative  Research 
Program.  Microfluidic  leukocyte  isolation  for  gene  expression  analysis  in  critically  ill  hospitalized 
patients. Clinical Chemistry 2008, 54(5):891‐900. 
255.  Sethu P, Anahtar M, Moldawer  LL,  Tompkins RG,  Toner M: Continuous  row microfluidic device  for 
rapid erythrocyte lysis. Analytical Chemistry 2004, 76(21):6247‐6253. 
256.  Sethu P, Moldawer LL, Mindrinos MN, Scumpia PO, Tannahill CL, Wilhelmy J, Efron PA, Brownstein BH, 
Tompkins RG,  Toner M: Microfluidic  isolation of  leukocytes  from whole blood  for  phenotype  and 
gene expression analysis. Analytical Chemistry 2006, 78(15):5453‐5461. 
257.  Stroock  AD,  Dertinger  SKW,  Ajdari  A,  Mezic  I,  Stone  HA,  Whitesides  GM:  Chaotic  mixer  for 
microchannels. Science 2002, 295(5555):647‐651. 
258.  Yang YJ, Liao HH, Huang KH, Huang YY, Lin CW, Yang LJ,  Jaw FS, Chang PZ, Lee CK: Novel designs of 
herringbone  chaotic  mixers.  In:  1st  IEEE  International  Conference  on  Nano/Micro  Engineered  and 
Molecular Systems, Vols 1‐3: 2006; 2006: 1307‐1310. 
259.  Dimaki M, Lange JM, Vazquez P, Shah PJ, Okkels F, Svendsen WE: Comsol Multiphysics Simulations of 
Microfluidic  Systems  for  Biomedical Applications.  In:  Proceedings  of  the  COMSOL User  Conference 
2008, Hannover, Germany. 2008. 
260.  Yang JT, Huang KJ, Lin YC: Geometric effects on fluid mixing in passive grooved micromixers. Lab on a 
Chip 2005, 5(10):1140‐1147. 
261.  Liu CC, Young JDE: A semi‐automated microassay for complement activity. Journal of  Immunological 
Methods 1988, 114(1‐2):33‐39. 
262.  Rummage JA, Leu RW: Photometric microassay for quantitation of macrophage FC and C3B receptor 
function. Journal of Immunological Methods 1985, 77(1):155‐163. 
263.  Williams AR, Miller DL: Photometric detection of ATP  release  from human‐erythrocyte exposed  to 
ultrasonically activated gas‐filled pores. Ultrasound in Medicine and Biology 1980, 6(3):251‐256. 
264.  Tan  WH,  Takeuchi  S:  A  trap‐and‐release  integrated  microfluidic  system  for  dynamic  microarray 
applications. Proceedings of the National Academy of Sciences of the United States of America 2007, 
104(4):1146‐1151. 
265.  Tan  WH,  Takeuchi  S:  Dynamic  microarray  system  with  gentle  retrieval  mechanism  for  cell‐
encapsulating hydrogel beads. Lab on a Chip 2008, 8(2):259‐266. 
266.  Lange  J: Growth of peripheral T‐lymphocytes on  chip. PhD Thesis, Technical University of Denmark; 
2010. 
Evoluting microfluidics: Moving toward clinical applications 
 
  199
 
 
267.  Bogar  L,  Tekeres M:  Leukocyte  flotation during  gravity  sedimentation of  the whole blood. Clinical 
Hemorheology and Microcirculation 2000, 22(1):29‐33. 
268.  Langehanenberg P,  Ivanova L, Bernhardt  I, Ketelhut S, Vollmer A, Dirksen D, Georgiev G, von Bally G, 
Kemper B: Automated  three‐dimensional  tracking of  living  cells by digital holographic microscopy. 
Journal of Biomedical Optics 2009, 14(1). 
269.  Wray W, Stubblef.E: A new method for rapid isolation of chromosomes, mitotic apparatus, or nuclei 
from mammalian fibroblasts at near neutral pH. Experimental Cell Research 1970, 59(3):469‐&. 
270.  Harned  HS,  Nuttall  RL:  The  Differential  Diffusion  Coefficient  of  Potassium  Chloride  in  aqueous 
solutions. Journal of the American Chemical Society 1949, 71(4):1460‐1463. 
271.  Bundgaard  F:  Prototyping  of  Microfluidic  Systems  with  Integrated  Waveguides  in  Cyclic  Olefin 
Copolymer (COC). PhD thesis. Technical University of Denmark; 2006. 
272.  Baudach  S,  Bonse  J,  Kruger  J,  Kautek  W:  Ultrashort  pulse  laser  ablation  of  polycarbonate  and 
polymethylmethacrylate. Applied Surface Science 2000, 154:555‐560. 
273.  Eddings MA,  Johnson MA,  Gale  BK:  Determining  the  optimal  PDMS‐PDMS  bonding  technique  for 
microfluidic devices. Journal of Micromechanics and Microengineering 2008, 18(6). 
274.  Satyanarayana S, Karnik RN, Majumdar A: Stamp‐and‐stick room‐temperature bonding technique for 
microdevices. Journal of Microelectromechanical Systems 2005, 14(2):392‐399. 
275.  Truckenmuller R, Henzi P, Herrmann D, Saile V, Schomburg WK: A new bonding process for polymer 
micro‐ and nanostructures based on near‐surface degradation. Mems 2004: 17th  IEEE International 
Conference on Micro Electro Mechanical Systems, Technical Digest 2004:761‐764. 
276.  Truckenmuller R, Henzi P, Herrmann D, Saile V, Schomburg WK: Bonding of polymer microstructures 
by UV irradiation and subsequent welding at low temperatures. Microsystem Technologies‐Micro‐and 
Nanosystems‐Information Storage and Processing Systems 2004, 10(5):372‐374. 
277.  Lyons  AB:  Divided  we  stand:  Tracking  cell  proliferation  with  carboxyfluorescein  diacetate 
succinimidyl ester. Immunology and Cell Biology 1999, 77(6):509‐515. 
278.  Lyons AB: Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye 
dilution. Journal of Immunological Methods 2000, 243(1‐2):147‐154. 
279.  Lyons AB, Hasbold  J, Hodgkin PD: Flow  cytometric analysis of  cell division history using dilution of 
carboxyfluorescein diacetate  succinimidyl ester, a  stably  integrated  fluorescent probe. Methods  in 
Cell Biology, Vol 63 2001, 63:375‐398. 
 
 
 
 
 
Evoluting microfluidics: Moving toward clinical applications 
 
200   
 
 
 
 
 
 
APPENDIX A 
 
 
 
 
 
 
A microfluidic system to capture single cells
Pranjul Shah∗and Jacob Moresco Lange†
MIC – Department of Micro and Nanotechnology, DTU bldg. 345 east
Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark
(Dated: 21 June, 2007)
The present paper is written for PhD course 33641, Topics in theoretical microfluidics. We here a
present a microfluidic system capable of capturing single cells using hydrodynamic confinement. The
system has been designed for downstream processing of cellular contents. We present a theoretical
study of the system which shows that the system should perform best with four or more traps
connected in series.
PACS numbers: 47.65.+a, 47.32.-y, 47.70.-n, 85.90.+h
I. INTRODUCTION
Chromosomal rearrangements, known as transloca-
tion, may result in diseases such as retardation and can-
cer but the analysis of chromosomes from one single pa-
tient easily takes weeks or months. Thus, it is desirable
to automate the process, which may indeed be realized
by ”on chip” analysis. One of the challenges, however, is
the dynamic nature of chromosomal architecture mean-
ing that the volume of e.g. chromosome 1 in one cell
may be different from another cell (although the con-
tained information is identical). Therefore, single cell
analysis is desirable if facilitating a robust capture of
single cells of various sizes (e.g diameter of 8-15 µm)
followed by their lysis and subsequent trafficking of the
chromosomes (structures of approximately 1-6 µm) to
the ”analysis area. Many approaches have indeed been
made; Deutsch et al [1] fabricated a chamber with small
reservoirs with the size of a cell facilitating the isolation
of single cells, and Carlo et al [2] succeeded in arraying
cells using simple structural traps. Although facilitating
the isolation of a single cell, they do not facilitate the sub-
sequent trafficking of single cell material with the size of
condensed chromosomes. Tan et al [3] developed a design
for arraying particles using flow dynamics combined with
structural traps and we used a similar principle in our ap-
proach while keeping an eye on downstream processing
of single cell material.
II. DESIGN
An overview of the trap is given in figure 1.
This system consists of two main features. Firstly, the
long meandering channel with n number of repeats which
finally joins the outlet channel. Secondly, the n number
of traps which lie parallel to the meandering channel and
connect the inlet channel to the outlet channel.
∗pjs@mic.dtu.dk
†jml@mic.dtu.dk
FIG. 1: Design of the system cell trap system
III. MATHEMATICAL DESCRIPTION
A. Validity of Hagen-Poiseuille law
The nonlinear term in the Navier-Stokes equation may
often be neglected in microfluidics because of trans-
lational invariance. In the design presented here the
traps introduces potential contribution from the non-
linear term, but at small Reynolds numbers this con-
tribution may be neglected. Ideally Reynolds number
should be found numerically through the whole system
but we restrict our analysis to three positions in the sys-
tem, namely the main channel and the two parts of the
trap (see below). Reynolds number (Re) can be calcu-
lated using:
Re =
ρV0h
η
(1)
where ρ is the density, V0 is the average velocity, h is the
smallest length-scale and η is the viscosity of the liquid.
2Using an average velocity of 10 mm s−1 and the viscos-
ity of water, Re becomes 0.25, 0.15 and 0.06 respectively.
Thus we consider the nonlinear term in Navier-Stokes as
negligible and the Hagen-Poiseuille law should be valid
since we expect to work with much lower velocities. The
following analysis will therefore originate from an equiv-
alent circuit diagram found in the following sections.
B. Equivalent Circuit
1. Case: One trap
Imagine, a system where we have just a single cell trap
in the microfluidic circuit (Fig.2a). Considering that a
cell is present at the point A, a cell in the fluid will have
choice of two pathways. Either travel the shorter dis-
tance through trap or take the longer path through the
meander and back to the outlet channel. The particle at
this point will consider the hydraulic resistances (Rhyd)
of both the paths to decide on the pathway (Fig.2b).
FIG. 2: (a) Design of the system (b)Equivalent electrical resistance
circuit
Considering the Rhyd of the trap as Rtrap and of the
alternate route with the meander and the straight outlet
channel as Ralt then we know that the majority of the
flow (and thereby the majority of cells) will follow the
trap-path only if: RtrapRalt < 1 or Rtrap < Ralt. For this
case, as
Ralt = Rmeander +Rchannel (2)
We know that the Rhyd’s of meander(Rmeander) and fol-
lowing outlet channel (Rchannel) can be calculated as be-
low [4].
Rhyd =
12 · η · L
1− (0.913) · (0.63)) · (25 · 10−6m)4 (3)
where Lmeander = 300·10−6m and Lchannel = 150·10−6m.
The hydraulic resistance of the trap, Rtrap, is calcu-
lated as the sum of hydraulic resistances of the cell trap
itself, Rsq,(15 µm cell trap square) plus the hydraulic re-
sistance of the 6 µm connection to the outlet channel,
Rconnection.
Rtrap = Rsq +Rconnection (4)
Placing all the values for our design, we can calculate
that:
Rmeander = 2.18 · 1013 Pa s m−3 (5)
Rchannel = 1.09 · 1013 Pa s m−3 (6)
∴ Ralt = 3.27 · 1013 Pa s m−3 (7)
In a similar manner we find the hydraulic resistance of
the trap,Rtrap.
Rtrap = 1.91 · 1013 Pa s m−3 (8)
Thus,
Rtrap
Ralt
= 0.58 (9)
Therefore, at the first trap as Rtrap < Ralt the majority
of the cells will tend to flow into the trap. While ≈
63% of the flow will flow through the trap ≈ 37% of the
flow will go through the alternate route through meander
providing a higher chance that a cell will get trapped in
the trap.
2. Case: Two traps
Considering that we add one more cell trap to the pre-
viously described single cell trap system, we have an ar-
ray of two cell traps in series as shown in fig.3a.
When we draw the equivalent electrical circuit, we re-
alize it can be considered as in fig 3b. Here again, the
particle flowing into the microfluidic channel will face
two choices at junction A. It will be faced with the hy-
draulic resistances of the trap Rtrap and series of mean-
der and the single trap system as considered in case A.
3FIG. 3: (a) Design of the system with two cell traps (b)Equivalent
electrical resistance circuit
i.e. Rtrap//Ralt(1), where Ralt(i) is the hydraulic resis-
tance of the alternate route with i number of cell traps.
Hence we get:
Ralt(2) = Ralt(1) +Rtrap//Ralt(1) (10)
Ralt(2) = 4.47 · 1013 Pa s m−3 (11)
In this case, the particle will flow towards the trap con-
sidering Rtrap < Ralt(2). Now the resistance ratio is
Rtrap
Ralt
= 0.43 (12)
meaning that ≈ 70% of flow will go through the trap and
the rest will continue through the meander.
Once, we have a cell trapped in the trap, we would like
to see if the flow will then be diverted towards the next
available trap. To calculate, the new Rhyd, Rtrap,cell, in
this case (figure 4a), we consider the cell to be a cube of
height 10 µ m and in this case as shown in (figure 4b)
the height of the trap will reduce to 15 µ m, which will
increase the hydraulic resistance of the trap as Rhydα 1h4 .
Hence we get, Rtrap,cell = 1.12 · 1014 Pa s m−3.
Thus, Rtrap,cell > Ralt(2), and so most of the fluid
will choose to flow through the meander and ignore the
FIG. 4: (a) Cross section of a cell trap with a spherical cell(b)Cross
section of a cell trap with an assumed cubic cell trapped
trap.
Also the flow division factor can be calculated as,
Ralt(2)
Rtrap,cell
= 0.40
Hence, ≈ 70% of the flow will travel through me-
ander, while only ≈ 30%will choose to go through the
reduced trap channel.
For the next cell reaching the point B, the cell will
consider the system as a single trap system as discussed
before and the cells will try to flow through the trap and
once a cell is trapped the rest of the cells will exit through
the meander to the outlet channel.
3. Case: Three traps
In this case, we place three traps in series in a mi-
crofluidic chip as shown in fig. Continuing the argument
for a cell at junction A in fig.5a like before, the cell will
choose its path based on Ralt(3) and Rtrap.
Here, Ralt(3) = Ralt(1) + Rtrap // Ralt(2)
Ralt(3) = 4.61 · 1013 Pa s m−3
Thus, Ralt(3) >> Rtrap, hence the cells will tend
to flow towards the trap and later the rest of the
cells will continue to travel through the meanders as
Rtrap,cell >> Ralt(3)).
4. General
Finally, considering the above three cases, we can now
generalize this system and conclude the behavior for a
system with n cell traps in series (fig.6),
Ralt(n) = Ralt(1) +Rtrap//Ralt(n− 1) (13)
which implies that as we pass through such a system,
the hydraulic resistance of the alternate route will con-
tinue to decrease with respect to n.
The graph of Ralt(n) for n = 10, is represented in fig 7.
4FIG. 5: (a) Design of the system with three cell traps
(b)Equivalent electrical resistance circuit
This graph implies that for a system with n greater
than 4, the hydraulic resistance of the alternate route
will always be almost constant. Thus, the change in re-
sistance for the alternative route becomes almost zero for
n = [4,∞].
Hence, the system will be able to function for a series
of large number of arrays because at each trap the ratio
Rtrap
Ralt(n)
≈ 0.4 < 1, for n = [4,∞] (14)
Hence, the cells will be trapped at each trap along
the system. Also as the ratio
Rtrap,cell
Ralt(n)
≈ constant > 1, for n = [4,∞] (15)
Once a trap captures on cell, the remainder of cells will
move through the meander or alternate route until they
find the next cell trap.
IV. CONCLUSION
Our goal for this system was to facilitate the capture of
single cells using the hydrodynamic resistance of traps.
FIG. 6: (a) Design of the system with n cell traps (b)Equivalent
electrical resistance circuit
FIG. 7: Graph of Ralt(n) for n = 10
We here presented a theoretical study into the perfor-
mance of the system, which concludes that the system
should function the best for n number of traps where n
is greater than four. We foresee that this system could
be used for the release of chromosomes from single cells
5to develop single cell analysis systems.
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Advanced microtechnologies for detection of 
chromosome abnormalities 
Dorota Kwasny, Indumathi Vedarethinam, Pranjul Shah, Maria Dimaki, Asli Silahtaroglu, Zeynep Tumer, 
Winnie E. Svendsen
The overall goal of cytogenetic analysis is to detect chromosome abnormalities in patient samples. This analysis 
is a standard procedure for prenatal as well as postnatal diagnosis and cancer detection. Cytogenetic techniques 
such as karyotyping by banding have been for the last years complemented by molecular cytogenetic techniques 
such as fluorescent in situ hybridization (FISH). FISH is recently evolving towards on chip detection of 
chromosome abnormalities with the development of microsystems for FISH analysis. The challenges addressed 
by the developed microsystems are mainly the automation of the assay performance, reduction in probe volume, 
as well as reduction of assay time. The recent focus on the development of automated systems for performing 
FISH on chip is summarized in this review. 
Keywords: Fluorescent in situ hybridization, FISH on chip, microsystems, cytogenetic analysis 
Introduction
Conventional methods for disease diagnosis are based on analysis of cells, biochemical pathways, and infectious 
agents. Chromosome studies provide cytogenetists with valuable information as chromosome disorders are a 
major category of genetic disease [1]. The incidence of chromosome abnormalities in live births is around 
0.7 % [2]. Specific chromosome abnormalities are responsible for more than 100 identifiable syndromes, thus an 
understanding of cytogenetics and chromosome disorders is important [1]. The rapidly growing field of 
biomedicine focuses on detecting the genetic causes of diseases by means of molecular diagnostics. This involves 
studying of DNA and RNA as diagnostic targets. Cytogenetics is a study that concentrates on cell analysis with 
special focus on chromosomes. The conventional cytogenetic analysis known as chromosome analysis or 
karyotyping is based on the analysis of metaphase chromosomes through banding techniques and microscopy. 
The typical resolution is in the range of 5 – 10 megabases and depends on the compaction of the chromosome 
and number of bands. Karyotyping is still a gold standard for cytogenetics; however, new technologies have been 
developed to improve the resolution power of chromosome abnormalities detection. One of the mostly used 
techniques in molecular cytogenetics is fluorescence in situ hybridization, which has been a bridge between 
cytogenetics and molecular genetics. Even though preparation of FISH analysis is laborious it has grown in 
popularity in cytogenetic laboratories all over the world. However, to make the analysis a more standard 
procedure in genetic diagnostics some efforts need to be done to automate the protocol. Nowadays researchers 
focus on the development of integrated, miniaturized systems for more sensitive and rapid analysis of biological 
samples at low cost. Recently some efforts have been made towards fabrication of systems for analysis of 
chromosome abnormalities with the goal being a reduction of costs, sample volume, and hybridization time 
related to FISH analysis, and automation of assay. In this paper, we review the current state of the art of the 
microsystems developed for abnormalities detection. 
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Chromosome abnormalities 
Chromosomes are nuclear structures composed of DNA and proteins. Their structure and number are highly 
preserved in different organisms with a typical human cell containing 46 chromosomes. Conventional and 
molecular cytogenetic techniques are used to study the structure and number of chrom
chromosome abnormalities [3]. A chromosome
abnormalities such as Down syndrome (thr
monosomy) occur when an atypical chromosome number is present in the cell. Structural abnormalities can be 
balanced rearrangements, such as inversions or translocations; or unbalanced, such as dele
duplications. Depending on the nature and size of the chromosome abnormality, different cytogenetic and 
molecular cytogenetic techniques are employed. Chromosome
anomalies, dysmorphic features, growth retardation and learning disabilities [
Figure 1 An interphase nucleus (blue) (A) and metaphase spreads (B) with X centromeric FISH probes (green dots).
Furthermore, numerical chromosome abnormalities, deletions and translocations are also associated with 
cancer [5, 6]. Over the years cytogenetic analysis has become an integral part of genetic disorders and myeloid 
malignancies diagnosis. Genetic material is available in cell
phase. During interphase cells do not divide, the DNA in the form of chromatin is enclosed in a nuclear membrane 
with the chromosomes visible but not detectable as single entities (Fig.1A). The most c
 abnormality may be numerical or structural. Numerical 
ee copies of chromosome 21), Turner syndrome (X chromosome 
 abnormalities are often associated with congenital 
4].  
 
 nucleus in different forms depending on the cell cycle 
osomes and to detect 
tions and 
 
ondensed and highly 
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coiled form of DNA – metaphase chromosomes - is visible during a metaphase, with the chromosomes still 
enclosed in a nuclear membrane (Fig.1B).  
Classical and molecular cytogenetics 
Any cytogenetic analysis starts with obtaining the cells as a chromosome source. The most commonly used cells 
for cytogenetic analysis are peripheral T-lymphocytes, because they can be obtained from peripheric blood 
samples (Fig.2A, B). To perform analysis on metaphase chromosome the cell culture is required to increase the 
amount of cells in metaphase (Fig.2C), which is not necessary for interphase analysis. Phytohemaglutinin is a 
typically used chemical to stimulate cell division during a 72 hours T-lymphocytes culture. A minimum of 20 cells 
needs to be fully analyzed to obtain reliable results [7]. A mitogenic stimulation with colchicine is further 
performed to arrest the cells in metaphase and thus increase the number of metaphase spreads for the analysis. 
After treatment with hypotonic solution, the cells are splashed on the glass slide with ice-cold water (Fig.2D) to 
obtain the metaphase spreads (Fig.2E). The karyotyping by banding relies on staining such chromosomes fixed 
on a surface and then further analyzing these under a microscope, while FISH requires a use of fluorescently 
labeled probes (Fig.2F). FISH is based on the hybridization between two DNA sequences, a fluorescently labeled 
probe and its complementary sequence on a chromosome. The fluorescent microscopy visualization of a hybrid 
between a probe and genetic material reveals the presence, number and distinct location of targeted sequences 
[8, 9].  
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Figure 2 The cytogenetics analysis protocol. Blood sample is collected from the patient (A)
cultured in a medium for 3 days at 37 °C (C). Colchicine is added at the end of the culture period to arrest the cells in 
metaphase. Followed by hypotonic treatment, the cells are splashed on a glass slide (D) to obtain metaphase chromosome 
spreads (E). At this point the chromosome spreads can either be analyzed by banding or FISH. 
Over many years cytogenetic techniques have been evolving enabling more accurate and
chromosome abnormalities. Nevertheless, the conventional karyotyping by banding technique is still a standard 
procedure in cytogenetic laboratories over the world despite the need for trained technical staff
simple, but time-consuming analysis, allows for inexpensive diagnosis of numerical and structural chromosome 
aberrations at a limited resolution [13-15
genome screening technique, where the entire genome can be visualized at once
quality metaphase chromosome spreads for karyotyping is challenging as some cells, such as solid tumor cells, 
cannot produce good spreads [12]. To overcome issues with the limited resolution of karyotyping, the 
requirement for dividing cell population and goo
The conventional banding analysis can only be carried out on metaphase chromosomes, while FISH may be 
. The collected blood (B) is 
 
]. The main advantage of karyotyping by banding is that it is a whole 
 [3]. The requirement for high 
d quality metaphase spreads; a FISH technique is often used. 
 
 faster detection of 
 [10-12]. Such a 
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performed both on metaphase and interphase chromosomes. Introduced over 30 years ago, the FISH technique 
commenced a new era in the cytogenetic studies providing greater resolution than was possible with the 
karyotyping by banding technique [4, 10, 16, 17]. The typical resolution obtained with FISH is in the range of 10-
100 kilo bases sequences while karyotyping by banding has a resolution of 5-10 mega bases [10, 13, 17, 18]. FISH 
provides a simple, fast and reliable means to assess genetic instability in cancer [5, 6, 19, 20]. Despite many 
advantages of performing FISH, it is not an alternative to karyotyping but a complementary technique. 
FISH analysis 
For the cases involving chromosome abnormalities that need a higher resolution or analysis on non-dividing cells 
FISH is often applied. After fixing metaphase chromosomes or interphase nuclei to the glass slide FISH analysis 
starts. Firstly, chromosomes are washed, dehydrated through a series of alcohol washes and air-dried. A probe 
solution is then prepared by mixing it with a hybridization buffer containing formamide, salt and dextran sulfate 
[21]. After that both, the chromosomes on a glass slide and the probe solution are heat denatured. The probe in 
solution is placed immediately on ice and then applied directly to the slides. They are incubated overnight at 
37°C in a moist chamber. After several washing steps to remove the unbound or nonspecifically adsorbed probe 
the slides are incubated in a dye solution (e.g. DAPI) to label the chromosomes. Stained chromosomes are 
visualized under an epifluorescent microscope with an appropriate set of filters to observe the probe signal and 
the chromosomes [22]. 
FISH complements karyotyping by banding, thus is often prepared as a second step to enhance diagnostic 
efficiency [7, 9, 23, 24]. Moreover, FISH enables identification of numerous microdeletions and microduplications 
syndromes that are not generally detectable by classical cytogenetics. Thus, it is often applied for cases with a 
visibly affected phenotype and apparently normal karyotype to identify otherwise undetectable chromosome 
abnormalities. Although, one of major limitations of FISH is that it can only be used to detect known 
abnormalities. It depends on a probe targeting a specific DNA sequence, e.g., to detect known translocations, 
microdeletions or specific chromosomes and hence can only be used to address questions for which DNA probes 
are available. 
FISH techniques 
One of the attractive features of FISH is that it can be performed both on metaphase spreads but also on 
interphase nuclei fixed on a glass slide providing valuable information about chromosome abnormalities [13, 20]. 
Interphase FISH has a great potential for screening large number of cells, as well as for examining archival 
samples. Interphase FISH is applicable for testing solid tumors as it eliminates the need for dividing cell 
population. It can also be performed very rapidly within 24 hours, as no cell culturing is required. Tumor cells 
often show numerical or structural changes in chromosomes that may provide information about the changes 
that initiated tumor formation. The analysis of metaphase chromosomes in solid tumors is hampered, as 
extensive culturing is necessary to obtain sufficient number of mitotic cells, which in few cases may induce 
additional chromosomal changes. Furthermore, the metaphase spreads obtained from solid tumors have poor 
quality that makes their proper analysis troublesome [17, 25, 26]. Interphase FISH is used to identify numerical 
abnormalities as well as specific structural abnormalities, by targeting them with a specific DNA probe.  
On the other hand, metaphase chromosomes are widely used in cytogenetic analysis for standard karyotyping 
and FISH analysis. FISH can be used in metaphase cells to detect specific microdeletions at high resolution. It is 
also applicable in cases where it is troublesome to determine whether a chromosome has a simple deletion or is 
involved in some more complex rearrangement. Using metaphase spreads for analysis is beneficial as one can 
visualize the entire genome at once. Applying whole chromosome FISH probes, a complex mixture of sequences 
from the entire length of specific chromosomes available for all human chromosomes, enables detecting 
abnormalities at the genome level [27]. Simultaneous visualization of spectrally distinct fluorophores enabled the 
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representation of different chromosomes with a unique fluorescent signature with a potential application to 
reveal complex structural abnormalities [3, 11, 13, 15, 20, 28, 29]. By performing such analysis we can obtain 
information about the unknown translocations between chromosomes at higher resolution than achievable by 
karyotyping by banding [20, 30-32]. However, such method requires specialized computer software, expensive 
equipment, and complex analysis by skilled technicians that can interpret the obtained data [3]. Moreover, 
limited use of FISH is also attributed to the high cost of FISH probes necessary to detect the chromosome 
abnormalities. 
Generally speaking, FISH techniques are utterly useful for the confirmation of chromosome abnormalities 
suspected based on previous findings, with the use of specific DNA probes. Its main advantage lies in the analysis 
that can be performed on both interphase and metaphase chromosomes depending on the specific disorder to be 
detected. Interphase FISH can be performed very fast, but metaphase FISH offers observation of the entire 
genome that may enable identification of complex rearrangements at a genome level. These techniques present 
many opportunities; however, their major disadvantage is the cost of reagents (mainly probes) and the 
requirement for an expensive high-resolution microscope. Development of novel micro assays could significantly 
increase the usage of these assays broadening our knowledge on chromosome abnormalities. 
FISH techniques worldwide application 
For the FISH techniques to be used routinely in the laboratories all over the world certain challenges need to be 
addressed. As stated above the FISH techniques are continuously evolving, however their use is still limited due 
to high cost and long experimental time. Their use is sometimes advantageous as they are capable of detecting 
chromosome abnormalities at a higher resolution than karyotyping by banding. 
The major drawback of FISH analysis is the cost of the reagents used for the assays, mainly the fluorescent 
probes. In standard lab protocols 10-15 µl of probe are used per slide containing metaphase spreads or 
interphase nuclei [19]. Such analysis is normally performed on a single patient’s sample, thus the cost of a single 
analysis is extremely high. The development of a high throughput device for metaphase or interphase FISH 
analysis would reduce the volume of the probe used per single sample, at the same time reducing the cost of an 
experiment. Also, addressing the need for reduction in probe volume for single analysis would greatly increase 
the application of FISH in routine analysis.  
Another bottleneck of the analysis is the long experiment time. To perform a complete FISH analysis, even well 
trained technicians spend several hours in sample preparation as well as the waiting time in between each pre- 
and post- hybridization washes. There are at least 12-15 different washes in a standard routine test that in total 
takes about 45 minutes. Apart from the cell culture work, the hybridization time is a very long process. At 
minimum, performing a FISH analysis with centromeric probes (repetitive sequences), will take 2 to 4 hours. 
Furthermore, in some FISH experiments the hybridization of a probe requires overnight incubation. The 
automation of sample preparation, probe delivery, imaging and analysis would result in molecular cytogenetic 
analysis to be performed routinely at the doctor’s office as a point-of-care diagnosis. 
For metaphase FISH analysis it is necessary to culture cells for three days. The disadvantage of such a culture 
method is the large volume of medium used and the fact that handling of suspension cells is tedious. This issue 
was currently addressed by developing a membrane based microfluidic bioreactor for suspension cell cultures, 
which makes preparation of chromosome spreads much easier [33, 34]. The proposed diffusion based 
microreactor facilitates culturing of lymphocytes but also expansion, hypotonic treatment, and fixation of cells 
with the possibility to avoid several tedious centrifugation steps [33]. Svendsen et al. developed a bioreactor for a 
suspension cells culture on the membrane with a microfluidic channel for media perfusion. The continuous flow 
ensures all the necessary nutrients to be delivered from the medium to the cells by diffusion. It enables fast 
solution changes for expansion and cell fixation to obtain high quality metaphase spreads. Separation of culture 
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chamber by a membrane from the channel is beneficial as it protects the cells from air bubbles formed in the 
flowing medium and allows the perfusion to be started even before the cells settle on the membrane. Shah et al. 
modified the media perfusion channel to ensure more thorough transport of nutrients across the membrane to 
the resting cells [33]. Moreover, by performing CellTraceTM CFSE cell staining protocol it was demonstrated that 
cell proliferation on chip is better than in control experiment in a well plate culture. 
One of the many advantages of microdevices for complete chromosome analysis is the possibility to perform high 
throughput analysis. In cytogenetic laboratories chromosome analysis is performed several times a day on 
different patient samples. High throughput automatic devices for cell culturing, preparation of chromosome 
spreads or interphase nuclei, followed by detail FISH analysis would drastically speed up the process and provide 
fast results. 
Microsystems developed for FISH analysis 
In recent years the integration and automation of cytogenetic techniques has gained more attention. Most 
reports in this field focus on the development of an integrated microfluidic chip for interphase FISH analysis. To 
our knowledge there has been only one report on a microfluidic platform for metaphase FISH on chip. This article 
reviews the recent developments in the field of microcytogenetics that address the need for automation, time and 
cost reduction in chromosome analysis. 
In 2007, Lee et al., presented one of the first examples of miniaturized devices for performing FISH analysis [35]. 
The presented work allows for high throughput FISH analysis on a cell array. The typically performed analysis 
lacks the possibility of conducting high throughput analysis as there is limited amount of samples available. To 
address this problem, the authors showed the possibility to array cells by spotting the small amounts of cell 
specimens onto a supporting matrix, which enables high throughput analysis. For the preparation of the chip, a 
glass slide was used as a supporting matrix.  1 mm thick perforated PDMS was bonded to a glass slide to form 96 
cavities of 1.5 mm in diameter for spotting cells (Fig.3). To enable microscopic cell identification a matrix 
corresponding to the 96 PDMS wells was microfabricated by photolithograpy on a glass slide. They have showed 
that 1 µl samples were spotted onto each PDMS well followed by air drying, removal of PDMS cover and 
performing conventional FISH protocol.  In this way, only 10 µl of probe were used to analyse 96 specimens. The 
device is very useful in mass sample analysis for the same kind of samples, in which the probe reduction is 
relevant. The authors have mentioned the probe volume reduction, but other major issues such as manual 
intervention and time consumption were not stated. 
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Figure 3 Fabricated bio-cell chip slide. (A) A PDMS layer with 96 wells for multiple cell analysis. (B) A glass slide with a gold 
pattern for sample numbering (used with permission 
The first implementation of FISH on chip was showed
conventional FISH except the cell immobilization step, where cell immobilization was achieved using 
temperature. They also investigated a method to reduce hybridization time by probe rec
peristaltic pumps, and electro-kinetic transport of probes by in
these two methods, they found out that electro
recirculation method. In addition, the electro
which involves valves and complex micro fabrication. Nevertheless, by performing the analysis at microfluidic 
volumes, they were able to achieve a tenfold reduc
reduction from $90 for 10 μL of probe, to $9 for 1 μL
 
from Lee et al, 2007) 
 in 2007 by Sieben, et al. [26]. They have adapted the 
irculation with on
troducing the electrodes into the end
-kinetic transport of the probes was slightly better than 
-kinetic chip design is simpler than the recirculating micropump, 
tion in DNA probe reduction per test, with equivalent the cost 
. 
 
-chip 
-wells. By 
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Figure 4 (A) The mask layouts and dimensions of an integrated FISH microchip. The microchip includes a reagent 
multiplexer, a cell chamber with an integrated thin
FISH chip (used with permission from Sieben et al
In 2008, Sieben, et al., published another paper 
were integrated onto one chip and automated
a PDMS layer sandwiched between two glass layers, one of which carried fluids, while the other transmitted air 
pressure for valve control, e.g. for peristaltic pumping
valves operated by computer, preloaded reagents could be multiplexed t
appropriate intervals for each step of FISH.  A copper thin
cell-immobilization and denaturation steps
the reduction in hybridization time, but instead focused mainly on minimizing the labor time and automation of 
the microfluidics FISH chip. One of the issue with the conventional FISH, which takes more than an hour of on
and-off attention of a skilled technician, using their time inefficiently, whereas the automated microfluidic FISH 
device would reduce human intervention and only involve the technicians work during reagent preparation, and 
image analysis . 
Figure 5 Microfluidic device for miniaturized FISH. (A) Diagram of the microfluidic PDMS pad with inlet and outlet 
connected by a straight channel. (B) Complete structure of the FISH device with the PDMS pad assembled with a TiO
functionalized glass slide (used with permission 
The most recent advances in integrated interphase 
They focused on the development of an analytical tool for performing interphase FISH on both living and fixed 
cells. The application of microfluidic technologies might reduce costs and improve assay performance by 
development of microchannels for easy reagent loading and cell immobilization. However, the fluid flowing in 
the microchannels causes intense shear stress on 
the surface. In this paper the authors’ addresse
FISH. By changing the surface chemistry they enhanced the cell immobilization on the surface that significantly 
reduced the cells detachment due to shear stress. In this article, the entire 
structured TiO2 using cluster beam technology which adds significant costs to the device owing to the need for 
access to cleanroom and costs of additional metal deposited. Moreover, routine genetic labs do not necessarily 
have access to cleanroom facilities, which
top cover bonded to the modified glass slide contains a microfluidic channel that is used for loading cells and 
other reagents in FISH protocol (Fig.5). Such a simple design facilitates handling of the fluids without generating 
bubbles that could affect assay performance.
-film heater, and a peristaltic pump. (B) Image of a complete integrated 
, 2008) 
in which all previously performed steps with microfluidic FISH 
 [36].  Similar to the recirculating design, the new chip consisted of 
, which is a very complex fabricated system. 
hrough the hybridization chamber at 
-film heater was built into the design as well, for the 
 (Fig.4). Unlike the previous designs, this new device did not 
 
from Zanardi et al, 2010) 
FISH analysis were presented in 2010 by Zanardi,
cells; this may result in their disruption or detachment from 
d this particular problem in the application of microfluidics for 
glass slide is coated with nano 
 makes the method very difficult to implement on
 
With the 
focus on 
-
2 
 et al [24]. 
 a larger scale. The 
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Figure 6 (A) The PMMA splashing device with two inlets for glacial water and cell suspension. (B) Ful
device with a PDMS chamber on a glass slide with chromosome spreads (from Vedarethinam 
In 2010, Vedarethinam et al. developed 
microdeletion or specific translocation of unknown origin with 
metaphase FISH is difficult to adapt to a closed microfluidic system. The chromosome immobilization n
preparation of chromosome spreads, which rely on certain factors, such as controlled angle
temperature gradient and humidity [38
demonstrates that the dropping angle and height are the important factors getting good metaphase spreads on 
glass slides [37, 39].  
Based on all these factors Vedarethinam 
for easy evaporation of the fixative (Fig.6
for cold water and one for the fixed mitotic cells suspension. The rapid and easy assembl
microFISH device allows for quick transformation of a simple glass slide into a microFISH device, which makes it 
a solution for integration into existing work routines at cytogenetic labs
focused on adapting the conventional metaphase FISH to lab
obtained using the splashing device are comparatively lower and the splashing chip device does not improve the 
chromosome spreading. However, the micro
slide, which is sufficient for conducting routine FISH analysis
optimized metaphase FISH protocol on a chip with over a 20
of probe volume, which is the most expensive part of the process, is not very large
automation of the microFISH device, reduction in probe volume and hybridi
metaphase FISH as widespread genetic testing of unknown translocation
setting [40]. 
For the complete FISH on chip a membrane based cell culture chamber was combined with a s
described above [41]. Shah et al. describes the FISHprep device for metaphase FISH slides preparation, which 
was validated by performing standard FISH protocol. The fabricated device consists of a diffusion based cell 
culture reactor [33] separated from the splashing device by a clip valve
performed for 72 hours with a CFSE staining to dete
 
et al, 2010).
the first metaphase FISH device, which can be use
high resolution [30]. Unlike interphase FISH, 
]. Recently, Qu et al. devised a chromosome dropper tool, which 
et al. made a novel splashing device with open chamber, which allows 
A). The device provides 11 mm dropping height with two inlets
 (Fig.6B). Nevertheless, they have mainly 
-on-a-chip method. The averag
-splashing device produces reliable metaphase spreads on a glass 
. Even though the microFISH device allows for an 
-fold reduction in the reagent volume,
. Considering the complete 
zation time, could improve the 
s more accessible in a clinical 
 [30]. The culture of T
rmine the proliferation rate. Further, by opening the clip 
ly assembled microFISH 
 
d to detect the 
eeds 
 of spotting [37], 
—one 
y protocol for the 
e numbers of spreads 
 the reduction 
preading device 
-lymphocytes was 
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valve the cultured and fixed lymphocytes were splashed on the glass slide. The quality of spreads obtained from 
the FISHprep was comparable to traditionally obtained spreads. The integration of all the steps required for 
successful metaphase FISH slide preparation in one FISHprep offers a possibility for an automation of the 
molecular cytogenetics in future by combining it with the described earlier metaphase FISH on chip 
protocol [41]. 
Future prospects 
The miniaturization of the integrated platforms for molecular cytogenetics will progress in the nearest future. 
Most of the work done in the field has addressed the probe volume used and further development will be 
directed towards automation of systems. The interphase FISH has been almost completely automated by means 
of microsystems, but some work still needs to be done in order to reduce the assay time. Moreover, the work on 
preparation of metaphase spreads in microdevices should be thoroughly studied. The advantages of making 
analysis on metaphase chromosomes are enormous and the development of such a system is of utmost 
importance. Further chemical modifications of the substrate surface could lead to obtaining high quality 
metaphase spreads even in the confined channels. Furthermore, some work needs to be done to develop 
systems amenable for simple and reliable detection of unknown translocations. 
Conclusion 
Cytogenetic analysis is an important tool commonly used in clinical diagnosis and treatment monitoring. FISH 
has a numerous applications in molecular biology, including gene mapping, diagnosis of chromosome 
abnormalities, and cancer detection.  In clinical research, FISH can be used for prenatal diagnosis of inherited 
chromosomal aberrations, postnatal diagnosis of carriers of genetic disease, diagnosis of infectious disease, viral 
and bacterial disease, tumor cytogenetic diagnosis, and detection of aberrant gene expression. Technical 
complexity of conventional FISH protocol has slowed down the usage of the technique in clinical settings. 
Significant effort has been put into enabling fast, reliable and high throughput analysis of samples. The assays 
and devices presented in this review can be easily incorporated in cytogenetic laboratories to improve the 
quality of analysis and reduce the time necessary to obtain significant results. The presented membrane based 
bioreactors for cell cultures offer the automation of the preparation of metaphase spreads on glass slides without 
the need for centrifugation steps. Most of the mentioned work was done to improve the interphase FISH analysis 
with just one work presenting metaphase FISH analysis. These platforms offer great advantages over 
conventional methods in regards to reduction of probe volume per analysis used as well as the possibility to 
automate the protocol. Nevertheless, there is still a gap between developing the technology and usage of these 
systems as a routine diagnostic tool in cytogenetic laboratories. And also, there is a great need for rapid and 
inexpensive detection of unknown translocations.  
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a b s t r a c t
In this paper some technological platforms developed for biological cell analysis will be presented and
compared to existing systems. In brief, we present a novel micro cell culture chamber based on diffusion
feeding of cells, into which cells can be introduced and extracted after culturing using normal pipettes,
thus making it readily usable for clinical laboratories. To enhance the functionality of such a chamber
we have been investigating the use of active or passive 3D surface modiﬁcations. Active modiﬁcations
involve miniature electrodes able to record electrical or electrochemical signals from the cells, while
passive modiﬁcations involve the presence of a peptide nanotube based scaffold for the cell culturing
that mimics the in vivo environment. Two applications involving ﬂuorescent in situ hybridization (FISH)
analysis and cancer cell sorting are presented, as examples of further analysis that can be done after cell
culturing. A platform able to automate the entire process from cell culturing to cell analysis by means of
simple plug and play of various self-contained, individually fabricated modules is ﬁnally described.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
In vitro cellular analysis has paved the way to major break-
throughs in the history of biology and drug discovery. However,
no matter how good in vitro experiments are, they will never be
able to represent the in vivo situation fully. But since in vivo exper-
iments are expensive and sometimes unethical, researchers strive
towards developing modiﬁcations of lab-on-a-chip systems so that
they better mimic the environment experienced by cells inside the
body.Micro- andnanotechnologyare twoverypromising technolo-
gies for achieving in vivo like conditions. A recent example is the
mimicking of the human kidney usingmicroﬂuidic chambers [1]. In
this paper we will illustrate the advantage of microﬂuidic handling
of cells in combination with nano- and microsensing platforms.
For cellular analysis it is often necessary to culture the cells.
The standard methods used for this, e.g. culture ﬂasks, do not in
any way represent the in vivo situation. Here we will demonstrate
a microﬂuidic culturing system for adherent and non adherent
cells, with controlled environment and diffusion based feeding, but
without ﬂushing away important signalling chemicals. Then a dis-
cussionof the surfaceof the culturing system isgiven,whereanovel
3D nanopattern method is investigated to mimic in vivo conditions,
where no smooth glass or plastic surfaces exist.
Probing intercellular dynamics and intercellular signalling is at
the research frontiers for understanding cellular function. There-
∗ Corresponding author.
E-mail address: winnie.svendsen@nanotech.dtu.dk (W.E. Svendsen).
fore, new technologies to address these issues are developing fast.
It has been demonstrated that cells can survive penetration by
nanoscale structures [2]. The obvious next step is to utilize this fact
for probing the dynamics of the interior of living cells. Novel meth-
ods for fabricating 3D micro- and nanoelectrodes for this purpose
will be presented.
Sorting of different types of cells is also an interesting research
area and one that has received a fair amount of attention. Several
methods have been used, both physical, based on cell dimensions
alone, e.g. bumper arrays [3], biological, based on functionaliz-
ing substrates with proper markers binding on speciﬁc cell types
[4], and electrical, based on differences in the dielectric properties
of cells, e.g. dielectrophoresis [5] or electrorotation [6]. We here
present the use of dielectrophoresis in order to sort cells expressing
stress markers on their surfaces from cells without stress markers.
As a ﬁnal point, the concept of a microﬂuidic motherboard,
equipped with valves, simple microﬂuidic devices, e.g. mixers, and
sockets for accepting microﬂuidic chips for speciﬁc applications
will be presented. This motherboard can by plug-and-play inte-
grate any chip that ﬁts a standard general speciﬁcation, irrespective
of material and fabrication process.
2. Cell culture microﬂuidic bioreactor for adherent and
non-adherent cells
Microﬂuidics enables cell culturingmimicking in vivo conditions
[7,8], i.e. physical, biochemical and physicochemical properties
such as pH, gas concentration and temperature, unlike the con-
ventional culturing methods. Chemical gradients represent a very
0924-4247/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
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Fig. 1. (A) A schematic of the membrane reactor with pipetting access holes. (B) The membrane reactor with three chambers and microﬂuidic inlets and outlets. (C) The
lymphocytes resting on the membrane at start, i.e. 0 h (left) and after 68h of post activation with phytohemagglutinin (right). Just after loading into the chamber, the
lymphocytes indicated by arrow A are small with minimum cytoplasm, only slightly larger than the pores shown at arrow B. A number of platelets can also be observed at
arrow C. After 68h the platelets have disappeared and the lymphocytes have expanded their cytoplasm and are now growing into aggregates.
important factor that regulates the cell’s function [9]. These gradi-
ents are obtained in the cell microenvironment by diffusion. This
can easily be adapted in a microﬂuidic setup by adjusting the geo-
metrical conditionsof the chamber,whichalsohelps to stabilize the
gradients in the microenvironment [10,11]. A microﬂuidic system
featuring continuousperfusionhelpsprovide freshmedia as cultur-
ingprogresses and the components aremetabolized. Byperforming
cell culture in the laminar ﬂow regime offered in microﬂuidic sys-
tems, precise control of pH, oxygen, nutrition and temperature can
be obtained [12].
The majority of micro cell culture reactors are designed for
adherent cells [13–17], as these are the dominant cell types used
in biological studies. The handling and perfusion of fresh media
for culturing of such cell types is much easier. Here a cell cultur-
ing microﬂuidic reactor is presented, where both adherent and non
adherent cells can be cultured, maintaining precise control of pH,
oxygen, nutrition and temperature, and sustaining the biochemi-
cal microenvironment of the cells, while supplying nutrients to the
cells by diffusion controlled processes.
The membrane cell culturing bioreactor is illustrated in Fig. 1A
and B. It is composed of two chambers: an upper cell culturing
chamber and a lower perfusion chamber. Both are fabricated using
micromilling and are bonded together, with a 7m thick polycar-
bonate membrane with a porosity of 0.14 and pore size of 5m
sandwiched between them. The cells are loaded and kept in the
upper chamber by pipetting or microﬂuidic inlet. The medium is
perfused in the bottom chamber and the cells are fed by diffusion
through a micromembrane. In Fig. 1C the culturing of lymphocytes
is illustrated. In this fashion it is possible to monitor the effects of
drugs on cells continuously.
There are several advantages of the membrane based cell cul-
ture chamber. Firstly, perfusioncan immediatelybe startedwithout
waiting for the loaded cells to settle. Secondly, the cells can be
protected fromair bubbles thatwill inevitably arise in themicroﬂu-
idic channels, as the ﬂow is not directly in contact with the cells.
Thirdly, the cells can be protected from any kind of agitation, as the
perfusion chamber and culture chamber are separately controlled.
To illustrate the usefulness of the chamber, a full protocol
for ﬂuorescent in situ hybridization (FISH) was carried out, map-
ping chromosomes translocations. The resultswere comparedwith
those achieved by applying the standard protocol on microscope
slides, as is the case for a routine FISH analysis, as shown in Fig. 2.
No striking differences between the ﬂuorescent images in the two
cases were observed.
3. Self-assembled 3D nanowire structure pattern for
cellular growth and sensing applications
Cell and tissue cultures have traditionally been done in 2D
ﬂat plastic or glass surfaces which are far from the topological
representations of the more complex 3D environment found in
the extracellular matrix. The suggestion that 3D porous nanoto-
pographies that mimic physiological conditions represent a more
accurate approximation for the growth of cells and tissue used in a
long list of studies (e.g. cell migration and adherence, signal trans-
duction) andbiomedical applications (e.g. drugassays, regenerative
medicine) has been supported by recent studies [18,19].
Epitaxial gallium phosphide nanowire arrays were used in
cellular force and cell survival investigations [2,20–23]. These stud-
ies demonstrated that cell adhesion and survival was better on
nanowire arrays than on planar substrates. However, the toxic
nature of the substrate material used for the fabrication of the
nanowires is a big limitation for the use of these nanostructures
in biomedical applications or in in vivo studies [24,25].
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Fig. 2. Comparison of the FISH results based on the spreads prepared (A) by conventional methods and (B) by the ﬁxed cells from the reactor. X-chromosome centromere
speciﬁc probes labelled with FITC are hybridized to chromosomes stained with DAPI.
Cell attachment on silicon pillars was previously studied
showing the advantages of using these structures to direct the
attachment, growth and morphology of cells [26,27]. Recently, Qi
et al. studied cell adhesion and spreading behaviour on vertically
aligned silicon nanowire (SiNW) arrays [28]. Their study showed
that the SiNW arrays exhibited good biocompatibility with HepG2
and LX-2 cells and could support and favour cell adhesion. Addi-
tionally their study demonstrated that SiNW arrays enhanced the
cell-substrate focal adhesion force and restricted cell spreading.
In another study using SiNW arrays, Jiang et al. investigated the
useof thesenanostructures as candidates for orthopaedicprocesses
to promote bone regeneration within the body [29]. In their study
theymodiﬁed the SiNWsurface andperformedproliferation assays
of mouse stromal cells in order to evaluate the biocompatibility of
the modiﬁed NWs. In 2006, Patolsky et al. integrated SiNW arrays
with the individual axons and dendrites of live mammalian neu-
rons enabling simultaneous measurement of signals propagating
along individual axons and dendrites [30]. However the fabrication
of these arrays requires several steps and cleanroom conditions
making the fabrication process tedious and expensive.
In a different work, platinum nanopillar arrays were used to
study cell migration in a cultured neuronal network [31]. Using the
nanopillar arrays it was possible to pin the position of neurons in a
non-invasive manner.
Cohen-Karni et al. explored the combination of graphene with
SiNW-FETs interfaced to electrogenic cells to record extracellu-
lar signals [32]. This combination demonstrated better results on
simultaneous recordings of beating cellular signals compared to
planar recording devices. However, this study did not explore the
use of the combined design as cell culture platform and graphene
biocompatibility studies were not performed.
In our work a 3D nanostructure surface formed by vertically
self-assembled diphenylalanine peptide nanowires was fabricated
on top of a gold electrode as described in [33].
First the 3D nanopattern was functionalized with a conductive
polymer, illustrated in Fig. 3B, and its ability to electrochemically
detect dopamine was evaluated. The electrochemical behaviour of
a gold electrode modiﬁed with peptide/polypyrrole nanowires is
shown in Fig. 3A. The voltammograms exhibit peak behaviour typ-
ical to polypyrrole on gold. The anodic and cathodic peaks reﬂect
the redox behaviour of the polypyrrole, and the increase in cur-
rent peak response with increasing potential sweep rate suggests
pseudo-reversibility.
This peptide nanowires/polypyrrole modiﬁcation of Au elec-
trodes was utilized for electrochemical dopamine sensing.
Chronoamperometric experiments were carried out, where the
modiﬁed electrodes were exposed to small injections of 10L
aliquots of dopamine. This system exhibited a minimum detection
value of 3.1M, a value in the range of the physiological dopamine
concentration.
Secondly the 3D structures were examined with respect to cul-
turing adherent cells; here HeLa cells were used. HeLa cells were
Fig. 3. (A) Cyclic voltammograms of peptide/polypyrrole nanowires modiﬁed gold disk electrodes in 0.1M KCl vs. a Ag/AgCl (3M KCl) reference electrode at potential scan
rates of 50, 100, 150, 200, 250 and 300mV/s; (B) SEM image of a peptide nanowire coated with a polypyrrole ﬁlm, scale bar correspond to 1m.
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Fig. 4. SEM image of HeLa cells grown on top of the 3D self-assembled nanowire
structure after 36h of culturing.
able to grow on top of the peptide nanowires for several days, as
observed in Fig. 4. The obtained results indicated that the synthe-
sized 3D nanostructure is a good platform for the growth of cells
and the detection of compounds of biomedical relevance released
from them. The chronoamperometric measurements performed
with the functionalizedpeptidenanowires showed theabilityof the
3D nanostructure to detect dopamine at concentrations present in
in vivo systems. This nanoplatform offers the advantage of having a
favourable environment for thegrowthof cells andanelectrochem-
ical sensor for the detection of compounds released from cells in
the same system.
4. 3D electrodes for single cell intracellular measurements
Electrical signals originating from cells are very small and
therefore very prone to noise. Therefore, electrodes developed to
investigate cellular dynamics need special consideration. Increas-
ing the surface area of such electrodes reduces their impedance
and thus increases the signal-to-noise ratio [34]. This can be done
by increasing the planar dimensions of the recording sites; how-
ever, this would reduce the spatial resolution of the arrays. The
solution is the fabrication of 3D electrodes. Many examples of such
structures can be found in the literature [35,36]. However, (1) their
dimensions are very large and thus unsuitable for single cell mea-
surements and (2) the fabrication process for the small electrodes
is complicated, serial in nature and involves the use of expensive
equipment.
Wehave developed a fabrication process based entirely on stan-
dard microfabrication techniques, which allows us to create up to
10m tall silicon pillars with sub 200nm tip diameter. These are
then electrically isolated from each other, metalised with a stan-
dard lift-off process and passivated leaving only the tip electrically
active for cell measurements. The pillars are made with a combina-
tion ofwet etch in aKOHsolution and a shortmaskless dry isotropic
etch in an Advanced Silicon Etcher. Fig. 5A shows an example of a
pillar fabricated in this way, but before the isolation, metallization
and passivation steps. A ﬁnished pillar is shown in Fig. 5B.
The electrodes have been tested both in terms of impedance and
in terms of electrochemical performance. Though their impedance
is high, electrical measurements done in DI water and varying
concentrations of NaCl show the expected differences [37]. More-
over, we have electrodeposited polyaniline on these electrodes
and recorded the related redox reaction. The result shows that the
electrodes are electrochemically active, though exhibiting an irre-
versible behaviour [37]. Moreover, larger electrodes covered with
polymerson topof themetal layers showincreasedelectrochemical
Fig. 5. (A) A sharp silicon pillar after etching. The pillar height is around 3m while
the tip diameter is under 200nm. (B) A ﬁnished pillar with 500nm PECVD oxide for
isolation, 100nm Pt layer for metallization and 200nm nitride layer for passivation.
The nitride layer has been opened at the top of the pillar for establishing electrical
contact with the cells.
activity than electrodes only coveredwithmetal [38]. This opensup
the possibility to create sensitive and selective metabolic sensors
by trapping enzymes inside the electrodeposited polymer. Future
work is concentrating on the fabrication and testing of these sen-
sors as well as on the modiﬁcation of the surfaces to enhance the
surface area andbetter isolationof the arrays to reduce theparasitic
capacitances.
Another approach to produce 3D electrodes is by applying
two-photon lithography. This method takes advantage of the
two-photon absorption process initiated when exposing a pho-
topolymer to femto-second laser with certain power. Chemical and
physical changes within a small size of the photopolymer occur to
form 3D polymerized structures [39]. 3D electrodes of photopoly-
mer (IP L [40])with different dimensions from3 to 10m in height
with sub 500nm tip diameter have been fabricated, as presented
in Fig. 6.
The fabricated structures are not easily susceptible to mechani-
cal strain and they have good rigidity, due to an increased number
of exposed points in the contour of the structures. The fabricated
electrode structures are not showing any deformation or collapse
Please cite this article in press as: W.E. Svendsen, et al., Micro and nano-platforms for biological cell analysis, Sens. Actuators A: Phys. (2011),
doi:10.1016/j.sna.2011.02.027
ARTICLE IN PRESSGModelSNA-7238; No.of Pages7
W.E. Svendsen et al. / Sensors and Actuators A xxx (2011) xxx–xxx 5
Fig. 6. (A) SEM image of single 3D electrode of polymerized IP-L with dimensions of 5m height and sub-micron tip diameter fabricated by two photon polymerization. (B)
SEM image of a 3D electrode 10m in height with sub-micron tip diameter, coated with a 50nm thick layer of silver.
as demonstrated in Fig. 6A. The ﬁnished structures can be covered
with a thin metal layer by e-beam evaporation to ensure conduc-
tivity, as seen in Fig. 6B.
5. Cell sorting using dielectrophoresis
Early detection of cancer in patients is a ﬁeld of research attract-
ing a lot of attention, as cancer is becoming more common in the
aging population. During transformation from a normal cell to a
cancerous cell, proteins known as stress markers will be expressed
on the cell surface. Their function is to activate the immune system
tokill the cells that are expressing them.Occasionally the cancerous
cell ﬁnd a way to terminate the expression of stress markers and
the cell can develop into a mature cancer cell without being rec-
ognized by the immune system [41]. Detection of cells expressing
stress markers in the blood would therefore indicate that a cancer
is under development and treatment can be initiated at this very
early stage.
Dielectrophoresiswas chosen as the sortingmethod and sorting
between normal Jurkat cells (referred to as cancer(−) cells) and
Jurkat cells transfected to express a stress marker known as MICA
on their membrane [42] (referred to as cancer(+) cells) was carried
out. The objective was to see if the expression of the MICA protein
would also change the dielectric properties of the Jurkat cells in a
way that sorting would be possible.
The chip design used for the purpose was adapted from
Demierre et al. [43] and is shown in Fig. 7A. Upon application of
an alternating potential on the electrodes cells would either move
towards the electrodes or away from them, depending on their
dielectric properties and the applied frequency. The objective was
to ﬁnd a frequency region, where cancer(−) cells would move one
way and cancer(+) cells the other way. This is shown in Fig. 7B,
where the cancer(−) cells experiencepositiveDEPandare attracted
towards the electrodes, while the cancer(+) cells experience neg-
ative DEP and are repelled from the electrodes at a frequency of
700kHz.
Simulating particle trajectories and ﬁtting them to the experi-
mental results can give more information on the dielectrophoretic
properties of the cells. The Comsol Multiphysics Finite Element
Analysis Software is used in order to simulate the ﬂow proﬁle and
the electric ﬁeld in the channel. The results are exported into Mat-
lab, where the trajectory simulation is done by applying Newton’s
2nd law.Weassume that the cell is a sphere and simulate themove-
mentof its centreofmass.Anexampleofone simulationcanbe seen
in Fig. 8. By ﬁtting the simulated trajectory to the cells ﬂow path
Fig. 7. (A) A schematic of the setup used for the dielectrophoretic manipulation of
cells. The cells ﬂow in the main channel and the ﬁeld is applied by the electrodes
in the side channels. (B) Fluorescence images of cancer(−) and cancer(+) cells in
the channel. At 700kHz the cancer(−) cells move towards the electrodes, while the
cancer(+) cells move away from them. The image is created by stacking all the video
frames.
Fig. 8. Simulation of trajectory for a cancer + cell in a PBS 1:50 solution. The CM
factor was adjusted to 0.07 in order for the simulation to follow the cells ﬂow path.
20V was applied across the electrodes the ﬂow rate was 0.01L/min.
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Fig. 9. (A) Sideview of the assembled modules with extended elastomeric tubules. (B) Attachment of the modules with the lab board. (C) Flow through the module (channel
width: 100m, module dimension 20×20mm).
it was possible to estimate the real part of the Clausius-Mossotti
(CM) factor which is a key parameter for the DEP force.
6. Integrating of the bioanalytical devices into total
analysis platforms
Integration of microﬂuidic and sensors systems into total analy-
sis systems is of great interest to handle the ﬂuidics and electronics
more efﬁciently [44]. This can be done in two principle ways, inte-
gration or modularization. We have moved towards the latter.
While integration provides the advantages of having smaller foot-
print devices, modularity provides easy and rapid adaptation of
current manual biological protocols into various individual mod-
ules for miniaturizing these lengthy sequential protocols [45].
We have developed a novel lab-board which allows the rapid
handling of different biological and analytical devices like cell cul-
ture, DEP, concentrators. The devices are assembled into modules
with extended hollow elastomeric tubules providing connections
with the board (Fig. 9A). The assemblies form tight seals with the
board by expansion of the elastomeric tubules by the connectors
on the board (Fig. 9B). This board provides an easy way of form-
ing ﬂuidic and electrical interconnections by means of integrated
ﬂuidic networks (Fig. 9C) and electrical spring pins. It is fabri-
cated using micromilling on a polymethyl-methacrylate (PMMA)
substrate, chosen for its high optical transparency. The board con-
stitutes anexcellent solution formicroﬂuidic applications requiring
optical analysis. The modular device, shown in Fig. 9C, can be fab-
ricated in any material, and plugged into the major lab board with
ﬂuidic and electronic connections, thereby enabling chips fabri-
cated in different materials to be tested sequentially.
All the devices presented earlier in this article are currently
being redesigned towards a more standard format to ﬁt with this
board. Moreover, this board highlights our efforts towards stan-
dardization of our future device development efforts.
7. Conclusion
We have presented a selection of micro- and nanoplatforms for
biological cell analysis. The presented systems cover a variety of
processes. We have demonstrated a simple in vivo like microﬂuidic
system for culturing adherent and most importantly non-adherent
cells in contrast to other previously described micro cell culture
reactors. The system was tested on the full protocol for FISH, i.e.
culturing lymphocytes, arresting them in the metaphase state of
the cell cycle and conducting FISH analysis, ﬁnally identifying the
centromere of the X-chromosome. We went on to show that a sim-
ple peptide based 3D nanostructured surface in the system could
be used to grow adherent cells (HeLa) and that it could also be
used for electrochemical studies. Although this idea is not novel,
the presented method creates such nanostructures in a very sim-
ple, cleanroom free – and therefore also cheap – way. The novelty
of using 3D nanoelectrodes in the culture chamber to potentially
investigate intercellular processes was introduced and the simple
fabrication of these nanostructures was presented as an alterna-
tive to expensive and serial nanofabrication techniques. Moreover,
new novel biocompatible materials for 3D nanoelectrodes were
discussed. An example of further analysis by using a microﬂuidic
system combinedwith dielectrophoresis to sort non-adherent cells
transfected with cancer markers from non-transfected cells was
presented and discussed. These preliminary results open up the
possibility of being able to identify early cancer signs and thus treat
patients at an early stage of the disease. Finally, a microﬂuidic plat-
form for the integration of the different modules into one single
device for rapid testingwas presented as an attempt to easily create
electrical and ﬂuidic connections to and interconnections between
multiple chips of different materials and functionality.
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Abstract. More and more diseases find their cause in malfunctioning genes. There is therefore 
still need for rapid, low-cost and direct methods to accurately perform genetic analysis. 
Currently the process takes a long time to complete and is very expensive. We are proposing a 
system that will be able to isolate white blood cells from blood, lyse them in order to extract 
the chromosomes and then perform chromosome sorting on chip. As the physical properties of 
the chromosomes, such as size and dielectric properties, are needed for designing the chip, we 
have measured them using an AFM microscope. 
1.  Introduction 
The identification and function of the genes in the human genome is an area where lot of research is 
being carried out. Of particular interest are malfunctioning genes that more and more seem to be the 
causes of various serious diseases, whose origin was previously unknown. Genes are particular DNA 
strands that can be transcribed and subsequently translated into proteins. In a malfunctioning gene, 
some of the DNA bases are deleted, added or exchanged with other ones. This can happen during cell 
division, when the chromosomes in the nucleus are copied and condense into compact structures that 
then separate into two different cells. During this process whole parts of a certain chromosome can be 
cut off and attached to a different chromosome. This particular mutation is called a translocation and is 
responsible for the well-known Down’s syndrome. 
For translocated chromosomes it is important to find the exact location of the breakpoint. A number 
of steps have to be carried out before this can occur. First, the white blood cells (WBCs) have to be 
isolated from a patient’s blood and cultured, so that enough material can be available for further 
processing. This is currently done by blood centrifugation and incubation for a few days. Then the 
division of the WBCs has to be stopped in the so-called metaphase, a point in the cell-cycle when the 
chromosomes are condensed but before they separate into two cells. Then the cells are lysed and a 
drop of material is placed on a microscope slide along with a fixative chemical in order for the 
chromosomes to stick on the substrate. A karyotype is made of the chromosomes and a trained lab 
technician can then identify translocated chromosomes from the banding patterns that are formed. 
When a pair of translocated chromosomes is found, the samples are sent to a dedicated laboratory 
where chromosome sorting by flow cytometry [1] is carried out. This process relies on fluorescence 
signals and can sort two chromosomes at a time. When the sorted chromosomes are returned to the 
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lab, lab technicians use FISH (Fluorescence In Situ Hybridization) and sequencing in order to find the 
exact breakpoint. 
This entire process usually takes more than a few months to complete, involves at least two 
different locations and highly trained personnel and is rather expensive. Therefore any system that can 
reduce the cost and time for each analysis will be of great interest both for genetic scientists and for 
medical doctors. In this paper we will describe such a system, which will be able to complete 
chromosome isolation and sorting in a small chip within a few minutes. We take advantage of the 
physical properties of cells and chromosomes for the purpose, therefore an investigation of these will 
also be presented.  
2.  Materials and methods 
In order to study the physical properties of the chromosomes such as size and dielectric constant, an 
Atomic Force Microscope (CP-II SPM system from Veeco) working in tapping mode was used. For 
the dielectric constant measurements a conducting cantilever with a platinum coating from 
Budgetsensors (model BS-ElectriMulti75) [2] was used. The principle of the measurement method has 
been described in [3-5]. The chromosome suspension was prepared from human lymphocytes by the 
method described in [6]. This ensures a stable stock of chromosomes in hexylene glycol buffer from 
which the chromosomes can be resuspended in fixative (methanol and acetic acid, 3:1) and deposited 
on a substrate. Further treatment with pepsin ensured that a minimum of cell debris was present on the 
surface of the chromosomes. 
For the isolation of WBCs from blood a method called pinched flow fractionation, first described in 
[7] has been used. In short the method takes advantage of the fact that small particles exiting a small 
channel into a large chamber will follow the streamlines passing through their center of mass. 
Separation can be achieved by making sure that particles of different sizes follow different streamlines 
that end up in different outlets. A device for the sorting of WBCs of a particular dimension 
corresponding to human lymphocytes from other WBCs and from smaller blood constituents such as 
platelets and red blood cells (RBCs) has been designed, simulated (using Comsol Multiphysics [8]) 
and fabricated. The fabrication process is very simple: A mould of the channel is made in SU8 2075 
obtained from Microchem [9] and PDMS (polydimethylsiloxane) obtained from Dow Corning [10] is 
poured on the mould and cured at 65 oC for 3 hours. The PDMS cast is then removed from the SU8 
mould and bonded to a pyrex wafer using a plasma asher treatment with an oxygen flow of 100 
ml/min for 30 s with a power of 100 W. Inlet and outlet holes are then made on the PDMS part of the 
bonded chip.  
After the WBCs are isolated they need to be trapped and lysed in order to extract the chromosomes. 
A structure inspired from [11] has been designed and fabricated for the purpose. Design considerations 
and results from our simulations will be presented in section 3. 
3.  Results 
The first step towards a total analysis system for chromosomes (C-TAS) is to make sure that the 
biological matter does not stick to the surfaces of the microfluidic channels. For this purpose all 
surfaces have been covered with one or more layers of PEG (Polyethylene glycol) molecules. This 
makes the surfaces more hydrophobic, as can be seen in figure 1, where the increased hydrophobicity 
is visualised by a droplet of water on a pure pyrex and on a PEG surface. 
 
Figure 1. On a pure pyrex surface the water droplet perfectly wets the surface. When the surface is 
functionalised with PEG it becomes more hydrophobic. 
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The second obstacle towards C-TAS is the isolation of the WBCs. For this purpose the structure 
shown in figure 2 was designed, simulated and fabricated in PDMS. The system consists of two inlet 
channels, one for the blood sample containing the cells and one for a pure buffer solution, a pinched 
segment, where the particle solution and the buffer come into contact and the particles can be pressed 
towards the upper wall, and a separation chamber with several outlet channels. Through Comsol 
simulations on this structure and considering that we would like to separate WBCs (average diameter 
of 10 μm) from RBCs (average minimum dimension of 3 μm) it can be shown that for given 
dimensions of the pinched segment the most critical parameters for the separation are the inlet flow 
rate ratio as well as the relative hydraulic resistance of the channels. It was calculated that a flow rate 
ratio of 0.1 between the particle carrying flow (channel a) and the buffer carrying flow (channel b) is 
necessary for a 40 μm wide pinched segment, as well as a hydraulic resistance which is 7 times larger 
for the first outlet (top left outlet E) than for the remaining five outlets. 
 
Figure 2. The chip design for the isolation of WBCs. A is the inlet for the blood, B is the inlet for the 
buffer, E are the long outlets (the hydraulic resistance from the separation chamber c to E is 7 times 
larger than the hydraulic resistance from c to the short outlets D) and d are the outlet channels. For the 
separation, outlet E is used for the first channel and outlets D are used for the remaining channels. 
 
After the WBCs have been collected in the second from the top outlet D (s. figure 2) they need to 
be isolated and lysed. The isolation is necessary due to the inevitable changes in chromosome sizes 
between cells occurring when stopping the cell cycle at different points in time in the metaphase. 
Figure 3a shows the structure designed and simulated for the purpose. The cells entrance and exit is 
indicated by the two arrows. There are two different structures, a meander and a cell trap. At each 
intersection the cell has to choose whether to move into the trap or continue through the meander. The 
structure is designed in a way so that the cell will always choose to move through the trap and as it is 
bigger than the trap it will stop there and block access for the remaining cells. The next incoming cell 
will therefore pass through the first meander structure and go down the second trap instead and so on. 
It can be shown that the system will function best when more than 4 traps are included in the structure. 
Once the cells are captured, a voltage applied through electrodes placed on each side of the trap will 
provoke lysis, releasing the chromosomes from the cell. 
The chromosomes will then be taken to the sorting part of the chip. Electrical forces 
(electrophoresis and/or dielectrophoresis) will be used for sorting the chromosomes. In order to find 
the optimal parameters an estimate of the chromosome dielectric constant, conductivity and 
dimensions is needed. The chromosomes were therefore imaged by AFM and the permittivity 
measurements were performed on several different chromosomes with cantilevers working at four 
different vibration frequencies. The results are shown in figure 3b and indicate that the permittivity is 
a constant independent on the chromosome height and the frequency of vibration, at least in the kHz 
range. The length of the chromosomes was in the range of 1 to 10 μm. 
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Figure 3. (a) The cell trapping structure. The cells enter and exit from the points indicated by arrows. 
Details of the meander and traps are also shown.  (b) The measured dielectric constant of different 
chromosomes as a function of chromosome height for different vibration frequencies. 
4.  Discussion and Conclusion 
We have shown experimental and theoretical results relating to the fabrication of a total analysis 
system for chromosome translocations. By surface functionalisation with PEG, sticking of the 
biological matter on the channels is avoided. The sorting of the WBCs from blood can be achieved 
without centrifugation by a method called pinched flow fractionation. We have shown that effective 
separation is possible for a 40 μm wide pinched segment when the flow rate ratio is adjusted between 
the two inlets. A system where each outlet channel has two possible outlets has been designed and this 
makes it possible to tune the separation radius further. 
After separation the cells are trapped in a special structure where they are lysed by help of electric 
fields generated by electrodes placed on each side of the traps. The extracted chromosomes are then 
led to the sorting chip. As electrical forces are going to be used for the sorting, it is necessary to 
measure the chromosomes dielectric constant and conductivity as well as their dimensions in order to 
be able to predict the correct parameters for the separation. The dielectric constant was measured for 
chromosomes of different heights and with cantilevers vibrating at different frequencies. It was shown 
that the dielectric constant is independent of the chromosome height as well as the frequency of the 
cantilever vibration (which corresponds to the frequency of the electric field for a dielectrophoresis 
experiment) in the range of ca. 60 – 300 kHz.  
Future work will involve the experimental confirmation of our theoretical results as well as 
measurements of the conductivity and charge of the chromosomes. 
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INTRODUCTION
In recent years, the interest in 
micro total analysis systems (μ-TAS) 
for the sorting and characterization 
of biological samples has increased. 
Considerable efforts have been put 
into realizing such a device, and 
several simple systems have already 
been produced (1). The devices of the 
current generation of μ-TAS rely on 
everything from cleverly designed 
microfluidic flow to light or electrical 
fields for manipulation and detection 
of the samples (2). Systems that 
currently use electrical readout are not 
optimal because the physical properties 
(e.g., size, permittivity, conductivity) 
of biological samples are mostly 
unknown. In order to optimize these 
devices, the physical properties need to 
be measured. This limited knowledge 
may be due to the biological samples’ 
rather complex structure compared 
with fabricated solid state samples 
(nanowires/nanotubes, etc.). In this 
context, chromosomes are interesting 
in that they contain a very complex 
architecture of DNA and proteins, and 
chromosomal abnormalities may result 
in diseases such as Turner Syndrome 
and leukemia among others (3,4). 
The physical properties of biological 
samples are important because they 
may be used in the design of micro 
systems that depend on electrotaxis 
and subsequent analysis of biological 
samples. One method for the study 
of physical properties is scanning 
probe microscopy (SPM), which 
has proven to be a flexible method 
for studying different sample types, 
both biological as well as solid state. 
Several SPM methods have already 
been used on chromosomes. Atomic 
force microscopy (AFM) (topography) 
imaging of stained G band patterns of 
the chromosomes was used to inves-
tigate the possibility of obtaining 
better resolution of the bands (5). 
Other reports of SPM applications 
on chromosomes include near-
field scanning optical microscopy 
measurements of the bands (6) and 
elasticity investigation of chromosome 
structure (7). One SPM method, 
scanning conductance microscopy 
(SCM), has in recent years been used 
to map out different properties of 
nano-sized particles, for example, 
the dielectric constant of nanopar-
ticles of poly(ethylene oxide) (8), the 
conductance of carbon nanotubes and 
DNA (9), and trapped charges on a 
surface by carbon nanotubes (10). This 
makes SCM an interesting method for 
studying the electrical properties of 
small samples. As we have not been 
able to locate any reports of SCM used 
on chromosomes, we believe that this is 
the first time this method has been used 
on chromosomes.
MATERIALS AND METHODS  
Principle of the Measurements
The principle and various applica-
tions of the SCM method have been 
well documented by M. Bockrath et al. 
(9), C. Staii et al. (8), and T.S. Jespersen 
et al. (10). The basic principle is that 
the tip of the AFM cantilever acts as a 
capacitor plate while a heavily doped 
Si layer with an insulating SiO2 layer 
on top acts as the other plate. The 
change in phase as the tip scans the 
samples deposited on top of the SiO2 is 
recorded. The data are used to estimate 
the dielectric constant of the sample. 
A sketch of the principle is shown in 
Figure 1.
The procedure of the SCM method 
used in this article is as follows: first a 
sample is dispersed on a SiO2 surface 
with a backgate, as shown in Figure 1. 
The SPM system performs a line scan 
along the surface of the sample in the 
dynamic mode using a conducting 
AFM tip. The tip is then raised several 
tens of nanometers and a new line scan 
is made following the topography trace 
of the previous scan. During the second 
scan a potential is applied between the 
tip and the doped layer. Because of the 
potential the phase in the second scan 
is different from the phase in the first. 
The only external force change on 
the AFM tip is the change in electric 
force. The phase difference depends 
on the cantilever parameters as well 
as the dielectric properties of the 
scanned objects, as was shown by C. 
Staii et al. (8). It is further assumed 
that the tip of the AFM cantilever is a 
flat disk according to studies done by 
T.S. Jespersen et al. (10). The phase 
shift between the bare SiO2 surface and 
sample is mapped out and, according to 
C. Staii et al. (8) and T.S. Jespersen et 
al., (10) is governed by
, 
(Eq. 1)
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Scanning conductance microscopy investigations were carried out in air on human chromo-
somes fixed on pre-fabricated SiO2 surfaces with a backgate. The point of the investigation 
was to estimate the dielectric constant of fixed human chromosomes in order to use it for 
microfluidic device optimization. The phase shift caused by the electrostatic forces, together 
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chromosomes were used to estimate a value for the dielectric constant of different human 
chromosomes.
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where Δf is the difference in the 
measured phase of the bare substrate 
and the fixed chromosomes, C1 is 
the capacitance between the tip and 
backgate without a sample lying on the 
SiO2, C2 is the capacitance between the 
tip and backgate with a sample lying 
on the SiO2, z is the distance between 
the tip and sample (lift-height), V is the 
potential difference between the tip and 
conducting layer, Q is the quality factor 
of the AFM cantilever, and k its spring 
constant. The second derivatives of the 
capacitances are given as
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where rtip is the radius of the tip, ε0 the 
vacuum permittivity, d the thickness 
of the oxide layer, h the height of the 
particle, εSiO2 the permittivity of the 
oxide layer, and εp the permittivity of 
the particle. The value of the quality 
factor of the cantilever is estimated 
by a measurement of the resonance 
frequency. The tip radius is estimated 
by the scanning electron microscopy 
images, and the spring constant is 
estimated by measuring the deflection 
of the AFM cantilever caused by 
another cantilever with a well-defined 
spring constant.
The lift-height z is estimated to 
be around a few tens of nanometers 
according to theoretical studies for 
optimal signal carried out by J. Colchero 
et al. (11). Further, J. Colchero et al. 
(11) showed that the phase shift due to 
beam and cone of the AFM cantilever is 
almost constant compared to the contri-
bution from the tip.
Experimental Methods
Substrates were fabricated by the 
use of four-inch heavily p-doped silicon 
wafers. A 100 nm thick silicon oxide 
layer was grown on the substrates, the 
oxide on the back was removed by 
hydrofluoric acid (HF), and a 20 nm 
layer of titanium was evaporated on the 
backside followed by a 1000 nm layer 
of gold.
The suspension of chromosomes 
was prepared from human T-lympho-
cytes (Model no. ACC282; DSMZ, 
Braunschweig, Germany) by a variant 
of the method developed by Wray 
et al. (12). Briefly, the cells were 
grown in RPMI-1640 media (Model 
no. 61870010; Invitrogen, Taastrup, 
Denmark) supplemented with 10% 
fetal bovine serum (Model no. F9665; 
Sigma, Brondby, Denmark) at 37°C 
and a 5% CO2 atmosphere. The cells 
were arrested in log-phase with 0.06 
μg/mL colcemide (Model no. D1925; 
Sigma) for 10 h and collected at 200× 
g for 10 min. After removing the media 
the cells were washed once with serum- 
free media and collected at 200× g for 
10 min. The media was removed and 
the pellet was exposed to 75 mM KCl 
(Model no. P9327; Sigma)  at 37°C, 
gently vortexed to resuspend the cells, 
and incubated at 37°C for 20 min. The 
cells were collected at 200× g for 10 
min and washed once with hexylene 
glycol buffer (1.0 M hexylene glycol 
[Model no. 112100; Sigma],  0.5 mM 
CaCl2 [Model no. 21115; Sigma], and 
0.1 mM PIPES buffer at pH 6.7 [Model 
no. 80637; Sigma])  at 37°C before 
resuspending the cells in fresh hexylene 
glycol buffer. The final chromosome 
stock solution was obtained by 
forcing the suspension through a 23 
G needle and purified by collecting 
unlysed cells at 200× g for 10 min. To 
deposit chromosomes on a substrate, 
the chromosomes were collected at 
7500× g for 20 min and resuspended in 
fixative (3 volumes methanol [Model 
no. 179337; Sigma] + 1 volume acetic 
acid [Model no. 320099; Sigma]). The 
chromosomes were finally deposited on 
the substrate by droplets and allowed to 
dry out at room temperature. The final 
resuspension in methanol/acetic acid 
was necessary in order to get sufficient 
and even spreading of the chromo-
somes. Using droplets of the hexylene 
glycol buffer resulted in a “pile” of 
chromosomes with salt residues on 
top because of the slow evaporation of 
hexylene glycol.
The scanning probe microscopy 
system used was a CP-II SPM system 
from Veeco (Breda, The Netherlands). 
AFM cantilevers were obtained from 
Budgetsensors (either model BS-
ElectriMulti75 or BS-ElectriTap300; 
Nanoandmore, Wetzlar, Germany) (13), 
which both have a platinum coating. 
Analysis of the obtained data from the 
SPM system was carried out using the 
“SPIP” software (Image Metrology, 
Horsholm, Denmark) (14).
RESULTS AND DISCUSSION
The SPM images were obtained 
with a resolution of 512 × 512 pixels, 
with a scan rate of 0.6 Hz, a potential 
difference of 2 V, and lift-height of 
30 nm. The topography images were 
obtained by non-contact scans.
Topography and lift-mode phase 
images of different chromosomes 
with different cantilevers were 
obtained under ambient condi-
tions. The phase shift and the corre-
sponding chromosome height for each 
chromosome were obtained by taking 
the average across the middle of two 
of the arms of the chromosome (10 
Figure 1. The principle of the SCM method. 
First a topography line scan is made, then the 
tip is lifted and another line scan is made with a 
potential difference between the AFM tip and the 
backgate.
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pixel to each side of the line profile [the 
gray line] in Figure 2, A and B). Using 
Equations 1, 2, and 3 the dielectric 
constant was estimated for each of 
the chromosomes. The chromosomes 
were investigated with different canti-
levers with relative uniform resonance 
frequencies (±15 kHz). Five of the 
chromosomes were mapped out twice 
with a cantilever with a relative higher 
(around three times higher or 265.1 
kHz) resonance frequency. This was 
done to check if the dielectric constant 
changed due to the frequency of the 
cantilever.
Figure 3 shows the different 
dielectric constant obtained for different 
chromosomes with respect to their 
height. The error bars are calculated 
on the background of measurement 
uncertainties of the spring constant, the 
quality factor, the tip radius, and the 
oxide thickness. These have been calcu-
lated to be ±5% to ±8%. Uncertainty 
values found for the lift-height and the 
sample height were ±1%, and for the 
potential difference an uncertainty of 
±5% was chosen.
As Figure 3 shows, the value for the 
dielectric constant is 10 (±4). Moreover 
the dielectric constant does not seem 
to vary with the chromosomes’ height 
or the cantilever. Neither does the 
dielectric constant seem to vary with 
cantilever frequency. The flat curve 
of the dielectric constant for different 
chromosome height indicates that 
no artifacts influence the measure-
ments. The spread in the values of the 
dielectric constant can be contributed 
to different effects. First of all, a 
chromosome is not a uniform material, 
rather it is composed of a complex 
mixture of proteins and DNA, and 
the dielectric constant may depend on 
the DNA-protein ratio at the point of 
measurement. This could give rise to 
the variation in the dielectric constant. 
Another thing that will influence the 
result is that the tip is not exactly flat 
but rather a bit curved. But according 
to researchers C. Staii et al. (8) and 
T.S. Jespersen et al. (10), who have 
reported good agreement between 
this assumption (flat tip) and experi-
mental observations when investigating 
nanoparticles, this does not seem to be 
the obvious case. Finally, the sample 
preparation may also affect the chromo-
somal integrity, which could influence 
the measured dielectric constant. For 
example, the chromosomes’ suspension 
will contain other biological material; 
the layer is not uniform and the layer 
thickness of the material is small 
(around 5 nm) compared with the 
chromosomes, making it hard to make 
a good prediction of the impact on the 
measured data.
Conclusion
We have used SCM to investigate 
electrical properties of chromosomes 
fixed on a surface. We have estimated 
a value of the dielectric constant of 
the fixed chromosomes to be around 
10. This was done by estimating the 
properties of the AFM cantilever 
(quality factor, spring constant, and tip 
radius) and from the measured phase 
shift. We also used the assumption 
that the tip and surface act as a parallel 
plate capacitor. By these assump-
tions we have estimated a value of 
the dielectric constant of the fixed 
chromosomes, which was found to be 
around 10. Future studies will compare 
the influence of different preparation 
methods on the dielectric constant 
and include tests of this method in 
liquid. This work was guided by our 
interest in automated microsystems for 
chromosome analysis, which has led 
us to estimate the dielectric constant of 
chromosomes for later electric manipu-
lation. It is believed that this method in 
the future can be used to characterize 
different biological samples and that 
the result will be used in design of 
future devices for biological sample 
detection.
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Figure 2. Topography and lift-mode phase images of different chromosomes. (A) topography image 
of chromosomes dispersed on a SiO2 surface with backgate; (B) phase shift image in lift-mode of the 
same chromosomes as in (A). The gray lines mark the line profiles across the chromosomes.
Figure 3. Measured dielectric constant of 
different chromosomes as a function of the 
height of the chromosome in question.
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ERRATA 
 
ERRATA 
Figure 3.13 in the chapter doesn’t contain scale bars and pointers to cells and pores. Since the 
figure in the chapter has already been published, we include this figure in the appendix to show 
the difference between cells and pores. We have also added scale bars to highlight the size of the 
cells. On day 3, typically the cells start clumping and they overlap as a result making them difficult 
to count via image analysis techniques. As a result, CFSE staining technique was used to quantify 
their growth and assess the proliferation quality. The cytoplasm of the cell highlight in the inset 
has expanded and can be clearly seen that the cell has reached the size of 18 µm. This is visual 
confirmation that the cell is undergoing cell cycle and proliferating.  
 
Figure 3.13: FISHprep culture (a) Day 0 (b) Day 3. (Red arrows point to cells, Black arrows indicate pores and all the 
scale bars are 10 µm). As can be seen in the inset picture, the diameter of the cell has expanded to 16 µm, which happens 
when the cytoplasm expands during mitosis and cells also tend to grow in clumps as in (b).  
